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Endoscopy is a fast moving field, and new techniques are continuously emerging. In recent
decades, endoscopy has evolved and branched out from a diagnostic modality to enhanced
video and computer assisting imaging with impressive interventional capabilities. The mod‐
ern endoscopy has seen advances not only in types of endoscopes available, but also in
types of interventions amenable to the endoscopic approach. To date, there are a lot more
developments that are being trialed. In fact, there are multiple researchers and physicians
attempting to innovate the field of endoscopy.
Minimal invasive procedure aims to minimize trauma of the interventional process but still
achieves a satisfactory therapeutic result. It is commonly performed because of several ad‐
vantages such as reduced post-procedural pain, faster recovery and more rapid return to
normal activities, shorter hospital stay, and reduced post-procedural complications. Modern
endoscopic equipment provides physicians with the benefit of many technical advances. En‐
doscopy is an effective and safe procedure even in special populations including pediatric
patients and renal transplant patients. It serves as the tool for diagnosis and therapeutic in‐
terventions of many organs including gastrointestinal tract, head and neck, urinary tract and
others. In this book, the authors will discuss some of the emerging techniques, innovations
and technologies used to increase the diagnostic and therapeutic yield in various organs.
The contributions in this book are very valuable. InTech Open Access Publisher selected
several known names from many countries with different levels of development. Multiple
specific points of view were presented together with several topics regarding diagnostic or
therapeutic endoscopy. The readers can take into consideration the practical knowledge in
the endoscopic field. This book actually represents a valuable tool for formation and contin‐
uous medical education in the endoscopy considering the performances or technical possi‐
bilities in different parts of the world.
I very much appreciate and thank all the authors of this book. Many thanks to InTech Open
Access Publisher which offered me the possibility of editing this attractive book. It was a
real pleasure to read such interesting works by so many experts from all over the world.
Finally, I also thank Ms. Iva Lipović for her perfect, prompt and efficient co-operation.
Assoc. Prof. Somchai Amornyotin MD, FRCAT
Department of Anesthesiology and Siriraj GI Endoscopy Center
Faculty of Medicine Siriraj Hospital






Guidelines for Reprocessing Non-Lumened,
Heat-Sensitive ENT Endoscopes
Matteo Cavaliere and Maurizio Iemma
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/61219
Abstract
Endoscopes have become an indispensable instrument in the ENT department, but
their use has introduced potential health risks such as the infection transmission.
Numerous  guidelines  have  been  issued  for  both  digestive  and  respiratory
endoscopes, while to date specific references to ENT endoscopes do not exist. The
diagnostic  ENT  endoscope  does  not  generally  have  an  operative  channel,  it  is
shorter,  thinner  and  has  a  much  more  frequent  usage.  As  a  consequence  the
guidelines  for  digestive or  respiratory endoscopes are  not  always functional  for
the ENT department.
This paper proposes:1. to standardize the correct way to carry out the disinfection
procedure of heat-sensitive non-lumened ENT endoscopes, 2. to guarantee the
disinfection within a limited time frame, appropriate for an ENT out-patients
department.
In the initial phase the critical areas encountered in ENT endoscopy were determined.
This was followed by a research of the literature in order to identify existing guidelines
for the reprocessing of endoscopes with a view to establishing a common disinfection
procedure of non-lumened ENT endoscopes. Finally, the new methods of disinfection,
developed specifically for the reprocessing of ENT endoscopes were examined and
discussed.
Keywords: Heat-sensitive ENT endoscopes, Cleaning, Disinfection
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
1. Introduction
The introduction of the endoscopes into clinical practice has certainly improved the diagnosis
and treatment of numerous pathologies, but has also brought the risk of transmission of
infections.
In the Literature, [1] the incidence of infection appears to be 1 per every 1,800,000 endoscopic
procedures performed (0.000056%).
Considering the high number of endoscopic procedures performed daily worldwide, the
endoscopy-related infections are those most often associated with the medical device.
In nearly all of the infections transmitted, the problem is a defect in the cleaning and disinfec‐
tion procedures, [2, 3, 4] in particular during
• the pre-washing step (12%),
• the washing/disinfection step (73%),
• drying and storage (12%).
Flexible endoscopes are heat-sensitive and therefore cannot be sterilised in an autoclave, but must be
disinfected. [5]
In otorhinolaryngology, unlike digestive and respiratory endoscopy, to date, no specific
guidelines yet exist. ENT diagnostic endoscopes do not have the operating channel, their size
is smaller and their use is more frequent, including in outpatient situations.
Then, the guidelines used in digestive and respiratory endoscopy are not always functional in
the ENT department, since they do not consider the dynamism and intensity of the work
carried out there.
2. Objectives
This document proposes to
1. standardise the correct method of disinfection procedures for heat-sensitive, non-
channelled ENT endoscopes,
2. reduce the risk of transmitting infections,
3. increase operator safety,
4. guarantee disinfection in fast times.
3. Methods
In the initial phase, we identified the main critical procedures within ENT endoscopy depart‐
ments. Next, we researched the literature to find all the guidelines on reprocessing endoscopes.
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Lastly, we discussed the new disinfection methods designed specifically for the reprocessing
of ENT endoscopes.
In order to form a basis for the guidelines for the reprocessing of flexible ENT endoscopes, the
working group decided to conduct a survey among the Italian ENT departments with the
objective to gather information regarding the methodologies actually employed for the
disinfection of heat-sensitive, non-lumened endoscopes. Two hundred and seventy two
questionnaires were sent out to the ENT departments. The questionnaire was divided into six
sections: the first dealt with general information, sections 2 to 5 considered the four principle
reprocessing methods of flexible ENT endoscopes (automated, manual immersion, wipes and
sheaths). The last section considered the storage of the endoscopes.
The information requested referred to the way the endoscope was reprocessed by each
participant and an evaluation of the method in relation to the needs of the department.
4. Survey findings
The following general considerations emerged from the study:
• The average number of endoscopic visits per day was around 10 and the majority of the
doctors referred to difficulties in performing more examinations due to the limited number
of instruments and the time necessary for reprocessing.
• Reference to guidelines is made in just above 30% of cases, they are not always the same
and generally refer to gastroendoscopes/bronchoscopes (Figure 1).
Figure 1. Dear Authors, Please add caption
• Manual immersion is the principle method (about 70% of cases) for the disinfection of ENT
endoscopes (Figure 2), followed by the sheath, which in 50% of cases is used in conjunction
with other methods. The automated endoscope reprocessor (AER) is present in about 20%
of the departments, but in over 60% of cases is used in conjunction with other systems,
evidence maybe of the difficulties of habitual usage.
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Figure 2. Dear Authors, Please add caption
a. Immersion
• Immersion is the most utilized method, both as a sole method and as a method used in
conjunction with others. A basin or tray is mostly utilized for the immersion of the instru‐
ment.
• The leak test is performed in about 80% of cases.
• The enzymatic detergent is mostly used in the pre-cleaning step (about 50% of cases), while
simple soap and water in about 20%. The time taken for pre-cleaning is normally less than
5 minutes, but can exceed 15.
• At least in 42% of cases the same detergent is re-used. It must be remembered that the
detergent does not have any biocidal activity and so it is plausible that microbes can survive
in the solution. As a consequence, a new solution should be used on each occasion.
• A wide variety of disinfectants are used for the disinfection step, mainly peracetic acid
based, but also glutaraldehyde and orthophthalaldehyde are used (Figure 3).
Figure 3. Dear Authors, Please add caption
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• From an analysis of the disinfectants used, it was noted that not all the products have been
tested according to current European norms (EN 14885) and that different contact times
have been indicated for the same product. It is therefore important to underline that even if the
disinfectants have the same molecular base, the formulations may be different and consequently the
way in which they are used can be different.
• The majority of disinfectants are multi-use which makes it difficult to implement a tracea‐
bility system.
• For 75% of cases, the rinse step is performed by using tap water and is completed in less
than 5 minutes.
• The use of a traceability system is practically impossible with a re-usable disinfectant, but 95% of the
respondents would appreciate a registration system.
• In the evaluation of the method employed, the respondents highlighted the problems of tracea‐
bility and personal protective equipment.
• The sheath is used in more than 30% of cases after disinfection, mainly for patients with a
perceived risk of infection.
• Microbiological controls of the instrument are performed in less than 20% of cases.
b. Sheaths
• About 30% of ENT departments use exclusively the sheath. It is mainly used in conjunction
with other reprocessing methods, primarily for cases where the instrument must be used on patients
with a recognized risk of infection.
• Respondents expressed a critical evaluation regarding:
1. the less than optimal adherence of the sheath,
2. possible damage to the instrument, particularly during removal (50% of respondents),
3. possible tearing of the sheath (17% of cases),
4. reduced image quality (70% of respondents),
5. patient discomfort, particularly children.
• The main reason for using the sheath is for better instrument turnaround (Figure 4), which
can mean less expenditure for instruments. Avoiding cross-contamination and chemical
products and practical usage are other important motivations.
• The overall evaluation is positive, but some perplexity remains, particularly regarding tracea‐
bility and the cost/benefit relationship (from the sample the average cost of the sheath is around
€10, but it can cost up to €25).
• The literature regarding the use of the sheath is limited, but where it exists, it is clearly
indicated that the instrument needs to be cleaned and disinfected with ethanol after the
sheath is removed in order to be equivalent with high-level disinfection. From the replies
this occurs in only 2% of cases.
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• Microbiological controls are performed in 17% of cases and leak tests in 82%.
c. Automated endoscope reprocessors (AERs)
• In most cases, they are used in conjunction with sheaths (more than 50% of cases).
• In more than 33% of cases, the AER is not located in the department but in a central
sterilization centre, affecting instrument rotation times.
• Cycle times vary between 20 and 30 minutes, which when added to the time for transporting
endoscopes (when the endoscope is reprocessed outside the department) means that the
rotation time is about 1 hour in 70% of cases.
• Pre-cleaning is mainly performed with an enzymatic detergent (75% of cases), but soap and
water or only water are also used.
• The automatic reprocessors use mainly chemical disinfectants, notably single-use peracetic
acid.
• The AERs can contain up to four instruments per cycle and in 75% of cases, both flexible
and rigid scopes at the same time.
• Rinsing is normally performed while the instrument is automatically dried in only 50% of
cases.
• The majority of AERs provide a confirmation print out for validation purposes, but the print
outs are not always filed in a special record book.
• Microbiological controls are performed in 50% of cases, normally on a monthly basis and
leak tests are nearly always performed.
d. Wipes
• They are used by less than 10% of respondents probably due to their recent introduction.
• The leak test is performed less often compared to other systems (60% of cases).
Figure 4. Dear Authors, Please add caption
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• The overall evaluation is favourable, both regarding the practicality and the traceability.
• For patients with a known risk of infection, normally the sheath is also used.
e. Storage
There  are  diversified  methods  of  storing  the  instrument  between one  visit  and another
(Figure 5).
Figure 5. Dear Authors, Please add caption
It is worth noting that about 10% of respondents store the instrument in its case, which actually
represents one of the main sources of contamination.
From the answers, it can be seen that over 50% of respondents believe the instrument can be
contaminated during storage, but, despite this risk, the disinfection cycle is performed in only
33% of cases on instruments being taken out of storage.
5. Principle problems related to endoscope reprocessing
Schematically, the problems most frequently encountered with endoscope reprocessing are
associated with [6]:
• environment,
• organization of endoscopic activity,
• personnel.
Problems associated with the environment:
1. the room or the disinfection area is not equipped with an extractor hood despite the use
of certain disinfectants where it is specified,
2. the presence of a sharp smell due to the disinfectant solution,
Guidelines for Reprocessing Non-Lumened, Heat-Sensitive ENT Endoscopes
http://dx.doi.org/10.5772/61219
9
3. insufficient space in relation to the volume of activity,
4. no distinct separation between dirty and clean work surfaces,
5. environmental cleaning can be of poor quality.
Problems associated with the organization of endoscopic activity:
1. excessive volumes of activity in relation to staff allocation and equipments available.
2. unplanned endoscopic examinations affect the organization of the programmed work.
Problems associated to personnel:
1. Insufficient number of nurses,
2. the personnel are not aware of the reprocessing procedures or, when they are available,
they are not known or shared,
3. respect of safety precautions by the operators is not optimal,
4. specific training of the personnel involved is not always performed.
6. Principles of hygiene in the endoscopic procedures [7, 8]
Abiding to the basic principles of hygiene represents the foundation for the control of risks of
infection associated with endoscopic procedures.
These basic principles must be applied to
• equipment and medical devices,
• environmental surfaces,
• health operator behaviour.
The equipment and medical devicesare the principle vehicles for cross-infections in that they are
continually contaminated by microbes originating from assistance to patients.
They must be carefully cleaned and subjected to a process of high-level disinfection (or
sterilization in the case of devices which can be placed in the autoclave) according to the
indications of the manufacturer.
The environmental surfacesare likewise a vehicle for cross-infections in that they are continu‐
ously contaminated not only by environmental microbes but also by those originating from
assistance to patients. The objective of the cleaning and disinfection of the surfaces is to ensure
a low-level bacterial count and interrupt the risk of transmission of pathogens. Sanitization
should be performed with water and detergent.
Disinfection should be performed preferably with chlorine-based disinfectants to ensure the
destruction of the more resistant microbes.
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The area where the disinfection of the endoscope takes place should be distinct from where
the endoscopic examination is performed. A separate and specific room is “highly preferable”;
but in the reality of the ENT department, unlike others such as gastroenterology, it is possible
that the reprocessing of the endoscope is carried out in the same room as the patient’s
examination. It is necessary therefore to highlight the need to ensure a clear division between
contaminated areas (where the used instruments are placed) and clean areas (from where the reprocessed
instruments are picked up) so that the used instruments are completely separate from the
reprocessed ones, avoiding risks of cross-contamination.
The wash basins should be of adequate dimension to allow the complete immersion of the
instruments, without causing damage, preferably in steel (ceramic basins can be the cause of
damage due to knocks to the terminal part of the instrument).
The necessity or not to install an extractor hood should be evaluated in function of the room
and the equipment installed. It is absolutely necessary and essential if chemical products are
used in open containers. Automatic systems which incorporate a device for the handling of
vapours do not necessarily require the hood.
Where the room is not naturally ventilated, an air ventilation system needs to be installed (supply
and extraction) in order to reduce to a minimum the exposition of everybody to the potentially
harmful vapours (e.g. glutaraldehyde). In Italy, the limit of 10 air changes per hour is consid‐
ered acceptable.
Operator behaviouris critical for the prevention of cross-infections. Fundamentally, the principle that
all patients are potential carriers of infections should be considered.
Standard precautions
• should be applied by all health operators for all patients who receive assistance, irrespective
of the diagnosis or the presumed state of infection,
• have the objective protecting health personnel and patients,
• should be based on the following healthcare practices:
1. washing of hands and use of gloves,
2. use of face masks, eye protection, smocks.
Written procedures should be present in all working environments with clear indications of each stage
of the process.
Personnel must be taught to apply the “standard precautions” published periodically by the
C.D.C. (Control Diseases Center of Atlanta) for infection control and should know:
• the procedure for cleaning and disinfecting each device,
• the conduct to follow in case of an alarm or malfunctioning of equipment,
• the biological and chemical risks which can be incurred during the disinfection procedure
and how they should be encountered.
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The responsibility of the disinfection procedure for endoscopes is attributed both to the nursing
staff and to the doctor using the instrument. [5]:
• the nurse and healthcare operator are responsible for performing decontamination, pre-
cleaning and disinfection of the equipment,
• the head nurse of the operating unit is responsible for verifying that the procedure is carried
out correctly,
• the doctor using the instrument must visibly check that the instrument has been reprocessed
before performing the examination,
• the head consultant of the operating unit is responsible for overseeing organizational aspects.
Endoscopes are very delicate instruments and therefore should be handled only by trained
operators authorized to use and disinfect them.
The ENT operating unit together with the infection control unit should organize courses to
train how to use and disinfect the endoscopes correctly and should keep an up to date list of
all authorized personnel.
7. Risk of infection in endoscopy
The sources of infection are represented by infected or colonized patients [9] and by environ‐
ment [10], in particular, the water used to rinse the endoscopes. Where possible, rinsing in
sterile water is recommended. Differently, rinsing in high-quality drinking water is also
acceptable using a bacteria-retentive filtering system (0.2 µ).
An observational study [11] conducted at 26 hospitals in the United States revealed that the
endoscopes and bronchoscopes can be improperly disinfected due to inappropriate disinfec‐
tant solution, lack of control of the disinfectant’s concentration, failure to clean all the parts of
the endoscope and failure to measure manual disinfection times.
The degree of risk is classified as
• low when there is contact with healthy skin,
• intermediate when there is contact with the mucous membranes or superficially damaged
skin,
• high for penetration into tissue or sterile cavities or into the vascular system.
The degree of risk determines the reprocessing level of the instrument used: the risk of infection
of the ENT endoscopes (entering into contact with mucous membranes or damaged skin) is
intermediate and the high-level disinfection is then required. [12, 7, 8]
High-level disinfection presumes the inactivation of all the bacteria, mycobacteria, fungi and
viruses, but not necessarily of all bacterial spores. In ENT this is sufficient to have a guarantee
regarding the transmission of pathogenic microorganisms for both the doctor and the patient.
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7.1. High-level disinfection of endoscopes: traditional and emerging methods [13– 14]
We have categorized disinfection systems into two types:
1. Traditional:
• Immersion: the operator manually performs all the steps of the disinfection,
• Automatic: the disinfection is handled automatically without manual intervention,
2. Emerging, methods designed specifically for the ENT department:
3. Complete reprocessing using wipes,
4. Immersion systems electronically controlled by a microprocessor: part of the process is handled
by the operator and part occurs automatically,
5. Sterile protective sheaths: constitute a protective barrier of the endoscope and not a system
of disinfection.
The steps to reprocess endoscopes common to all traditional disinfection systems are described
in Table 1. We must first emphasize the following points:
1. reprocess the endoscope immediately after use to prevent the formation of encrustations and
consequent damage to the instrument.
2. the entire endoscope must be cleaned and disinfected: to be avoided are the wall tubes fitted in
cui only the insertion tube of the instrument is placed, preventing contact between the
control head and the disinfectant.
After analysing the reference literature, the authors suggest the following recommendations
divided according to the type of disinfection system (Table 2).
In the following, we provide in detail the main considerations and evaluations for each system
presented.
8. Traditional systems
1. Manual disinfection system by immersion
The manual procedure is relatively inexpensive but has the following disadvantages:
• errors or forgetfulness,
• lack of traceability,
• risk of contact between operators and contaminated material,
• damage to the instruments,
• disinfection times of at least 20 minutes.
2. Automatic disinfection systems
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While until very recently only automatic systems for gastroscopies and bronchoscopies were
available, today several companies realized washer-endoscopes for non-channelled ENT
endoscopes.
The automatic systems can
• automatically cleanse, disinfect and dry,
• perform only the disinfection step.
These systems are composed of
• a tub for the disinfectant and one for the cleaning solution,
• a basin with a cover for the positioning of the endoscope. Washer-disinfector-endoscopes
normally can reprocess several endoscopes simultaneously,
• a panel for setting the washing cycle (in general, the time and the temperature of the washing
and disinfection sequences).
The disinfectant is transferred from the tub to the basin containing the endoscope and remains
here for the time indicated on the technical sheet. This is followed by rinsing and the endoscope
is ready for re-use.
In order to reduce the risk of contaminations, the washer-disinfector-endoscopes are usually
equipped with thermal auto-disinfection systems.
It is advisable to position washer-disinfector in well-ventilated areas separated from those in
which occurs the endoscopic examination.
When buying a washer-disinfector-endoscope, one should pay attention to the following
aspects:
• automatic loading of cleanser and disinfectant,
• capacity to reprocess more than one endoscope simultaneously,
• programmability,
• the possibility of performing a complete cycle of cleansing, disinfection and rinsing,
• cycle time,
• the type of disinfectants for which the system is certified and their cost per cycle,
• the possibility of performing auto-disinfection/auto-sterilization,
• the presence of visual and sound alarms,
• required space,
• registration of procedures performed, an aspect strongly advised today because of medical–
legal lawsuits. In general, the data that is recorded and/or printed are
◦ identification number of the instrument;
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◦ details of the operator;
◦ operating parameters relating to procedures;
• date and time of the procedure.
The automatic procedures therefore
• standardizes the process, reducing the possibility of errors,
• allows the immersion of the entire endoscope,
• makes it possible to “track” the procedures by printing a receipt after every disinfection
cycle,
• reduces the risk of contact between operators or environment and contaminated instru‐
ments,
• reduces the risk of damage to endoscopes.
The main disadvantages are
• the cost of equipment and maintenance expenses; some companies have product-specific washer-
disinfector-endoscopes for ENT, smaller and less expensive (Figure 6),
Figure 6. Dear Authors, Please add caption
• the possibility of recontamination of the endoscopes by the same washer-disinfector,
• time required for the disinfection process (in general at least 20 minutes).




9.1. Manual disinfection system with wipes
The disinfection system by means of wipes is a manual sporicidal disinfection treatment of
semi-critical, non-channelled and heat-sensitive endoscopes.
The active ingredient used is chlorine dioxide (ClO2), patented under the name “Tristel”.
The Tristel Wipe System consists of a wipe for the pre-disinfection cleaning step, a wipe for
the disinfection process and one for the post-disinfection rinsing step. The mechanical wiping
action increases the efficacy of the cleaning and disinfection. The wipes are single-use and thus
permit tracking of the procedures.
Treatment time is only 2–3 minutes allowing a notable reduction in disinfection times compared with
other disinfectants in immersion methods. The Tristel Wipe System was in fact designed for the rapid
turnaround of the ENT endoscope.
In addition, the wipes are non-toxic and non-irritating, thus allowing manual wiping technique not
possible with the other traditional high-level disinfectants.
This simple system, however, is manual and can lead to different results between the various operators:
accurate training is necessary to ensure that all operators are capable of optimal performance.
9.2. Immersion disinfection system electronically controlled by a micro-processor
This is a high-level disinfection system of the endoscopes by immersion controlled electroni‐
cally. The time necessary for disinfection is 5 minutes, but the overall treatment time depends on
the cleaning and rinsing method used, respectively, before and at the end of disinfection.
The system (Figure 7) consists of a base unit with a cover in which the instrument is placed,
after cleaning, and to which is added the high-level disinfectant, ClO2-based [15, 16].
Figure 7. Dear Authors, Please add caption
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At the end of the disinfection cycle, the disinfectant is automatically emptied out in the sink
and the instrument is rinsed manually.
At the end of the treatment, the base unit can be used as an aseptic container for short-term
storage and/or for transport of the endoscope. The base unit and the cover are made of
polycarbonate resin and can tolerate up to 30 autoclave cycles.
The micro-processor records every disinfection cycle and the recorded data can be downloaded
on to the PC and archived, making it possible to track the entire process.
Placing the instrument in the empty unit and removing it only when the disinfectant is emptied
out avoids any skin contact with the disinfectant.
Furthermore, the system is easily transportable because no connection to the electrical network
is necessary; the only installation requirement is its positioning close to a sink in order to empty
out the used disinfectant.
The immersion system with electronic control, by means of the micro-processor, ensures
adequate contact time with the disinfectant and potentially damaging chemical overexposure,
in addition to the ability to track the entire procedure.
9.3. Sterile protective sheaths
This is an endoscope encasing system that can represent an alternative to the high-level
disinfection of endoscopes (Figure 8).
Figure 8. Dear Authors, Please add caption
Various studies [17, 18] have demonstrated the necessity to clean the entire endoscope with an
enzymatic cleanser, followed by a disinfectant with 70% ethanol, immediately after the removal of
the sheath, in order to guarantee the equivalent of a high-level disinfection. In fact, it was seen
that small viruses are capable of penetrating the sheath.
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From our investigation conducted at ENT departments in Italy in 2010, we have seen that the
practice of cleaning and disinfecting is done in only 2% of cases after removal of the encasing.
The advantage of this system is the speed.
The disadvantages are represented by:
• an increase of the diameter of the endoscope with the subsequent discomfort for the patient,
• the possibility of contamination of the control head unprotected,
• the risk of breakage of the sheath during the exam [19],
• the possibility of damage to the endoscope when removing the sheath,
• vision is not optimal,
• costs: endoscopes of various brands moreover require specific sheaths and their cost ranges
from 8 to 25 euros.
To remember:
• The choice of disinfection systems should be made in agreement between the head of the
operating unit, the hospital pharmacy, the hospital infection control committee and the
indications of the endoscope manufacturer.
• Endoscopes which cannot be fully immersed should be substituted.
• Instruments should be reprocessed immediately after use because if allowed to dry for a
long period, the residues can become encrusted and even damage the instrument.
• If the endoscope is immersed for too long a period, the outer casing and the seals can be
damaged.
• The endoscopic examination should be avoided for patients with suspected Creutzfeldt-
Jakob disease (prions are resistant to all forms of conventional sterilization). When the
endoscope is considered really necessary, a dedicated endoscope should be used, maybe
single-use, or else an instrument which is reaching the end of its life cycle. After use, the
endoscope must be put in quarantine until definitive confirmation of the pathology.
10. Disinfection of endoscopes contaminated by HVB, HVC, HIV or
mycobacterium [20, 21]
At the time of writing, there have been no reports of the transmission of viruses by means of
bronchoscopes, while cases of the transmission of HBV and HBC by means of gastroendo‐
scopes inadequately reprocessed have been reported.
The majority of viruses, including HVB, HVC and HIV, are quickly neutralized with disinfec‐
tion solutions. The major risks of virus transmission reside in the unsuccessful removal of
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biological residues during the manual pre-clean, which allows the virus to avoid contact with
the disinfectant.
Mycobacterium are responsible for an elevated percentage of contamination incidents referred
to in the literature. All cases of tuberculosis have been attributed to the failed observance of
infection control procedures.
Although some authors have sustained the need for longer disinfection times for endoscopes
after use in patients affected by mycobacterium, this strategy is not required if infection control
guidelines are carefully followed. Numerous studies have, for example, demonstrated that
immersion for 20 minutes in a basic 2% solution of glutaraldehyde at 20°C, after an adequate
pre-clean, significantly reduces the bacterial count of M. Tuberculosis.
11. Disinfection of endoscopes contaminated by prions [22– 23]
Prions are responsible for transmissible spongiform encephalopathy (TSE), capable of
provoking degenerative diseases to the central nervous system in animals and man.
The most frequent disease from prions is Creutzfeldt Jakob Disease (CJD); other forms include
variant Creutzfeldt Jakob Disease (vCJD), Gertsmann Straussler Scheinker syndrome (GSS),
Fatal Familial (FFI), insomnia and Kuru.
Prions are resistant to common disinfectant substances. The tissues at high risk of infection include the
brain, the dura mater, the spinal cord and the eyes, while tissues at low risk include cerebrospinal fluid,
liver, lymph nodes, kidneys, lungs and spleen.
There have been no indications of cases of CJD attributable to devices contaminated with blood.
Recognized cases of CJD as iatrogenic have been attributed to contaminated medical devices
such as cerebral electrodes, cerebral neurosurgical instruments, dura mater grafts, corneal
grafts, gonadotropins and human growth hormones.
From an analysis of the literature, it can be deduced that endoscopes (apart from those used in
neurosurgery) are devices which do not normally come into contact with tissues at risk of TSE and
consequently, even when used during diagnostic procedures on high-risk patients, standard
reprocessing protocols are adequate.
The primary and principle preventive measure, however, in the case of high-risk patients, is
to limit endoscopic examinations exclusively to when necessary. If the examination is effectively
necessary, it is advisable to designate one endoscope for such patients also for the future.
In the case of an endoscopic examination which envisages contact with high and low risk
tissues in a probably or certainly infected patient, the WHO guidelines indicate special
treatments (sodium hydroxide, sodium hypochlorite, phenol, sterilization in autoclave) which
are not compatible with endoscopes.
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Seeing that the most common disinfectants used for endoscopes are not efficacious and
considering the high cost of the instrument, some authors suggest covering the endoscope with
a plastic sheath as a partial protection which can be eliminated after use as a special waste.
The ENT endoscopic procedures can, however, be managed without any special precautions
due to the fact that the tissues with which there is contact are not considered infectious. For
these patients, the standard protocols of pre-cleaning and high-level disinfection are adequate.
12. Biological controls
The monitoring infections resulting from endoscopic procedures cannot be an indicator of the
efficacy of disinfection since infections are rarely linked to the execution of the endoscopic
exam performed.
Moreover, the culture methods currently in use have not been rigorously validated, with the
danger of underestimating or overestimating results, consequently causing potential harm to
patients and health facilities. [24]
In the absence of adequate scientific evidence, the APIC (Association for Professionals in
Infection Control and Epidemiology) and the CDC (Centres for Disease Control and Preven‐
tion) do not recommend routine microbiological tests and advise them only in cases of epidemics.
13. Tracking systems [5]
In every endoscopy unit, it is desirable to have a registration system in which the following
information would need to be recorded for each procedure:
• examination number,
• patient generality,
• doctors and nurses generality,
• type of procedures,
• time,
• endoscope identification number,
• type of disinfection carried out.
The nursing coordinator of the unit should maintain
• documentation relating to installation, testing and maintenance of the washer-disinfector-
endoscope machines (up to 5 years following the end of service),
• user’s manuals for all the equipment,
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• registration of biological controls carried out on the washer-disinfector-endoscope machines
and on the endoscopes (at least 5 years),
• a copy of the print-out issued by the washer-disinfector-endoscopes, certifying the disin‐
fection cycle (at least 5 years).
14. Disinfectants for the reprocessing of heat-sensitive, non-lumened ENT
endoscopes
The survey findings indicated that peracetic acid and orthophthalaldehyde are the high-level
disinfectants most commonly used for endoscopes. Chlorine dioxide is a disinfectant which is
being increasingly used over the past few years.
Often, it is possible to find different disinfection solutions used for the same type of endoscope
in the same hospital, and the use of a disinfectant as opposed to another is dependent on the
operating unit.
Before examining the principle disinfectants, it is necessary to consider the following points
regarding choice and usage [25, 26]:
1. Disinfectants must be registered at the Health Ministry and the technical bulletin should
clearly indicate





2. Choose the disinfectant which is compatible with the endoscope in accordance with the
indications of the instrument manufacturer.
3. The choice of solutions should be made in agreement with the pharmacy, health man‐
agement and the heads of the operating units involved.
4. The disinfectants in use must be managed and stored in such a way as to avoid contam‐
ination (for example, containers handled with dirty hands and gloves, partial closure of
packaging, etc).
5. When the disinfectant is re-usable, it is necessary
• to test the minimum effective concentration (MEC) at the beginning of the day. Results
should be documented and the solution discarded when inferior to MEC,
Guidelines for Reprocessing Non-Lumened, Heat-Sensitive ENT Endoscopes
http://dx.doi.org/10.5772/61219
21
• discard the disinfection solution at the end of the indicated usage period irrespective of the
MEC. In cases where the disinfectant is added to AERs, the determination of the expiry date
should be based on the original preparation date.
Monographs of the most commonly used disinfectant solutions are reported below according
to the information supplied by the manufacturers and the data from scientific literature.
14.1. Glutaraldehyde (e.g. Cidex, Asep, Glutaster basica, Sporex) [27, 28]
Active ingredient
Glutaraldehyde or glutaric aldehyde in aqueous solution has a colourless or verging on yellow
clear appearance and a pungent odour. The most common usage is a 2% alkaline solution.
Characteristics
Glutarladehyde is mainly commercialized in an acid form which is stabile for long periods
when stored in cool conditions and in tightly closed container (up to 5 years).
Before use, glutaraldehyde must be “activated” by adding a buffer and surfactant in order to
obtain a pH of 7.5–8.5. The activator (e.g. bicarbonate) is supplied separately and is used to
obtain a working solution stable for 14 days. This period of validity refers to the activated
solution in its original bottle, while the period of reusability should be considered in function
of the concentration level, generally not less than 1.5% (the concentration diminishes in time
and in function of the number of disinfections).
Mode of action
Glutaraldehyde is also defined as glutaric dialdehyde because it is endowed with two
aldehydic groups (CHO), positioned at the extremes of the molecule, which are the real source
of biocidal action; they are directly involved in the alkylation of sulphide, carboxylic, amino
and hydroxyl groups of the proteins of the microorganism, causing an irreversible alteration
of the protein synthesis and the nucleic acids.
Glutaraldehyde is not deactivated significantly by organic material even though its presence
renders the disinfection less effective due to the fixative capability of glutaraldehyde, which
creates a protective covering that prevents the destruction of the microbial cells. It is recognized
in fact that glutaraldehyde is not efficacious against biofilm.
Spectrum of activity
The spectrum of activity of glutaraldehyde is almost complete but the contact times vary notably
according to conditions, e.g. a 2% solution in laboratory has been demonstrated to be active in
• 1–2 minutes against bacteria in vegetative form (e.g. Staphylococcus aureus, including the
penicillin, Pseudomonas aeruginosa, Escherichia coli),
• 5–10 minutes against viruses (e.g. Poliovirus Type 1, Coxsackie B1, ECHO 6, Rotavirus, HAV,
HBV, HCV, HTLV-III/LAV),
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• discard the disinfection solution at the end of the indicated usage period irrespective of the
MEC. In cases where the disinfectant is added to AERs, the determination of the expiry date
should be based on the original preparation date.
Monographs of the most commonly used disinfectant solutions are reported below according
to the information supplied by the manufacturers and the data from scientific literature.
14.1. Glutaraldehyde (e.g. Cidex, Asep, Glutaster basica, Sporex) [27, 28]
Active ingredient
Glutaraldehyde or glutaric aldehyde in aqueous solution has a colourless or verging on yellow
clear appearance and a pungent odour. The most common usage is a 2% alkaline solution.
Characteristics
Glutarladehyde is mainly commercialized in an acid form which is stabile for long periods
when stored in cool conditions and in tightly closed container (up to 5 years).
Before use, glutaraldehyde must be “activated” by adding a buffer and surfactant in order to
obtain a pH of 7.5–8.5. The activator (e.g. bicarbonate) is supplied separately and is used to
obtain a working solution stable for 14 days. This period of validity refers to the activated
solution in its original bottle, while the period of reusability should be considered in function
of the concentration level, generally not less than 1.5% (the concentration diminishes in time
and in function of the number of disinfections).
Mode of action
Glutaraldehyde is also defined as glutaric dialdehyde because it is endowed with two
aldehydic groups (CHO), positioned at the extremes of the molecule, which are the real source
of biocidal action; they are directly involved in the alkylation of sulphide, carboxylic, amino
and hydroxyl groups of the proteins of the microorganism, causing an irreversible alteration
of the protein synthesis and the nucleic acids.
Glutaraldehyde is not deactivated significantly by organic material even though its presence
renders the disinfection less effective due to the fixative capability of glutaraldehyde, which
creates a protective covering that prevents the destruction of the microbial cells. It is recognized
in fact that glutaraldehyde is not efficacious against biofilm.
Spectrum of activity
The spectrum of activity of glutaraldehyde is almost complete but the contact times vary notably
according to conditions, e.g. a 2% solution in laboratory has been demonstrated to be active in
• 1–2 minutes against bacteria in vegetative form (e.g. Staphylococcus aureus, including the
penicillin, Pseudomonas aeruginosa, Escherichia coli),
• 5–10 minutes against viruses (e.g. Poliovirus Type 1, Coxsackie B1, ECHO 6, Rotavirus, HAV,
HBV, HCV, HTLV-III/LAV),
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• 10 minutes against yeasts, fungi and moulds (e.g. Trichophyton interdigitalis, Microsporum
gypseum, Candida albicans, Aspergillus niger),
• 20 minutes against Mycobacterium tuberculosis whereas the activity is slower against other
types of mycobacterium (at least 60 minutes) due to the lipidic component in the cellular
wall which makes them almost impermeable. The contact time can be reduced by using a
3–4% solution and/or increasing the temperature to 25°C,
• 3 hours against spores. Concentrations less than 2% do not offer guarantees of being
sporicidal, even with an increase in the contact time.
Material compatibility
Glutaraldehyde is not corrosive to metals and does not present particular problems for rubber, plastic,
glass and optical fibres. It is necessary, however, to take precautions:
• objects in carbon steel should not remain in contact with the solution for more than 24 hours.
• it is necessary to avoid contact between different metals during immersion (danger of
causing an electrolytic reaction, capable of corroding instruments).
Toxicity/precautions
Glutaraldehyde is a toxic, irritant and sensitizing substance and can cause, in the case of
inadequate rinsing, rhinoconjunctivitis, asthma, diarrhoea and abdominal cramp.
The main risk of glutaraldehyde toxicity is run by the staff who have to handle it, because:
• frequent contact with the skin can cause dermatitis and a persistent yellow or brown
colouring of the skin,
• contact with the eyes can cause reddening of the conjunctiva or grievous damage to the
cornea.
• irritation to the conjunctiva with burning, lachrymation and reddening,
• damage to the respiratory system with bronchitis, dyspnoea, bronchial asthma,
• damage to the central nervous system with headache, depression,
• ingestion can cause from moderate to marked irritation to the mouth, throat, oesophagus
and stomach, pains in the chest and abdomen, nausea, vomiting, diarrhoea, dizziness,
drowsiness, shock.
The product did not result to be carcinogenic, for inhalation, on laboratory animals after
continued exposure.
The literature reports TLV/TVA1values from 0.2 to 0.05 ppm.
For these reasons the use of glutaraldehyde must
1 Threshold limit value-time weighted average: average concentration of a chemical agent weighted on an exposure level
of 8 hours and for 40 hours per week, to which operators may be exposed without adverse effects for their health being
apparent.
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1. Envisage the use of adequate personal protective equipment:
• protective eyewear,
• authorized ventilators with filters for organic vapours, only in the presence of elevated
vapours,
• protective smock,
• butyl or nitrile gloves or a double pair of latex gloves.
2. Envisage use in a ventilated environment, in closed containers and in the presence of adequate
extraction systems.
3. Envisage staff training for correct usage and relative information regarding toxicity.
In the case of exposure, the first aid measures depend on the affected site:
• Contact with eyes: wash with plenty of water for at least 10 minutes. Remove contact lenses
if possible to do easily. Visit the optician.
• Skin contact: remove contaminated clothes and wash with soap and water the affected parts
of the skin. Consult a doctor if irritation persists.
• Ingestion: the product can cause ulceration and inflammation of the upper digestive system;
it is preferable, therefore, not to cause vomiting but to resort to a cautious gastric lavage.
• Inhalation: transfer the person to a ventilated area. Artificial respiration may be necessary.
The use of glutaraldehyde as a high-level disinfectant is in constant decline, not particularly for reasons
of efficacy, but rather for reasons linked to staff health and safety issues. It is worth noting that this
chemical solution can no longer be used in British hospitals.
Disposal
The starting concentration of glutaraldehyde (2%) is possibly harmful. The concentration level,
however, diminishes progressively due to re-use, evaporation and progressive dilutions.
According to Italian legislation, which has adopted European norms, disposal of the exhausted
solution to sink is permitted, considering the high levels of dilution by water used daily for
patient care. The sink must, however, be in a well-ventilated environment and disposal should
be followed by running water to accelerate the discharge. Attention must be taken disposing
large quantities directly into the sewers due to possible damage to the purification system
through the inhibition of bacterial activity.
Indications for use
2% glutaraldehyde is indicated for the high-level disinfection of endoscopes and semi-critical medical
devices with a contact time of not less than 20 minutes at a temperature of 20°C or more.
A contact time of 1 hour is advisable for bronchoscopes due to the slower mycobacterial activity. A
satisfactory sporicidal activity is achieved after 3 hours.
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After studying glutaraldehyde residues in plastic and rubber, after immersion in 2% glutaral‐
dehyde, it was concluded that a 2 minute rinse is sufficient to significantly reduce the quantity
of the active ingredient absorbed in the exposed material, with the exception of natural rubbers
for which a prolonged soak and rinse is recommended.
14.2. Orthophthalaldehyde (e.g. Cidex OPA, Opaster) [29– 30]
Active ingredient
An aromatic dialdehyde in commerce for a few years also in Italy, generally used at a concen‐
tration of 0.55% in an aqueous solution, with a lowly accentuated odour and blue colour. It is
stable at 15–30°C for 2 years.
Characteristics
Unlike glutaraldehyde, orthophthalaldehyde (OPA) is ready to use and does not require
activation. Once opened, the unused solution can be stored in the original bottle for up to 2
months while the solution poured into the disinfection tray can be used for no more than 14
days, providing that the concentration level is superior to the MEC (at least 0.3%) indicated by
special test stripes. After 14 days the product must be disposed, even if the concentration is
still superior to the MEC.
Mode of action
In the case of bacteria, OPA provokes the formation of crossed bonds between the cytoplasmic
membrane lipoproteins with a subsequent cementation effect on the external layer of the cell
and limitation of the exchanges. The periplasmic enzymes are also deactivated with conse‐
quent rapid death of the cell.
In the case of fungi and yeasts, the main interaction site is the chitin, principle component of
the cellular wall, as well as the superficial enzymes present in the cellular membrane. As with
glutaraldehyde, OPA is not effective against biofilm.
Spectrum of activity
OPA is capable of performing a rapid disinfection action in just 5 minutes at room temperature
(20°C) on the majority of tested microorganisms, with the exception of spores for which higher
concentrations and contact times (1% for 10–12 hours or 0.55% for 24 hours) are required.
Specifically, in laboratory, it is effective in:
• 5 minutes against bacteria in vegetative form (e.g. Staphylococcus aureus, Pseudomonas
aeruginosa, Salmonella choleraesuis, Enterococcus, Escherichia coli).
• 5 minutes against viruses (Adenovirus, Coxsackie virus, Citomegalovirus, Herpes simplex,
HIV-1, Human Coronavirus, Influenza Type A, Poliovirus, Rhinovirus),
• 5 minutes against yeasts, fungi and moulds (Candida albicans, Aspergillus niger and Tricho‐
phyton mentagrophytes),
• 5 minutes against Mycobacterium bovis, M. avium, M. terrae, M. smegmatis,
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• 10 hours against the spores Clostridium difficile and Bacillus subtilis.
Material compatibility
OPA has proved to be compatible with a wide range of materials commonly used in the
production of re-usable medical devices (metal, plastic, elastomers and adhesives) and, in
many cases, it was found to be less aggressive than glutaraldehyde. Endoscopic instruments
have undergone tests and are considered to be compatible with the solution. For prolonged
contact times (greater than 15 minutes), the substrates with which it comes into contact can be
subjected to permanent discolouring.
Toxicity/precautions
OPA is a molecule less volatile than glutaraldehyde and its toxicity, considering the same target organs,
is of minor relevance.
Exposure to OPA has different effects according to the type of contact:
• Ingestion can cause irritation to the pharynx, esophagus and stomach with nausea, vomiting
and diarrhoea.
• Skin contact can cause temporary blotches and slight irritations mainly after prolonged
exposure. Such symptoms usually disappear when exposure is terminated.
• Eye contact can cause marks, excessive lachrymation and conjunctivitis.
• Inhalation: OPA is not considered volatile and is not thought to carry risks for inhalation
during normal use. Exposure to spray or particulate can provoke, however, bland irritation
to respiratory tracts with coughing and sneezing.
This product does not result to be mutagenic, embryotoxic or terotogenic in humans. Its
components are not considered carcinogenic.
Occupational exposure limits have not, however, been established.
As with glutaraldehyde, the use of OPA also must
1. Envisage the use of adequate personal protective equipment:
• protective eyewear,
• authorized ventilators with filters for organic vapours, only in the presence elevated
vapour concentrations,
• protective smock,
• butyl or nitrile gloves or a double pair of latex gloves.
2. Envisage use in a ventilated environment and in closed containers (if these requisites are
satisfied, extraction systems are not necessary).
3. Envisage staff training for correct usage and relative information regarding toxicity.
In case of exposure, the same first aid measures for glutaraldehyde are valid:
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• Eye contact: wash with plenty of water for at least 10 minutes. Remove contact lenses if
possible to do easily. Visit the optician.
• Skin contact: remove contaminated clothes and wash the affected parts with soap and water.
Consult a doctor if irritation persists.
• Ingestion: the product can cause ulceration and inflammation of the upper digestive system
if ingested; it is preferable, therefore, not to cause vomiting but to resort to a cautious gastric
lavage.
• Inhalation: transfer the person to a ventilated area. Artificial respiration may be necessary.
Disposal
According to Italian legislation, as with glutaraldehyde, disposal of the exhausted solution to
sink is permitted, taking into account the high levels of dilution by water used daily for patient
care. The sink must, however, be in a well-ventilated environment and disposal should be
followed by running water to accelerate the discharge. The disposal of large quantities directly
into the sewers can, however, cause damage to the purification system through the inhibition
of bacterial activity.
Indications for use
0.55% OPA is indicated for the high-level disinfection of endoscopes and semi-critical medical devices
with a contact time of at least 5 minutes at a temperature of 25°C in an AER and 12 minutes at 20°C
in a manual immersion system.
Rinsing for at least 1 minute with copious water is sufficient to remove all traces of the
disinfectant.
14.3. Peracetic acid (e.g. Nu Cidex, Steris, Persafe, Gigasept, Adaspor, Oxydrox, Perax liquid,
Steradrox, Anioxide, SP3) [31, 32]
Active ingredient
Peracetic acid solutions are colourless or slightly yellow aqueous solutions, with a pungent
odour and pH of around 6, containing a mixture of hydrogen peroxide and acetic acid.
The peracetic acid solutions commonly used in the medical field are:
• diluted working solution from concentrates,
• working solutions prepared by automatic systems which control all variables (dilution,
temperature, contact times and pH),
• prepared to a defined concentration (0.35%).
Characteristics
Peracetic acid is an unstable compound and therefore it is necessary to store the concentrated
solutions in bottles, preferably in a cool environment. The working solutions should be prepared
Guidelines for Reprocessing Non-Lumened, Heat-Sensitive ENT Endoscopes
http://dx.doi.org/10.5772/61219
27
and are valid from 1 hour to 12 days depending on the type of dilution, on the pre-cleaning procedure
and on the minimum recommended concentration.
Mode of action
It has not been defined definitively; the activity seems to be linked to the strong oxidizing
power both at the cellular membrane level of the microorganism (interruption of the chem‐
iosmotic function) and inside the microbial cell (irreversible damage to the essential enzymatic
system).
Being an oxidant, peracetic acid cleans and de-scales eventual deposits of the material.
Spectrum of activity
Peracetic acid is characterized by a rapid disinfection activity. A 0.35% solution in laboratory
was seen to be effective in 10 minutes at room temperature against the following microorgan‐
isms:
• Bacteria in vegetative form (e.g. Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus,
Escherichia coli).
• Viruses such as HCV, HIV, HBV, Coronarovirus.
• Yeasts, fungi and moulds (Candida albicans, Aspergillus niger).
• Mycobacterium such as Mycobacterium tuberculosis, M. avium, M. terrae, M. smegmatis.
• Spores of Clostridium sporogenes, Bacillus subtilis, Bacillus cereus.
Material compatibility
The activated solution demonstrates good compatibility with materials commonly present in
medical devices, particularly endoscopes and AERs. It can cause discolouring of the insertion
tube.
Toxicity/precautions
The concentrated solutions (>0.35%) and the peracetic acid vapours in contact with the skin and the
mucous membranes can cause irritation, sometimes even severe; for this reason, it is necessary to rinse
carefully all disinfected medical devices and wear appropriate personal protective equipment during
handling:
• mask for acid vapours in case of emergency,
• protective gloves (neoprene or heavy rubber),
• protective eyewear,
• complete protective clothing.
The 0.15% commercial solutions are neither corrosive nor irritants (only slightly for the eyes).
The literature indicates TLV/TVA2 values of 10 ppm.
In case of exposure, the following are required:
Endoscopy - Innovative Uses and Emerging Technologies28
and are valid from 1 hour to 12 days depending on the type of dilution, on the pre-cleaning procedure
and on the minimum recommended concentration.
Mode of action
It has not been defined definitively; the activity seems to be linked to the strong oxidizing
power both at the cellular membrane level of the microorganism (interruption of the chem‐
iosmotic function) and inside the microbial cell (irreversible damage to the essential enzymatic
system).
Being an oxidant, peracetic acid cleans and de-scales eventual deposits of the material.
Spectrum of activity
Peracetic acid is characterized by a rapid disinfection activity. A 0.35% solution in laboratory
was seen to be effective in 10 minutes at room temperature against the following microorgan‐
isms:
• Bacteria in vegetative form (e.g. Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus,
Escherichia coli).
• Viruses such as HCV, HIV, HBV, Coronarovirus.
• Yeasts, fungi and moulds (Candida albicans, Aspergillus niger).
• Mycobacterium such as Mycobacterium tuberculosis, M. avium, M. terrae, M. smegmatis.
• Spores of Clostridium sporogenes, Bacillus subtilis, Bacillus cereus.
Material compatibility
The activated solution demonstrates good compatibility with materials commonly present in
medical devices, particularly endoscopes and AERs. It can cause discolouring of the insertion
tube.
Toxicity/precautions
The concentrated solutions (>0.35%) and the peracetic acid vapours in contact with the skin and the
mucous membranes can cause irritation, sometimes even severe; for this reason, it is necessary to rinse
carefully all disinfected medical devices and wear appropriate personal protective equipment during
handling:
• mask for acid vapours in case of emergency,
• protective gloves (neoprene or heavy rubber),
• protective eyewear,
• complete protective clothing.
The 0.15% commercial solutions are neither corrosive nor irritants (only slightly for the eyes).
The literature indicates TLV/TVA2 values of 10 ppm.
In case of exposure, the following are required:
Endoscopy - Innovative Uses and Emerging Technologies28
• Eye contact: wash with plenty of water for at least 10 minutes. Remove contact lens if
possible to do easily. Visit the optician.
• Skin contact: remove contaminated clothes and wash with soap and water the affected parts
of the skin. Consult a doctor if irritation persists.
• Ingestion: the product can cause ulceration and inflammation of the upper digestive system
if ingested; it is preferable, therefore, not to cause vomiting but to resort to a cautious gastric
lavage.
• Inhalation: transfer the person to a ventilated area. Artificial respiration may be necessary.
Disposal
Peracetic acid is not harmful and does not pollute the environment because it breaks down into acetic
acid, water and oxygen.
Indications for use
Cartridges containing 35% peracetic acid inserted into a specific AER obtain, in controlled
conditions, a 0.2% solution and operate at around 55°C with a contact time of 12 minutes. This
does not seem to be a particularly suitable system for flexible endoscope reprocessing due to
the cost of each cycle.
The stabilized and buffered 0.35% solution has, according to studies, the same indications, being effective
in 5 minutes against bacteria, fungi, virus and mycobacterium and 10 minutes against spores. It should
be prepared as a working solution and is stable for 24 hours. It can be used for up to 20 cycles or up to
a concentration of not less than 2500 ppm.
Even though the solution contains anti-corrosion inhibitors, it is not recommended for use in
AERs which contain aluminium or copper. Tests have demonstrated variations in the plating
of rigid endoscopes which contain such metals.
The technical bulletin for the 0.15% stabilized solution indicates a contact time of 10–15 minutes for
high-level disinfection and 30 minutes for sporicidal action. This solution must also be activated and
disposed of every 24 hours.
As confirmed by the study carried out among the ENT departments, there are a variety of
products marketed under the name of peracetic acid. The usage and the contact times vary
according to the product and consequently it is necessary, to carefully follow the instructions
supplied by the manufacturer, as well as verifying the compatibility of the product with the
instruments which need to be disinfected.
14.4. Chlorine dioxide (e.g. ClO2 Tristel) [26, 35, 36]
Active ingredient
A molecule composed of one atom of chlorine and two atoms of oxygen (ClO2). The biocidal
power of ClO2 has long been recognized for use in different industrial applications and for the
2 Threshold limit value-time weighted average: average concentration of a chemical agent weighted on an exposure level
of 8 hours and for 40 hours per week, to which operators may be exposed without adverse effects for their health being
apparent.
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disinfection of drinking water. The particular characteristic of this disinfectant is its broad
spectrum of activity in rapid contact times at low levels of concentration. Its oxidizing capacity
is the equivalent of 2.5 times that of chlorine. It can be used in manual systems, electronically
controlled manual systems and also automatic systems.
Characteristics
ClO2 is an unstable gas, it cannot be transported and therefore must be generated at the moment
of use. The patented Tristel method envisages generation by means of mixing a sodium chlorite
solution with a mixture of organic acids, prevalently citric acid. The almost instantaneous
reaction between the two precursors produces chlorous acid, which in turn dissociates to
release a ClO2 gas in solution for immediate use at a level of concentration suitable for the
sporicidal disinfection of semi-critical medical devices. The concentration of ClO2 (read by
spectrophotometry immediately at the end of the activation time) in the wipes system is 175–
225 ppm (approximately 0.02%) while the diluted liquid format for immersion is 50–60 ppm
(0.005–0.006%).
Mode of action
ClO2 reacts almost instantaneously with of all types of microorganisms, creating an electron
transfer to form a breach in the surface from which all vital constituents pour out of the
microorganism with consequent destruction by lysis. The particular means of microbial
destruction prevents bacteria, fungi and viruses developing resistance to the molecule and
creating mutant strains.
Spectrum of activity
The ClO2 activity in its different formulations has been tested microbiologically in laboratories
according to the European norms EN 14885 to demonstrate its effectiveness.
It is effective in 30 seconds in the ready–to-use format and in 5 minutes in the diluted liquid format
for immersion on the following microorganisms:
• Spores (e.g. Bacillus subtilis and Clostridium difficile),
• Mycobacterium (e.g. M. tuberculosis, M. avium e M. terrae),
• Viruses (e.g. HBV, HCV, HIV, Poliovirus Type 1, Adenovirus, Orthopoxvirus),
• Fungi (e.g. Candida albicans, Aspergillus niger),
• Bacteria (e.g. Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus).
Material compatibility
Instrument integrity is guaranteed when used with single-use ClO2, providing the instructions
are followed: no damage has ever been noted from using the wipes system, neither after extensive
laboratory testing nor after a decade of use in the field.
Toxicity/precautions
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The safety for people using ClO2 has been confirmed by toxicological studies performed on
both humans and animals. The results demonstrated that at the concentrations used there are
no reactions or contraindications. It is however recommended to use gloves during handling.
Disposal
The solution of ClO2 decomposes into a simple saline solution and consequently has no
negative impact on the environment and does not entail additional disposal costs.
Indications for use
ClO2 is indicated for the high-level disinfection of endoscopes and semi-critical medical devices. The
formulation used in the wipes system is ready to use with a contact time of 30 seconds, while the diluted
liquid formulation has a contact time of 5 minutes.
There is only one dilution with water at room temperature and pH adjustment is unnecessary.
14.5. Glucoprotamin (e.g. Sekusept Plus, Sekumatic) [36]
Active ingredient
Glucoprotamin is a substance with a wide spectrum of activity obtained from the reaction of
glutamic acid and coco alkyl propylene diamine. Both precursors are natural compositions
and therefore highly biodegradable.
Characteristics
A clear aqueous solution, yellow in colour, not volatile, which must be diluted in water from
1–4% without the necessity of additional activators. It is usable in both manual and automatic
systems.
The solution is valid for 14 days.
Mode of action
Glucoprotamin operates by disrupting the cell membrane, by inhibiting the activity of the
principle enzymes and denaturing the cell proteins.
Spectrum of activity
Glucoprotamin has a wide spectrum of activity against bacteria (including mycobacterium),
yeast and fungi, enveloped viruses and partially effective against non-enveloped viruses. It
acts specifically on the following microorganisms:
• Bacteria (tested on Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Microccocus
luteus, Enterococcus hirae, Gemella morbillorum, Corynebacterium spp.),
• Mycobacterium (tested on M. tuberculosis, M. avium and M. terrae),
• Viruses (tested on HIV, HBV, HCV),
• Yeasts (tested on Candia albicans).
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The contact time for bacteria is 5 minutes and 15 minutes for yeasts.
Material compatibility
The product has been tested and approved for use on Olympus and Storz endoscopes, Rusch
anesthesia materials and Martin instruments.
Toxicity/precautions
Health risks: eye irritation.
The literature indicates TLV/TVA3 values of 500 ppm.
Respiratory tract protection: none, in normal usage conditions.
Hand protection: wear protective gloves in nitrilic or butylic rubber.
Eye protection: wear protective eyewear.
Skin protection: none, in normal usage conditions.
In case of exposure, the following first-aid measures should be adopted:
• Eye contact: wash with plenty of water for at least 10 minutes. Remove contact lens if
possible to do easily. Visit the optician.
• Skin contact: remove contaminated clothes and wash with soap and water the affected parts
of the skin. Consult a doctor if the irritation persists.
• Ingestion: the product can cause ulceration and inflammation of the upper digestive system
if ingested; it is preferable, therefore, not to cause vomiting but to resort to a cautious gastric
lavage.
• Inhalation: transfer the person to a ventilated area. Artificial respiration may be necessary.
Disposal
The discharge of the product into the water network is damaging to microflora, microfauna
and aquatic organisms for a brief period.
According to Italian legislation, disposal of the exhausted solution to sink is permitted,
considering the high levels of dilution by water used daily for patient care. The sink must,
however, be in a well-ventilated environment and disposal should be followed by running
water to accelerate the discharge.
Indications for use
Glucoprotamin is indicated for the high-level disinfection and simultaneous detersion of flexible
endoscopes, anaesthesia materials and semi-critical medical devices.
3 Threshold limit value-time weighted average: average concentration of a chemical agent weighted on an exposure level
of 8 hours and for 40 hours per week, to which operators may be exposed without adverse effects for their health being
apparent.
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Glucoprotamin has been taken into consideration because its usage in some ENT departments
was found in the survey findings. Evaluation studies of its microbial efficacy currently
available indicate a wider spectrum of activity than intermediate disinfectants, but its efficacy
against spores, a fundamental requisite for a high-level disinfectant, is not documented.
Further research is necessary in order to confirm its use for the reprocessing of endoscopes.
15. Conclusions
15.1. General norms
1. Every patient should be considered a potential source of infection and consequently, each
examination and all reprocessing procedures must be performed with the same accuracy.
2. The responsibility of the disinfection process is attributed to the nursing staff and the
doctor using the instrument.
3. The choice of disinfection systems should be made in agreement between the head of the
operating unit, the hospital pharmacy and the hospital infection control committee.
4. Staff should wear personal protective equipment during the endoscopic procedure and
in the various phases of reprocessing of the instrument.
5. Contaminated and clean areas should be distinctly divided.
6. Disinfection should be performed by adequately trained staff, whose competence is
periodically checked.
7. Periodic microbiological controls are not advisable as an indicator of the disinfection
process. In case of suspected contamination, endoscope, tap water and instruments used
in the disinfection process should be microbiologically tested.
8. When there is a suspected or ascertained case of infection, consult the hospital infection
control committee.
15.2. Reprocessing steps
1. After the endoscopic exam, a leak test and a visual check of the integrity of the instrument
should be performed before reprocessing.
2. Endoscopes which cannot be completely immersed should be substituted.
3. Before using the pre-clean or disinfection solution, consult the technical bulletin and the
safety data sheet: concentration levels, temperature, contact time should be respected in
order to achieve an effective disinfection.
4. The thorough cleaning of the instrument (immediately after use) with a detergent solution
in order to remove soil and organic material is fundamental for a successful disinfection.
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5. The disinfectant should be registered with the Health Ministry and the registration
includes the indication of how to use, the concentrations, contact time, temperature and
pH.
6. In the case of the disinfectant being reusable, it is necessary to:
• Test the MEC of the disinfectant at the beginning of each working day. The results
should be documented and the solution should be disposed if the concentration is
below the minimum required.
• Dispose of the disinfection liquid at the end of the period indicated for use without
taking into account the MEC.
7. Rinse the endoscope according to indications and dry before storing. The humidity
increases the risk of infections.
8. Keep a register of the endoscope usage and of the management and disinfection of
eventual AERs.
15.3. Disinfection systems
The ideal disinfection system should allow
• standardization of the process, to reduce the possibility of error,
• rapid turnaround of endoscopes,
• reduction of risks of operator contamination,
• reduction of risks of damage to endoscopes.
Advantages and disadvantages of the various disinfection systems are indicated so that
everyone can choose the one most adaptable to their local situation (human and economic
resources, available space, volume of activity, number of endoscopes).
1. Manual immersion systems do not require big investments but have the following
disadvantages:
• risks of errors or forgetfulness,
• inadequate “traceability”,
• risk of operator contamination,
• risk of environmental contamination,
• damage to endoscopes,
• disinfection times of at least 20 minutes.
2. AERs:
• standardized process which avoids errors or forgetfulness,
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• allows “traceability” of the process,
• reduces possible operator contact with contaminated instruments,
• reduces the possibility of environmental contamination,
• reduces risk of damage to endoscopes.
Possible disadvantages:
• equipment and maintenance costs,
• adequate space for installation of equipment (often at a distance from the endoscopic room
with consequent loss of time due to transport and the increased risk of damage to the
instrument during transport),
• time required for the disinfection process (normally at least 20 minutes). Added to transport
times, the endoscope may not be available before 1 hour.
Some manufacturers produce AERs specifically for ENT endoscopes, smaller than those used
for gastroenterology, easier to locate and at lower cost.
3. The wipes system using ClO2
• allows a rapid rotation of the instrument (less than 5 minutes),
• allows traceability because the wipes are single use.
Although easy to use, the system is manual and therefore requires careful and continuous staff
training to ensure that the procedure is performed correctly.
4. Manual immersion system with microprocessor:
• guarantees the contact time and avoids over exposure to chemistry which can potentially
damage the instrument,
• allows traceability,
• has lower purchase and maintenance costs compared to AERs.
The pre-clean step and the rinse step are both manual and therefore require care.
5. Sterile protective sheaths:
allow a rapid rotation of the instrument, but the correct usage envisages cleaning and disin‐
fection after sheath removal.
Disadvantages include
• possible discomfort for the patient,
• optical part of the endoscope not protected against contamination,
• possible rupture of the sheath during patient visit,
• possible damage to the endoscope when removing the sheath,





The choice of the disinfection system is made in consultation with the Director of the Unit, the
Pharmacy Service and the Infection Control Task.
The nursing staff as well as the doctor using the endoscope are responsible for the disinfection
process and must be adequately trained.
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Abstract
Gastrointestinal endoscopy (GIE) is a procedure for diagnosis and treatment of
gastrointestinal tract abnormalities. This procedure requires some forms of anesthe‐
sia. The goal of procedural anesthesia is safe, effective control of pain and anxiety, as
well as an appropriate degree of memory loss or reduced awareness. Generally, the
majority of GIE procedures are performed by using topical anesthesia and intravenous
sedation. General anesthesia is carried out in long and invasive procedures such as
endoscopic retrograde cholangiopancreatography, endoscopic ultrasound, and small
bowel enteroscopy, as well in patients with history of failed sedation or drug and
substance abuse, uncooperative or pediatric patients, and patients with cardiorespir‐
atory system instabilities. The appropriate anesthetic agents for GIE procedures could
be short acting, rapid onset with little adverse effects and also improved safety
profiles. To date, the new anesthetic drugs and monitoring equipments for safety and
efficacy are available. The present review focuses on pre-anesthetic assessment,
anesthetic drugs used, monitoring practices, and post-anesthesia care for anesthesia
innovations in GIE procedures.
Keywords: Anesthesia, Innovation, Gastrointestinal endoscopy, Safety, Efficacy
1. Introduction
Anesthesia is one of the important components of gastrointestinal endoscopic (GIE) proce‐
dures. The aim of anesthesia for these procedures is to improve patient’s comfort and endo‐
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
scopic practice as well as patient and endoscopist satisfaction. The requirement for anesthesia
is dependent on the type and duration of endoscopy, experience of endoscopist, and patient’s
physical status. The anesthetic regimens for GIE procedures are quite different. Several
guidelines from American Society of Anesthesiologists (ASA) [1] and American Academy of
Pediatrics [2] are established. Appropriate pre-anesthetic assessment, anesthetic drugs used,
monitoring practices and post-anesthesia care for anesthesia in GIE procedures are essential.
1.1. Pre-procedure assessment
All patients scheduled to receive anesthesia/sedation should have a history and appropriate
physical examination. Several risk factors including history of obstructive sleep apnea, alcohol
or drug abuse, and history of adverse reaction to previous anesthesia/sedation are investigated.
The patient physical status should be classified according to the ASA. The pregnancy test is
recommended in women of childbearing age [3]. Consequently, written consent should be
obtained. An anesthesia consultation should be done in high-risk patients including patients
with respiratory or hemodynamic instability, obstructive sleep apnea, and high-risk airway
management, as well as patients with ASA physical status >III and history of anesthesia-related
adverse events.
2. Monitoring
Cardiorespiratory-related adverse events are a leading cause of morbidity and mortality
associated with GIE procedures. Continuous monitoring of anesthetized patients is very
important for safety. The physicians need to monitor the patients’ status throughout the
procedure. Clinical observations including pattern of respiration, skin or mucosa color, and
level or depth of anesthesia are continuously observed.
2.1. Pulse oximetry
Pulse oximetry is a noninvasive device for continuous measurement of arterial oxygen
saturation. Because clinical observation alone is inaccurate in the detection of hypoxemia, pulse
oximetry has become a standard of care during GIE procedures. Oxygen saturation levels
under 90% must be treated. However, pulse oximetry and oxygen supplementation do not
diminish the severity or incidence of cardiorespiratory complications. In addition, oxygen
desaturation is relatively a late sign [4].
2.2. Capnography
Moreover, pulse oximetry and clinical observation cannot detect the development of hyper‐
capnea. Capnography has been utilized to permit the safe titration of propofol by a qualified
gastroenterologist during invasive procedures such as endoscopic retrograde cholangiopan‐
creatography (ERCP) and endoscopic ultrasonography (EUS).
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2.3. Noninvasive blood pressure
Blood pressure and heart rate are important parameters of cardiovascular monitoring. The
alterations of blood pressure are mediated by the depressive effects of anesthetic agents.
Baseline hemodynamic parameters also provide useful information of the effects of various
medical conditions. Generally, blood pressure and heart rate will be documented before
anesthesia, and at least 5 min for deep sedation and general anesthesia, as well as every 15 min
for mild and moderate sedation. Blood pressure is more likely to predict increasing and
decreasing doses of anesthetic drugs.
2.4. Electrocardiography
The use of electrocardiography (ECG) was aimed to detect cardiac arrhythmias in high-risk
patients undergoing anesthesia. However, the use of ECG during GIE procedure remains
controversial [6]. American Society for Gastrointestinal Endoscopy (ASGE) and ASA practice
guidelines recommend the use of ECG during GIE anesthesia in patients with significant
cardiovascular diseases or arrhythmias. However, ECG is not recommended for routine use
of ECG in patients with ASA physical status I or II [1, 4, 7].
2.5. Other monitors
Other monitors such as invasive arterial blood pressure, central venous pressure (CVP), and
pulmonary arterial catheterization (PAC) are infrequently used during GIE anesthesia.
However, these invasive monitors should be used in some high-risk patients including patients
with severe hemodynamic instabilities and patients with shock.
2.6. Bispectral index monitoring
The depth of anesthesia cannot be reliably judged by clinical assessments alone. Currently, the
Bispectral (BIS) index has been reported to be more accurate in measurement of the depth of
anesthesia. The BIS scale ranges from 0 to 100 (0, no cortical activity or coma; 40-60, uncon‐
scious; 70-90, varying levels of conscious sedation; 100, fully awake). In the past, BIS monitor
was used to assess the patient consciousness during general anesthesia [4, 8]. To date, its use
has subsequently expanded into the procedural sedation technique. However, the use of BIS
during GIE procedures remains a controversial issue.
The usefulness of BIS monitoring for GIE procedure was confirmed by the study of Bower and
colleagues. This study showed the correlation of BIS index and the Observer’s Assessment of
Alertness/Sedation (OAA/S) scale for sedation during GIE procedures. It also suggested that
a bispectral index near 82 corresponded with acceptable sedation level for GIE procedure [9].
Al-Sammak and coworkers compared BIS with clinical assessment for sedation during ERCP
procedure in pediatric patients. The duration of sedation, recovery period, patient satisfaction,
and total dose of sedative agents in the BIS group were better than in the clinical assessment
group. This study demonstrated that BIS might be a valuable monitor for safe level of sedation
and endoscopist’s satisfaction during ERCP [10]. Another study also showed that BIS moni‐
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toring guided to a decrease in the propofol dose for sedation in ERCP procedures. Mean BIS
values throughout the procedure and during the maintenance period of sedation were 61.68
± 7.5 and 53.73 ± 8.67, respectively [11].
In contrast, several reports demonstrated that BIS index had low accuracy for detecting deep
sedation and it was not helpful for titrating propofol to an adequate depth of sedation level.
For example, Chen and Rex evaluated the utility of BIS as a monitoring device for nurse-
administered propofol sedation (NAPS) during colonoscopic procedure. The study showed
the mean time required to accomplish BIS values ≤60 was significantly longer than the mean
time required to achieve an Observer’s Assessment of Alertness/Sedation score of 1 (deep
sedation). Additionally, there was also a lag time between the time required from the last dose
of propofol and the time returned to baseline. The authors concluded that BIS index was not
a useful device in titrating propofol to an adequate depth of sedation level [12].
Drake and coworkers also confirmed that BIS did not lead to the reduction in mean propofol
dose or recovery time when used for sedation in colonoscopy [13]. Moreover, an observational
study also showed that BIS index had a low accuracy for detecting deep sedation because of
an overlap of scores across the sedation levels. Further improvements in BIS are needed to
differentiate deep from moderate sedation for GIE procedures [14].
2.7. NarcotrendTM
NarcotrendTM accomplishes a computerized analysis of the raw EEG. A statistical algorithm is
used for analysis, resulting in a six-stage classification from A (awake) to F (general anesthesia/
coma) and 14 substages [4, 15]. Wehrmann and colleagues evaluated 80 patients who under‐
went ERCP procedures by using EEG monitoring and clinical assessment for sedation. Their
study demonstrated that mean propofol dose, decrease in blood pressure, and recovery time
in the EEG monitoring group were significantly lower than in the clinical assessment group.
The authors confirmed that EEG monitoring permitted more effective titration of propofol
dosage for sedation during ERCP procedures and was associated with more rapidly patient
recovery [16].
My previous study used the NarcotrendTM to guide the depth of sedation for ERCP procedure.
NarcotrendTM monitoring was an effective tool for maintenance of the depth of sedation level
in this procedure [17]. The other study compared the clinical efficacy of NarcotrendTM
monitoring and clinical assessment used to provide deep sedation in patients who underwent
ERCP procedure. In the study, Modified Observer’s Assessment of Alertness/Sedation scale 1
or 2 and the NarcotrendTM index 47-56 to 57-64 were maintained during the procedure. All
endoscopies were completed successfully. Both NarcotrendTM and clinical-assessment-guided
propofol deep sedation were equally safe and effective as well as demonstrated comparable
propofol dose and recovery time. However, the NarcotrendTM-guided sedation showed lower
hemodynamic changes and fewer complications compared with the clinical-assessment-
guided sedation [18].
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3. Anesthetic technique
3.1. Topical anesthesia
Esophagogastroduodenoscopy (EGD) is  commonly performed by using topical  pharyng‐
eal anesthesia. Topical lidocaine is normally used as pretreatment for pharyngeal anesthe‐
sia. My previous study evaluated the clinical efficacy of topical viscous lidocaine solution
and lidocaine spray when each was used as a single agent for unsedated EGD [19].  All
patients were randomized into the viscous lidocaine (V) group (n = 930) or the lidocaine
spray (S) group (n = 934). The results showed the procedure was successfully completed
in 868 patients from group V and 931 patients from group S. Patient’s and endoscopist’s
satisfaction, pain score, patient tolerance, and ease of intubation in group S were significant‐
ly  better  than those  in  group V.  Additionally,  adverse  events  in  group S  also  occurred
significantly  lower  than group V.  This  study demonstrated that  the  use  of  topical  lido‐
caine spray was shown to be a  better  form of  pharyngeal  anesthesia  than viscous lido‐
caine solution in unsedated EGD procedure [19].
Consequently, the use of posterior lingual lidocaine swab can apply for EGD procedure.
Soweid and colleagues evaluated the effect of posterior lingual lidocaine swab in 80 patients
who underwent diagnostic EGD procedures on patient tolerance, the ease of performance of
EGD procedure, and to determine if such use would decrease the need for intravenous sedation
[20]. The result of their study demonstrated that patients in the lidocaine swab group tolerated
the procedure better than those in the lidocaine spray group. The procedural difficulty and
the need of intravenous sedation in the lidocaine swab group were lower than in the lidocaine
spray group. Additionally, the patients and the endoscopists in the lidocaine swab group were
more satisfied than in the lidocaine spray group. They suggested the use of posterior lingual
lidocaine swab for EGD procedure because of patient comfort and tolerance, endoscopist
satisfaction, and reduction of the need for intravenous sedation.
Ramirez and coworkers also compared the effect of glossopharyngeal nerve block and topical
anesthetic agent for EGD procedure [21]. The aim of the study was to evaluate the sedation,
tolerance to the procedure, hemodynamic stability, and the adverse events. They performed
a clinical trial in a total of 100 patients who underwent EGD procedures. All patients in both
arms also received intravenous midazolam. The procedures were reported without discomfort
in 48 patients (88%) in the glossopharyngeal nerve block group and 32 patients (64%) in the
topical anesthetic group. There were no significant differences in the incidence of nausea and
retching in both groups. The study confirmed that the use of glossopharyngeal nerve block
provided greater patient comfort and tolerance as well as also diminished the need for sedation
in EGD patients [21].
3.2. Intravenous sedation
Sedation for GIE procedure can be safely and effectively performed with a multidrug regimen
utilizing anesthesiologist or nonanesthetic personnel with appropriate monitoring. Currently,
sedation practices for GIE procedures vary widely. The need for sedation is decided by the
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type of endoscopy, duration of procedure, degree of endoscopic difficulty, patient physical
status, and physician’s preferences. However, the sedation regimen for GIE procedures is still
varied. Benzodiazepines and opioids are commonly used by nonanesthetic personnel. In
contrast, propofol in combination with opioids and/or benzodiazepines is usually used by
anesthetic personnel.
3.3. General anesthesia
The choice of anesthetic technique for GIE procedure depends on the patient and the type of
procedure. General anesthesia is commonly utilized in patients with ASA physical status >III
and patients with cardiorespiratory instability, as well as in long duration and complicated
procedures. Traditionally, tracheal intubation is also performed when general anesthesia is
used. An anesthesiologist usually uses balanced anesthesia technique including opioid,
inhalation agent, and neuromuscular blocking drug. The majority of these anesthetic agents
have short-acting and short-duration properties.
4. Anesthesia innovative techniques
4.1. Target-controlled infusion
Target-controlled infusion (TCI) is a computer-controlled open-loop administration of
anesthetic drugs. A continuous infusion technique uses a pharmacokinetic model to predict
the patient plasma and effect site concentrations from the infusion design and allows the
anesthesiologist to target a selected concentration. The device computes the appropriate
infusion system to accomplish this concentration [22]. The TCI rapidly attains and maintains
a predefined plasma or effect site concentration of the anesthetic drug. An appropriate target
concentration for achieving the desired clinical endpoint is selected. The TCI delivery system
performs better than the manual system. Presently, TCI devices for propofol administration
are approved in several countries.
Mazanikov and colleagues compared TCI (initial targeted effect-site concentration 2 mcg/mL)
with patient-controlled sedation (PCS) (single bolus 1 mL, lockout time set at zero) in 82
patients who underwent elective ERCP procedures. Alfentanil was supplemented if needed.
All procedures were performed successfully. Mean consumption of propofol and the recovery
time in the TCI group was significantly greater than in the PCS group. However, mean
consumption of alfentanil in both groups was comparable. The authors concluded that there
were no benefits of TCI over PCS for propofol administration in ERCP procedures [23].
4.2. Patient-controlled sedation
Because of interindividual variability, new techniques of administration for sedation have been
developed. Patient-controlled sedation (PCS) devices deliver a predefined bolus of intrave‐
nous drug during a defined time with or without a lockout interval. A prospective, random‐
ized, controlled study compared the use of PCS with propofol and remifentanil and the
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anesthesiologist-administered propofol sedation for 80 elective ERCP patients. Sedation level
was assessed every 5 min by using Ramsay and Gillham sedation scores. All ERCP patients
were completely successful except two patients in the PCS group. Mean level of sedation and
total propofol consumption in the PCS group were significantly lower than in the anesthesi‐
ologist-administered propofol group. However, patient and endoscopist satisfaction were
equally high in both groups. The study confirmed that PCS with propofol and remifentanil
was a safe and well-accepted sedation technique for ERCP patients [24].
Moreover, the use of PCS with propofol and remifentanil has been compared with fentanyl
and midazolam for sedation in patients who underwent colonoscopy by Mandel and collea‐
gues [25]. Their study demonstrated that time to sedation and the recovery time in the PCS
with the propofol and remifentanil group were significantly shorter than in the PCS with the
fentanyl and midazolam group. However, the perceptions of patients, nurses and endoscopists
were comparable between the two groups.
Procedural sedation in cirrhotic patients is challenged. Titration of sedative and analgesic
drugs is needed for an optimal sedation level. The use of PCS for sedation in these patients is
an alternative technique. Although, dexmedetomidine is suggested for procedural sedation
and reported effective for alcohol withdrawal, the efficacy of dexmedetomidine as a sole
anesthetic agent is controversial. Mazanikov and coworkers evaluated 50 patients with chronic
alcoholism scheduled for elective ERCP procedures. All patients in the PCS with propofol and
alfentanil group were successfully sedated, and in 19 of 25 (76%) patients in the dexmedeto‐
midine group. They also suggested that a loading dose of dexmedetomidine 1 mcg/kg over 10
min, followed by continuous intravenous infusion 0.7 mcg/kg/h was insufficient for the ERCP
procedure. In addition, dexmedetomidine was also related with prolonged recovery [26].
4.3. Computer-assisted personalized sedation system
The use of propofol for sedation in GIE procedures may allow for better quality of sedation
and faster recovery. Computer-assisted personalized sedation system (CAPS) is based on the
patient response to stimulation and physiologic profiles. It presents an attractive means of
delivering safe and effective doses of propofol. The closed-loop target-controlled system or
continuous EEG recordings are used to assess the degree of sedation. Patient-controlled
platforms may also be used. These devices may help physicians titrating propofol adminis‐
tration and controlling the physiological functions [27].
The SEDASYS System is a CAPS integrating propofol delivery with patient monitoring to allow
physicians to safely administer propofol. The efficacy and safety of this system for sedation
during GIE procedures was evaluated and compared with the combination of benzodiazepine
and opioid in 1000 adult patients with ASA physical status class I-III. All patients were sedated
in mild to moderate depth of sedation level. The study demonstrated that SEDASYS system
was safe and effective for sedation during EGD and colonoscopic procedures. Additionally,
patient and physician satisfaction as well as recovery time in the SEDASYS group were
significantly better than patients in the combination of benzodiazepine and opioid group [28].
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The use of inadequate sedative agents results in over and under depth of sedation. The use of
CAPS for administration of propofol by nonanesthetic personnel achieving mild to moderate
sedation in patients who underwent GIE procedures was evaluated by Pambianco and
coworkers [29]. This study showed that propofol administration in mild or moderate sedation
level by nonanesthetic personnel used with CAPS system in patients who underwent EGD
and colonoscopic procedures was safe and effective. Moreover, low propofol dosage and short
recovery time were noted.
4.4. Closed-loop administration of anesthesia
Closed-loop administration of anesthesia systems can provide anesthesia automatically and
its effect feedback controlled. This system contains a central system, a target control device
such as syringe pump, vaporizer, and other drug delivery systems [30]. Currently, there are
several closed-loop administration systems for neuromuscular blockade, depth of anesthesia,
and pain control during decreased levels of consciousness. In addition, McSleepy is also a
closed-loop control system that displays the patient’s depth of consciousness, muscular
movement during surgery, and the level of pain [30].
4.5. Teleanesthesia
Teleanesthesia is the use of telemedicine technology in anesthetic management including
preoperative assessment at distance, video consultation, and performing anesthesia in remote
locations where experienced anesthesiologists are not always present [30, 31]. The impact of
telemedicine pre-anesthesia evaluation on periprocedural processes was confirmed by
Applegate II and colleagues. Their study demonstrated that telemedicine pre-anesthesia
evaluation offered patients time- and cost-saving benefits without more surgical delay.
Moreover, telemedicine and in-person assessments were comparable, with high patient and
physician satisfaction [32].
5. Anesthetic agents
5.1. Local anesthetic agents
Generally, lidocaine is the most common local anesthetic agent used for GIE procedure. The
viscous lidocaine solution and lidocaine spray are usually performed for upper GIE procedure.
In addition, lidocaine gel or jelly is frequently employed for lower GIE procedure. Recently,
lidocaine lozenge has been tried to use for EGD procedure. Mogensen and colleagues evalu‐
ated the effect and acceptance of a lidocaine lozenge compared with a lidocaine viscous oral
solution as pharyngeal anesthesia before EGD [33]. The 110 adult patients were randomized
to receive either 100 mg lidocaine as a lozenge or 5 mL lidocaine viscous solution 2%. Supple‐
mental intravenous midazolam was administered if needed. They concluded that the lozenge
could reduce gag reflex and patients’ discomfort, and improved patients’ acceptance during
the procedure. In addition, the lozenge form had also a good taste [33]. Another study of the
lidocaine lozenge used for pharyngeal anesthesia in EGD procedure has been reported by
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Tumminakatte and Nagaraj [34]. The authors compared the efficacy, safety, and patient
comfort for the lidocaine lozenge and lidocaine viscous as a single agent before EGD proce‐
dure. This study showed that lidocaine lozenge was effective and safe for pharyngeal anes‐
thesia before EGD procedure. It was relatively better than lidocaine viscous in terms of lesser
discomfort and procedural difficulty as well as increased tolerability of the EGD procedure
[34].
Moreover, topical bupivacaine could be used as pretreatment for pharyngeal anesthesia in
unsedated EGD. The effect of a bupivacaine lozenge as pharyngeal anesthesia and a lidocaine
spray before EGD was assessed by Salale and coworkers [35]. Ninety-nine adult patients were
randomized to receive either a bupivacaine lozenge or lidocaine spray. Patient discomfort and
the acceptance of gag reflex during EGD procedures were evaluated. The results showed that
patient discomfort and gag reflex during procedure in the bupivacaine lozenge group were
significantly lower than the lidocaine spray group. The authors also suggested that bupiva‐
caine lozenge for topical pharyngeal anesthesia before an unsedated EGD procedure verified
to be a superior option as compared with lidocaine spray [35].
Chan and colleagues studied the effectiveness of 10% lidocaine pump spray plus plain Strepsils
and Strepsils anesthetic lozenge plus distilled water spray for EGD procedure in terms of
patient tolerance, taste of anesthetic agent, intensity of numbness, amount of cough or gag,
and the degree of discomfort at esophageal intubation. They concluded that topical lidocaine
spray was superior to the flavored anesthetic lozenge as a topical pharyngeal anesthesia in
unsedated EGD procedure [36]. Furthermore, the safety and efficacy of a lidocaine lollipop as
single-agent anesthesia for EGD has been evaluated by Ayoub and coworkers [37]. The main
outcome variables of the study were the success rate and safety of local anesthesia by using
lidocaine lollipop in addition to the need for intravenous sedation. Their study showed that




Midazolam is one of the most common drugs used for sedation during GIE procedures. It is a
rapid-onset, short duration of action, and water-soluble benzodiazepine with anxiolytic,
amnesic, sedative, muscle relaxant, and anticonvulsant properties. These actions are due to
the effect of binding to gamma-amino butyric acid receptors in the central nervous system.
Midazolam has few adverse effects. Respiratory depression is the most important adverse
effect and is synergistic when used in combination with opioids. The standard dose in adult
patients is 0.015-0.06 mg/kg [38].
5.3. Opioids
5.3.1. Fentanyl
Fentanyl is a potent synthetic opioid and also commonly used for GIE procedures. It has a
rapid onset, short duration of action, and lack of direct myocardial depressant effects. The
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onset of action is 30–60 s, and the duration of action is 30–45 min. Generally, the dose for GIE
procedure is usually 1–2 mcg/kg, with a maximum dose of 100–150 mcg in adult healthy
patients. Because of its analgesic effect, fentanyl is commonly used for therapeutic GIE
procedures. Of late, the combination of fentanyl and midazolam is an accepted regimen with
a safety profile [39-41]. However, fentanyl can cause respiratory depression including apnea
as well as nausea and vomiting. It can reduce the heart rate.
5.3.2. Remifentanil
Remifentanil is a fentanyl analog with a methyl ester group and is hydrolyzed by plasma and
tissue esterases. Its metabolism is not affected by genetics, age, hepatic failure, and renal failure.
Its action is rapid. The use of remifentanil for sedation in GIE procedures is not entirely
recognized. Remifentanil is generally performed by using the continuous infusion technique.
The TCI of remifentanil is another preference. The combination of propofol and remifentanil
for sedation in GIE procedures is usually used. The study of Abu-Shahwan and Mack dem‐
onstrated the efficacy and safety of a combination of propofol and remifentanil for deep
sedation in children who underwent GIE procedures [42]. In their study, anesthesia was
induced with sevoflurane and nitrous oxide in oxygen, and was maintained with infusion of
propofol and remifentanil. All GIE procedures were successfully completed with no compli‐
cations. However, this combination of propofol and remifentanil demonstrated the reduction
of heart rate, blood pressure, and respiratory rate.
Remifentanil in TCI appears to be a satisfactory drug for sedation in GIE procedures. However,
propofol in TCI for GIE procedures demonstrates better sedation than remifentanil in TCI. This
issue was confirmed by Munoz and colleagues [43]. They compared remifentanil and propofol
in TCI for sedation in 69 patients during GIE procedures. The authors concluded that propofol
in TCI for sedation in patients who underwent GIE procedures seemed to be an adequate agent.
Additionally, propofol in TCI created less adverse effects and higher patient satisfaction than
remifentanil in TCI.
5.4. Remimazolam
Remimazolam is a rapidly acting intravenous sedative drug. It combines the properties of
midazolam  and  remifentanil.  Additionally,  its  tendency  to  cause  apnea  is  very  low.
Remimazolam has potential to be used as a sedative drug in the intensive care unit and as
a novel agent for procedural sedation [44, 45]. Recently, remimazolam was evaluated for
sedation in patients who underwent upper GIE procedures by Rogers and McDowell. This
clinical  trial  demonstrated that the time to recovery from sedation of remimazolam was
faster  and  more  reliable  than  midazolam  [46].  Moreover,  Worthington  and  colleagues
assessed the feasibility of remimazolam for sedation during colonoscopy and reversing the
sedative effects of remimazolam with flumazenil in 15 healthy volunteers. The sedation for
colonoscopy  was  successfully  completed  in  more  than  70%  of  subjects.  In  addition,  all
subjects rapidly reversed with flumazenil  and also rapidly recovered within 10 min. No
serious adverse events were observed [47].
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5.5. Propofol
Propofol has sedative, hypnotic, and anesthetic properties. However, it does not have analgesic
effects. Propofol rapidly crosses the blood–brain barrier. The onset of action is 30–60 s. Dose
reduction is needed in patients with cardiac dysfunction and in elderly patients. However, the
dose reduction of propofol in patients with moderately severe liver disease or renal failure is
not required. Propofol potentiates the effects of analgesic and sedative drugs. The advantage
of propofol has been demonstrated for therapeutic GIE procedures and not for diagnostic GIE
procedures.
Propofol in combination with opioid or benzodiazepine can cause significant cardiovascular
depression and may result in a deeper than expected depth of sedation because of its narrow
therapeutic window. Pain at the injection site is the most frequent local complication. Several
methods for propofol delivery have been used for GIE procedures. Generally, propofol is
administered intravenously as a repeated bolus injection, continuous infusion, or a mixture of
both. Currently, the nonanesthesiologist-administered propofol is a controversial issue and
also varies among countries.
5.5.1. Propofol for GIE procedures
Generally, propofol is usually used for various GIE procedures. A previous study confirmed
that sedation with propofol alone or propofol combined with fentanyl or midazolam in
children was safe and effective. However, the use of propofol alone provides lesser sedation
and ease of endoscopy than the use of propofol in combination with fentanyl or midazolam
[48]. In Siriraj GI Endoscopy Center, the combination of propofol, fentanyl, and/or midazolam
was usually used for GIE procedures even in pediatric patients. Moreover, our previous
studies also demonstrated the clinical effectiveness of an anesthesiologist-administered
sedation outside of the operating room for pediatric GIE procedures. Although, all sedation-
related complications were relatively high, all of these complications were transient and easily
treated [39, 40, 49, 50]. In terms of procedure-related complications, propofol-based sedation
does not increase the rate of colonoscopic perforation [51].
For invasive GIE procedures, propofol-based sedation for ERCP and percutaneous endoscopic
gastrostomy procedures in sick and elderly patients by anesthetic personnel with appropriate
monitoring was also safe and effective without any serious complications [52-54]. The safety
of propofol sedation for EUS with fine needle aspiration procedure was confirmed by Pagano
and coworkers [55]. The complication rates for propofol deep sedation and meperidine/
midazolam administered for moderate sedation were not significantly different. Furthermore,
propofol combined with fentanyl and midazolam is frequently used for GIE procedures
including EUS and small bowel enteroscopy [56-60].
5.5.2. Nurse-administered propofol
Several guidelines do not recommend the use of propofol for routine GIE procedures. The
safety and efficacy of propofol administered by registered nurses has been reported in a case
series including 2000 patients undergoing elective EGD and/or colonoscopy [61]. Another
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study demonstrated that trained nurse-administered propofol for GIE sedation in patients
with ASA class I, II, and III was safe and effective. The anesthetic support was assisted in 11
patients (0.4%) [62].
5.5.3. Gastroenterologist-administered propofol
Similar to qualified nurses, the gastroenterologist can administer propofol effectively. Several
guidelines recommend that gastroenterologist-administered propofol should be used to sedate
patients only at mild or moderate sedation levels. Additionally, the patients must have ASA
physical status not more than III. The study of Vargo and colleagues confirmed that gastro‐
enterologist-administered propofol for elective ERCP and EUS procedures resulted in the
reduction of propofol dosage and the improvement of recovery activity as well as the rapid
detection of respiratory depression. This study also demonstrated that gastroenterologist-
administered propofol should be a cost-effective sedation technique [63].
5.5.4. Anesthesiologist-administered propofol
Propofol is commonly used by anesthesiologists for anesthesia in GIE procedures. To date, the
use of propofol is still controversial. Propofol can be used by well-trained registered nurses or
physicians in some countries. However, in developing countries, propofol-based sedation is
performed by anesthesiologists or anesthetic nurses. Berzin and coworkers accomplished a
cohort study of sedation-related adverse events, patient- and procedure-related risk factors
associated with sedation, as well as endoscopist and patient satisfaction with anesthesiologist-
administered sedation in 528 patients who underwent ERCP procedures. The study confirmed
that anesthesiologist-administered sedation for ERCP patients was safe and effective. Cardi‐
orespiratory-related adverse events were generally minimal [64].
5.6. Fospropofol
Fospropofol is a water-soluble prodrug of propofol that is currently approved for sedation for
diagnostic and therapeutic procedures. It is characterized by a smooth and predictable rise
and decline rapidly observed following intravenous administration. It does not cause pain on
intravenous injection, but it has been associated with paresthesia in the perineal and perianal
area. However, fospropofol causes dose-dependent hypotension, respiratory depression, and
apnea. Generally, a standard of fospropofol sedation is 6.5 mg/kg. In high-risk and elderly
patients, a lower dose should be administered. Bergese and coworkers compared the efficacy
and safety of fospropofol in a dose of 4.875 mg/kg and 6.5 mg/kg for sedation in high-risk
elderly patients who underwent colonoscopy. This study showed that fospropofol in a dose
of 4.875 mg/kg for sedation in high-risk elderly patients who underwent colonoscopy was not
a clinically significant advantage. Fospropofol in a dose of 6.5 mg/kg was recommended in the
elderly, obese, and high-risk patients when used for moderate sedation [65].
5.7. Ketofol
Ketofol is the combination of ketamine and propofol in various concentrations. It isan agent
of choice for a variety of GIE procedures. Ketamine, a neuroleptic anesthetic agent, works on
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thalamocortical and limbic N-methyl-D-aspartate receptors. Ketamine stimulates the cardior‐
espiratory system. A direct effect increases cardiac output, arterial blood pressure, heart rate,
and central venous pressures [66]. In contrast, propofol has antiemetic, anxiolytic, hypnotic,
and anesthetic properties. Additionally, propofol has a short recovery time without an increase
of cardiorespiratory side effects. As a result, the combination of these two drugs has several
benefits because of hemodynamic stability, lack of respiratory depression, good recovery and
post-procedural analgesia. The safety and efficacy of ketofol as a sedoanalgesic agent are
dependent on the dose and the ratio of the mixture [67].
Ketofol is also commonly used for sedation during GIE procedures. My previous study
evaluated the clinical efficacy of the ketofol and propofol alone when each regimen is used as
sedative agents for colonoscopic procedure. A 194 patients were randomized into two groups;
97 patients in group PK received propofol and ketamine and 97 patients in group P received
propofol and normal saline for sedation. All patients were premedicated with 0.02–0.03
mg/kg of midazolam. All colonoscopic procedures were completely successful. There were no
significant differences in patient tolerance, hemodynamic parameters, recovery activity,
patient and endoscopist satisfaction, as well as the sedation-related adverse events between
the two groups. In addition, these adverse events were transient and mild in degree [68].
5.8. Dexmedetomidine
Dexmedetomidine is a specific central alpha-2 adrenoreceptor agonist with sedative and
analgesic properties. Dexmedetomidine has no effect at the GABA receptor, and is not
associated with significant respiratory depression. The patients can be sedated but are able to
be awakened to full consciousness easily. It induces a biphasic blood pressure response: high
doses cause hypertension, and lower doses cause hypotension and bradycardia. The other
disadvantages of dexmedetomidine include a slow onset and longer duration of action [42].
To date, the role of dexmedetomidine for GIE procedures is not entirely established and
remains a controversial issue. Samson and colleagues compared the sedation efficacy and the
hemodynamic effects of dexmedetomidine, midazolam, and propofol in 90 patients with ASA
physical status I or II, who underwent elective diagnostic upper GIE procedures. The results
demonstrated that endoscopist satisfaction level, recovery, and the hemodynamic stability in
the dexmedetomidine group were significantly better than in the midazolam and the propofol
groups [69]. However, dexmedetomidine alone is less effective than the combination of
propofol and fentanyl for moderate sedation during ERCP procedure [70]. Most of the patients
needed supplementary analgesic and sedative drugs to accomplish the depth of sedation level.
However, these findings do not allow us to conclude that propofol alone is better than
dexmedetomidine alone, because the conclusion was established for propofol combined with
fentanyl. Moreover, dexmedetomidine was associated with higher hemodynamic instability
and a prolonged recovery phase [70].
5.9. Ketodex
Ketamine is a dissociative anesthetic agent and works on thalamocortical and limbic N-methyl-
D-aspartate (NMDA) receptors. Its actions are described by catalepsy in which eyes remain
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open and there is slow nystagmic gaze while corneal and light reflexes remain intact. Direct
effects increase cardiac output, blood pressure, heart rate as well as pulmonary arterial and
central venous pressures, which stimulates the cardiorespiratory system. However, ketamine
produces unpleasant psychological effects including hallucinations, nightmares, and emer‐
gence reactions. Dexmedetomidine is a specific central alpha-2 adrenergic agonist that
decreases central presynaptic catecholamine release. It has no effect at the GABA receptor, and
is not associated with significant respiratory depression. Its properties of sedation, anxiolysis,
and analgesia together with its beneficial pharmacokinetics make it a valuable adjunct for
procedural and intensive care sedation [66].
The use of ketodex for GIE procedures was reported by Goyal and colleagues [71]. They used
a bolus dose of ketamine 2 mg/kg and dexmedetomidine 1 mcg/kg for upper GIE procedures
in pediatric patients. The results of the study showed that blood pressure, heart rate, and
oxygen saturation did not change significantly from the baseline. The airway interventions
were not used. In addition, there were also no laryngospasm and postprocedural shivering.
The delirium score was lower than 4 in all patients except for two cases. This case series




Cisatracurium, an isomer of atracurium, is about three times more potent than atracurium and
less tendency to release histamine than atracurium. It experiences spontaneous degradation
at physiological pH and temperature by Hofmann elimination. Liver disease does not appear
to have an effect on cisatracurium. Pharmacokinetics and pharmacodynamics of cisatracurium
in normal adult and liver transplant patients do not show clinically significant differences in
the recovery profiles [72]. Because of its beneficial properties, cisatracurium is a muscle
relaxant drug of choice for tracheal intubation and maintenance during general anesthesia in
GIE procedures [50, 59].
5.10.2. Rocuronium
Rocuronium is a steroidal nondepolarizing neuromuscular blocking drug and has a rapid
onset of action. It is a muscle relaxant drug of choice for tracheal intubation and maintenance
during general anesthesia in GIE procedures [50, 59, 73]. Rocuronium has emerged as an
alternative to succinylcholine for facilitating rapid tracheal intubation in full stomach patients.
It is predominantly useful as a relaxant agent for tracheal intubation in patients at risk of
hyperkalemia and patients with known or suspected increased intracranial or intraocular
pressure. However, rocuronium may be used cautiously in patients with impaired liver
function [74].
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5.11. Reversal drugs
5.11.1. Naloxone
Naloxone is a pure mu-opioid antagonist with a high affinity for the receptor. It can reverse
both the analgesic and respiratory effects of opioids [4, 42]. The standard dosage of intravenous
naloxone is 1–2 mcg/kg with a maximum dose of 0.1 mg/kg and up to 2 mg. However, naloxone
has a short duration of action and one dose typically only lasts for 30–45 min. Patients should
be monitored for at least 2 h after the last dose of naloxone. The adverse reactions of naloxone
include reversal of opioid withdrawal, nausea/vomiting, hypertension, tachycardia, pulmo‐
nary edema, and cardiac dysrhythmias.
5.11.2. Flumazenil
Flumazenil is a benzodiazepine antagonist. It is a highly specific benzodiazepine receptor
antagonist and can safely reverse the sedative and respiratory effects caused by benzodiaze‐
pines. The adult dose is 0.01 mg/kg and up to 1 mg. Its duration of action is just about 1 h.
However, this effect is reversible. Importantly, the patients should be observed for at least 2 h
after the administration of flumazenil [4, 42]. The adverse reactions of flumazenil consist of
sweating, flushing, nausea/vomiting, hiccup, agitation, abnormal vision, paresthesia, and
seizure.
5.12. Sugammadex
Sugammadex is a selective relaxant binding drug that quickly reverses the effects of amino‐
steroid neuromuscular blocking agents such as rocuronium and vecuronium. It was success‐
fully used to reverse rocuronium-induced neuromuscular block in patients where neostigmine
was insufficient. Dogan and colleagues investigated the efficacy of sugammadex after
unsatisfactory decurarization following neostigmine administration. This study was per‐
formed on 14 patients who experienced inadequate decurarization (TOF < 0.9) with neostig‐
mine after general anesthesia. A dose of 2 mg/kg of sugammadex was used. The result
confirmed that sugammadex was successfully performed to reverse rocuronium-induced
neuromuscular block in patients where neostigmine was insufficient [75]. The capability to
reverse a rocuronium-induced neuromuscular block at any stage and possibly to improve
patients’ safety might make sugammadex a very attractive drug for the use in day-case
anesthesia.
Another study compared the efficacy of sugammadex and neostigmine for the reversal of
vecuronium-induced neuromuscular blockade in elective surgical patients [76]. All patients,
ASA physical status I-III obtained a dose of 0.1 mg/kg vecuronium for tracheal intubation and
maintenance dose of 0.02–0.03 mg/kg if needed. Neuromuscular blockade was monitored by
using acceleromyography. At the end of surgery, patients were randomized to receive either
sugammadex 2 mg/kg or neostigmine 50 mcg/kg and glycopyrrolate 10 mcg/kg. The study
showed that mean recovery times to a TOF ratio of 0.8 and 0.7 in the sugammadex group were
significantly shorter than in the neostigmine group. No serious adverse events were noted.
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The authors concluded that sugammadex presented significantly quicker reversal of vecuro‐
nium-induced neuromuscular blockade compared with neostigmine [76].
5.13. Inhalation agents
5.13.1. Sevoflurane
Sevoflurane is an inhalation agent with ideal properties for deep sedation during GIE proce‐
dures in pediatric patients. In addition, it is commonly used for balanced general anesthesia.
A retrospective study reviewed data from children receiving sevoflurane inhalation adminis‐
tered by an anesthesiologist via laryngeal insufflation to attain deep sedation for outpatient
GIE procedures. All patients were adequately sedated with sevoflurane, and no intravenous
line was needed. Time to awakening, discharge, and complication rate in the sevoflurane group
were significantly lower than in the combination of midazolam, fentanyl, and ketamine, as
well as in the propofol alone groups. This report suggested that deep sedation with sevoflurane
insufflation for pediatric outpatient GIE procedure is as safe as conventional sedation techni‐
ques [77].
Consequently, Meretoja and colleagues compared anesthesia with sevoflurane or halothane
for bronchoscopy or gastroscopy, or both in 120 infants and children. All pediatric patients
were assigned to receive either 7% sevoflurane or 3% halothane in 66% nitrous oxide in oxygen
for induction of anesthesia. Induction time and psychomotor recovery as well as the incidence
of nausea/vomiting and cardiac arrhythmia in the sevoflurane group were significantly lower
than in the halothane group. This study confirmed that the use of sevoflurane was better than
the use of halothane for bronchoscopy and gastroscopy procedures in pediatric patients [78].
5.13.2. Desflurane
Desflurane is an ether inhalational anesthetic agent. It offers the advantage of precise control
over depth of anesthesia along with a rapid, predictable, and clear-headed recovery with
minimal postoperative adverse events. It also has advantages when used in extremes of age
and in obese patients. Desflurane is generally used for the maintenance of balanced general
anesthesia because of its rapid recovery. Currently, the use of desflurane may increase the
direct costs of anesthetic care [79]. However, no significant differences were demonstrated
between desflurane and sevoflurane in the late recovery period.
6. Post-anesthesia care
Blood pressure, heart rate, respiratory rate, oxygen saturation, and level of consciousness are
monitored and documented at least every 15 min or less, for a minimum of 30 min after the
last dose of sedation drug. These parameters should be monitored and noted in the recovery
period. Moreover, the patients should be monitored for at least 2 h after the last dose of a
reversal drug. All patients will be discharged from the recovery room once the discharge
criteria are completed. Generally, the majority of sedated patients would complete an accept‐
able score on or before 1 h after GIE procedure. Most delays after satisfactory scores were due
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to nonmedical causes [80]. In ambulatory cases, the presence of an escort must be confirmed,
and the patients should not drive for at least 24 h.
7. Conclusion
GIE procedure requires some forms of anesthesia. To date, sedation for GIE procedure can be
effectively and safely performed by anesthesiologist or nonanesthetic personnel with appro‐
priate patient selection and monitoring. The new anesthetic drugs and monitoring equipments
for safety and efficacy are available. However, pre-anesthetic evaluation and preparation,
anesthetic drugs used, monitoring practices and post-anesthesia management are still essential
for the anesthesia innovations in GIE procedures.
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Abstract
Tissue biopsies are required for diagnosis, prognosis, and to measure individual drug
response markers for patient management. For pancreatic adenocarcinoma, surgically
harvested tissues are often used to collect data and perform genomic analysis to
identify driver oncogenes and specific mutations, or to quantify a handpick of
(micro)RNAs and proteins biomarkers. However, such strategy raises many concerns
not only because 80% of patients diagnosed with pancreatic adenocarcinoma are not
eligible for surgery, meaning that biopsies are not collected, but also because repeated
core biopsies are related to higher risk of morbidity, are expensive and logistics can
be limiting. Alternative sample collection methods include fine-needle aspirates
(FNA) collected under endoscopic ultrasound (EUS). In this chapter, we will describe
how EUS-FNA material can be a wealthy source of biomarkers for pancreatic cancer
patient management. In greater details, we will review how DNA, micro(RNA), or
protein analysis can help stratify pancreatic adenocarcinoma patients, from single
events analysis, to cutting-edge, high-throughput studies.
Keywords: FNA, microbiopsies, pancreatic diseases, NGS, miRNA, digital PCR
1. Introduction
Tissue biopsies are required for diagnosis, prognosis, and to measure individual drug response
markers for patient management. For pancreatic adenocarcinoma, surgically harvested tissues
are often used to collect data and perform genomic analysis to identify driver oncogenes and
specific mutations, or to quantify a handpick of (micro)RNAs and proteins biomarkers.
However, such strategy raises many concerns not only because 80% of patients diagnosed with
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pancreatic adenocarcinoma are not eligible for surgery, meaning that biopsies are not collected,
but also because repeated core biopsies are related to higher risk of morbidity, are expensive
and logistics can be limiting. Alternative sample collection methods include fine-needle
aspirates (FNA) collected under endoscopic ultrasound (EUS). In this chapter, we will describe
how EUS-FNA material can be a wealthy source of biomarkers for pancreatic cancer patient
management. In greater details, we will review how DNA, micro(RNA), or protein analysis
can help stratify pancreatic adenocarcinoma patients, from single events analysis, to cutting-
edge, high-throughput studies.
2. Fine-needle aspirates for pancreatic cancer diagnosis and prognosis
Pancreatic cancer remains one of the most deadly types of tumor. The five-year survival rate
after diagnosis is less than 3.5% [1]. Only 15% of pancreatic ductal adenocarcinoma (pancreatic
cancer) patients can be diagnosed at a resectable and possible curative stage. The remaining
patients diagnosed with locally advanced and/or metastatic tumors are treated in a palliative
way. Single-agent gemcitabine, although not dramatically improving survival, has demon‐
strated a significant clinical benefit and has become the standard chemotherapy for advanced
pancreatic cancer [2]. Recently, FOLFIRINOX protocol and association gemcitabine-Nab-
paclitaxel regimens were found to improve the survival of metastatic patients when compared
to gemcitabine alone [3, 4]. However, median survival does not exceed six and ten months for
metastatic and locally advanced pancreatic cancer, respectively [5]. One way to improve
pancreatic cancer management is to establish a rapid and clear diagnosis in order to operate
or to start a medical treatment as soon as possible. One of the critical clinical conditions is the
differentiation of pancreatic cancer from focal pancreatitis. It is indeed necessary to avoid
unnecessary resection of benign lesions (such chronic pancreatitis in its pseudotumoral form
or autoimmune pancreatitis) or to delay the treatment of pancreatic cancer in a subset of
patients. Recent advances in abdominal imaging techniques may favor a more rapid histolog‐
ical diagnosis and also may resolve some of these problems of differential diagnosis. Among
these imaging techniques, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)
is a rapid, safe, cost-effective, and accurate technique for evaluating and staging pancreatic
tumors [6–8]. EUS allows to guide FNA of solid pancreatic lesions for cytopathological
analysis. However, its performance for the diagnosis of malignancy varies widely with a
sensitivity ranging from 75–94% and an accuracy of 78–95%. In addition, if the specificity
approaches 100%, its negative predictive value ranges from 40–75%. In addition, EUS-FNA
may be inconclusive in up to 20% of cases [8, 9]. Overall, false-negative rates and atypical or
suspicious diagnoses remain relatively frequent using cytopathological analysis [9]. The
improvement of molecular biology techniques, including DNA and RNA amplification,
permits the analysis and quantification of molecular markers in cytological samples. In
addition, EUS-FNA is the main clinical appliance for cytological and histological material
collection from locally advanced pancreatic cancer that represents 85% of pancreatic cancer
patients. This chapter depicts the widespread potential for the molecular analysis of samples
obtained by EUS-FNA in conducting translational studies to improve knowledge and diag‐
nosis of pancreatic cancer.
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3. Identification of key mutations in tumor suppressor genes and
oncogenes using FNA material
We and others have demonstrated that DNA extracted from EUS-FNA material may permit
to detect single DNA mutations in key tumor suppressor genes and oncogenes for better
pancreatic cancer patients management (for review [6]). The next challenge is to identify new
technologies that are more sensitive than standard quantitative PCR (qPCR) or that may allow
screening of multiple mutations in a few nanograms of DNA. Recently, digital PCR (dPCR)
has shown promise in cancer diagnosis, although current dPCR systems have lower through‐
put than qPCR systems. dPCR is based on absolute nucleic acid quantification following
partitioning of individual molecules into multiple replicate reactions at limiting dilution.
Following reaction, the starting concentration of template is determined by Poisson statistical
analysis of the number of positive (with amplified target) and negative (without amplified
target) detected reactions [10]. By essence, dPCR is anticipated to be more tolerant to PCR
inhibitors by virtue of being an end-point approach; with improved amplification efficiency
and, thus, sensitivity. Accordingly, Hindson et al. recently compared the performance of dPCR
to real-time PCR in clinical specimens. When applied to serum microRNA biomarker analysis,
dPCR was proved to provide superior diagnostic performance for identifying individuals with
cancer than qPCR [10]. Similar results have been reported in a small cohort of patients with
pancreatic cancer. Dr Capella’s group recently demonstrated that digital PCR provides a
robust and quantitative assay for KRAS mutant alleles detection in routinely obtained samples
[11]. The next objective is to transfer this approach to the screening of DNA mutations in
material from EUS-FNA.
Large pancreatic cancer sequencing initiatives are revealing a vast array of molecular aberra‐
tions in histologically indistinguishable tumors (for review [12]). Of importance, the muta‐
tional burden seems to be particularly heterogeneous and this has major implications in
therapeutic development and clinical care. Indeed, better understanding the genetic and
molecular basis of cancer may not only help to stratify patients but also develop new classes
of therapies that selectively target molecular mechanisms that are essential for the survival
and proliferation of cancer cells. Unfortunately, such analysis requires amounts of material
that are out of reach following EUS-FNA. Alternatively, targeted next-generation sequencing
(NGS) can be performed with minimal amount of DNA. One of these approaches is based on
the Ion Torrent Ampliseq technology. In thyroid cancer, 5–10 ng of input DNA is sufficient for
the successful analysis of virtually all samples, either thyroid tissue or fine-needle aspiration
samples, and revealed point mutations in specific types of thyroid cancer [13]. We recently
translated this method to the analysis of FNA material from pancreatic tumors; we found that
this approach is feasible with minimal amount of DNA. Using the comprehensive cancer panel,
we verified KRAS mutation and discovered new mutations in key oncogenic drivers and tumor
suppressor genes that are currently validated by qPCR. Thus, targeted NGS holds great
promise for pancreatic cancer patient stratification and management.
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4. Quantification of microRNA in FNA material
Beside DNA, microRNAs are well-characterized biomarkers for pancreatic cancer manage‐
ment (for review [14]). To date, most studies are limited to the quantification of a handful of
selected candidate microRNAs in EUS-FNA material. For example, Dr Szafranska’s group
recently validated a 5-miRNA expression classifier to improve preoperative detection of
pancreatic cancer [15]. While these results are encouraging, further developments are needed
to analyze simultaneously several dozens of microRNA in EUS-FNA material. Current
methods for the detection and measurement of microRNA expression include the abovemen‐
tioned standard quantitative PCR and microarray based analysis. However, these methods
suffer several limitations when used in large clinical studies where a high-throughput and
highly quantitative technology is needed for the efficient characterization of a large number
of microRNA transcripts in clinical samples. Recently, high-throughput qPCR-based micro‐
fluidic technology (Biomark Fluidigm) has been evaluated to quantify microRNA expression
in lung cancer [16]. The authors demonstrate that (1) the technic is highly reproducible, (2)
multiplex results correlate closely with singleplex qPCR, (3) throughput is 5–20 times higher,
and (4) cost is approximately 50–100 times lower than conventional assays [16]. We recently
benchmarked and validated this approach for the analysis of 96 candidate microRNAs in EUS-
FNA material from pancreatic cancer patients, starting from 200 ng of total RNA (Fig. 1). In
addition, we found that amplification quality was greater when using material collected from
FNA and conserved in RNA later, as compared to material extracted from archived slides
(personal observation).
While the measurement of microRNA expression in rare cell populations or in precious
samples such as FNA still poses practical challenges due to the low amount of RNA present,
alternative techniques have been developed to quantify the complete microRNA landscape in
less than 50 ng of total RNA. Such highly sensitive real-time quantitative PCR strategy utilizes
microfluidic array cards containing prespotted TaqMan probes that allows the detection of
mature miRNAs in small reaction volumes. This approach, namely OpenArray® MicroRNA
Panels, was used for the characterization of microRNA expression in mouse hematopoietic
stem cells [17]. We have recently validated this approach for the detection and quantification
of circulating microRNA in patients (Buscail et al., Molecular Therapy, in press); similar
experiments are currently ongoing to characterize the microRNA pattern of expression in EUS-
FNA material from patients with pancreatic cancer.
5. Multiplexed protein analysis in FNA material
EUS-FNA has been proven as a useful method for diagnosing pancreatic lesions and is
associated with high accuracy in moderately to poorly differentiated pancreatic cancer.
However, diagnosis of well-differentiated cancer or early stage tumors can be challenging; in
these situations, an indeterminate diagnosis is often rendered. Ancillary stains can provide
much needed supportive evidence. Many studies have used a large number of stains to
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document an immunohistochemical profile of pancreatic cancer [18–25], but the number of
proteins than can be analyzed is often limiting. Recently, multiplexed flow cytometry and mass
cytometry have been proposed to examine an expanded set of markers (up to 50). However,
flow cytometry is often limited by the number of markers that can be analyzed due to spectral
overlap. Also, mass cytometry requires cells to be vaporized during sample preparation,
resulting in sample loss [26]. Very recently, Ullal et al. designed a remarkable strategy based
on antibody barcoding with photocleavable DNA platform to perform multiplexed protein
measurements in small amounts of clinical sample material [27]. This method showed high
reproducibility and achieved single-cell sensitivity. Using this strategy, the authors success‐
fully analyzed the expression of 90 candidate proteins and demonstrated that this method
could be used to identify pathway responses to molecularly targeted drugs in FNA, to help
predict drug response in patients with lung cancer [27]. While technically challenging, it is
tempting to speculate that this approach will be soon translated to the analysis of EUS-FNA
material from patients with pancreatic cancer.
Figure 1. qPCR-based microfluidic analysis of microRNA expression in pancreatic tumors FNA. Unpublished results.
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6. Future development: Defining pancreatic tumors heterogeneity at the
cellular level
As stated before, large-scale genomic studies on pancreatic tumors revealed marked inter- and
intratumoral heterogeneity and complexity, and may explain the lack of success of conven‐
tional, disease-based approaches, therapies. A better understanding of the underlying
molecular pathology at the cellular level may undoubtedly lead to novel therapeutics devel‐
opment. Indeed, many biological programs are performed under the assumption that all cells
of a particular type are identical. However, recent data suggest that individual cells within a
single population may differ quite significantly and these differences can drive the health and
function of the entire cell population, including major variation in the tumor cell microenvir‐
onment. Single cell analysis comprises a broad field that covers advanced optical, electro‐
chemical, mass spectrometry instrumentation, and sensor technology, as well as separation
and sequencing techniques. Although the approaches currently in use can offer snapshots of
single cells, the methods are often not amenable to longitudinal studies that monitor changes
in individual cells in situ. Recently, David Ting et al., from Dr Harber’s group in Harvard, have
performed epitope-independent microfluidic capture, followed by single-cell RNA sequenc‐
ing, to analyze circulating pancreatic tumor cells (CTCs) in experiment models [28]. The
authors demonstrate that CTCs exhibit a very high expression of stromal-derived extracellular
matrix proteins, including SPARC, a tentative prognosis marker for nab-paclitaxel-based
therapy. At present, the clinical use of single-cell analysis is – with the exception of preim‐
plantation diagnosis – still in its infancy. However, we are facing an era of integrated single-
cell genomic, epigenomic, transcriptomic, and proteomic analysis that will revolutionize
whole-organism science. Single-cell diagnostics will be instrumental for the realization of
personalized medicine for pancreatic cancer patients and for the development of completely
novel therapeutic concepts.
7. Conclusion
At present, the classification of tumors is mainly based on observational characteristics, such
as morphology, phenotype, or developmental origin. The current progress in developing
sophisticated approaches for investigating EUS-FNA material will definitely improve our
understanding of pancreatic cancer at multiple levels, through (1) a better definition of cell
types and intercellular variability, (2) a possibility to carry large-scale mutational, transcrip‐
tomic, or epigenomic analyses, and (3) an improved identification of rare cell types, to play an
increasing role in the detection of minimal residual disease or in the analysis of circulating
tumor cells. Accordingly, there are existing opportunities for more rapid improvement in
outcomes by adopting a more stratified or personalized approach using markers from different
molecular species. However, these progresses will have to complain not only with the
development of new drugs but also with clinical care and regulatory agencies. Nonetheless, it
is tempting to speculate that EUS-FNA-based molecular evidences will soon drive decision
making for patients with advanced pancreatic cancer.
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Abstract
Digestive endoscopy represents an essential diagnostic and curative tool used when
presented with a suspicion of gastrointestinal (GI) bleeding. Its role is not only
confined to primary detection but also to establishing the severity of a lesion and
providing relevant information regarding its risk of bleeding. New endoscopic
techniques, accessories and compounds make the minimally invasive treatment
suitable for a vast array of lesion types. Our main goal in this chapter is to summarize
the main presentation of lesions at risk of bleeding, briefly classify them according to
the gastrointestinal segment and finally detail the endoscopic treatment options
currently available.
Therapeutic endoscopy significantly reduced mortality from upper gastrointestinal
bleeding. Most common causes of lower gastrointestinal bleeding are: colon cancer,
diverticulosis, colon polyps, inflammatory bowel disease, hemorrhoids, anal fissures
and angiodysplasia. Digestive bleeding diagnosis strategy requires rapid clarification
of the following elements: recognition of gastrointestinal bleeding, specifying the
location of bleeding, assessment of its severity, specification of the etiology of bleeding
and patient’s risk factors. Early diagnosis of the cause of bleeding and endoscopic
hemostasis reduced the need for hospitalization, blood transfusions and emergency
surgery.
Keywords: endoscopic hemostasis, gastrointestinal, endoscopic treatment, colon
cancer
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1. Introduction
Digestive endoscopy represents an essential diagnostic and curative tool used when presented
with a suspicion of gastrointestinal (GI) bleeding. Its role is not only confined to primary
detection but also to establishing the severity of a lesion and providing relevant information
regarding its risk of bleeding. New endoscopic techniques, accessories and compounds make
the minimally invasive treatment suitable for a vast array of lesion types. Our main goal in
this chapter is to summarize the main presentation of lesions at risk of bleeding, briefly classify
them according to the gastrointestinal segment and finally detail the endoscopic treatment
options currently available.
2. Endoscopic semiology
In general, we can describe four main types of gastrointestinal lesions that may present a risk
of bleeding.
Hemorrhagic lesions are described as either active injury bleedings or the stigmata of bleeding.
The first type is found mainly as point hemorrhagic lesions that bleed. They appear in uremic
gastritis, some toxic or drug-induced gastritis. Bleeding stains are described as areas of 2-5 mm
in diameter, highlighted in alcohol or NSAIDs-induced gastropathies. A hemorrhagic area of
approximately 5-20 mm can present active bleeding, either diffuse, with areas of normal
mucosa, caused by capillary bleeding, or bleeding from a vessel [1], either continuous (vein)
or pulsating (arterial). The stigmata of bleeding persist after the bleeding has stopped, until full
healing occurs. Re-bleeding can be predicted from injuries: ulcers, varices, hemorrhagic erosive
gastritis [1-3].
They are described as petechial lesions (small hyperemic points that generally do not bleed),
bruising (blue area of the mucosa caused by extravasated blood) and blood clots (blood vessel
coated with a clot).
2.1. Flat lesions at risk of bleeding
The most commonly described is erythema, reddish appearance of the mucosa. Aftae are very
superficial erosions covered by fibrin debris with peripheral leukocytes and surrounded by
an intensely hyperemic halo. Deposits are usually purulent, a thin layer under which erosions
are usually found. Angiodysplasia lesions are dilated vascular structures, usually pulsatile,
and with multiple ramifications.
Vascular protrusions and protruding lesions at risk of bleeding are described as hemangio‐
mas - clusters of capillaries and veins produced by anarchic proliferation; varices - dilated
veins located in the submucosa, which protrude to the surface mucosa and have tortuous paths
[4] and polyps (polypoid lesions - Figure 1) that may have an ulcerated surface, covered with
detritus, or active bleeding.
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or pulsating (arterial). The stigmata of bleeding persist after the bleeding has stopped, until full
healing occurs. Re-bleeding can be predicted from injuries: ulcers, varices, hemorrhagic erosive
gastritis [1-3].
They are described as petechial lesions (small hyperemic points that generally do not bleed),
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2.1. Flat lesions at risk of bleeding
The most commonly described is erythema, reddish appearance of the mucosa. Aftae are very
superficial erosions covered by fibrin debris with peripheral leukocytes and surrounded by
an intensely hyperemic halo. Deposits are usually purulent, a thin layer under which erosions
are usually found. Angiodysplasia lesions are dilated vascular structures, usually pulsatile,
and with multiple ramifications.
Vascular protrusions and protruding lesions at risk of bleeding are described as hemangio‐
mas - clusters of capillaries and veins produced by anarchic proliferation; varices - dilated
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detritus, or active bleeding.
Endoscopy - Innovative Uses and Emerging Technologies76
Figure 1. Bleeding polyp of the sigmoid
Excavated injury at risk of bleeding are either cracks, ulcerations or ulcers. Cracks are
extremely narrow linear ulcerations that generally go deep and may be covered by necrotic or
hemorrhagic debris. Ulcerations are superficial, up to 2 mm deep, with a more or less regular
outline, having a diameter of 4-5 mm; they are generally acute. The ulcer (niche) represents a
loss of substance above 2-3 mm, with generally well-cut edges. Their shape varies depending
on the age of the lesion.
3. Lesions at risk of bleeding
3.1. Esophageal lesions
Esophageal varices are venous dilatations that continue gastric coronary veins, piercing the
wall of the esophagus above the cardia or in the submucosa. They usually appear in portal
hypertension of any etiology. Their color varies with depth: the deepest appear white, while
superficial varicose veins display a more bluish hue.
The caliber of esophageal varices varies depending on peristalsis, being more turgid and more
tortuous during movement. The classical classification of esophageal varices identifies 5
degrees, depending on size: Ist grade - protrude into the lumen, veins are tortuous, with sizes
up to 1-1.5 mm; IInd grade have dimensions between 2 and 4 mm and 3-4 mm beyond the
mucosa plan; IIIrd grade are more turgid, have more than 5 mm in diameter and may occupy
half of the esophageal lumen; IVth grade varices are 6-7 mm in size, exceeding half of the
esophageal lumen, without occluding it; Vth grade are larger than 6-7 mm (giant varices) and
are extremely dilated, frequently occluding the lumen of the esophagus.
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3.1.1. Early esophageal cancer
Malignant lesions limited to the mucosa and submucosa, with or without lymph node
metastases. Upper endoscopy can highlight different aspects: background mucosa erosion,
surface hyperemia and erythema, slightly elevated plates with grainy surfaces, or confluent
plaques which give the appearance of “orange peel” edema and congestion as red spots that
bleed easily. Cancer superficial erosion is friable, bleeding when touched by the endoscope,
and represents the most common lesion. It can produce an enteric fistula with massive aortic
bleeding which is often fatal.
3.1.2. Candidal esophagitis
Flat lesions with very thick fibrin and leukocyte deposits; underneath, we can find granulation
tissue, hyperemia, spontaneous bleeding.
3.2. Pathology of the stomach
Congestive mucosa is characterized by hyperemia, edema and exudation; may be the result
of irritation, functional disorders and gastritis. It can appear as red freckles distributed
throughout the gastric mucosa; mosaic-like (multiple areas of erythema, bordered by a whitish
reticular network); cherry-red spots, representing confluent areas of diffuse bleeding; black-
brown spots representing hematin, indicating an old bleedings.
Hemorrhagic gastritis is defined by the presence of hemorrhagic spots, either as ecchymosis
areas or diffuse gastric bleeding.
3.3. Vascular abnormalities of the colon
Angiodysplasia is diagnosed especially in the elderly, often in the cecum and ascending colon.
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is characterized by
small lesions that are found on the skin, lips and the entire gastrointestinal tract.
Hemangiomatosis cavernous is a rare condition characterized by cavernous hemangiomas of
the skin and is bluish in color in the gastrointestinal tract, including the colon. Cavernous
hemangiomas may be located remote from the rectum.
Varices can be located on any segment of the colon or rectum, more frequently in patients with
portal hypertension. Varicose veins of the anorectal junction are considered hemorrhoids.
Ischemic colitis can sometimes be encountered during the diagnosis of acute rectal bleeding.
Endoscopic changes are varied and depend on the severity and duration of ischemia. Endos‐
copy finds pale mucosa with multiple petechiae and hemorrhagic necrosis of superficial areas.
Similar ulcers may occur in late Crohn's disease (Figure 2), only less deep. Usually, these cases
do not reach endoscopy as they present as an acute surgical abdomen, soliciting emergency
intervention.
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Figure 2. Crohn's disease
3.3.1. Bleeding after endoscopic procedures
Bleedings are rare and usually minor after gastrointestinal endoscopy diagnostic procedures,
unless associated with anticoagulant therapy, thrombocytopenia and portal hypertension.
Postbiopsy bleedings are minor and stop spontaneously. Upper endoscopy with biopsy
diagnosis is generally a safe procedure, even at a platelet count of 20,000/mmc; currently
available data suggest that anticoagulation therapeutic target in appropriate doses and
treatment with standard doses of NSAIDs are not associated with increased risk of bleeding.
However, both biopsy and therapeutic procedures should be avoided if the platelet count is
below 20,000/mmc or if the anticoagulant treatment is overdosed.
4. Endoscopic therapeutical options
4.1. Endoscopic hemostasis
Endoscopic hemostasis is one of the most common applications of interventional endoscopy
procedures [5], due to the bleeding frequency and vital digestive and immediate risk that these
entail. Endoscopic hemostasis requires techniques used in combination to stop gastrointestinal
bleeding. Correct identification of the source of bleeding is a very important step as approxi‐
mately 2% of lesions are not identified at the first endoscopy. Once the source of bleeding is
identified, the next step is the application technique and hemostasis and the initiation of the
pharmacological treatment. “Second-look” endoscopy, defined as endoscopic revaluation
24-48 hours after successful hemostasis, is a controversial practice.
The main techniques used for endoscopic treatment of digestive bleeding are: endoscopic
ligation, injection techniques (such as injection of adrenaline or of sclerosing substances);
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laser therapy; argon plasma; thermocoagulation; electrocoagulation; mechanical techni‐
ques (metal clips, sewing equipment or equipment for mechanical suture).
Endoscopic ligation is indicated in digestive bleeding caused by rupture of esophageal varices,
Dieulafoy’s lesions rupture of varices stomach (lower but effective). It is based on fitting a
Saeed ligator multiband type (4-6-8 ligatures) at the end of therapeutic endoscope before the
examination. Consists of a plastic cylinder that is fitted with elastic bands that are issued by
tractioning a wire (non-metal or metal) into the biopsy channel. Ligatures of the wire are at
risk of trauma on channel biopsy, although this risk is reduced. Complications are possible:
postligature ulcerations (higher risk for varicose gastric), bacteremia, postligature pain and
strictures.
Endoscopic sclerotherapy uses a wide range of sclerosing agents [6, 7]: 70 degrees alcohol or
absolute alcohol sodium morrhuate, ethanolamine oleate and polidocanol. The main indica‐
tion is represented by gastric or esophageal varices. Alcohol is cheaper, but most endoscopy
centers in developed countries are using polidocanol. To gastric varices, the preferred
technique is injecting N-butyl-2 cyanoacrylate histoacryl (super glue) through a special
catheter. The main risks are the pulmonary embolism, as well as sticking of the biopsy channel
of the catheter, which resulted in serious damage in endoscope and even irreversible. Varicose
esophageal varices may be associated with risk of stricture of bacteremia and chest pain.
Sclerosing technique is relatively as simple as endoscopic ligation. Varicose is done by entering
the sheath sclerotherapy biopsy channel, with the needle inside (to avoid damage to the biopsy
channel). At the end of the sheath when viewing off peak endoscope, remove the needle from
the sheath and inject about 1-2 ml tangent in variceal path immediately below the bleeding,
repeating the procedure in the four quadrants. The maneuver can be repeated if bleeding is
not found to stop within 1-2 minutes. Higher doses may be associated with local necrosis.
After the endoscope advances to the identified place, the endoscopist can place the tip of the
endoscope immediately in place, as close as possible to the variceal path of the ligation cylinder.
Maintaining aspiration, one can apply a ligature by tractioning the ligation wire, continuing
for 2-3 seconds after the aspiration application of the ligature. Then repeat the procedure in
the four quadrants and the variceal tracts projecting from the lower to the portion on top of
the esophagus.
Injection of hemostatic solutions is useful in gastric ulcers, duodenal or anastomotic, Mallory-
Weiss syndrome even more effective in bleeding tumors or bleeding Dieulafoy’s lesions
postpolipectomy [7]. The 1/10000 adrenaline solution used is prepared by diluting 1 ml
adrenaline in 1/1000 9 ml saline. The needle sheath channel biopsy is used as in sclerotherapy
of esophageal varices. Injection of adrenaline around the lesion is bleeding in all four quad‐
rants, starting with the most distal point. The favorable effect is visible through bleaching and
raising the lining around the area where the injection is stopping bleeding. Electrocoagulation
consists in the application of high-power frequency of the tissue directly, resulting in a local
heat of 100°C. Thus, the bleeding vessel is closed by coagulation necrosis of the surrounding
tissue and the vascular wall. Efficiency of the method is shown in 80-95% of patients. The
multipolar electrocoagulation version is the most common today, consisting of applying three
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equally spaced bipolar electrodes. Multipolar electrocoagulation eliminates some drawbacks
of proof pole as unpredictable depth of tissue damage, adherence of tissue and mobilization
of clots.
The effectiveness of coagulation is expressed by flattening or even depression visible vessel,
which indicates the need for pressure, otherwise rebleeding might occur. Both coagulation and
polypectomy require an endoscopy laboratory device electrosurgical cutting and coagulation
current. Thermocoagulation is defined as a source of bleeding and coagulation by means of an
aluminum spatula coated with Teflon. The tool can be irrigated with a jet of water to prevent
the accumulation of debris and tissue clots on it. The method of coagulation is similar to
electrocoagulation.
Mechanical techniques include applying metallic clips and use of sewing machines and
equipment for mechanical suture. The available applicators clips are placed on the biopsy
channel and are applied by pressing the clip, then applicator detachment clip applicator is
withdrawn, with the clip remaining at the bleeding.
The primary indication is bleeding from larger vessels, but can be used for closure of holes or
iatrogenic postpolipectomy perforation. Both for hemostasis as well as for the treatment of
perforations recommend using multiple clips at the same lesion site.
Argon plasma coagulation (APC) requires argon plasma apparatus with argon cylinders.
Application is made from a distance of a few millimeters, without the need for direct contact
with the mucosa. Safe coagulation is possible because the effect is limited to 3 mm depth [8].
Introducing excess gas is one of the adverse effects. The major indication is represented by
angiodysplasia or diffuse bleeding from the rectum, but can also be used for palliative
purposes such as radical digestive tumors. Adenomatous tissue remnants can be destroyed,
postpolipectomy being useful in supplementing it. The laser can stop the bleeding by vaso‐
constrictive properties associated with protein wall degradation and dehydration, but its use
in endoscopic hemostasis is reduced.
5. Endoscopic treatment of some of the most prominent gastrointestinal
bleedings
5.1. Endoscopic treatment of variceal bleeding
Endoscopic sclerotherapy involves injecting sclerosing substances that cause coagulation
necrosis and induces instantaneous and local thrombosis. Endoscopic sclerotherapy is superior
to conservative measures, with a success rate of about 90% for the control of variceal bleeding;
early rebleeding frequency decreases and increases survival [9].
Thrombosis of esophageal varices is achieved by endoscopic injection of sclerotic agents
(absolute alcohol, sodium morrhuate 5%, ethanolamine oleate 5-10%, 1-2% sodium tetradecyl
sulfate) just above the esogastric junction. Paravariceal injections are performed, both intra‐
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variceal or combinations. Comparative studies of the effectiveness of different substances are
numerous, but the relative effectiveness of different substances is not clear.
The risk of rebleeding and complications is high. The most common cause of esophageal ulcers
appears to be massive rebleeding and mortality of 2-3%. Almost all patients have fever,
transient dysphagia and chest pain. Other possible complications are chest pain, aspiration
pneumonia, pleural effusions and mediastinitis [10, 11]. Frequency of complications depends
on the experience of the operator and is proportional to the amount of sclerosant injected; and
mortality induced complications are between 2-5%.
Endoscopic variceal ligation uses small rubber rings or strips of nylon for varicose veins
occlusion, promoting hemostasis by physical contraction, followed by local thrombosis.
Ligation with multiple lanes is used which allows strangulation of esophageal tract, followed
by local necrosis. Variceal path is drawn in clear plastic a cylinder loaded with elastic bands,
followed by the release of the first bands. The effectiveness of elastic ligatures is similar to
sclerotherapy to control acute bleeding esophageal varices rupture, the success rate of
approximately 90%. The number of sessions required for eradication is significantly lower
compared with sclerotherapy.
Complications are significantly reduced and mainly consist of dysphagia or esophageal ulcers.
However, esophageal ulcers laid after ligation tend to be small, with low risk of perforation
and strictures. Aspiration pneumonia is a complication of endoscopic examination in the
context of upper gastrointestinal bleeding [12]. A recently described complication consisted of
ligation circumference esophageal strictures after pushing to form a band with the endoscope
into the stomach [13].
Compared with sclerotherapy, endoscopic ligation gives better results in terms of frequency
of complications, prolonged survival but also a better control of active bleeding [14-16]. Meta-
analysis of published studies demonstrated that esophageal varices ligatures are significantly
more effective than sclerotherapy variceal rebleeding prevention, with fewer sessions needed
on average for eradication and fewer major complications [17]. Endoscopic ligation efficiency
of endoscopic sclerotherapyis superior to the use of somatostatin or octreotide drug therapy
[16, 17]. Usually, six elastic bands are used in the ligation sessions. Using a higher number of
bands is not associated with a higher efficiency and is accompanied by an increased time of
the procedure [18].
Endoscopic treatment by ligation of esophageal varices is more effective than medical therapy
in active variceal bleeding and to prevent early rebleeding [19]. Other options included the use
of cutouts (Endoloop) compared with elastic ligatures that appeared to have a similar efficiency
[20]. Plastic mini-loops (nylon) are passed through the biopsy channel and placed on the inside
of the cylinder. Similar elastic bands in variceal path are drawn into the transparent cylinder,
and then loop is detached and tightened. Similar elastic bands and sclerotherapy detachable
loops are associated with these possible complications: esophageal ulcers laid, laid pierce,
strictures and infections. Although the authors consider cutouts as an option compared to
treatment with elastic ligatures, this method has not gained popularity due to technical
difficulties using cutouts in acute hemorrhage.
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5.2. Gastric varices
In esogastric varices Type I (continuation of esophageal along the lesser curve gastric),
treatment should be similar to HDS treatment of esophageal varices rupture. If gastric varices
are isolated using adhesive agents (N-butylcyanoacrylate, isobutyl-2-cyanoacrylate and
thrombin), endoscopic ligation compared with sclerotherapy and alcohol is superior to a better
initial control of bleeding and rebleeding rate of less [21, 22]. In a recent pilot study of a new
adhesive agent, 2-octyl cyanoacrylate appears to be as effective in obtaining hemostasis and
prevents rebleeding from initial background varices [23].
Other invasive treatments (TIPS, surgical shunts, splenectomy, retrograde transvenous
obliteration balloon occlusion) are still used. An attractive option was to use elastic ligatures
or cutouts, which are being evaluated, taking into account the low efficiency of sclerotherapy.
Endoscopic obstruction by 2-cyanoacrylate isobutyl (bucrylate) or 2-cyanoacrylate N-butyl-
(histoacryl) is used for large esophageal or gastric varices. The mechanism of action consists
in polymerization and rapid solidification after intravariceal injection. Complications include
emboli (lung, kidney, brain, etc.) in up to 5% of the patients, the passage of the adhesive through
the inferior vena cava or gastrorenal or damage to the endoscope (channel occlusion) or needle
impaction varices. Dilution with lipiodol is preferred since the polymerization process delays
by 20 sec [24].
In the absence of tissue adhesives, conventional endoscopic techniques involve the use of
elastic ligatures with or without combinations with sclerotherapy. Sclerotherapy classic
sclerosing substance is not currently listed, complications are due to large and high frequency
of severe and fatal rebleeding [24]. Elastic ligatures combined use of sclerotherapy with
cyanoacrylate seems to be superior to simple methods [25, 26].
Combined treatment (ligatures + sclerotherapy) in patients with gastric variceal bleeding assets
seems very promising, 100% taking into account initial hemostasis (after ligation and injection
of 1% polidocanolinto the neighboring submucosa) [27]. These promising results will be
confirmed in prospective studies with large numbers of patients. Retrograde transvenous
obliteration occlusion balloon is a method recently used with good results in patients with
gastric and gastrorenalvarices [28, 29]. Left adrenal vein is cannulated through a retrograde
path from the right femoral vein or right internal jugular vein. After vein occlusion, left renal
venography is performed and sclerosating agents are injected (ethanolamine oleate) mixed
with iopamidol, with radiological control up to complete filling of gastric varices. Compared
to treatment with TIPS, transvenous obliteration has the same proportion of hemostasis,
rebleeding and encephalopathy, the major drawback being that it cannot be performed in
patients with gastrorenalvarices [18].
5.3. Non-variceal upper gastrointestinal bleedings
Endoscopic treatment allows definitive stop of active bleeding in over 90% of the cases [30-32].
Meta-analysis of published studies have clearly indicated that active bleeding stops endo‐
scopic treatment in most cases and significantly reduces the frequency of rebleeding, transfu‐
sion requirements, emergency surgical interventions and mortality [33-35]. Mortality is
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directly correlated with rebleeding, both dependent on different variables and clinical stigmata
of bleeding as defined by Forrest classification. A consensus was reached that endoscopic
treatment must be performed only in patients with increased risk of bleeding or rebleeding
and thus increased mortality [36].
Patients with active bleeding (Forrest Ia and b) and visible vessel (Forrest IIa) are treated by
endoscopy. Although initial studies recommended treatment of ulcers with adherent clot
(Forrest IIb), several recent studies have demonstrated these patients require treatment by
endoscopic removal of the adherent clot [37, 38]. Patients with pigment spots in the ulcer crater
(Forrest IIc) or clean base (Forrest III) did not receive endoscopic treatment; with a low
frequency of rebleeding, a proton pump inhibitor treatment is sufficient. Different endoscopic
hemostasis treatments are currently available for endoscopic hemostasis: injection (adrenaline
or sclerosing agents), thermal methods (argon plasma coagulation or multipolar) or mechan‐
ical methods (clips, ligatures elastic). The primary hemostasis is achieved in over 95% of cases,
rebleeding seen in 5-10% of patients, respectively mortality of approximately 5% [39]. How‐
ever, there is an extremely high variability of methods used and results obtained from different
centers, probably due to experienced endoscopists and risk category included for patients (age,
associated diseases, etc.) [40].
5.4. Hemostasis injection
Endoscopic hemostatic treatment by injection is applied using a metal retractable catheter
needle, which is inserted through the biopsy channel of the endoscope. Live view of the needle
tip allows precise positioning of endoscopic control. If the lesions are located at tangential face
of needle, the needle can be removed to cling to the lining and to facilitate positioning catheter.
Injection of epinephrine 1:10,000 is used frequently in ulcer bleeding but can be used on other
types of non-variceal lesions). Injection of epinephrine 1:10,000 has very few risks and
complications. The risk of perforation is also negligible. According to a recent study, it was
shown that injection of submucosa adrenaline can cause significant hemodynamic changes
that can lead to severe cardiac adverse effects [41]. In this regard, monitoring heart after
administration of epinephrine is the recommended cautious attitude more especially when
used in large doses. In the treatment of bleeding lesions, esophagus total dose of adrenaline
should be carefully titrated and should be used with a minimum dose that can achieve
hemostasis. Sclerosing substances are generally reserved for hemostasis in patients with
variceal bleeding, especially for esophageal varices. Histoacryl (N-butyl-2-cyanoacrylate) is a
tissue adhesive which instantly coagulates in contact with blood. Injection of the varices
histoacryl determines the solidification path of the variceal occlusion by inducing thrombosis
vein, being used mainly for gastric varices. Rubber band ligation is not effective in mucous
coating and is gradually affected by exulceration favoring the use of extrusion solidified
adhesive, with the emergence of a profound ulcer. The main complication consists of glue
embolization at brain and lung.
Thermal hemostasis methods can be divided into direct contact and non-contact thermal
coagulation. Non-contact coagulation refers to the use of laser treatment or argon plasma
coagulation jet. Coagulation is used in baked, i.e. non-variceal, hemorrhage when a vessel is
visible. There are significant differences between monopolar coagulation probes, bipolar and
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centers, probably due to experienced endoscopists and risk category included for patients (age,
associated diseases, etc.) [40].
5.4. Hemostasis injection
Endoscopic hemostatic treatment by injection is applied using a metal retractable catheter
needle, which is inserted through the biopsy channel of the endoscope. Live view of the needle
tip allows precise positioning of endoscopic control. If the lesions are located at tangential face
of needle, the needle can be removed to cling to the lining and to facilitate positioning catheter.
Injection of epinephrine 1:10,000 is used frequently in ulcer bleeding but can be used on other
types of non-variceal lesions). Injection of epinephrine 1:10,000 has very few risks and
complications. The risk of perforation is also negligible. According to a recent study, it was
shown that injection of submucosa adrenaline can cause significant hemodynamic changes
that can lead to severe cardiac adverse effects [41]. In this regard, monitoring heart after
administration of epinephrine is the recommended cautious attitude more especially when
used in large doses. In the treatment of bleeding lesions, esophagus total dose of adrenaline
should be carefully titrated and should be used with a minimum dose that can achieve
hemostasis. Sclerosing substances are generally reserved for hemostasis in patients with
variceal bleeding, especially for esophageal varices. Histoacryl (N-butyl-2-cyanoacrylate) is a
tissue adhesive which instantly coagulates in contact with blood. Injection of the varices
histoacryl determines the solidification path of the variceal occlusion by inducing thrombosis
vein, being used mainly for gastric varices. Rubber band ligation is not effective in mucous
coating and is gradually affected by exulceration favoring the use of extrusion solidified
adhesive, with the emergence of a profound ulcer. The main complication consists of glue
embolization at brain and lung.
Thermal hemostasis methods can be divided into direct contact and non-contact thermal
coagulation. Non-contact coagulation refers to the use of laser treatment or argon plasma
coagulation jet. Coagulation is used in baked, i.e. non-variceal, hemorrhage when a vessel is
visible. There are significant differences between monopolar coagulation probes, bipolar and
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multipolar heater samples and the mechanism of action is similar [42]. Area bleeding or visible
vessel is compressed while applying electrical or thermal energy in pulses that lasts up to 8
consecutive seconds. The preferable accessories are large (3.2 mm) and a current of 15-25 W.
The application of thermal energy in the absence of compression of the vessel wall may worsen
breakthrough of bleeding vessel wall. The risk of perforation is substantially increased in acute
ulcers approached by thermal coagulation.
Argon plasma coagulation (APC) transmits heat to tissues through ionized gas and does not
require direct contact probe to target lesion. APC cannula is placed 1-2 mm distance from target
lesion and activated to induce coagulation of tissue surrounding surface. The risk of perfora‐
tion is lower, excluding attachment of the cannula tube to the wall tract. Argon plasma
coagulation is used for the treatment of superficial injury of vascular malformation type. In
addition, APC was elastic ligatures used in combination with secondary prophylaxis variceal
bleeding due to reduction of variceal recurrence. Although they are highly effective achieving
hemostasis, mechanical devices are extremely difficult to place in lesions that are difficult to
reach (small gastric curvature and posterior wall of the duodenum).
Metal clips are similar to surgical sutures and can be placed endoscopically under direct vision.
Two to five clips are generally placed for achieving hemostasis in the area of bleeding or visible
vessel. The main advantage lies in the absence of tissue damage and the possibility of using in
deep ulcers or large blood vessels. Videos can also be used to close small punctures on them,
although difficult to locate, especially when using tangential or ulcers central fibrosis.
Elastic ligatures are currently considered the treatment of choice for the rupture of esophageal
varices. Elastic ligatures are particularly effective for stopping jet bleeding (spurting), although
equally difficult to place in conditions like fibrosis of ulcers [43-45]. Placement is facilitated by
the injection of mucosa adrenaline 1:10,000. Both clips as well as elastic ligatures are relatively
easy to place and have good efficiency in cases of non-variceal HDS of due to non-ulcer:
Mallory-Weiss syndrome, arteriovenous malformations, Dieulafoy’s lesion, or bleeding
postpolipectomy, such as endoscopic mucosa resection [46-48]. Rebleeding seems to be greatly
reduced by using mechanical hemostasis (clips or ligatures) versus adrenaline injection in
patients with Dieulafoy’s lesions [49]. Removable clips were initially used to reduce bleeding
occurring after the resection of formations protruding the mucosa, tailored with a plastic
cylinder used for variceal bleeding. In patients with chronic colitis with HDS, non-variceal
hemostasis is more effective in combination by applying heat treatment and injection.
Hemostasis techniques may be ineffective in a variable number of cases. In these situations,
alternative techniques are used which include coagulation jet argon plasma (APC) or mechan‐
ical devices (metal clips, ligatures removable nylon elastic loops) [50-52]. Good results occur
after placement of the ligatures, elastic, in particular small lesions (Dieulafoy’s lesions,
hemangiomas, small ulcers <1 cm, etc.).
5.5. Rebleeding and “second-look” endoscopy
Active bleeding cannot be controlled by endoscopic and it requires emergency surgical
intervention [53]. Patients who rebleed after endoscopic treatment must repeat endoscopy to
confirm the source of bleeding and bleeding stigmata. After rebleeding, endoscopic retreat‐
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ment intervention is comparable to surgical prognosis [54]. The management of rebleeding
after endoscopic treatment and correct medical treatment depend largely on local expertise
and clinical judgment [53]. Endoscopic or surgical treatment decision after rebleeding obvi‐
ously depends on the age, associated diseases and bleeding stigmata. Thus, a patient duodenal
ulcer with a giant rear face with stigmata of recent hemorrhage requires surgical intervention,
while a young patient without leather rot associated with a small curvature gastric ulcer on
endoscopy can be restated. “Second-look” endoscopy is controversial, published studies have
demonstrated only a smaller proportion of rebleeding, but the same survival and required
surgical intervention [55]. Repeat endoscopy is indicated in patients with clinical suspicion of
rebleeding (hematemesis, melena, tachycardia, decreased pressure). Although some patients
require direct surgical intervention, the majority of repeat endoscopy are indicated to confirm
rebleeding [53].
5.6. Vascular malformations
Vascular malformations laid comprise several entities: angiodysplasia (Figure 3), telangiecta‐
sia (Osler-Weber disease, Rendu syndrome or Turner CREST) phlebectasia (varicosities and
well-defined circular) and hemangiomas. Moreover, although endoscopically identified as a
possible cause of bleeding, they cannot be differentiated based on endoscopic appearance. The
diagnosis of leather rot are used and other imaging techniques such as angiography or, more
recently, positron endoscopic optical coherence Doppler (Doppler optical coherence tomog‐
raphy) is a method that detects different vascular patterns [56].
Angiodysplasia (Figure 3) are found within 5% of gastrointestinal bleeding higher, being more
common in the stomach, duodenum and proximal portion small intestine. Prevalence of
angiodysplasia appears to be greater in patients with chronic renal insufficiency. Endoscopic
treatment was performed along time with different methods (injection, multipolar electrocoa‐
Figure 3. Gastric angiodysplasia and duodenal ulcer
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gulation and bimechanical methods), but the degree of success is variable. Rebleeding is
frequently encountered by all forms of treatment, due to the presence of lesions that are
multifocal, inaccessible and the potential for the formation of new lesions [57]. The most
common method remains bipolar coagulation and laser treatment Nd: YAG [58]. Recent
studies have indicated the usefulness of eradication lesions using argon plasma coagulation
(APC) [59]. Isolated gastric angiodysplasia can be treated with elastic ligatures [60]. Multiple
other non-endoscopic treatments of angiodysplasia were tested with variable results: hormo‐
nal medication, administration of octreotide, antiangiogenic agents used in oncology and
(thalidomide, lenalidomide bevacizumab, etc.), the management of acid aminocaproic [61-63].
Endoscopic treatment reduces the rebleeding and transfusion needs. Surgery is an indication
only in cases with severe or acute hemorrhage in patients with severe anemia; persistent
bleeding in the intestinal segment is usually well defined.
5.7. Gastrointestinal tumors
Gastrointestinal tumors are a common cause of non-variceal bleeding, most cases the gastric
adenocarcinomas (Figure 4). Other tumors encountered are ampullary or duodenal tumor
invasion of pancreatic head cancers, submucosal or metastatic tumors. Immediate survival of
these patients is similar to other patients with non-variceal HDS, but prognosis term is
reserved. Endoscopic treatment has limited benefits; endoscopic hemostasis has a role to delay
until the intervention is definitive or palliative surgery. Inoperable patients may benefit from
palliative treatment with laser or argon plasma.
5.8. Esophagitis and esophageal ulcers or contravention of junction esogastric
Reflux esophagitis occurs due to prolonged contact of contents of peptic esophageal mucosa
and being characterized pathologically by esophageal mucosal inflammatory lesions that are
Figure 4. Gastric adenocarcinoma
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potential sources of bleeding [64]. 5% of reflux esophagitis and be complicated by gastroin‐
testinal bleeding. It can be located at esogastric junction or mucosal metaplasia of Barrett’s
esophagus, requiring repeat biopsies to exclude esophageal cancer that can develop within the
lesion. Reflux esophagitis occurs frequently in the presence of hiatal hernia. In the context of
the presence of hiatal hernias, large Cameron ulcers can occur, which are longitudinal ulcers
identified in approximately 1/3 of patients [65].
Esophagitis can occur during or after radiation treatment for lymphoma, lung cancer, breast
cancer or other mediastinal malignancies. These patients have increased risk of developing
esophageal cancer in a few years. Acute necrotizing esophagitis (black esophagus) is a
particular form of severe damage to the esophagus, rarely met, but frequently associated with
upper gastrointestinal bleeding. It generally appears in patients with severe general condition,
with cancer or after severe infections.
5.9. Erosive gastritis and hemorrhagic gastropathy
Erosive  gastritis  stress  and  hemorrhagic  gastropathy  accounts  for  25% of  cases  of  non-
variceal bleedings [64]. Stress gastritis generally occurs in patients with shock, burns, sepsis,
severe trauma, multiple organ insufficiency after complicated surgical interventions and so
on.  In  general,  stress  gastritis  is  characterized  by  the  occurrence  of  multiple  superficial
gastric ulcers, with diffuse bleeding. These lesions are located initially at the back of the
gastric body then extend throughout the gastric surface. In most patients the bleeding stops
spontaneously,  but  medical  treatment  and  angiographic  or  surgical  excision  may  be
necessary to a small fraction of patients [64]. Prophylaxis of stress gastritis is much more
important,  being  necessary  to  prevent  bleeding  by  increasing  digestive  intragastric  pH
above 4.  Hemorrhagic erosive gastropathy consists  of  multiple erosive and subepithelial
bleeding, endoscopic views, which may cause digestive bleeding. These injuries occur in
different clinical circumstances, the most common being the intake of NSAIDs, aspirin and
alcohol. Bleeding from gastric and gastropathy have low severity, stop spontaneously, and
mortality is relatively low. Stop the NSAID or aspirin and patients are treated with standard
PPI doses. Endoscopic treatment is not necessary.
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Abstract
Research Focus - NOTES is a new technique that faces numerous challenges. Current
technology, training and research activities are conducted to make it a safe and
effective minimal access technique.
Research Methods Used - This chapter is based on the current evidence of published
NOTES studies. Medline search is conducted through November to December 2014,
including English literatures only. The search words are NOTES, natural orifice
translumenal endoscopic surgery, hybrid NOTES and hybrid natural orifice translu‐
menal endoscopic surgery; additional search words are specific for the titles like
NOTES gastric, NOTES oesophageal, NOTES biliary, NOTES cholecystectomy,
NOTES pancreatic, NOTES small bowel, NOTES colorectal and NOTES appendicec‐
tomy. Animal and human studies are selected after 2008. Small studies are excluded
unless they report a novel approach or a new procedure.
Results/Findings of the Research - There is development in the technology by
installing new platforms, instruments and closure devices to add more safety and
security. There is also development in training and research activities across the
continents; a number of NOTES procedures are performed safely on human beings
including cholecystectomy, appendicectomy, peritoneoscopy, POEM and other
procedures. Feasibility studies are conducted on animal and human cadaver models
including numbers of complex procedures.
Main Conclusions and Recommendations - NOTES is evolving and gaining popular‐
ity. The growth rate however is slowed by challenges of the need for an ideal working
platform and closure devices that are easy to use, cheap and time effective, in addition
to the dedicated effective training.
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1. Introduction
Modern endoscopy began in 1805, when Phillip Bozzini first used a system to visualise the
inside of the rectum and bladder through a mirror, a candle and a double-lumen ureteral
catheter. The first source of inner light was invented by Bruck [1]. In 1878, Maximilian Carl-
Friedrich Nitze introduced the first working cystoscope that contained a prismatic lens system
and a channel through which you could insert a ureteral catheter, conducted in collaboration
with Joseph Leiter [2]. Diagnostic methods of gastrointestinal tract have been evolving using
flexible endoscopy. Dimitrij Oscarovic Ott (1855–1929) can undoubtedly be called the true
pioneer of laparoscopy, especially of natural orifice translumenal endoscopic surgery
(NOTES). In 1901 already he performed abdominal examinations via a transvaginal (Tv) access
calling this procedure ‘ventroscopy’ [3]. In 1954 Hopkins made a crucial development by the
idea of incorporating the light into scopes using the concept of multiple lenses separated by a
room of air. Hopkins could never make the fibrescope, and it was a South African, Basil
Hirschowitz, who made the first flexible fibreoptic gastroscope using Hopkins’s idea [4].
Endoscopic retrograde cholangiopancreatography (ERCP) which was developed in 1968 and
endoscopic ultrasound (EUS) in the 1980s are important milestones. With the development of
sophisticated flexible scopes, it became feasible to conduct certain diagnostic and therapeutic
GI procedures. Anthony Kalloo in 2000 reported the first peritoneoscopy on pigs [5]. Gastro‐
intestinal (GI) NOTES is a further development in the minimal access surgery (MAS). It has
been received by surgical community with scepticism similar to what happened with the first
laparoscopic cholecystectomy (LC) when Muhe introduced it for the first time to the German
Surgical Society in 1985. In 2004 Rao and Reddy performed the first transgastric (Tg) appen‐
dicectomy [6]. In 2012, authors considered that rigid standard laparoscopy provided better
organ visualisation, better lesion detection and better biopsy capability than the transgastric
(Tg) and transrectal (Tr) NOTES approaches [7], and that is expected as NOTES still undergo
refining and development which should push for more efforts to overcome these challenges.
In spite of uncertainty, GI NOTES proved itself for a number of procedures that are applied
in elective and emergency settings with significant contribution to improve the care and
attained a high level of patient satisfaction and most importantly a great scale of safety and
efficacy. The GI NOTES is gaining popularity but at slower rate compared to LC. It has been
limited to the university institutions and big teaching tertiary centres across Europe, America
and Asia. Nevertheless, large series are reported on human beings. Many centres are conduct‐
ing feasibility studies on animals as well as cadavers and patients. Several obstacles are
preventing the wide applications of NOTES. Of these is the need for advanced endoscopic and
laparoscopic skills, infrastructure setting, funding and local health authority approval and
health systems bureaucracy. Germany reports the highest number of human NOTES proce‐
dures in the Europe, while the USA is the leading state in the American continent.
Endoscopy - Innovative Uses and Emerging Technologies96
Keywords: Upper GI NOTES, Lower GI NOTES, Oesophageal NOTES, Gastric
NOTES, Duodenal NOTES, Liver NOTES, Pancreatic NOTES, Splenic NOTES
1. Introduction
Modern endoscopy began in 1805, when Phillip Bozzini first used a system to visualise the
inside of the rectum and bladder through a mirror, a candle and a double-lumen ureteral
catheter. The first source of inner light was invented by Bruck [1]. In 1878, Maximilian Carl-
Friedrich Nitze introduced the first working cystoscope that contained a prismatic lens system
and a channel through which you could insert a ureteral catheter, conducted in collaboration
with Joseph Leiter [2]. Diagnostic methods of gastrointestinal tract have been evolving using
flexible endoscopy. Dimitrij Oscarovic Ott (1855–1929) can undoubtedly be called the true
pioneer of laparoscopy, especially of natural orifice translumenal endoscopic surgery
(NOTES). In 1901 already he performed abdominal examinations via a transvaginal (Tv) access
calling this procedure ‘ventroscopy’ [3]. In 1954 Hopkins made a crucial development by the
idea of incorporating the light into scopes using the concept of multiple lenses separated by a
room of air. Hopkins could never make the fibrescope, and it was a South African, Basil
Hirschowitz, who made the first flexible fibreoptic gastroscope using Hopkins’s idea [4].
Endoscopic retrograde cholangiopancreatography (ERCP) which was developed in 1968 and
endoscopic ultrasound (EUS) in the 1980s are important milestones. With the development of
sophisticated flexible scopes, it became feasible to conduct certain diagnostic and therapeutic
GI procedures. Anthony Kalloo in 2000 reported the first peritoneoscopy on pigs [5]. Gastro‐
intestinal (GI) NOTES is a further development in the minimal access surgery (MAS). It has
been received by surgical community with scepticism similar to what happened with the first
laparoscopic cholecystectomy (LC) when Muhe introduced it for the first time to the German
Surgical Society in 1985. In 2004 Rao and Reddy performed the first transgastric (Tg) appen‐
dicectomy [6]. In 2012, authors considered that rigid standard laparoscopy provided better
organ visualisation, better lesion detection and better biopsy capability than the transgastric
(Tg) and transrectal (Tr) NOTES approaches [7], and that is expected as NOTES still undergo
refining and development which should push for more efforts to overcome these challenges.
In spite of uncertainty, GI NOTES proved itself for a number of procedures that are applied
in elective and emergency settings with significant contribution to improve the care and
attained a high level of patient satisfaction and most importantly a great scale of safety and
efficacy. The GI NOTES is gaining popularity but at slower rate compared to LC. It has been
limited to the university institutions and big teaching tertiary centres across Europe, America
and Asia. Nevertheless, large series are reported on human beings. Many centres are conduct‐
ing feasibility studies on animals as well as cadavers and patients. Several obstacles are
preventing the wide applications of NOTES. Of these is the need for advanced endoscopic and
laparoscopic skills, infrastructure setting, funding and local health authority approval and
health systems bureaucracy. Germany reports the highest number of human NOTES proce‐
dures in the Europe, while the USA is the leading state in the American continent.
Endoscopy - Innovative Uses and Emerging Technologies96
1.1. Challenges to NOTES
1.1.1. Experience
The NOTES main tool is a flexible scope and unstable working platform. Preliminary endo‐
scopic, and to less degree laparoscopic, experience is a pre-request for conducting NOTES
procedures. An excellent endoscopic experience is crucial in conducting NOTES procedures
[8]. A study from Germany showed endoscopic experience was the strongest influencing
factor, whereas laparoscopic skills had limited impact on the performance of NOTES surgeons
with previous endoscopic experience [9]. This can be explained by the ability of the endoscopist
to adapt for movement and to perform procedure using unstable and flexible platform.
Reputable institutions are organising training courses for NOTES, and a good example is
Strasbourg in France. Training on animal models is providing opportunity of operating on
living subjects and increasing the confidence of performing the procedure on patients [10]. An
example of the training model is the endoscopic–laparoscopic interdisciplinary training entity
(ELITE) used in Germany. One of the important issues in training is the willingness and interest
of the junior surgeons to adapt NOTES in their institutions.
1.1.2. Governance, regulations and training
Extensive training is required for surgeons to overcome the vision–motion difficulty before
they can perform NOTES safely and effectively [11]. Different bodies are sponsoring NOTES
training in the USA, Europe, South America and Asia. NOSCAR and EAES are leading the
research, training and development of NOTES. In 2005, the American Society of Gastrointes‐
tinal Endoscopy (ASGE) and the Society of American Gastrointestinal Endoscopic Surgeons
(SAGES) formed the Natural Orifice Surgery Consortium for Assessment and Research
(NOSCAR) and published the NOTES white paper [12, 13]. In Europe, the New European
Surgical Academy (NESA) founded the NOS (Natural Orifice Surgery) working group, which
is exploring another surgical route, the TransDouglas (Td) one. The NOS/SLO group is an
interdisciplinary working group of the NESA. Its goal is to develop surgical procedures using
the natural openings of the human body and “scarless” operations [14]. There are similar
scientific bodies in South America like Brazilian group and also in Asia like Japanese, Chinese
and Indian NOTES groups. The Virtual Translumenal Endoscopic Surgical Trainer (VTEST
(TM)) is being developed as a platform to train for NOTES procedures and innovate NOTES
tools and techniques [15]. Different tools are used in NOTES training courses. These include
operating on animal models with an acceptable grade of satisfaction. One of such tool is the
endoscopic–laparoscopic interdisciplinary training entity. A study has shown the constructing
validity for the ELITE model which seems to be well suited for the training of NOTES as a new
surgical technique [16].
1.1.3. Funding
The rising costs of healthcare are forcing all parties to consider both the medical risks/benefits
and the economic efficiency of proposed tools and therapies [17]. Funding is required for
research and for setting of the infrastructure to perform NOTES procedures on animals and
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patients. NOTES surgery needs extra cost for the instruments. The endoscopic closure devices,
the working platforms and scope are very expensive compared to the classical laparoscopic
instrumentations. Funding is a problem in the current era, and the leading teaching centres
across America and Europe can afford it. The collaboration with businesses and industries has
resulted in huge budget of funds to the NOTES research. For example, by 2009 Olympus has
donated $1.25 million supporting NOTES activities in the USA [18]. Ethicon offered similar
support and funding for NOSCAR research in the USA. The Center for Integration of Medicine
and Innovative Technology’s (CIMIT) investment in NOTES research will top $3 million
overall, making CIMIT the largest financial sponsor of this technology worldwide [19].
1.1.4. Pressure of common acute and elective surgical take
Undertaking NOTES procedures in addition to the common surgical workload is adding a
practical challenge. However, this can be resolved by dedicated time for specific NOTES
activities. It is expected that NOTES will be a separate and distinguished speciality for the
gastrointestinal surgeons.
1.1.5. Bureaucracy of health systems
It is not a surprise that the first reported NOTES procedure of appendicectomy was from the
Hyderabad group in India which has less bureaucratic health system compared to Europe and
the USA. The bureaucracy because of high grade of concerns about safety of any new technique
or intervention. While this is a healthy issue, sometimes it defers innovations and frustrates
surgeons who are trying to bring in reality and clinical practice new ideas and approaches.
NOTES is not an exception to be rejected as a new method. In order to install NOTES technique,
one would need extra efforts to pass through the hurdles that built up across modern health
systems. In the UK we are much behind the fellow Europe states like Germany as far as NOTES
is concerned. This may also be explained by less popularity of the technique in the UK. South
London’s Surrey University, Guildford, held the first ever NOTES training course in 2008. In
the UK, there is no specific body to support NOTES research like NOSCAR in the USA or the
NESA group of Europe.
1.1.6. Public opinion
As expected a study of 1006 patients demonstrated public’s interest in these new techniques
and thus gave further support to continued research and development in this area [20]. The
Swanstrom group from the USA reported that majority of the patients surveyed (56%) would
choose NOTES for their cholecystectomy [21]. It is not surprising that patients would choose
an approach that provides excellent cosmetic and clinical outcomes with high safety profile
[22]. Surgical societies are committed to work towards perfection, and NOTES is the ultimate
approach for the management of a number of surgical conditions and provides extra benefits
of minimal access techniques.
1.1.7. Septic complications
NOTES is not different from classical surgery of possible risk of infection. Intravenous
antibiotics in addition to topical Betadine or chlorhexidine have effectively reduced microbial
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burden in both gastric and colonic mucosa in porcine model [23]. The common Tg and Tv
routes are compared in animal models, and authors concluded that without gastric or vaginal
lavage and antibiotic peritoneal irrigation, the Tg procedure has a higher infection rate than
the Tv access. After antiseptic preparation, the bacterial load significantly decreased in the Tg
group, which seems as safe as the sterile Tv approach [24]. However, in a study of 40 patients
who underwent Roux-En-Y gastric bypass (RYGBP), contamination of the peritoneal cavity
does occur with Tg endoscopic peritoneoscopy (TEP), but this does not lead to an increased
risk of infectious complications [25]. Another study of 130 patients who underwent Tg NOTES
showed that the risk of bacterial contamination secondary to peroral and Tg access is clinically
insignificant [26]. Pure Tg endoscopic surgery results in less perioperative inflammatory
response than laparoscopy in the early postoperative phase [27]. In a review of literature by
the Darzi group, UK showed that recommendation requiring no preoperative preparation can
be made for the Tg approach. Antiseptic irrigation is recommended for Tv (grade C) NOTES
access, as is current practice [28].
1.1.8. Intraoperative NOTES complications
The management of intraoperative NOTES complications could be challenging. Adequate
experience is therefore necessary to recognise and treat them to avoid morbidity and mortality
and to minimise conversion to hybrid NOTES or open technique. Effective management of
NOTES complications however is reported, for example, bleeding complications and splenic
laceration [29]. For intestinal perforation, the case may be different. Authors found that small
intestinal injuries are difficult to localise with currently available flexible endoscopes and
accessories. Endoscopic clips, however, may be adequate for closure of small bowel lacerations
if the site of injury is known [30]. A study has shown that urinary bladder injury occurring
during NOTES can be successfully managed via a NOTES approach using currently available
endoscopic accessories [31].
1.2. Principles of NOTES
1.2.1. Indications
NOTES approach is indicated in a variety of conditions across surgical specialities, not only
gastrointestinal tract but also urology, gynaecology and thoracic field. NOTES indications
could be an emergency or elective which is the majority. This chapter is concentrating on upper
GI NOTES.
1.2.2. Access
1.2.2.1. Major sites for access
1. Transgastric (Tg): The first human NOTES procedure was performed using Tg route. The
experimental studies proved ultrasonography-guided access through the stomach to be
feasible and safe without iatrogenic complications [32]. There are two challenges in the
Tg route: the closure and the abdominal contamination and septic complications. The ideal
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Tg access closure is expected to be easy, effective, cheap and less time consuming. Tg
NOTES peritoneoscopy and the gastrotomy can be closed by deploying a 2-sided ECM
occluder on animal model [33]. The results indicated that closure of gastrotomy by Eagle
Claw VIII could withstand higher endoluminal pneumatic bursting pressure than
endoclips [34]. Submucosal approach is a new and promising technique for the develop‐
ment of NOTES [35] (see Figure 1).
Figure 1. Submucosal tunnel technique is used (Lee SHI et al. 2012)
The Tg access closure is provided by different techniques including clips (over-the-scope clip),
sutures, etc. [36, 37]. There are different closure methods in literature, but safety is shown in
one of animal studies at least comparable to the classical laparoscopy procedure [38]. A novel
gastric closure device, the loop-anchor purse-string (LAPS) closure system, had been described
[39]. If hybrid technique is used, then laparoscopic stapler can be applied to the gastric access
[40]. A multilayer extracellular matrix (ECM) occluder is assessed on animals, and it was safe
and effective [41]. A loop and clip [KING closure], (see figure 2), [42] and QUEEN closure are
other methods [43]. Self-approximating translumenal access technique (STAT) and implanta‐
tion of a cellular matrix in the STAT tunnel are the two methods that have shown safety and
efficacy on animal model [44]. There has been a method of testing support closure with T-tags
and Padlock-G-clips over OVESCO OTS-clips and standard endoscopic clips [45].
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Figure 2. KING closure, loop and clip by Ryska O et al. 2012
2. Transvaginal (Tv): A recent meta-analysis confirmed high safety profile with this techni‐
que [46]. Infectious complications and the closure are the two important areas in this
approach. A recent study of 102 Tv NOTES procedure reported only one case of infection
following appendicectomy [47], which is comparable to the laparoscopic approach for
similar pathology. Closure of the Tv access can be easier than Tg one [48]. Simple suturing
under direct vision is the norm.
3. Transrectal (Tr): Animal studies have shown safety and efficacy [49]. The flexible endo‐
scopic stapler is an effective device for the safe closure of a colon access, which in this
feasibility study was equivalent to other well-established techniques [50]. Closure of Tr
viscerotomy using end-to-end (EEA) circular stapler technique is feasible, easy to perform
and histologically comparable to suture closure through a TEO platform. It may offer an
attractive alternative for NOTES segmental colectomies and endoscopic resections [51].
The colostomy was closed by occlusion loop-and-clip (KING closure) technique [52]. To
access the retroperitoneal space, significant challenges locating identifiable landmarks
were faced mostly transrectally and improved in transgastric prone position [53].
4. Transvesical (Tve): Many animal studies have reported feasibility of NOTES procedures
through the urinary bladder [54, 55]. Still there are no significant clinical applications on
patients because of the challenging access closure and also because of the specimen
delivery. J Bhullar et al. from Providence and medical centre, USA, used Vicryl loop for
bladder access closure on a porcine model [56], (figure 3).
Figure 3. Vicryl loop closure of transvesical access (J Bhullar et al. 2012)




Developing interfaces that are both intuitive and simple to use is crucial for NOTES dissemi‐
nation [57]. The minimally invasive cardiac surgery (MICS) robot [58] is another step towards
optimisation of the NOTES technique and to address the problems of optics, flexibility and the
comfortable and adequate exposure. Abdominal navigation and accessing the pancreas was
investigated on animals, and based on its success, pancreas resection was performed. A
prototype multitasking platform “EndoSAMURAI” with the use of a biosimulation model and
ex vivo porcine stomach was reported [59], (figure 5). There are new ancillary instruments like
forceps, and training on using them is continuing [60]. The SPIDER platform is a sterile and
disposable device that contains 4 working channels (2 flexible instrument delivery tubes
positioned laterally and 2 rigid channels superiorly and inferiorly to accommodate an
endoscope or any of the shelf rigid surgical instruments) [61]. This device has addressed some
of the technical problems, and it is relatively expensive which limits its wide use. Authors
concluded that the new manual handling system (MHS) is fully capable of achieving payload
transport during a NOTES operation. The system is intuitive and easy to use. It dramatically
decreases collateral trauma in the natural access point and can advantageously reduce the
overall duration of a procedure [62]. The 3D display system is a great step in optics develop‐
ment. At least 34 systems are developed, for example, Aesculap’s EinsteinVision (see Figure
4). This is in current use for laparoscopy and has the potential to improve the vision and
anatomy at challenging NOTES procedures [63]. The Direct Drive Endoscopic System (DDES;
Boston Scientific, Natick, MA) is a flexible laparoscopic multitasking platform that consists of
a 55-cm steerable guide sheath that houses 3 lumens extending from a rail-based platform with
interchangeable 4-mm instruments [64], (figure 6). Incisionless Operating Platform (IOP) is
another flexible scope used for NOTES procedures including cholecystectomy [65].
Figure 4. Aesculap’s EinsteinVision® system
1.2.4. Anaesthesia
There are three main issues when using transoral access to perform upper GI NOTES proce‐
dures: The first one is to intubate via transnasal route to spare the oral space for NOTES flexible
scope, the second issue is to position the patient according to the type of procedure, and the
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1.2.3. Instrumentation
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transport during a NOTES operation. The system is intuitive and easy to use. It dramatically
decreases collateral trauma in the natural access point and can advantageously reduce the
overall duration of a procedure [62]. The 3D display system is a great step in optics develop‐
ment. At least 34 systems are developed, for example, Aesculap’s EinsteinVision (see Figure
4). This is in current use for laparoscopy and has the potential to improve the vision and
anatomy at challenging NOTES procedures [63]. The Direct Drive Endoscopic System (DDES;
Boston Scientific, Natick, MA) is a flexible laparoscopic multitasking platform that consists of
a 55-cm steerable guide sheath that houses 3 lumens extending from a rail-based platform with
interchangeable 4-mm instruments [64], (figure 6). Incisionless Operating Platform (IOP) is
another flexible scope used for NOTES procedures including cholecystectomy [65].
Figure 4. Aesculap’s EinsteinVision® system
1.2.4. Anaesthesia
There are three main issues when using transoral access to perform upper GI NOTES proce‐
dures: The first one is to intubate via transnasal route to spare the oral space for NOTES flexible
scope, the second issue is to position the patient according to the type of procedure, and the
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third point is to monitor ETCO2 [66], (figure 7). For other NOTES accesses, transnasal intuba‐
tion is not necessary. Anaesthetic technique can be different from laparoscopic surgery. The
effect of pneumoperitoneum may be not different; both techniques will have pneumoperito‐
neum if it is abdominal NOTES procedure. POEM procedure, for example, does not need
pneumoperitoneum [67, 68]. Any patient that cannot tolerate pneumoperitoneum because of
cardiopulmonary disease is not a candidate for NOTES procedure. Cardiorespiratory physi‐
ology is affected by laparoscopic procedure mainly because of pneumoperitoneum. However,
the non-inferiority of NOTES compared to the laparoscopy is demonstrated from reported
studies, although the evidence is limited by a number of researches [69]. When administering
anaesthetic care to a patient undergoing NOTES, anaesthesiologists should closely monitor
the patient’s position as well as ETCO2 to minimise the incidence of mediastinal emphysema
and pneumomediastinum and to ensure early detection of pneumoperitoneum-related
respiratory and hemodynamic changes [70].
Figure 5. EndoSAMURAI platform, Yasuda K et al. 2014
Figure 6. Direct Drive Endoscopic System (DDES), S Shaik et al. 2010
Natural Orifice Translumenal Endoscopic Surgery of the GastroIntestinal Tract
http://dx.doi.org/10.5772/60552
103
Figure 7. Transnasal intubation in upper GI NOTES. The patient was placed in the supine position and intubated via a
nasal RAE™ tracheal tube. The endoscopic operator stood near the head of the patient and inserted the endoscope via
the mouth (Ji Hyeon Lee et al. 2014)
1.2.5. Setting
NOTES units are part of surgical departments whether upper or lower GI, gynaecology and
urology units. These units are usually located in well-established teaching hospitals. Theatre
facilities are available for minimal access approach. Staffs are trained in NOTES, and they are
familiar with the preparation and assistance.
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1.2.6. Expertise
NOTES experience is crucial for the quality and safety of this intervention. The current
guidelines advise to run through milestones of animal studies, cadaveric and live subject
experimental and pilot projects. Once the learning curve is achieved after a number of
procedures, NOTES can be performed under strict governance system. This has been achieved
in a number of US and European states.
1.2.7. Complications
All minimal access surgery serious complications are those of organ injury due to suboptimal
exposure that results from bad technique. It is anatomical and visual hallucination. This is to
be avoided to provide the high grade of safety. Industries, related professionals and surgeons
are striving to address all the issues that preclude safety.
2. Upper GI NOTES
2.1. Oesophagus NOTES
A number of oesophageal NOTES procedures are conducted safely on patients. Oesophageal
discontinuity, which is a very complex procedure, is performed using a modification of NOTES
[71]. The peroral endoscopic myotomy (POEM) for lower oesophageal conditions like achalasia
has been performed on animals and patients with great success. NOSCAR has recently
produced its white paper about the milestones of the POEM technique and the current opinion
about the indications and quality and safety [72]. Distal oesophageal spasm that can progress
to achalasia is another indication for POEM [73]. In 2002, Smith et al. found that the endoscopic
stapling technique for the treatment of Zenker diverticulum results in a statistically significant
shorter operative time, hospital stay and time to resume oral feedings compared with the
standard open technique [74]. Transesophageal approach to posterior mediastinum has been
reported on animal models [75]. Transoesophageal, anterior spinal NOTES reported lymph
node resection, vagotomy, thoracic duct ligation, thymectomy, biopsy of the lung and pleura,
epicardial coagulation, saline injection into the myocardium, pericardial fenestration and
anterior thoracic spine procedures [76]. Exposure of the GOJ and placement of an anti-reflux
prosthesis via a hybrid NOTES procedure were feasible, despite some complications [77].
Translumenal oesophago-oesophageal anastomosis was feasible on animal model [78].
Transoesophageal thoracic NOTES are a growing field. Diagnostic procedures have been well
described. Closure of the oesophageal access is managed by different approaches including
stenting [79].
2.2. Gastric NOTES
Gastric resection and specimen extraction through the upper GI route are reported by authors
[80]. On animal models, a gastrojejunostomy was feasible with a 4-cm length using an
anastomosing metal stent. After gastrotomy formation using a needle knife, a jejunotomy was
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then performed in the gastric cavity, which was followed by deployment of an anastomosing
metal stent under fluoroscopic guidance [81]. Also on porcine model, combined NOTES and
single trocar sleeve gastrectomy is feasible in a porcine model [82]. Through Tv NOTES
gastrectomy for gastric submucosal tumours, with the assistance of two transabdominal ports,
“oncologically acceptable” partial gastrectomy was successfully performed [83].
The hybrid NOTES technique is a combined method, including the advantages of both
laparoscopic resection and endoscopic resection for gastric subepithelial tumours (SETs) [84].
After a 40-mm submucosal tunnel was created using an endoscopic submucosal dissection
technique, in TGP, balloon dilation of a serosal puncture and intraperitoneal exploration were
performed; in EFTR, a full-thickness incision and snaring resection were performed. Closure
of the mucosal incision was performed by endoclips [85].
Hybrid sleeve gastrectomy (SG) and delivery of the specimen by transoral remnant extraction
(TORE) are feasible and avoid port complications [86]. A study of 136 patients showed that Tv
hybrid NOTES SG technique can be performed, but there is still a need for additional trocars
through the abdominal wall [87]. Combined use of laparoscopy and NOTES enabled gastric
pull-up without cervical and thoracic incisions [88]. NOTES omental repair of gastric perfo‐
ration appears comparable to that of laparoscopy [89]. Hybrid NOTES resection of gastric
gastrointestinal stromal tumour (GIST) was successfully reported on patients [90].
2.3. Duodenal NOTES
Currently, there is scarce of literatures on duodenal NOTES. This is because of rarity of
duodenal pathologies that benefits from NOTES. Peritoneoscopy is actively used to assess
upper GI tract including the duodenum [91]. This approach is feasible in selected series of
patients [92].
2.4. Liver NOTES
Continued development of NOTES techniques may further alter the approaches to the biliary
tract, liver and pancreas [93]. On animal models intraoperative NOTES-EUS is feasible to assess
liver lesions [94]. Liver biopsy was performed successfully without any bleeding, and adequate
samples were obtained in animal cases [95]. Using the Erbe Jet2 water-jet system, transanal
and transvaginal wedge hepatic resection was successfully performed [96]. Tr liver resection
and delivery of specimen were feasible and safe without problem of the rectal access [97].
Another study reported an animal liver wedge resection using MASTER robot [98]. Human
cases of liver resection were reported as well. A combined laparoscopic Tv approach was used.
Four 5-mm trocars were used. The liver parenchyma was divided using the harmonic scalpel,
whereas the left hepatic vein was transected using the laparoscopic Tv vascular stapler. The
specimen was placed in an Endobag and extracted transvaginally [99]. Complex liver surgery
like hepatico-jejunostomy, major hepatic resection and transplantation is unlikely to be
introduced at this stage due to the current limitations of the technique.
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2.5. Pancreas NOTES
It is technically possible by EUS-guided NOTES procedures to achieve a systematic anterior
and posterior access for NOTES transgastric peritoneoscopy and direct pancreatic endoscopic
procedures [100]. Peripancreatic abscess can be managed by transgastric endoscopy and
debridement with successful outcome, which provides great benefits of minimal access
approach [101, 102]. NOTES cystogastrostomy for pancreatic pseudocyst management
included endoscopic ultrasound (EUS)-guided puncture of the stomach just below the
gastroesophageal (GOJ) junction to gain access to the pseudocyst, guidewire placement and
then dilatation with a balloon to 18–20 mm. Endoscopic necrosectomy and debridement were
performed, followed by transoral surgical anastomosis under endoscopic visualisation with
the SurgAssist™ SLC 55 (Power Medical Interventions, Langhorne, PA) using 4.8-mm stapler
[103]. A robotic platform to perform complex distal pancreatectomy on animal model was
described [104].
2.6. Spleen NOTES
To dissect the upper end of the gastrosplenic ligament and the marginal region between the
left diaphragm and upper pole of the spleen, a flexible single-channel endoscope was intro‐
duced into the peritoneal cavity simultaneously with the use of a rigid laparoscope. This is
also providing the benefits of water-jet lens cleaning, effective suction and better visualisation
in dissection of all splenic attachments and ligaments [105]. Hybrid splenectomy is performed
on animal models without major complications indicating safety and feasibility [106]. Tv
visualisation of the spleen and standard dissection of attachments were feasible, and splenec‐
tomy was completed using Tv stapling of the splenic hilum which is safely performed on
patient [107].
2.7. Biliary NOTES
A comparison of the surgical errors during electrosurgery gallbladder dissection establishes
that the NOTES procedure, while still new, is not inferior to the established laparoscopic
cholecystectomy procedure [108]. NOTES cholecystectomy is the commonest upper GI
procedure performed on patients. More than 3000 procedures are reported by now. Largest
series of more than 2653 cases is from Germany [109]. Only 15% of NOTES cholecystectomy
is performed in the USA. Two recent review studies showed increasing number of NOTES
cholecystectomy [110, 111]. NOTES peritoneoscopy for accurate diagnosis and staging of intra-
abdominal cancers is already in clinical use. Peritoneoscopy can accurately assess hepato-
pancreatic-biliary malignancy and lymph node status [112].
2.8. Bariatric Surgery NOTES
Authors reported combined Tv and abdominal variant of SG on humans [113]. On animal
models, hybrid NOTES SG is reported [114, 115]. The procedure was performed on humans
using hybrid technique [116]. Roux-En-Y GBP was very challenging procedure and needed
development of NOTES instruments to make it safe, feasible and time-effective operation.
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Trials on human cadavers concluded feasibility, but long operative time mainly because of the
lack of proper instrumentation resulting in insufficient tissue traction, countertraction and
instrument manipulation complicated several steps during the procedure [117]. There are
human series of hybrid NOTES RYGBP for obesity [118]. NOTES gastric band procedure was
reported on a patient [119].(see table 1).




Spaun GO et al. 2010 [134] Transcervical Heller’s myotomy Yes Yes
Swanstrom et al. 2010 [135] Oesophageal mobilisation Yes Yes
Welhelm et al. 2010 [77] Anti-reflux surgery No Yes
Swanstrom et al. 2011 [136,137,72] Endoscopic myotomy Yes No
Rieder et al. 2011 [138,74] Zenker diverticulectomy No Yes
Ishimaru et al. 2011 [139] Gastric pull through for oesophageal
atresia
No Yes
Turner et al. 2011 [140] Closure of oesophageal access site No Yes
Turners et al. 2011 [141,79] Stent closure of oesophageal access site No Yes
Rolanda et al. 2011 [142] Peroral oesophageal segmentectomy No Yes
Cho et al. 2011 [143] Resection of early gastric cancer Yes No
Abe et al. 2009 [144] Gastric submucosal tumour resection Yes No
Nau et al. 2011 [118] Staging pancreatic mass Yes No
Hybrid gastric bypass Yes No
Pure gastric bypass Yes No
Chiu et al. 2010 [145] Tg gastrojejunostomy No Yes
Campos et al. 2010 [146] Tg drainage of abdominal abscess Yes No
Cahill et al. 2009 [147] Tv gastric lymph node mapping No Yes
Luo et al. 2012 [148] Tg gastrojejunostomy No Yes
Ikeda et al. 2011 [149] Gastric full-thickness resection No Yes
Lacey et al. 2009 [150,112,87] Hybrid sleeve gastrectomy Yes No
Michalik et al. 2011 [117] Hybrid gastric band Yes No
Branco et al. 2011 [151] Transvesical peritoneoscopy, liver biopsy,
appendix manipulation
Yes No
Truong et al. 2012 [152] Hybrid liver resection Yes No
Shi et al. 2011 [153] Pure liver resection No Yes
Lehman et al. 2014 [122] Cholecystectomy Yes No
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Bakker OJ et al. 2012 [101,102] Tg pancreatic necrosectomy Yes No
Pallapothu et al. 2011 [103] Cystogastrostomy Yes No
Targarona et al. 2009 [107] Tv splenectomy Yes No
Table 1. Important upper GI NOTES procedures
3. Lower GI NOTES
3.1. Small bowel NOTES
Small intestinal anastomosis was performed in a porcine intestinal Tr NOTES model using two
robotic arms and a camera inserted through the proctoscope and a rectal anterior wall incision
[120]. NOTES gastroenterostomy with a biflanged lumen-apposing stent was reported recently
by collaboration of French and US centres. The procedure was feasible and safe with only one
minor complication [121]. This has the potential to treat variable distal gastric pathology by
this type of NOTES anastomosis.
3.2. Appendicectomy
The first human NOTES procedure was Tg appendicectomy performed by Rao and Reddy in
2004 in India. Many cases were reported after that [122, 123]. German registry showed that
more than 6% [182 cases] of human NOTES procedure was appendicectomy done by Tg and
Tv routes. Not only slim patients but also morbidly obese patients benefited from NOTES
appendicectomy [124]. A 5-mm trocar was inserted through the umbilicus and a 5-mm
telescope was placed. A 12-mm trocar and a 5-mm grasper were inserted separately through
the posterior fornix of the vagina under laparoscopic guidance. The appendix was divided
with an endoscopic stapler through the Tv 12-mm trocar and removed from the same trocar
[125].
3.3. Colonic NOTES
Pure NOTES resection and anastomosis of the large bowel were feasible, and the colorectal
anastomosis was achieved using circular stapler [126]. Early clinical series of transanal TME
with laparoscopic assistance (n = 72) were promising, with overall intraoperative and postop‐
erative complication rates of 8.3% and 27.8%, respectively, similar to laparoscopic TME [127].
NOTES TME was feasible and safe in this series of patients with mid- or low rectal tumours
[128]. Transanal full-thickness circumferential rectal and mesorectal dissections were per‐
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formed, and a colorectal anastomosis was performed using a circular stapler with a single
stapling technique. During the transanal approach, the gastrotomy was closed using four
endoscopic clips [129]. On large series of human cadavers, transanal NOTES rectosigmoid
resection with TME was feasible and demonstrates improvement in specimen length and
operative time with experience. Transrectal retrograde rectosigmoid dissection was achieved
in all attempts and showed numbers of lymph nodes similar to the laparoscopic group [130,
131]. A transrectal endoscopic device was used for optic assistance, colon dissection, ileum
section and specimen retrieval. Transrectal MA-NOS total colectomy was assisted by three
laparoscopic ports: A 12-mm port is used as the terminal ileostomy site [132]. Hybrid Tv
resection of descending colon was feasible on animal model. Only one 5-mm transumbilical
port was added for safety [133]. Long-segment Hirschsprung’s disease was managed by
NOTES. Authors reported the technique, which starts by a rectal mucosectomy 0.5 cm proximal
to the dentate line and extending proximally to the level of the intraperitoneal rectum. Three
cannulas were inserted through the muscular sleeve into the abdominal cavity. After colonic
mobilisation, the ganglionic distal bowel segment was pulled through the anus and resected
and the colo-anal anastomosis was created [134], (see table 2).




Demura et al. 2013 [119] Small bowel anastomosis No Yes
Barthet M et al. 2015 [120] Gastroenterostomy Yes No
Lehman et al. 2014 [122] Appendicectomy Yes No
Bernhardt J et al. 2012 [125] Sigmoid colectomy No Yes
Chouillard et al. 2014 [127] TME Yes No
Park SJ et al. 2013 [128] Rectosigmoid resection No Yes
Telem DA et al. 2013 [129] TME [cadavers] Yes No
Lacy AM et al. 2012 [131] Hybrid total colectomy Yes No
Alba mesa et al. 2012 [132] Descending colon resection No Yes
Li N et al. 2013 [133] Hirschsprung’s segment resection Yes No
Table 2. Important lower GI NOTES procedures
4. Further research
NOTES is evolving and refinement of the technique is warranted for feasibility, safety,
operative time effectiveness and practicality. Three hot areas are expected to be the focus for
further research:
1. Development of technology: this includes instruments, optics and working platforms.
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2. Exploration of practicality of NOTES application in complex abdominal procedures and
new fields like thoracic and retroperitoneal procedures.
3. Training: NOTES needs an advanced endoscopic and minimal access skills. Surgeons who
already attended this level are those who are leading NOTES research in the respected
academic institutions in the USA, Europe and Asia. What is needed is to organise an
effective and specific dedicated training programme to produce NOTES trained surgeons.
NOTES is expected to be an independent specialty that works to meet patient’s expectation
by making the most use of modern surgery and technology.
5. Conclusions
NOTES is gaining interest and popularity among surgeons. Many new procedures are reported
as feasibility studies on animal models. Other procedures are starting to establish itself in
clinical practice like NOTES cholecystectomy, appendicectomy and peritoneoscopy. Tv and
Tg access routes are the commonest and closure technique is evolving to achieve a high degree
of safety and effectiveness. Many new clinical procedures are introduced and currently are at
experimental level. Development of the technology and instrumentation, effective training and
support are expected to push NOTES further towards its long track of refinement and
milestone journey towards an accepted and well-established standard technique.
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Abstract
The cardiac mucosa of the human stomach is composed mainly of branched PAS
positive mucous glands that occupy the deep half of the mucosa thickness. This
morphological pattern of the mucous glands present in endoscopic biopsies from the
gastric fundus region or near the gastroesophageal junction (GEJ) serves as parameter
for the histological diagnosis of gastric cardia. However, this morphological pattern
is highly variable along the gastric part of the GEJ: in some areas these mucous glands
are abundant and in others they are scarce, if not totally absent. Depending on the
concept adopted for some, the cardiac mucosa would be a native structure attached
to human GEJ, while for others it would have a metaplastic origin that would occur
during the extra-uterine life. In cardiac mucosa the mixed glands (mucous/oxyntic
glands) are almost always present in between mucous glands and in between oxyntic
glands; such as the parietal cells which could also be detected in greater or lesser
amounts. The aim of this work was to evaluate the presence of serotonin-immunor‐
eactive cells (EC cells) in these different types of glands in both normal cardiac mucosa
as well as in the Barrett´s esophagus. The main results concerning the endocrinology
of gastric cardia allows to consider that the human cardia has exocrine and endocrine
elements that together constitute its specific differential characteristic in relation to
the gastric fundus and to the antropyloric regions of the stomach. On the other hand,
the histologic and immunohistochemical analysis of endoscopic biopsies of 26 patients
showed that 23 (88.5%) of them presented varying amounts of mucous glands
associated with intestinal metaplasia in distal esophagus. Moreover, many of these
patients presented a rich component of serotoninergic EC cells. The major population
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of serotonin-immunoreactive cells was found both in intestinal metaplasia as well as
in its associated mucous glands. Among these patients, 16 (70%) presented foci of high
concentration of serotoninergic EC cell in the distal esophagus. Whatever the
neuroendocrine actions of serotonin in the GEJ, these actions should be enhanced in
many patients who present a large population of EC cells in gastric cardia as well as
in the areas of intestinal metaplasia of those with Barrett´s esophagus.
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1. Introduction
The gastric cardia is generally defined as the area of mucosa located distal to the anatomic
gastroesophageal junction (GEJ) and proximal to the oxyntic mucosa of the gastric body. It is
an area of the stomach that raises many controversies about its native glandular components.
The gastric cardia mucosa is absent in the stomach of some mammals species, such as rat and
guinea pig; in others, such as swine, it covers a large area of the stomach competing for space
with the body's mucosa [1].In humans it is very limited in size. The gastric cardia mucosa
cannot be evaluated by standard endoscopy, or even through direct visual examination of
surgical specimens or when performing necropsies. However, it can often be detected by
histological examination of tissues removed from the gastric mucosa close to the GEJ. In most
individuals the edges of cardiac mucosa have an irregular shape and also it has a variable
average length, usually <2.0 cm. Mucous glands morphologically similar to those of the antral
mucosa are found in this region in varying amounts, usually predominating over other
histological types of glands, namely, the mixed glands (mixed mucous/oxyntic glands) and
the oxyntic glands. The latter are morphologically identical to the oxyntic glands in the body
and can occupy large areas of cardiac mucosa, juxtaposed to the squamocolumnar junction.
The gastric cardia mucosa is histologically very similar to the mucosa of the antral region, i.e.,
the foveolas are long occupying about half of the mucosa thickness which are composed of
branched mucous glands that occupy the deep half of the mucosa thickness. This morpholog‐
ical pattern of the mucous glands of tissues collected by the endoscopist from the gastric fundus
region or near the GEJ serves as parameter for the histological diagnosis of gastric cardia. This
histological criterion is used by a large number of pathologists. However, due to the highly
variable distribution of mucous glands along the gastric part of the GEJ, in some areas they
are abundant and in others they are scarce, if not totally absent. In short, in some areas the
pure mucous glands may be missing altogether, and replaced by mixed gland and/or oxyntic
glands. Typical oxyntic glands are easily recognized by histology lining the human gastric
body and the gastric fundus. This type of mucosa can be easily recognized in histological
sections due to the high density of compact glands, rich in acidophilus parietal cells, and
basophil zymogen cells. In this case, the histology of endoscopic samples does not reveal the
presence of typical mucous glands, which may cause erroneous endoscopic–histologic
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of serotonin-immunoreactive cells was found both in intestinal metaplasia as well as
in its associated mucous glands. Among these patients, 16 (70%) presented foci of high
concentration of serotoninergic EC cell in the distal esophagus. Whatever the
neuroendocrine actions of serotonin in the GEJ, these actions should be enhanced in
many patients who present a large population of EC cells in gastric cardia as well as
in the areas of intestinal metaplasia of those with Barrett´s esophagus.
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correlation. Because of the gastric cardia irregularity, divergent hypothesis arises on its real
constitution and on its real presence in all subjects [2-5].
The cardiac mucosa also has a component of endocrine cells with unknown functions. This
gap in knowledge about the importance of the endocrine population of the gastric cardia may
be due to its conceptual status not yet well defined. In addition, the occurrence of local
pathological processes of the GEJ modifies its structure hindering its proper identification.
Among these processes the reflux esophagitis, the H. pylori infection, and the occurrence of
intestinal metaplasia [6-8] should be mentioned.
2. Aims
Numerous endocrine cells stained with antibodies anti-chromogranin was found in gastric
cardia in patients with endoscopically normal GEJ. This bunch of endocrine cells was found
to be formed by a single population of serotonin-producing EC cells [9]. In gastrointestinal
mucosa the serotonin-producing cells are also called “enterochromafin cells” (abbreviated: EC
cells). It was then proposed that the EC cells were the only representatives of the rich gastric
endocrine component of the gastric cardia. In the present work we studied standard endo‐
scopic biopsies from the GEJ region aimed to assess the presence of different types of glands
which occur in the gastric cardia and its component of serotoninergic EC cells. We also
evaluated in a series of patients with Barrett's esophagus the different types of glands seen in
the distal tubular esophagus and its content of serotonin-producing EC cells.
3. Material and methods
3.1. Histology and EC cells in gastric cardia
Endoscopic biopsies of two groups of consecutive patients attended at the Instituto Alfa de
Gastroenterologia (IAG), Hospital das Clinicas, Universidade Federal de Minas Gerais
(UFMG), Belo Horizonte, Brazil were studied. Group 1: made up of 21 patients who underwent
upper gastrointestinal endoscopy in whom no significant changes of the esophagus and
stomach were found. From these patients at least 2 biopsies containing cardiac mucosa were
obtained from the area of the GEJ, and also 2 biopsies were obtained from each, antral and
body mucosa of the stomach. Group 2: made up of 26 patients with endoscopic diagnosis of
Barrett's esophagus (> 3 cm) in which at least 2 biopsies were performed for the diagnosis
confirmation.
Sections of tissue were stained with Hematoxylin and Eosin (HE), Giemsa and PAS / Alcian
Blue for histology. Ancillary stains used for cardiac mucosa analysis were: (1) immunohis‐
tochemical  staining  for  demonstration  of  serotonin-producing  EC cells  using  a  primary
monoclonal antibodies against serotonin (Dako A / S, Denmark), and (2) Grimelius staining
for  demonstration  argyrophil  cells  [10].  Because  of  the  irregularity  of  the  gastric  cardia
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tissue specimens,  the  EC cells  and argyrophil  cells  were  quantified in  glandular  tissues
where they presented the highest concentration (hot spot). In order to quantify the hot spot
cell number, the high-power microscopic field was used and, thus, the number of cells/hpf
was obtained. According to this criterion, the cell number was classified as few (<10/hpf)
or numerous (≥10/hpf).
The presence of parietal cells in cardiac mucosa was evaluated in slides stained with HE. With
this routine staining method these cells are easily recognizable, particularly in areas where
they were numerous. In cases where they were not evident in HE preparations, or apparently
very scarce, ancillary immunohistochemical stainingwas carried out using primary monoclo‐
nal antibodies against secretory canaliculi antigen of parietal cell (Barbosa, A.J.A., personal
information).
3.2. EC cells in Barrett´s esophagus
Twenty six patients (mean age 36 years, range 22–69 years) with Barrett´s esophagus in whom
at least 2 biopsies were performed for diagnostic confirmation were studied. All of them
presented salmon-colored columnar mucosa extending in tongue-shaped projections at least
3 cm above the GEJ. The cases associated with gastrointestinal cancer and high-grade dysplasia
of the columnar epithelium were excluded. Histological sections were reviewed to confirm the
diagnosis and assessment of tissue structures present, namely, squamocolumnar junction,
typical mucous glands, intestinal metaplasia with goblet cells, and the presence of hot spots
of serotonin-immunoreactive EC cells. The quantitative evaluation of EC cells followed the
same criterion as for the gastric cardia, i.e., few cells (<10 hpf) or numerous cells (≥10/hpf).
4. Results
4.1. Gastric cardia
Most of the 21 patients (mean age 36 years; range 22–69 years; 14 female) underwent endoscopy
looking for obscure causes of anemia, obscure GI bleeding, or as a preoperative control. H.
pylori was negative in 11 (52.4%) patients, both in cardiac mucosa and in the gastric body and
antrum. Among these 11 patients 3 had the diagnosis of atrophic body gastritis (ABG). The
histology results of the 8 remaining H. pylori-negative patients showed gastric mucosa of the
antrum and body histologically normal and mononuclear inflammatory infiltration in cardiac
mucosa. This inflammatory infiltrate was mild in 3 patients (mild carditis) and moderate in 5
patients (moderate carditis). Parietal cells were absent in cardiac mucosa of 4 H. pylori negative
patients, 3 of them with ABG. In one patient, a small number of glands with goblet cells was
found, indicating the presence of intestinal metaplasia (Table 1).
H. pylori infection occurred in 10 (47.6%) patients, and in 5 of these patients this microorganism
was demonstrated in cardiac mucosa. The results of histology showed the presence of gastritis
with mild inflammatory activity (+) or moderate (++) in the gastric mucosa of the antrum and
body, with greater intensity in the antral mucosa. All patients in this subgroup had carditis of
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moderate intensity, regardless of the presence of H. pylori. Typical parietal cells were present
in the cardiac mucosa samples in varying amounts. In two patients PAS / AB staining revealed













1 ++ / + ++ + + PAS+ / PC+
4 ++ / + ++ + + PAS+ / PC +
5 ++ / + + + + PAS+ / PC +
6 ++ / + ++ - + PAS+ / CP+
9 ++ / ++ ++ - + PAS+IM+/PC+
10 + / ++ ++ - + PAS+ / PC +
11 ++ / ++ ++ - + PAS+ / PC +
14 + / ++ ++ - + PAS+ / PC -
15 ++ / + ++ + + PAS+ / PC +
21 ++ / ++ ++ + + PAS+IM+/ PC+
+/++ =Mild/Moderate degree of inflammatory cells; PAS+ = Mucous glands present; IM+ = Intestinal metaplasia present;
PC+ = Parietal cell present; PC− = Parietal cell absent.













2 N + - - PAS+ / PC+
3 N + - - PAS+ / PC+
8 N ++ - - PAS+ / PC+
13 N + - - PAS+ / PC+
18 N ++ - - PAS+IM+/PC+
19 N ++ - - PAS+ / PC+
20 N ++ - - PAS+ / PC+
22 N ++ - - PAS+ / PC+
N= Normal histology; +/++ = mild/moderate degree of inflammatory cells in lamina propria; PAS+ = Mucous glands
present; IM+ = Intestinal metaplasia present; PC+ = Parietal cell present.
Table 1. Histology of the gastric mucosa of the antrum, corpus, and cardia of the 8 H. pylori negative patients. The 3 H.
pylori negative patients with ABG were not included in this table.
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4.2. H. pylori, gastritis, and carditis
Inflammatory infiltrate of mononuclear cells and neutrophils (PMNs) were present in the
gastric antrum and gastric body in all H. pylori positive patients and in the 3 patients with
atrophic body gastritis. Mild or moderate chronic carditis was seen in all patients, regardless
of the presence of the bacterium H. pylori (Table 2, Figure 1).
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Figure 1. Presence of gastritis and carditis in H. pylori positive and H. pylori negative patients. The only three patients
who were H. pylori negative with gastritis had ABG (type A gastritis).
4.3. Argyrophil and EC cells in gastric cardia
In 2 (9.5%) patients, argyrophil or serotonergic cells were not detected in the samples of cardiac
mucosa. The number of patients with few argyrophil and EC cells (<10 / hpf) were similar,
respectively, 38.1% vs 42.8%. Moreover, the number of patients presenting hot spots with
numerous argyrophil and EC cells (≥10 / hpf) was also similar, respectively, 52.4% vs 47.6%











Figure 2. Quantitative relationship of argyrophil and 5HT- cells (EC cells) in cardiac mucosa of the 21 patients studied.
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Figure 3. High-power photograph of the argyrophil (A) and serotoninergic (B) cells in mucous glands of the 










Figure 4. High-power photograph of gastric cardia mucosa composed mainly by mucous glands 
as a background of immunohistochemical staining. In between the mucinous cells there are few 
unexpected parietal cells with their secretory canaliculi stained in brown. A mild degree of 






Figure 3. High-power photograph of the argyrophil (A) and serotoninergic (B) cells in mucous glands of the gastric
cardia mucosa of patients with no endoscopic changes in the upper digestive tract.
4.4. Parietal cells in cardiac mucosa
The presence of parietal cells in histological sections of the cardi c ucosa was observed in 17
patients. Among them, 10 patients (47.6%) present d pari  cells relatively n merous and
easily identifiable by routine staining; however, in 7 ( ) the parietal ce ls could only be
identified with certainty by immunohistochemical stainin .  4 (19.1%) patients parietal cells
were negative by routine stai ing a d im ohistochemistry. Among them 3 had the
diagnosis of atrophic body gastritis (Tables 1 and 2, Figure 4).
4.5. Barrett´s esophagus
In all 26 patients with Barrett's esophagus the presence of intestinal metaplasia with goblet cell
was confirmed. In 23 (88.5%) of them, cardiac type mucous glands were present in tissue
sections associated with intestinal metaplasia. In 2 of these patients no detectable EC cells were
found in these glands. It should be considered that in most of the patients with Barrett´s
esophagus the areas of intestinal metaplasia were significantly more extensive than the areas
occupied by mucous glands. Oxyntic glands were not observed in Barrett's esophagus samples.
The major EC cell concentrations were found both in areas of intestinal metaplasia and in areas
occupied by mucous glands. In the 23 patients with mucous glands in the histological sections
the foci of high concentrations of EC cells (≥ 10 / hpf) occurred in 16 (70%) of them. Similar
frequency of high concentrations of serotonergic cells was observed in the areas of intestinal
metaplasia: among the 26 patients studied 15 (58%) presented with nu erous EC cells foci in
metaplastic glands (Table 3, Figure 5).
Type of glands n<10 EC cells/hpf ≥ 10 EC cells/hpf
Mucous (21/23) 05 (24%) 16 (76%)
IM (26/26) 11 (42%) 15 (58%)
IM = Intestinal metaplasia
Table 3. Type of glands present in the columnar mucosa of 26 patients with Barrett´s esophagus, and their
concentration of few (< 10 EC cells/hpf) or numerous (≥ 10 EC cells/hpf) serotonin-immunoreactive cells.
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Figure 4. High-power photograph of gastric cardia mucosa composed mainly by mucous glands as a background of
immunohistochemical staining. In between the mucinous cells there are few unexpected parietal cells with their secre‐














Table 3. Type of glands present  in the columnar mucosa of 26 patients with Barrett´s esophagus, 









Figure 5. (A) Gastric cardia composed of mucinous columnar epithelium with underlying mucous 
glands that exhibit numerous serotonin-immunoreactive EC cells stained in brown. A mild degree 
of inflammatory mononuclear cells in lamina propria is present which seems to be a normal 
component of the gastric cardia in most individuals. (B) Barrett´s esophagus presenting the 
A  B
Figure 5. (A) Gastric cardia composed of mucinous columnar epithelium with underlying mucous glands that exhibit
numerous serotonin-immunoreactiv  EC cells stai ed in br wn. A mild d gree of inflammatory mononuclear cells in
lamina propria is present which seems to be a normal component of the gastric cardia in most individuals. (B) Barrett´s
esophagus presenting the mucosa composed of mucinous columnar epithelium (upper side) with underlying glands
presenting intestinal metaplasia (stars), and mucous glands in the bottom (arrows) of the photograph. Presence of sero‐
tonin-immunoreactive EC cells in both type of glands.
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5. Discussion
Outside the limits of the standard endoscopy the mucosa of the gastric cardia remains an issue
of much controversy due to its variable glandular constitution and its imprecise limits. Because
there is no established knowledge about its functions this region of the stomach is usually
relegated to the background when studying the physiology and pathophysiology of gastric
mucosa. Usually cardiac mucosa is histologically defined as consisting of mucous glands
which occupy the most proximal area of the gastric mucosa. It has a variable length, occupying
an irregular band of approximately 0.5–2 cm in most individuals.
Many of the controversies in the literature about the status of the gastric cardia derive from
concepts still poorly defined of its nature. Those who consider it to be a specific type of gastric
mucosa characterized by the presence of well-defined lobes of PAS-positive mucous glands
believe that the cardiac mucosa would occur only in a certain number of individuals, increasing
its presence and extent progressively with age. Depending on the concept adopted, for some
the cardiac mucosa would be a native structure attached to human GEJ, while for others it
would have metaplastic origin that occurs during the extra-uterine life [2, 3].
Another question not always easy to answer is the definition of the GEJ. Often the endoscopist
sets the GEJ as the transition area between squamous mucosa ends and the level of the rise of
visible gastric folds. That is, in most individuals the GEJ can be endoscopically defined as the
most proximal area of the stomach folds which represents the transition point between the
squamous epithelium of the esophagus and the columnar mucus-secreting epithelium of the
stomach, called Z line. However, this endoscopic criterion may be flawed due to frequent
pathological changes that occur in this area. In these cases the Z line may move proximally
and consequently taking anatomical position above GEJ [11].
We do not intend to discuss here the anatomical limits of the cardiac mucosa. At this point it
would be better to forget the anatomical limits of the cardia and to turn our gaze to its
morphological components. On the other hand, we should seek to learn about its seemingly
exclusive endocrine component, made up of EC cells, a fact that is not usually taken into
account in the conceptual controversies on this specific type of gastric mucosa. In general
cardiac mucosa is understood as located in the most proximal region of the gastric mucosa,
and presenting PAS-positive mucous glands and mixed glands whether or not accompanied
by oxyntic glands. However, this concept only becomes complete after setting its endocrine
pattern, characterized by a striking or exclusive presence of the population of EC cells. Once
conceptualized thereby the cardiac mucosa would acquire its own characteristics making it
distinct from the antropyloric and corpus mucosa of the stomach. Moreover, the gastric cardia
also could acquire a greater degree of independence from endoscopic reports, since it would
become possible to fit both its location in the stomach as in a heterotopic location of the distal
esophagus, with or without the Barrett´s epithelium.
5.1. H. pylori and gastric cardia
It is well known that the standard endoscopy of the gastric mucosa does not relate well with
the histological findings of H. pylori-associated gastritis of the antrum and corpus. The same
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seems to happen with the cardiac mucosa in the absence of ulcerative lesions. In this series of
21 patients with endoscopically normal gastroesophageal mucosa, 10 (47.6%) had H. pylori
infection and chronic gastritis of the antrum and corpus, and in 5 of these patients (50%) the
bacteria were also identified in cardiac mucosa. However, all 10 patients had chronic carditis
(Table 2). Chronic carditis with similar intensity was also observed in the 8 patients (38.1%)
who were H. pylori-negative (Table 1).
The presence of H. pylori only in cardiac mucosa is not common. In nearly all cases if it is found
in gastric cardia it should also be found in the gastric body or in antral regions. Therefore, all
cases of H. pylori-positive chronic carditis will occur always with H. pylori-associated chronic
gastritis [12]. On the other hand, regardless the presence of the bacteria, the carditis we found
here had similar intensity in all 10 patients, H. pylori negative or positive. It is known that the
main cause of inflammatory reaction of the gastric antrum and corpus is the H. pylori infection.
In turn, the nonspecific inflammatory processes occurring in cardiac mucosa are frequently
said to be a consequence of gastroesophageal reflux disease occurring in subclinical conditions,
as appears to be the case of the present series of patients.
5.2. Parietal cells and gastric cardia
Atrophic body gastritis (ABG) occurred in 3 (14.3%) patients of the present series. The corpus
glandular atrophy was due to the total depletion of oxyntic glands in the tissue samples that
were examined. It should be noted that while this atrophy has been intense and easily
identified by histology, it was unnoticed by standard endoscopy. This discrepant result,
apparently surprising, is not at all uncommon in reports from hospital units of standard
gastrointestinal endoscopy. ABG can also go undetected by routine histopathological exami‐
nation, as a consequence of the morphological disruption getting the atrophic body's mucosa
[13]. Most of the cases of ABG would have an autoimmune background, and thus it could
explain the absence of parietal cells in the gastric cardia of the 3 patients with ABG, even using
immunohistochemistry for the identification of these cells.
With the exception of the 3 patients with ABG only one patient among the other 18 subjects
had no parietal cells in gastric cardia, which could be a sampling bias. This result shows that
oxyntic glands with typical parietal cells easily demonstrated by HE staining are commonly
found interposed between mucous and mixed glands. We think that this morphologic pattern
is a common finding near to GEJ and could be considered as a normal structure of the human
cardiac mucosa. In some cases, as seen in the present study, the parietal cells were apparently
absent at the HE examination; nevertheless they could be identified by immunohistochemical
staining (Figure 4). In areas of the GEJ where parietal cells are abundant, frequently juxtaposed
to the squamocolumnar junction, the examiner may have the false impression about possible
absence of cardiac mucosa [14].
In cardiac mucosa the mixed glands are almost always present in between mucous glands and
in between oxyntic glands; such as the parietal cells which could also be detected in greater or
lesser amounts [7]. Thus, the concept of human cardiac mucosa should cover this large range
of different types of glands and in different proportions.
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5.3. Endocrine component of the gastric cardia
The population of endocrine cells of the human cardiac mucosa is almost entirely, if not all,
constituted by serotonin producing EC cells. EC cells have high affinity for silver salts, which
is frequently employed to stain these cells. Two general silver methods may be used for this
purpose, the argentaffin (Fontana-Masson method) and the argyrophilic stains. Among the
latter the Grimelius method seems to be the most widely used.
At this point we should remember that: (a) the EC cells are argentaffin cells and can be easily
stained in ammoniacal silver nitrate solution and this method can be applied to reveal
gastrointestinal EC cells from different animal species [15]; (b) EC cells, as being argentaffin,
can also be stained by the Grimelius indirect argyrophilic method; (c) the EC cells could not
only produce serotonin; there are subsets of these cells that express, in addition to serotonin,
different peptidergic hormones [16-18]; (d) finally it should be remembered that there are
numerous different types of neuroendocrine cells which produce different peptides and
having the same argyrophilic properties described above. In fact, almost all the neuroendocrine
cells of the digestive tract of man can be easily demonstrated by Grimelius staining method.
In the present study, we found that the population of serotonin-producing EC cells in gastric
cardia, specifically demonstrated by immunohistochemistry, was roughly equivalent to the
population of argyrophil cells.
Our results concerning the endocrinology of gastric cardia, along with those previously
published by others, allow to consider that the human cardia, although occupying a restricted
area of the stomach, has exocrine and endocrine elements that together constitute its differ‐
ential characteristic (maybe specific) in relation to the gastric fundus and the antropyloric
regions. Briefly, it could be said that in the antral mucosa the EC cells divide the space mainly
with the G cells (gastrin) and D cells (somatostatin). In turn, in the body region of the human
stomach EC cells are rare or absent, giving space mainly for the enterochromaffin-like (ECL)
cells, the most numerous in this region. Finally, in the gastric cardia the EC cells are numerous
and constitute the sole or predominant cell type (Figure 6).
Therefore, considering all the exocrine and endocrine elements of the human gastric cardia,
many controversies reported in the literature on its morphological characteristics and also
about its definition seem to be half-finished. Usually these discussions are mainly based on
arguments related to its histologically most characteristic exocrine component, i.e., the
presence of PAS-positive mucous glands [3]. At this point it could be summarized regarding
the anatomy of the human gastric cardia mucosa: [i] a wide variation of different types of
exocrine glands and [ii] the presence of a large number of serotoninergic EC cells in mucous
glands and in mucous/oxyntic glands (mixed glands).
Serotonin (5-HT) seems to present important neuroendocrine functions in different segments
of the gastrointestinal tract, including the control of gastrointestinal motility. Serotonin
functions are mediated via specific receptors [19-21]. Some of these receptors have been
described recently in the lower esophageal sphincter (LES) and the authors speculate on the
role of serotonin in the modulation of its activity [22]. The 5HT1 and 5HT7 receptors are
considered to be muscle relaxation promoters while 5HT2, 5HT3, and 5HT4 to be stimulating
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muscle contraction [23-25]. Therefore, the frequent and relatively abundant presence of
serotonergic cells in the human gastric cardia, next to GEJ, could act as a modulating factor of
the neuromuscular activity of the LES. The disruption of LES functional activity is considered
nowadays as the main cause of the gastroesophageal reflux disease, frequent pathological
condition in the general population, and the main cause of reflux esophagitis and Barrett's
esophagus.
5.4. Serotoninergic cells and Barrett´s esophagus
The diagnosis of Barrett's esophagus requires endoscopic evidence showing columnar mucosa
above the GEJ, lining the distal esophagus, and this change must be confirmed by histopatho‐
logical analysis. Thus, the result of histology should confirm the presence of columnar
epithelium emphasizing the presence of goblet cells. Endoscopicaly the GEJ is identified as
being the most proximal area to the start of gastric folds. Therefore, projections shaped like
red salmon–color tongues above this area, lining the distal esophagus, are interpreted by the
endoscopist as Barrett's esophagus. Macroscopically, these red-salmon tongues are often quite
irregular in their proximal limits, and the microscopic foci of intestinal metaplasia, with or
without goblet cells, can also have an irregular distribution.
Therefore, when biopsies are done near the limits of salmon-red areas the histopathological
results can reveal the squamocolumnar junction in the absence of intestinal metaplasia. That
Figure 6. High-power microscopic field shows a marked number (> 10 cells/hpf) of serotonin-immunoreactive EC cells
in mucous glands of the gastric cardia. The EC cells appear to be the only (or largely predominanting) population of
endocrine cells in this region of the human stomach. This fact seems to be characteristic of these mucous glands, and as
such it should be included in the morphological definition of the human gastric cardia.
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is, the histological examination may notice the presence of columnar mucosa composed mainly
by glands lined by mucous-secreting epithelium with or without brush border, and with
mucous cardiac-like glands, however, without the presence of goblet cells. In general, the
North American gastroenterology societies require the presence of goblet cells to confirm the
intestinal metaplasia and, consequently, the diagnosis of Barrett's esophagus; differently, the
British societies admit that the presence of columnar epithelium lining the esophagus with
cardiac type mucous glands can be accepted as a criterion for the definitive diagnosis of
Barrett's esophagus [26, 27].
Regardless of this conceptual controversy on the definition of Barrett´s esophagus it should
be stressed the presence of the abundant serotoninergic cells in the intestinal-, and cardiac-
type glands that cover the inner wall of the tubular esophagus. These groups of cardiac-type
glands are found frequently in endoscopic biopsies of Barrett's esophagus and seem to have
preserved their rich component of serotonergic cells. The analysis of the present series of
biopsy fragments showed that among patients with Barrett's esophagus, 23 (88.5%) of them
showed varying amounts of mucous glands associated with intestinal metaplasia; among these
patients, 16 (70%) had foci with high concentration of serotoninergic EC cells.
Therefore, it seems to happen in Barrett's esophagus a fertile soil for serotonergic cells
proliferation since they can replicate themselves both in the cardiac-like epithelium as in the
intestinal metaplastic glands. Mucous glands present in the tubular esophagus and associated
with intestinal metaplasia do not have a well-explained histogenesis. Whether metaplastic or
not, they are mirror images of its sisters present in the normal gastric cardia, even as a
depository of serotonergic cells. Whatever the neuroendocrine actions of serotonin in the lower
esophagus, these actions should be enhanced in large number of patients with Barrett's
esophagus, because of the simultaneous presence in these patients of the extra population of
serotoninergic cells present in the areas of intestinal metaplasia.
We have seen that in the normal gastric cardia the population of argyrophil cells is represented
almost entirely by the serotoninergic EC cells. However, in the areas of Barrett's intestinal
metaplasia the population of argyrophil cells should be a more diverse bunch of endocrine
cells since the intestinal mucosa is a rich depository of different types of these cells. Indeed,
immunohistochemical studies of Barrett's esophagus demonstrated not only the significant
presence of EC cells as well as varying numbers of immunoreactive cells to somatostatin,
motilin, pancreatic peptide, gastrin, glucagon, secretin, and neurotensin. These findings led
the authors to propose that Barrett's epithelium would be derived from multipotent stem cells
with ability to differentiate into gastric and intestinal epithelium [28, 29].
Although 30 years have passed after the first suspicions by Buchan, Rindi, and colleagues about
the multipotent stem cells as an explanation for the histogenesis of Barrett's epithelium, it still
remains in the territory of speculations. Nowadays various hypothesis of multipotential stem
cells are still in focus. It is proposed that these stem cells would be derived from the bone
marrow, or from the basal layer of the squamous epithelium or from the mucous gland ducts
located in the submucosa of the esophagus. Other possibility would be the possible remaining
of embryonic tissues in the area of GEJ. Similar issues occur nowadays regarding the histo‐
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genesis of the epithelium of the human gastric cardia. From what we see, here too we have no
definitive answers.
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Abstract
The introduction of colorectal endoscopic submucosal dissection (ESD) has expanded
the applications for endoscopic treatment; as a result, lesions with low metastatic
potential can be treated endoscopically regardless of the lesion size. The most
attractive feature of ESD is the achievement of en bloc resection with a lower local
recurrence rate in comparison to that of endoscopic piecemeal mucosal resection.
However, in case of gastric cancers, ESD is not as widely applied to the treatment of
colorectal neoplasms because of its technical difficulty, longer procedural time, and
increased perforation risk. In the movement toward diversified endoscopic treatment
strategies for superficial colorectal neoplasms, endoscopists who begin to perform
ESD need to recognize the indications of ESD, as well as the technical issues and
associated complications of this procedure.
Keywords: Superficial colorectal neoplasm, pit pattern, endoscopic submucosal dis‐
section
1. Introduction
Endoscopic therapy is a major step forward in the management of early-stage gastrointestinal
cancers. In the colorectum, lymph node metastasis always occurs only with deep invasion of
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
the submucosa (≥1000 µm), and lesions that are diagnosed as well-differentiated adenocarci‐
nomas that are limited to the mucosa (intramucosal) or that superficially invade the submucosa
(<1,000 µm from the muscularis mucosa) without lymphovascular invasion or a component
with poor differentiation component (or both) are usually considered to not involve lymph
node metastasis [1-3]. Among these factors, however, only the depth of invasion can be
estimated by endoscopy prior to treatment. Thus, the depth of invasion must be accurately
estimated before any therapeutic decision is made. Endoscopic resection plays two important
roles in gastrointestinal surgery: achieving curative resection and allowing an accurate
histological evaluation of lesions. As lesions measuring more than (or equal to) 10 mm have
the potential for malignancy, they should be resected en bloc to avoid either residual or
recurrent lesions (or both) [4].
Endoscopic submucosal dissection (ESD) is a state-of-the art technique for the treatment of
large colorectal neoplasms that enables en bloc resection regardless of lesion size [5-8]. This
chapter describes in detail the method for estimating depth invasion and ESD for colorectal
neoplasms.
2. Diagnosis
Magnifying observation techniques, including chromoendoscopy and narrow-band imaging
(NBI), have been recognized as high-precision methods for the diagnosis of depth invasion.
With NBI, avascular or loose vascular findings are considered a key indicator of a submucosal
and deep invasive cancer [9, 10]. However, NBI is a relatively new method with an unknown
learning curve and different classifications, even within a single country like Japan. In contrast,
pit pattern analysis using crystal violet staining has now become standardized due to its longer
availability and one-to-one comparisons of endoscopic and pathological findings. In our view,
pit pattern analysis is the most reliable predictor of depth invasion. During this analysis, each
lesion should be confirmed to include a non-invasive pattern and Type V pit(s) with clearly
demarcated areas, as this indicates that the lesion is suitable for endoscopic mucosal resection
(EMR) or ESD with an estimated depth of invasion less than that of a submucosal invasive
cancer [11].
In this section of the chapter, we will describe in order of the actual clinical process an
endoscopic evaluation focused on the invasion depth of an early colorectal cancer, which is
defined as confirmed cancer cells present in the mucosa or the submucosa, regardless of lymph
node metastasis.
2.1. White-light non-magnifying endoscopy
The first diagnostic step is determination of the macroscopic lesion type. Most early-stage
colorectal cancer lesions are classified as Type 0 according to Borrmann classification, which
is equivalent to a superficial lesion in the Paris classification. In the latter classification,
superficial lesions are divided into two groups: polypoid and non-polypoid lesions; in
particular, non-polypoid lesions have received considerable attention, given their clinical
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importance. Non-polypoid lesions include superficial elevated (0-IIa), completely flat (0-IIb),
and depressed (0-IIc) lesions. Moreover, a superficial-type lesion of size more than 10 mm with
no increase in height is called a laterally spreading tumor (LST). LSTs can be further divided
into two main classes: granular type (LST-G) and non-granular type (LST-NG) (Figure 1). We
know that LST-NG tumors of size more than (or equal to) 20 mm and LST-G tumors of size
more than (or equal to) 30 mm harbor a significantly higher likelihood of submucosal invasion
[12]; therefore, a careful evaluation of morphological features is crucial for the depth diagnosis.
A  B 
C  D 
Figure 1. Subtypes of tumors with lateral spread. A: Laterally spreading tumor (LST), homogeneous granular type; B:
LST, mixed granular type; C: LST, non-granular, flat elevated type; D: LST, non-granular, pseudodepressed type.
Some findings regarding the important conventional colonoscopic findings for determining
the invasion depths of non-polypoid lesions have been reported in previous studies: redness,
white spots (chicken-skin appearance), appearance of expansion, firm consistency, deep
depression surface, irregular bottom of depression surface, and fold converging toward the
tumor. Matsuda et al. verified these findings retrospectively to clarify the clinically important
characteristics. White spots, redness, firm consistency, and a deep depressed area were
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significantly associated with an increased risk of submucosal deep invasion in a univariate
analysis [13].
2.2. Narrow-band imaging with magnifying endoscopy
NBI is an innovative optical technology that uses interference filters for spectral narrowing of
the bandwidth used in conventional white-light medical videoscopy. NBI allows a more
detailed visualization of the mucosal architecture and capillary pattern without the need for
dye spraying. Upon reviewing microvascular architecture using NBI, our institution identified
four different patterns according to Sano classification [9]. By examining a lesion’s microvessel
pattern using NBI, invasion depth was subsequently classified as intramucosa/shallow
submucosa (lack of uniformity and high vessel density; capillary pattern IIIA) or deep
submucosa (nearly avascular or loose microvessel diameters; capillary pattern IIIB). Ikematsu
et al. reported the diagnostic accuracy of this technique for determining the invasion depth as
follows: the sensitivity, specificity, and diagnostic accuracy of capillary pattern IIIB for
differentiating the intramucosa/shallow submucosa from deep submucosa were 84.8%, 88.7%,
and 87.7%, respectively [9].
On the other hand, we assessed the interobserver agreement in terms of estimating the depth
of invasion using NBI and pit pattern analysis and found substantial agreement with pit
pattern analysis and moderate agreement for NBI with magnification [14]. Regarding the lower
interobserver agreement in the interpretation of the NBI findings, we should remember that
the NBI system is still a relatively new diagnostic method with an unknown learning curve;
to complicate the matter, several different classifications for the evaluation of mucosal
morphology in colorectal neoplasms have been proposed recently in Japan. Regarding a
consensus on the microvascular architecture and classification of findings, there has not been
sufficient discussion for the worldwide use of NBI to become a reality.
2.3. Pit pattern evaluation using crystal violet staining
According to the classification of colonic crypts described by Kudo and Tsuruta, type V pit
patterns include areas of irregular crypts (type VI) and apparently non-structured areas (type
VN). Type VI pit patterns allow further subdivision into areas with mild irregularity (type VI
mild) and severe irregularity that show destroyed and severely damaged pits (type VI severe).
Type VI severe pit patterns were defined by Tobaru et al. as areas containing pits with poor
demarcation and those which contain faded or unstained stromal areas [15]. Regarding
diagnostic standardization by magnifying chromoendoscopy, this classification should be
directly linked to the choice of the most appropriate treatment. The depth of invasion of an
early colorectal cancer is normally determined from the accumulated data of serial observa‐
tions, which includes conventional imaging with no magnification. In this regard, Matsuda et
al. described the clinical classification of an “invasive/non-invasive pattern” that incorporates
conventional observations of lesion configuration, including depression, large nodules, and
reddened areas (Figure 2) [13]. When differentiating between intramucosal/shallow submu‐
cosal lesions and deep submucosal lesions, an interpretation using this invasive pattern
demonstrated a sensitivity of 85.6% and a specificity of 99.4%. In this report, the diagnostic
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accuracy was sufficient to demonstrate the efficacy of magnifying chromoendoscopy, and the
clear advantage of this classification was directly reflected in the choice of treatment: endo‐
scopic or surgical resection. Based on the pit pattern classification, the invasive pattern might
include some cases classified as VI severe and VN pit patterns.
A  B 
C  D 
Figure 2. An invasive lesion exhibiting the “invasive pattern” visualized by magnifying chromoendoscopy with crystal
violet staining. A: Large lesions with a reddish, protruding component; B: Depth diagnosis should focus on the reddish
part; C, D: Reddish part displays a highly irregular type VI pit, which was demarcated as the reddish area.
2.4. Alternatives
2.4.1. Endoscopic ultrasonography
Data on the utility of high-frequency endoscopic ultrasonography (EUS) for the management
of the malignant colorectal polyps is conflicting. Some previous reports have demonstrated
the usefulness of EUS, in particular the advantages of high-frequency ultrasound for diagnos‐
ing the invasion depth of early colorectal cancer [16-19]. Hurlstone et al. reported that high-
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frequency ultrasound was superior to magnifying chromoendoscopy for determining depth
invasion (accuracy of 93% vs. 59%, respectively). Matsumoto et al. also demonstrated the
diagnostic superiority of EUS (probe-EUS) in their study (negative predictive value for deep
invasion of 91% vs. 54%, respectively) [19]. In contrast, Fu et al. reported that there was no
significant difference between magnifying chromoendoscopy and EUS for the preoperative
staging of early colorectal cancer [20].
EUS is definitely very useful for determining the invasion depth or predicting submucosal
fibrosis in flat or depressed lesions; however, its limited penetration depth is a recognized
disadvantage. In particular, it might be difficult to accurately evaluate the invasion depth or
submucosal fibrosis in protruding lesions. Moreover, the use of EUS to observe lesions located
on the oral side of folds is also considered difficult.
2.4.2. Non-lifting sign
Uno et al. first described the “non-lifting sign” in 1994 [21]. Lesion observation during and
after submucosal saline injection is a simple and crucial method for not only assessing the
potential for deep invasion but also predicting the technical difficulty of endoscopic resection.
Lesions may not lift as a result of submucosal fibrosis, a desmoplastic reaction, or the presence
of large amounts of elastic fibers in vessels [22].
Regarding the diagnostic accuracy of the non-lifting sign for predicting deep invasion,
Kobayashi et al. reported a sensitivity of 62% and specificity of 98%. However, magnifying
chromoendoscopy displayed a sensitivity of 85% and specificity of 98% in the same study,
resulting in a significant difference in sensitivity [23]. Therefore, despite its simplicity, the non-
lifting sign could not reliably predict deep invasion when compared with a magnifying
observation.
3. Indication of endoscopic treatment
In Japan, colorectal ESD has been covered under health insurance since 2012. Before 2012, the
performance of colorectal ESD was allowed at only a restricted number of advanced medical
centers that had been approved in 2009 by the Japanese Ministry of Health, Labor, and Welfare.
From this, “The Colon ESD Standardization Implementation Working Group,” a sub-organi‐
zation of the “Gastroenterological Endoscopy Promotion Liaison Conference,” produced a
draft titled “Criteria of Indications for Colorectal ESD” [24]. In essence, ESD is indicated when
lesions require en bloc resection for evaluation of histological features and for lesions whose
resection using conventional EMR techniques is problematic. In other words, cancerous lesions
that have the potential to invade the submucosal layer require treatment using ESD. In these
cases, the size and morphology of the lesion are considered as critical factors. For example, a
nodular mixed type LST of size more than (or equal to) 30 mm and an LST-NG of size more
than (or equal to) 20 mm are considered to contain some risk of an invasive component. In
addition, lesions for which resection is technically difficult via conventional EMR are also
considered an indication for ESD; these include lesions exhibiting the non-lifting sign after
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submucosal injection, local recurrent lesions following previous treatment, and relatively large
protruding-type lesions (except pedunculated polyps). In general, the en bloc resection of large
neoplastic lesions (≥20 mm in size) via conventional EMR is technically difficult, and endo‐
scopic piecemeal mucosal resection (EPMR) is typically applied. Undoubtedly, EPMR is an
important method for removing lesions that harbor minimal potential for submucosal
invasion, such as intramucosal neoplasms; however, it is crucial to recognize an important
disadvantage of EPMR, specifically the increased risk of local recurrence. We previously
reported that the removal of more than (or equal to) 5 specimens from a single patient is an
independent risk factor for local recurrence following EPMR [25]. Moreover, colonoscopy with
careful surveillance is required after multiple EPMR. Given the risk and occurrence of invasive
recurrence in EPMR-treated patients, it is advisable to avoid such multiple resections and
explore alternative treatment strategies.
4. Endoscopic submucosal dissection
Various treatment materials have been developed and applied in the context of ESD since the




A well-cleansed colon is a key element of safe ESD in preventing such adverse events such as
bacterial peritonitis following iatrogenic perforation of the colonic wall. In our institution,
patients generally receive 3 to 4 L of polyethylene glycol over 4 hours in the morning before
ESD. Further, they also receive 1 g of cefmetazole in a 100-mL saline solution 20 to 30 minutes
prior to ESD.
4.1.2. Sedation
Intravenous administration of an anti-peristaltic agent (10 mg of scopolamine butylbromide
or 0.5 mg of glucagon) is mandatory, and intravenous administration of a sedative (2–3 mg of
midazolam) and analgesic (15 mg of pentazocine) is provided as required during the proce‐
dure. Maintenance of conscious sedation during the procedure is essential, as patients are
occasionally required to change position to enable the dissected part of the lesion to hang down
due to gravity to improve identification of the submucosal layer.
4.1.3. Treatment devices
Here, we describe the equipment that is commonly used at our institution. ESD is done using
a water jet endoscope (PCF-Q260JI and GIF-Q260J, Olympus Medical System Co., Tokyo,
Japan). In cases in which handling the endoscope as the operator intended during the ESD
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procedure would be difficult due to the location of the lesion or paradoxical movements, a
double-balloon colonoscope (EC-450BI, Fujifilm, Japan) is an available option for precise
endoscope control [26].
A ball-tip bipolar needle knife with a water jet (Jet B knife, XEMEX Co., Tokyo, Japan) is used
for both incision of the mucosa and dissection of the submucosa in the first step of the
treatment. An important feature of this device is its use of a bipolar current system, which
minimizes damage to deep tissue and decreases perforation risk [27]. Next, an insulation-
tipped electrosurgical knife (IT knife nano, KD-612Q, Olympus Optical Co., Tokyo, Japan),
fitted with a smaller insulation tip and short blade designed as a small disk to reduce burning
of the muscular layer, is usually used to shorten the procedure time [28].
For distal attachment, we use a short-type ST hood (DH-28GR and 29CR, Fujifilm Medical Co.,
Tokyo, Japan) that facilitates broadening of the visual field of the operator and dissection of
the submucosal layer due to its characteristic tapered configuration.
4.1.3.1. Electrosurgical current generator
The ERBE VIO 300 D (Erbe, Tubingen, Germany) is mainly used in our institution. Table 1
describes the output settings for ESD procedures.
Table 1. Output setting of VIO 300D for colorectal ESD at the National Cancer Center Hospital, Tokyo, Japan
4.1.3.2. Submucosal injection
ESD procedures are critically dependent on the maintenance of suitable submucosal elevation
by injection. We therefore prefer solutions for submucosal injection which enable a longer
period of submucosal elevation. Two solutions are used in our center, as follows: glyceol (10%
glycerin and 5% fructose; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan) mixed with small
quantities of indigocarmine and epinephrine, and a 0.4% sodium hyaluronate solution
(MucoUp; Seikagaku Corp, Tokyo, Japan) [29]. In practice, a small amount of Glyceol is first
injected into the submucosal layer to confirm the appropriate submucosal layer elevation;
MucoUp is subsequently injected into the properly elevated submucosal layer, after which an
additional small amount of Glyceol is injected to flush any residual of MucoUp [30].
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4.1.4. Carbon dioxide insufflation
Carbon dioxide (CO2) gas should be used for colonic lumen insufflation, as previously
confirmed [31, 32]. CO2 insufflation reduces the risk of pneumoperitoneum in cases of
perforation, and also reduces the development of abdominal conditions pre- or post-treatment
(or both).
4.1.5. ESD technique
In this section, the key points of the ESD technique performed at our institution are described
(Figure 3).
The process begins in the retroflex view because endoscope handling can be better stabilized
than is achievable with the forward view. After ensuring suitable submucosal elevation via
injection, the initial mucosal incision is produced with the Jet B knife from the lesion’s distal
aspect.
In cases where a retroflex view is difficult to obtain, the tunneling method described by
Yamamoto is a useful approach [33]. Briefly, incision and trimming of the mucosa are com‐
menced from the distal aspect of the lesion until the last tissue segment is approached. Incision
of the mucosa and dissection of the submucosa are then continued from the lesion’s proximal
aspect.
In most cases, insertion of the tip of the endoscope into the submucosal layer immediately after
the initial mucosal incision is difficult. For these, trimming of the mucosa is performed. As the
space for dissection is inadequate for continuation of submucosal dissection during trimming,
the submucosal layer is gently and carefully cut near the mucosal layer.
Once the submucosal layer is secure in the visual field, submucosal dissection is furthered with
the Jet B knife. One advantage of ESD is the clear visualization of structures in the submucosal
layer, such as vessels and fibrosis. This allows the prevention of bleeding by pre-coagulation
of the involved vessels. Cutting devices are used to perform pre-coagulation for thin-walled
vessels; for thick-walled or pulsatile vessels, however, coagulation forceps should be used. In
our center, we use Hemostat-Y forceps (H-S2518, Pentax Co., Tokyo, Japan) in bipolar mode
(25 W) for the control of visible bleeding and minimization of any risk of burning of the muscle
layer. In ESD, adjustment of the cutting line during submucosal dissection is also possible. In
adenomatous lesions, the line of incision can be located near the mucosal layer to minimize
perforation risk. In contrast, for potentially submucosal invasive cancer-type lesions, which
require R0 resection, the line of incision should be located in the deeper tissues, for example
near the muscularis propria, notwithstanding that the risk of perforation is increased.
Once an adequate visual field has been obtained as described, dissection is continued using
the IT knife nano. The usable section of this “blade”-type knife is longer than that of other
“needle”-type knives and can therefore reduce procedure time compared to those done
without this knife. During the entire procedure, submucosal injection should be repeated
whenever necessary to ensure suitable submucosal elevation.






Figure 3. A case of ESD performance. A: Flat elevated lesion (85 mm) located in the ascending colon. It was impossible
to maintain the retroflex view for this lesion. B, C: The submucosal injection of glyceol and first circumferential incision
were initiated from the oral side of the lesion with a forward view. The first cut was made with a Jet B knife. D: After
the first circumferential incision, it was difficult to slide the top of the short-type ST hood into the submucosal layer.
Next, the visual field was broadened by carefully cutting the blue-colored submucosal layer near the mucosa (white
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Following the completion of colorectal ESD, a routine colonoscopic review is done to identify
possible perforations or exposed vessels, and minimum coagulation is conducted with
hemostat-Y forceps on visible but non-bleeding vessels to minimize the risk of bleeding after
the operation.
4.2. Alternative technique
Hybrid ESD, which was first reported as “endoscopic resection with local injection of hyper‐
tonic saline–epinephrine” by Hirao et al. in 1986, is considered an alternative to ESD. This
procedure could enable en bloc resection or at least reduce the number of piecemeal resections
for large colorectal neoplasms in a manner that is both safe and relatively rapid. The technique
is simple; the first step is a circumferential incision of the mucosa, followed by placement of a
snare around the mucosa via the circumferential incision, and tightening of the snare (Figure
3) [34, 35]. However, there are some limitations associated with this technique. From our
limited experience, lesions of size more than (or equal to) 35 mm and LST-NG pseudo-
depressed−type tumors are often difficult to treat via en bloc resection, and we consider hybrid
ESD to be most suitable for lesions measuring 20 to 30 mm.
4.3. Outcomes
In Japan, The Japan Society for Cancer of the Colon and Rectum conducted a multicenter
observation study of all patients treated via conventional endoscopic resection and ESD for
colorectal neoplasms of size more than 20 mm from October 2007 to December 2010 [36]. A
total of 816 lesions were treated via ESD, and the short-term outcomes were as follows. The
mean lesion diameter was approximately 40 mm. En bloc resection was achieved in more than
90% of cases regardless of lesion size, with a perforation rate of 2.0% and delayed bleeding
rate of 2.2%. No perforation cases required emergency surgery and all were treated conserva‐
tively by endoscopic closure; nothing per os, antibacterial therapy. Hence, most iatrogenic
perforations are very small and can be closed by endoscopic clip placement.
4.4. Training for ESD
Given the high risk of complications that arise from the anatomical characteristics of the colon,
ESD requires a high level of skill and experience in endoscopy. A better understanding of the
learning curve for ESD is therefore required to standardize training, and to achieve a more
global acceptance of this technique. At our institution, endoscopists who will begin using ESD
must meet the following prerequisites to perform colorectal ESD: a high level of skill in the
non-loop insertion colonoscopy technique (more than 10 cases of total colonoscopy completed
within 5 minutes without any abdominal discomfort), skill in conventional EMR or EPMR
techniques, experience with more than 20 gastric ESD cases, and assistance in more than 20
colorectal ESDs conducted by experienced endoscopists [37]. In Western countries, however,
gastric cancer is less common than colorectal cancer, and the introduction of trainees to ESD
using colorectal lesion resection as a first step might be difficult. When required, trainees
should start clinical training in colorectal ESD with lower rectal lesions, which carry a lower
risk of perforation and a similar setting to gastric lesions.
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We reported the short-term outcomes of colorectal ESD performed by less-experienced
endoscopists [37, 38]. In terms of the learning curve, the endoscopists could perform the
technique safely and independently after preparatory training and experience of 30 or more
cases. On the other hand, most LST-G tumors of size less than (or equal to) 40 mm could be
treated safely within a 120-minute procedure time without any adverse events. Therefore, we
recommend that an LST-G tumor of size less than 40 mm is likely suitable for introducing
trainees to ESD.
5. Conclusion
Various treatment materials have been developed and applied to ESD since the introduction
of this technique. Of note, ESD is reliable for the en bloc resection of large colorectal superficial
neoplasms. It has a better success rate than EPMR and enables more accurate pathological
evaluations. In addition, colorectal ESD reduces unwanted surgery for mucosal carcinomas
and improves the overall quality of life of patients with lesions in the lower rectum. Never‐
theless, the technical difficulty of ESD and the complications associated with it, including
iatrogenic perforation, have held back its wider global adoption. We consider that adoption
of this technique will improve in future following further development of treatment devices
with improved safety and reduced technical difficulty. However, there is no exact standar‐
dized procedure for ESD, and it is important to continue efforts toward improving the safety
and technical ease of the procedure.
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Abstract
Endoscopic therapy has been increasingly recognized as an effective method of
treatment in selected patients with pancreatic diseases. Various endoscopic proce‐
dures, classical and modified, are used for the complex treatment of acute and chronic
pancreatitis, as well as their complications. In pancreatic carcinoma, some endoscopic
methods are applied mainly as palliative measures. There are still open questions
regarding the placing and timing of various endoscopic procedures in the multidis‐
ciplinary management approach of pancreatic diseases.
Keywords: endoscopy, EUS, acute pancreatitis, pancreatic cancer
1. Introduction
Acute pancreatitis (AP) is a disease with multiple etiologies and an increasing incidence,
showing a wide spectrum of outcomes – from a mild, self-limited to severe, life-threatening
illness [1]. According to the revised Atlanta classification of 2012, AP can be either edematous
interstitial pancreatitis or necrotizing pancreatitis, involving necrosis of the peripancreatic
tissues and/or pancreatic parenchyma [2]. In AP, there are 3 degrees of severity: mild, mod‐
erate, and severe – mild AP lacks both organ failure and local complications; moderately severe
AP has transient organ failure (<2 days), local complications, and/or exacerbation of a coexis‐
tent disease; and severe AP is defined by the presence of persistent organ failure (≥2 days).
Local complications are classified according to the presence of fluid or solid (necrosis)
component as acute peripancreatic fluid collections, pseudocysts, acute (pancreatic/peri‐
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
pancreatic) necrotic collection, and walled‑off necrosis. Acute peripancreatic fluid collection
is a true fluid collection that develops in the early phase of interstitial edematous AP, lacks a
wall, and usually resolves without intervention. Pancreatic pseudocysts (PPC) are encapsu‐
lated collections of fluid with a well-defined inflammatory wall and with minimal or no
necrosis, which usually occurs more than 4 weeks after onset of AP. Acute necrotic collections
(ANCs) are present in the first 4 weeks of the necrotizing AP and contain variable amounts of
solid (necrotic) and fluid material secondary to pancreatic and/or peripancreatic necrosis.
Walled‑off pancreatic necrosis (WOPN) represents the mature phase of an ANC, confined by
a wall of reactive tissue which develops usually 4 or more weeks after the onset of necrotizing
disease. Both ANCs or WOPN can be sterile or infected. Severe AP is estimated to occur in up
to 20% of patients and is associated with high morbidity and mortality (approximately 15%)
due to the development of sterile or infected necrosis, sepsis, and progressive multisystem
organ failure [3, 4]. Development of infected necrosis is observed in 25%–70% of patients with
necrotizing disease and usually requires an intervention to control the sepsis [5, 6]. Currently,
endoscopic therapy, including various endoscopic procedures, is a part of multidisciplinary
management of AP. It is indicated as a minimal invasive method of therapy in selected cases
with acute biliary pancreatitis and local complications of AP. In addition, pancreatic endo‐
therapy has been demonstrated to be effective in selected cases of idiopathic AP.
1.1. Endoscopic management in acute biliary pancreatitis
The most common cause of AP is gallstones. In most of the patients presenting with acute
biliary pancreatitis the gallstones pass spontaneously to the duodenum but in minority of
patients (about 20%) the persistent biliary obstruction can lead to cholangitis and severe AP
[1]. The duration of bile duct obstruction is an important contributing factor for the severity
of AP. It was reported that pancreatic necrosis develops more often when the biliary obstruc‐
tion exceeds 48 h [7]. In the past, urgent surgery to decompress the bile duct soon after the
diagnosis of pancreatitis was associated with increased mortality [8, 9]. Endoscopic retrograde
cholangiopancreatography (ERCP) is a less invasive method to clear the bile duct and it could
favorably affect the clinical outcome of AP if utilized properly [10, 11]. It is generally accepted
that early ERCP and endoscopic sphincterotomy (ES) are indicated in cases with acute
cholangitis and obstructive jaundice [12, 13]. In such patients, early ERCP and ES, preferably
within 72 h from the onset of AP, ameliorate the symptoms and the progression of AP [14].
There is no clear consensus on the benefit from the endoscopic approach in patients with ERCP
in patients with elevated liver function tests and obstructive jaundice with a septic-appearing
picture and severe disease graded by an accepted scoring system. The role and timing of ERCP
in patients with acute biliary pancreatitis have been evaluated in a number of clinical trials
and meta-analysis (Figure 1) [12, 13, 15-23]. The authors of the first study found that patients
with predicted severe biliary pancreatitis (using modified Glasgow criteria) had fewer
complications if they underwent ERCP within 72 h (24% vs 61%) compared to the control group
on conservative management [15]. After excluding the patients with concomitant acute
cholangitis (the most probable to benefit from early ERCP), the difference remained (15% vs
60%). Similar results were reported in another randomized study, in which the ERCP was
performed within 24 h after admission [12]. The early ERCP group with predicted severe
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pancreatitis had fewer complications (13% vs 54%) compared to the patients group on
conservative treatment. One multicenter study evaluated the benefit of early ERCP in pre‐
venting severe AP in patients without acute cholangitis and/or biliary obstruction (serum
bilirubin levels < 5 mg / dl) [13]. Their results showed no superiority of early ERCP regarding
morbidity and/or mortality in the study group, but also an unusually high mortality (8%)
among the patients with predicted mild pancreatitis. The most recent meta-analysis, including
7 randomized trials (n=757), found no evidence that early routine ERCP significantly affects
mortality or local/systemic complications, regardless of the predicted severity of biliary
pancreatitis, but it should be considered in patients with coexisting cholangitis or biliary
obstruction [23]. Among the trials that included patients with cholangitis, the early routine
ERCP strategy significantly reduced mortality, local and systemic complications as defined by
the Atlanta Classification. Among trials that included patients with biliary obstruction, the
early routine ERCP strategy was associated with a significant reduction in local complications
as defined by authors of the primary study, but a nonsignificant trend toward reduction of
local and systemic complications as defined by the Atlanta Classification. Although accurate
prediction of common bile duct stones in acute biliary pancreatitis is warranted to select
patients for early therapeutic ERCP, it should be noted that predicting their presence in the
early stages of disease with complete liver biochemistry, transabdominal ultrasonography, or
CT is unreliable [24]. In cases with severe biliary pancreatitis, the differential diagnosis
between acute cholangitis and severe AP with systemic inflammatory response syndrome may
be also difficult [10, 11]. In cases with suspected biliary obstruction, magnetic resonance
cholangio-pancreatography (MRCP) or endoscopic ultrasound (EUS) when accessible are the
preferred diagnostic modalities to identify it [25-28]. In patients with AP, the sensitivity and
specificity of EUS and ERCP were the same (96% vs 96% and 85% vs 92%, respectively) for
detecting choledocholithiasis [27]. By their use, ERCP would be reserved for patients with
strong evidence of obstruction. In 2012, the IAP/APA (International Association of Pancrea‐
tology/American Pancreatic Association) evidence-based guidelines for the management of
AP has been published [29]. It provides recommendations concerning the key topic on
multidisciplinary management of AP. The following recommendations for the management
of acute biliary pancreatitis, classified to their GRADE strength (1-strong, 2-weak) and quality
of evidence (A - high, B - moderate, C- low) have been given: “ERCP is not indicated in
predicted mild biliary pancreatitis without cholangitis. ERCP is probably not indicated in
predicted severe biliary pancreatitis without cholangitis. ERCP is probably indicated in biliary
pancreatitis with common bile duct (CBD) obstruction. ERCP is indicated in patients with
biliary pancreatitis and cholangitis. Urgent ERCP (<24 h) is required in patients with acute
cholangitis. Currently, there is no evidence regarding the optimal timing of ERCP in patients
with biliary pancreatitis without cholangitis. MRCP and EUS may prevent a proportion of
ERCPs that would otherwise be performed for suspected common bile duct stones in patients
with biliary pancreatitis who do not have cholangitis, without influencing the clinical course.
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Figure 1. Endoscopic management of acute biliary pancreatitis. a) A view of compression of duodenal wall by enlarged
gall bladder. b) Papillary sphincterotomy with extraction of impacted gall stone. c) A periampullary diverticulum
neighboring on sphincterotomy.
1.2. Endoscopic management of local complications in AP (pancreatic necrosis/WOPN, PPC,
disrupted pancreatic duct)
In the last years, the minimally invasive interventions for management of necrotizing pan‐
creatitis have replaced the traditional open necrosectomy. Laparotomy and immediate surgical
debridement of the infected necrotic tissue have been the gold standard treatment for a long
time [5, 30]. This concept has been changed by multiple reports showing that early surgical
intervention for pancreatic necrosis could result in a worse prognosis compared to cases where
surgery is delayed or avoided [31-35]. Besides percutaneous drainage and minimally invasive
surgery, endoscopic transmural drainage (ETD) and necrosectomy have an increasing role as
an alternative to open surgery. The results of different multicenter studies and randomized
trials, as well as systematic reviews, evidence-based guidelines and consensus statements have
supported the safety and efficacy of endoscopic and other minimally invasive techniques in
the management of severe AP and its complications [1, 29-32, 35-44]. In summary, intervention
is primarily indicated for infected necrosis and less often for symptomatic sterile necrosis. They
should be delayed 4 weeks or longer after the onset of disease, for better demarcation and
liquefaction of the necrosis. Both the step-up approach using percutaneous drainage followed
by minimally invasive video-assisted retroperitoneal debridement and endoscopic necrosec‐
tomy have been shown to have superior outcomes to traditional open necrosectomy with
respect to short-term and long-term morbidity. Applicability of these techniques depends on
the availability of specialized expertise and a multidisciplinary team dedicated to the man‐
agement of severe AP and its complications [38]. According to the guidelines of IAP/APA
Endoscopy - Innovative Uses and Emerging Technologies162
Figure 1. Endoscopic management of acute biliary pancreatitis. a) A view of compression of duodenal wall by enlarged
gall bladder. b) Papillary sphincterotomy with extraction of impacted gall stone. c) A periampullary diverticulum
neighboring on sphincterotomy.
1.2. Endoscopic management of local complications in AP (pancreatic necrosis/WOPN, PPC,
disrupted pancreatic duct)
In the last years, the minimally invasive interventions for management of necrotizing pan‐
creatitis have replaced the traditional open necrosectomy. Laparotomy and immediate surgical
debridement of the infected necrotic tissue have been the gold standard treatment for a long
time [5, 30]. This concept has been changed by multiple reports showing that early surgical
intervention for pancreatic necrosis could result in a worse prognosis compared to cases where
surgery is delayed or avoided [31-35]. Besides percutaneous drainage and minimally invasive
surgery, endoscopic transmural drainage (ETD) and necrosectomy have an increasing role as
an alternative to open surgery. The results of different multicenter studies and randomized
trials, as well as systematic reviews, evidence-based guidelines and consensus statements have
supported the safety and efficacy of endoscopic and other minimally invasive techniques in
the management of severe AP and its complications [1, 29-32, 35-44]. In summary, intervention
is primarily indicated for infected necrosis and less often for symptomatic sterile necrosis. They
should be delayed 4 weeks or longer after the onset of disease, for better demarcation and
liquefaction of the necrosis. Both the step-up approach using percutaneous drainage followed
by minimally invasive video-assisted retroperitoneal debridement and endoscopic necrosec‐
tomy have been shown to have superior outcomes to traditional open necrosectomy with
respect to short-term and long-term morbidity. Applicability of these techniques depends on
the availability of specialized expertise and a multidisciplinary team dedicated to the man‐
agement of severe AP and its complications [38]. According to the guidelines of IAP/APA
Endoscopy - Innovative Uses and Emerging Technologies162
(2012), common indications for intervention (either radiological, endoscopical, or surgical) in
necrotizing pancreatitis are clinical suspicion or documented infected necrotizing pancreatitis
with clinical deterioration, preferably when the necrosis has become walled-off [29]. At
present, there are insufficient data to define subgroups of patients with suspected or confirmed
infected necrotizing pancreatitis who would benefit from a different treatment strategy, but
percutaneous catheter or ETD should be the first step in the treatment of these patients,
followed by endoscopic or surgical necrosectomy if needed. In the multicenter randomized
trial, including 88 patients with infected necrotizing pancreatitis, the Dutch Pancreatitis Study
group showed that the step-up approach of percutaneous (retroperitoneal) catheter drainage
and followed, if needed, by minimally invasive necrosectomy, decreased major short-term
complications (40% vs 70%) and costs as compared to primary open necrosectomy [36]. The
rates of late complications as diabetes and exocrine pancreatic insufficiency were also lower
in the step-up cohort of patients. Lately published trial by the same group, in which the patients
were randomized to endoscopic transgastric versus open necrosectomy, demonstrated a lower
rate of proinflammatory response, organ failure, and major complications in patients under‐
going EUS-guided necrosectomy as compared to surgical necrosectomy [41]. The results from
a currently performed multicenter randomized controlled trial (TENSION trial) comparing
endoscopic transluminal to minimally invasive surgical step-up approach are awaited [45]. A
small proportion of patients with documented infected necrosis who remain clinically stable
can be managed with antibiotics alone, without the need for percutaneous catheter drainage
or necrosectomy. Future studies should compare (initial) antibiotic treatment of infected
necrosis with other, more invasive, strategies [29]. The vast majority of patients with sterile
necrotizing pancreatitis can be managed without intervention. Indications for intervention
(either radiological, endoscopical, or surgical) in this group of patients are: ongoing gastric
outlet, intestinal, or biliary obstruction due to mass effect of WOPN; persistent symptoms
(“persistent unwellness”) in patients with WOPN without signs of infection; disconnected duct
syndrome in the presence of persisting symptomatic collection with necrosis. Rare complica‐
tions requiring (nonsurgical) intervention in the follow-up after sterile necrotizing pancreatitis
are pancreaticopleural fistula, pancreatic ascites, and a “true” (no necrosis found in the
collection on MR or ultrasonography) symptomatic pseudocyst.
Several comprehensive reviews discussing indications, timing, standard and novel ap‐
proaches, outcomes, and complications regarding ETD and necrosectomy in infected necrot‐
izing pancreatitis have been published recently [2, 3, 38, 39, 42-47]. The technique of endoscopic
transluminal necrosectomy (ETN) involves a transmural (transgastric or transduodenal) access
to the WOPN, followed by large-caliber balloon dilation of the tract between the collection and
the gastrointestinal wall, allowing the insertion of an endoscope into the collection to visualize
the necrotic material, mechanical debridement, and lavage. A variety of tools, such as baskets,
snares, and nets have been used to remove the necrotic tissue. A stent (plastic/metal) is left in
place at the end of the procedure to keep the fistula patent and to allow access into the necrotic
cavity at a later session. Most patients with severe AP complicated by WOPN require multiple
sessions to achieve radiographic and clinical success. One recent systematic review on the ETN
of pancreatic necrosis found that a median of 4 (1-35) sessions are needed to achieve resolution
of the necrotic collection [42]. EUS-guided necrosectomy is increasingly used due to the ability
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of EUS to visualize and determine the optimal access into the collection, to avoid intervening
blood vessels, to assess the contents of the cavity, and to visualize bleeding into the collection
and other complications during and immediately after the procedure [46]. One recent system‐
atic review reported that EUS-guided necrosectomy has been performed in 283 published cases
so far [48]. Currently used endoscopic accessories during ETN are designed for other purposes
and are not optimal in achieving adequate necrotic debridement in a limited time. The authors
of one study showed that drainage of necrotic collections with multiple instead of a single
transmural access, placing multiple stents and a nasocystic drainage in each tract (multiple
transluminal gateway technique), led to better long-term clinical outcomes [49]. Other authors
reported that the use of hydrogen peroxide in their small case series facilitates the removal of
necrotic debris, but the benefit and potential complications need to be further investigated [50,
51]. The use of metal stents specially designed for drainage of pancreatic fluid collections was
also reported in small case studies and the results regarding their efficacy are awaited [52-54].
The summary results of various studies show that ETN is an effective minimally invasive
treatment in infected necrotizing pancreatitis. It was reported that the success rate of peroral
endoscopic drainage/debridement of WOPN was 81% of 53 studied patients [55]. Results from
a multicenter US series demonstrated a resolution rate of 91% (95/104 patients with WOPN)
as the mean time to resolution was 4.1 mo from the initial procedure [56]. A recent systematic
review, including 15 studies (455 patients), reported that with ETN definitive successful
treatment was achieved in 81% of patients, mortality was 6%, and complications occurred in
36% of patients [44]. Bleeding was the most common complication (18%), following perfora‐
tions to the peritoneum. Other reported complications included infection, aspiration, stent
migration, occlusion, pancreatic duct damage, complications of sedation, and gas embolism.
In the systematic review on EUS-guided necrosectomy, it was found that the mean technical
and clinical success rates were 100% and 88%, respectively; mean overall complication rate
was 28%, and mean overall recurrence rate was 7% [48]. The results of one recently published
systematic review and meta-analysis of ETN for WOPN (8 studies) showed that the mean time
of ETN after onset of AP was 7 weeks; the mean size of the necrotic cavity was 12.87 cm and
the weighted mean number of endoscopic procedures needed to resolve the necrotic cavity
was 4.09 [43]. The pooled proportion of successful resolution of pancreatic necrosis using ETN
was 81.84% and that of recurrence after ETN was 10.88%. Complications were noted in 21.33%
of patients, including bleeding, sepsis, and perforation. For pancreatic necrosis that did not
resolve, surgery was performed in 12.98% of patients. The authors of this meta-analysis
conclude that ETN is safe and effective at treating patients with symptomatic WOPN and offers
the advantage of minimally invasive endoscopic treatment without transabdominal surgery
but better techniques and equipment are still needed to improve procedural efficiency. The
decisions to perform ETN should be made by advanced endoscopists in collaboration with a
multidisciplinary team with the facilities and personnel to manage these complex patients.
Symptomatic pancreatic pseudocysts (abdominal pain, gastric outlet, obstructive jaundice)
and  disrupted  pancreatic  duct  in  AP  are  also  indicated  for  endoscopic  therapy.  The
literature data show that the incidence of APFC in acute edematous pancreatitis is around
40% and development of PPC is approximately 10% of these cases [57]. Earlier it had been
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reported that pseudocysts result from pancreatic duct disruption in up to 10%–25% of cases
with AP and in 20%–40% of chronic pancreatitis (CP) cases [58]. Endoscopic drainage of
PPC (transpapillary,  transmural,  or  combination of  the  both)  has  been demonstrated as
effective minimally invasive method for their treatment in a number of studies. The results
regarding technical success, recurrence, and complications rates will be discussed below,
in endoscopic therapy of PPC in CP.
Disruption of the pancreatic duct (PD) secondary to pancreatic necrosis occurs in attacks of
AP and leads to leakage of the pancreatic secretion and its accumulation inside the abdomen
in the neighborhood of the pancreas and pseudocyst formation [4]. It may also result in
pancreatic ascites or pancreatic fistulae. Endoscopic treatment of the disrupted PD includes
transpapillary stent bridging of the pancreatic leak or diverting pancreatic duct flow [59]. The
efficacy of these techniques has been demonstrated in several studies [60-62]. Complete duct
disruptions are refractory to transpapillary stenting because the upstream disconnected
segment maintains secretion. Therefore, ETD has arisen as the procedure of choice for cases
with complete duct disruptions [62].
1.3. Endoscopic therapy in idiopathic acute pancreatitis
Idiopathic AP is defined as pancreatitis with no etiology established after initial laboratory
and imaging tests (transabdominal ultrasound and CT in the appropriate patient) [63]. Patients
with idiopathic AP should be evaluated at specialized centers on pancreatic diseases, applying
combined multidisciplinary approach, including advanced endoscopy [1]. Various anatomic
(pancreas divisum, anomalous anomalous pancreatobiliary duct junction, choledochal cysts/
choledochocele, periampullarry diverticulae, ampullary tumors) and physiologic anomalies
(sphincter of Oddi dysfunction/SOD) can contribute to recurrent episodes of AP and many of
them can often be diagnosed and treated endoscopically [3, 64, 65]. The diagnostic role of ERCP
can help define specific causative factors in patients with idiopathic AP, but its major limitation
is the risk of post-ERCP pancreatitis, which varies from 5% to 10% and reaches 30% in cases
with SOD. For this reason, diagnostic and therapeutic endoscopy in these cases should be
performed in specialized units.
Pancreas divisum (PD) is reported in about 20% of patients with acute recurrent pancreatitis
[65]. Endoscopic therapy in PD includes minor papilla sphincterotomy, papillary dilation, stent
placement, or a combination of these techniques. Endoscopic and surgical therapy are
comparably effective in 70%-90% of patients with PD but endoscopic therapy as minimally
invasive method is preferred in most cases [66]. In patients with dilated dorsal duct or
abnormal function test, and no ductal strictures upstream of the minor papilla, sphincterotomy
is the procedure of choice. A short-term dorsal pancreatic duct stent placement is recommend‐
ed to avoid postprocedure complications. Although endoscopic therapy has been proved
effective in a large percentage of cases with PD, there is only one small randomized controlled
trial [67]. The authors reported that in the treatment group, 9 out of 10 patients (90%) had no
further episodes of AP during a 3-year follow-up, while 6 of 9 patients (67%) who were
randomized to no treatment had at least one episode.
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Endoscopic management, including biliary sphincterotomy alone, is also the method of choice
for patients with uncomplicated type 3 choledochal cyst/choledochoceles. Treatment of most
other choledochal cysts is mostly surgical because for their potential of malignant degeneration
[3]. The presence of periampullary diverticulum, although rarely, can also be a cause for acute
relapsing pancreatitis. Endoscopic sphincterotomy in a small series of patients was found to
be effective with no further episodes of AP during the follow-up period [68]. It has been
estimated that 5%–14% of patients with benign or malignant pancreatobiliary tumors present
with idiopathic AP [69-72]. Pancreatic cancer should be suspected in any patient >40 years of
age with idiopathic pancreatitis, especially those with a prolonged or recurrent course [72].
Ampullary tumors can be resected either surgically or endoscopically [3]. It was reported that
endoscopic treatment (snare polypectomy with sphincterotomy) was successful in the removal
of ampullary tumors with no ductal invasion in up to 90% of cases [73, 74]. Procedure-related
pancreatitis could be reduced by prophylactic stent placement and a long-term surveillance
with endoscopic biopsies was recommended.
Sphincter of Oddi dysfunction is a nonmalignant condition resulting in impairment in
sphincteric physiology, leading to outflow obstruction. SOD is reported in about one-third of
cases with recurrent pancreatitis [65]. The diagnosis is confirmed by endoscopic SO manom‐
etry. In documented SOD, endoscopic therapy includes biliary and/or pancreatic sphincterot‐
omy. Prophylactic pancreatic stenting for two weeks after sphincterotomy has shown to reduce
the incidence of post-ERCP pancreatitis [75]. Clinical improvement after sphincterotomy has
been reported in 55%–95% of patients, depending on the type of SOD, and manometric
recordings [76, 77]. The analyses of published studies (237 patients with follow-up ranging
from a mean of 3 months to 5 years) showed that favorable outcomes are the highest in type I
SOD cases (83%–100%) while in type II SOD patients long-term symptom relief was reported
in up to 79%, depending on whether manometry was abnormal. One recent study, including
69 patients with recurrent AP and pancreatic SOD randomized to biliary sphincterotomy with
and without pancreatic sphincterotomy showed that the recurrence of pancreatitis was similar
in both groups (48.5% vs 47.2%) [78].
2. Endoscopic therapy in chronic pancreatitis
In recent years with advances in technology, endoscopic therapy is one effective management
option in CP along with medical and surgical treatments. Endoscopy became preferable
management in selected patients with CP because of high success rate and low morbidity and
mortality. The results are comparable to surgery [79-82]. In addition, the procedure may be
repeated with no extra risk [83]. Endoscopic therapy may reduce or eliminate the need for
surgical procedures, may serve as a bridge to surgery in poor operative candidates, and can
predict the response to surgical therapy [84-85]. If endoscopic therapy is unsuccessful, surgical
therapy is still a potential option for most patients.
Today endoscopic therapy is performed in patients with CP who are unlikely to respond or
have failed medical therapy, or when it is necessary to resort to long-term opioid administra‐
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tion [83, 86-89]. The aims of endoscopic therapy in CP are to relieve outflow obstruction of
main pancreatic duct (MPD) to control of pain, as well as to manage complications such as
ductal strictures, calculi, pseudocysts, and biliary strictures [83, 86-90]. Endoscopic therapy is
based on different techniques and procedures, such as ERCP, pancreatic sphincterotomy,
pancreatic stones extraction, pancreatic and biliary stenting, and drainage of pseudocysts.
Extracorporeal shockwave lithotripsy (ESWL) for MPD stones may be combined with endo‐
scopic procedures. Advances in EUS have improved PPC drainage and cannulation of
inaccessible MPD, as well as celiac plexus block [83, 86, 87, 89].
We evaluated the endoscopic methods of therapy in patients with CP (n=114, group ), and
compared the results to those of control group of patients, treated by conventional conservative
methods (n=100, group ) [91]. All cases were followed-up for a period of 3 years. The early and
late results showed that endoscopic treatment led to clearance of common pancreatic duct by
stone extraction (82% and 71%), control of strictures/fistulae by stenting (76% and 68%), (Figure
2), and pseudocyst decompression by cystogastrostomy under EUS plus dilation and stenting
(73% and 30%), (Figure 3). Symptoms improvement, especially pain, was observed in 86%
versus 17% (6th month) and 70% versus 14% (3rd year) in group and group , respectively
(p<0.001). Endoscopic treatment significantly reduced the incidence of new pancreatic attack
(p<0.01). New formation of pancreatic duct stones occurred in 2/17 patients. Replacement of
pancreatic prostheses was needed in 41%. New ductal or parenchymal changes were observed
in 25%. According to these data we suggest that endoscopic procedures are one alternative
strategy in chronic pancreatitis with impaired drainage, leading to pancreatic duct or pseu‐
docysts drainage, reductions of pain and incidence of pancreatic attack, but recurrent and
complications rates are higher.
Figure 2. a, b) Endoscopic therapy in CP- insertion of endoprosthesis in a case with pancreatic ductal stricture.
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Figure 3. a, b, c, d, e) EUS-guided transgastric drainage of pancreatic pseudocyst in a case with CP.
In the last 10 years, there are accumulating data for the utility of endoscopic therapy and its
efficacy and limitations in various painful conditions and complications associated with CP.
2.1. Painful uncomplicated CP
In the last version of the European Society of Gastrointestinal Endoscopy (ESGE) Guideline
[86] on endoscopic treatment of painful uncomplicated CP, the following recommendations
are given:
“Endoscopic therapy is the first-line therapy for painful uncomplicated CP. The clinical
response should be evaluated at 6–8 weeks. If it appears unsatisfactory, the patient’s case
should be discussed again in a multidisciplinary team with endoscopists, surgeons, and
radiologists and surgical options should be considered, in particular in patients with a
predicted poor outcome following endoscopic therapy” (Recommendation grade B).
Randomized controlled clinical trials comparing endoscopic and surgical pain treatment in CP
showed better results for surgery [92-94]. In [92], it was reported that pain relief was 15% for
endoscopic therapy versus 34% for surgery after 5 years of follow-up. It has been discussed
that these results showed that neither of these options is satisfactory, and also that endoscopic
therapy was not optimal [86]. ESWL and cumulative stenting were not used, and endoscopic
therapy was not repeated in the case of recurring symptoms. In the trials of [93, 94], the initial
stenting period was relatively short as stents were removed when the stricture had disap‐
peared on the pancreatogram, but recurrence was observed when pain and stricture persisted.
This is in contrast to most other studies, in which stenting is continued for 1–2 years. In
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addition, included were patients with advanced disease with strictures and stones, as well as
opioid-dependence. For these reasons, the results cannot be extrapolated to all patients with
CP [86]. The long-term follow-up after endoscopic therapy in a total of 1890 patients with CP
showed that 83% of them had no need of pancreatic surgery [82, 95-99]. In addition, surgery
was associated with higher morbidity (18%–53%) and mortality (0%–5%) in comparison with
endoscopic therapy of CP (3%–9% morbidity and 0%–4% mortality) [82, 100-103]. Pain relief
was observed in 70%–94% of patients in the short-term followed-up, and in 52%–82% of
patients in the long-term followed-up endoscopic treatment [104-108]. Similar results of
endoscopic decompression therapy were found in patients with all types of obstruction,
including calculi alone, stenosis alone, or a combination of both [87, 104]. After endotherapy,
the number of pain-related hospitalizations and the need for analgesics decreased, but patients’
quality of life was not improved significantly [89, 96, 109]. According to the Spanish Pancreatic
Club’s recommendations for the diagnosis and treatment of CP, endoscopic decompression
treatment is less effective and has shorter-term effects compared to surgery [88]. Endoscopic
pain treatment has been shown to be effective for patients with a dilated MPD, particularly
when various endoscopic techniques are combined [88, 89]. Reference [88] shows also some
limitations of endoscopic treatment. Better pain control following surgery compared to
endoscopic therapy was observed in randomized clinical trials, but both endoscopic and
surgical therapy had been tested in a randomized trial versus medical therapy. It is difficult
to assess pain control of endoscopic therapy in long-term studies without a control group,
given the tendency of its decreasing effects over time. Finally, endotherapy is a technically
difficult and an operator-dependent procedure. ESGE experts [86] have shown some factors
independently associated with long-term (≥2 years) successful endoscopic pain relief. These
factors include: the obstructive calcifications in the head of the pancreas; short disease duration
and low frequency of pain attacks before endoscopic therapy; complete MPD stone clearance;
absence of MPD stricture at initial endoscopic therapy; and discontinuation of alcohol and
tobacco during follow-up [96, 97, 99, 110-111].
In a painful CP with minimal or no ductal change with absence of ductal strictures or stones
(mild CP according to Cambridge classification), endoscopic pancreatic sphincterotomy (EPS)
is a method of therapy and it offers symptomatic relief in some of these patients. Both the
standard pull type and the needle knife sphincterotomy over a stent can be performed [83,
87]. A total of 64% pain relief on follow-up of 6.5 years was reported following EPS in patients
with idiopathic CP [112]. Other authors observed high success rates of 98% and low compli‐
cation rates of around 4% in retrospective analysis [113].
Risks of pancreatic sphincterotomy include early complications of pancreatitis (2%–12%),
bleeding (0%–3%) and perforations (<1%), and late complications of sphincter stenosis (up to
10%) [83, 87, 114]. Placement of a nasopancreatic tube or pancreatic stent can reduce their
incidence [87, 102]. In reference [87], a 3 Fr single-pigtail plastic stent, 4–6 cm in length had
been used to prevent postprocedure pancreatitis. The small-diameter single-pigtail stent
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needle knife technique [115]. Restenosis is reported in around 14% of patients on long-term
follow-up [116]. It is less common after the pull-type EPS with longer incision than the needle
knife technique [117]. On the other hand, the use of EPS as a single therapeutic manipulation
in patients with mild CP has not been studied well [86-89]. Therefore, endoscopic therapy is
recommended as the first-line therapy for painful uncomplicated CP only in patients with
moderate or marked changes at pancreatography according to the Cambridge classification.
2.2. Pancreatic duct stones
Nonsurgical clearance of stones obstruction of MPD can be achieved by ESWL or endoscopy
alone, and by both of these techniques [83, 86-90]. In most patients, EPS with or without a
biliary sphincterotomy via the major or minor papilla is performed to facilitate removal of
pancreatic stones. The MPD stones are often impacted and difficult to extract, but up to 50%
of MPD stones can be removed effectively by standard techniques, including endoscopic
sphincterotomy or stone retrieval with a balloon, basket, and/or forceps alone [90, 101,
118-120]. Endoscopic stent placement, mechanical lithotripsy, intracorporeal lithotripsy with
a pulse-dye laser, or electrohydraulic lithotripsy, are other possibilities [90, 121-125]. Adding
ESWL increases clearance rates to 60%–90% [90]. The best candidates for endoscopic removal
are MPD stones of the head or body with upstream MPD dilation [87, 90]. These devices are
used to sweep or capture pancreatic duct stones to deliver stones, sludge, and debris out of
the duct system and into the small-bowel lumen. Extraction balloons are very safe to use during
ERCP [126]. Smaller pancreatic stone baskets are more effective if the duct lumen is less than
5 mm. In a case series, it was reported that endoscopic balloon dilation (12–15 mm) of the
pancreatic orifice after sphincterotomy is a safe technique that facilitates the removal of large
radiolucent stones from the MPD [127]. Further studies are needed before routine use of such
large balloons can be recommended. On the other hand, in [86], the low success rate in a
retrospective series of endoscopic stone extraction using Dormia baskets is discussed. In
addition, mechanical lithotripsies are associated with relatively high morbidity rates in
retrospective multicenter series [125].
ESWL has been usually used to facilitate the removal of PD stones during therapeutic endos‐
copy, especially in larger stones more than 5 mm in size [83, 86-90]. ESWL is now accepted as
the standard of care in treatment of MPD stones. ESWL is highly effective at fragmenting
radiopaque and radiolucent stones with high level of spontaneous elimination of stone
fragments and pain relief [83, 86, 88, 90, 101]. In ESGE Guideline [86], successful stone
fragmentation following ESWL has been defined as stones broken into fragments ≤2 or 3 mm,
or by the demonstration of a decreased stone density at X-ray, an increased stone surface, and
a heterogeneity of the stone which may fill the MPD and adjacent side branches. The ESGE
Guideline group prefers the latter definition [86]. Performance of ESWL prior to endoscopy
was associated with the success of MPD stone clearance in a retrospective study [111]. A meta-
analysis of 17 studies with a total of 491 patients revealed a clearance rate between 37% and
100% and decreasing pain [128]. A review of 11 studies with over 1100 patients showed
successful stone fragmentation in 89% [129]. Other authors reported complete clearance in 76%
of 1000 patients and partial clearance in another 17% patients following ESWL and endother‐
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apy for large stones [101]. According to their opinion, patients with pain and large MPD stones
in the head or body can be treated by ESWL. Patients with isolated calculi in the tail; multiple
MPD strictures; extensive calculi in head, body, and tail; associated head mass; pseudocysts;
and pregnancy are excluded from ESWL [83]. In [86], it has been discussed that in the majority
of series, stones targeted by ESWL were mostly obstructive radiopaque MPD stones with a
minimal diameter in the range of 2–5 mm. It has been also confirmed that factors significantly
associated with success of MPD stone clearance after ESWL included the presence of a single
stone, and confinement of calculi to the head of the pancreas.
A few studies have advocated the use of ESWL alone followed by spontaneous expulsion of
fragments [83]. Patients frequently require several ESWL sessions to achieve stone clearance
from the duct [130]. The results of uncontrolled series, including 350 patients followed-up for
44 months, showed spontaneous MPD stone clearance in 70%–88% of patients and long-term
pain relief in 78% of patients [98, 131], whereas other investigators have had less impressive
results [109, 132]. It has been discussed that complete removal rates differ among institutions
[90]. These differences may be due to the type of lithotriptor used, the power setting, the
number of shocks delivered, the number of treatment sessions, and differences regarding the
definition of complete removal of pancreatic stones among institutions. A randomized
controlled trial of 55 patients compared the performance of ESWL plus ERCP or ESWL alone
[111]. The only significant differences between the groups were the longer hospital stay and a
higher treatment cost in the ESWL plus ERCP group. ESWL is a relatively safe technique. The
minor complications from ESWL include skin or duodenal lesions, exacerbation of pancreatitis,
mild abdominal discomfort, and asymptomatic hyperamylasemia. Acute pancreatitis attrib‐
uted to ESWL has been reported in 6.0%–12.5% of patients after ESWL “alone” for treating
calcified CP [97, 98, 111, 131]. Serious complications after ESWL have been reported in less
than 1% of patients [133]. The reported morbidity and mortality rates are 5.8% and 0.05%,
respectively [97, 98, 101, 124]. Contraindications to ESWL include coagulation disorders,
pregnancy, and presence in the shockwave path of bone, calcified aneurysms, or lung tissue
[86]. Implanted cardiac pacemakers are not universally contraindicated to ESWL [134].
Finally, ESWL combined or not with ERCP is recommended as the first-line therapy for painful
uncomplicated CP. The last ESGE Guideline [86] recommended: “For treating patients with
radiopaque stones ≥ 5mm obstructing the MPD, ESWL as a first step, immediately followed
by endoscopic extraction of stone fragments. In centers with considerable experience with
ESWL, ESWL alone should be preferred over ESWL systematically combined with ERCP
(Recommendation grade B). Endoscopic attempts to extract radiopaque MPD stones without
prior stone fragmentation should be considered only for stones <5mm, preferably low in
number, and located in the head or body of the pancreas. Intraductal lithotripsy should be
attempted only after failure of ESWL (Recommendation grade D)”. Intraductal laser or electro‐
hydraulic lithotripsy are second-line interventions after failed ESWL, with success rates for
stone fragmentation of 47%–83% [135, 136]. Stone dissolution therapy may have a role only in
patients in whom all other methods have failed and who are not surgical candidates [86].
Several studies reported that pain relapse occurs more frequently with incomplete stone
removal [97, 137, 138]. In contrast, other series reported no difference in pain relapse rates
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between complete and incomplete removal groups [132, 139]. In one study, all patients with
relapse had intraductal pancreatic stones, suggesting that the main cause of pain relapse is
recurrent (or remnant) pancreatic stones [97]. Failure to achieve pain relief despite adequate
clearance of the pancreatic duct stones indicates other mechanisms of pain in patients with CP.
2.3. Pancreatic ductal strictures
Endoscopic therapy is indicated for single strictures in the head while isolated strictures in the
tail or multiple strictures are not amenable to endotherapy [85, 87]. Prior to MPD stenting, EPS
of the major or minor papilla has been performed [83, 86, 87, 140]. Stricture dilation with Teflon
bougies, Sohendra stent retriever, or a balloon dilator is also performed prior to stenting in
most cases. High-grade strictures require dilation prior to insertion of the endoprosthesis [86,
87]. Because chronic pancreatitis-related MPD strictures may be very tight and resilient,
dilation alone of the pancreatic duct stenosis is not a useful treatment [87, 88]. Large bore plastic
stents should be deployed as they have longer patency [140]. Stents measuring 8.5 Fr or 10 Fr
in diameter are used in most studies. A retrospective study of 163 patients showed that thinner
MPD stents (≤8.5 Fr) are associated with 3 times more frequent hospitalizations for abdominal
pain than 10-Fr stents [141]. In addition, stents should be kept in place for a long time (1–2
years) and require replacement in cases of obstruction and recurring symptoms [142]. MPD
stenting for a short duration (6 months) has been shown to be poorly effective. The recurrence
rate of pain after the stent removal was 30%–48%; as such pain often improves when a new
stent is placed [86, 95, 105, 106]. In [140], a protocol was followed where a single stent was
placed across a stricture and exchanged every 6 months or when the patient was symptomatic.
Stents were placed for 24 months. Patients were restented if symptoms recurred. Surgery was
considered if patients responded to stent placement but needed frequent or repeated stenting.
Placement of a single pancreatic plastic stent achieves MPD stricture resolution in nearly 60%
of cases [86]. Cumulative data from several trials showed that pancreatic stenting is technically
successful in 85%–98% of cases, revealed pain relief in 65%–95%. Sustained pain relief was
observed between 32% and 90% of patients on follow-up of 14–69 months [85, 105-108, 143,
144]. Recurrence of strictures was reported in 38% of patients after 2-year follow-up [96].
Restenting was reported in 22%–30% of patients, and 4%–26% of patients had pancreatic
surgery. A pancreas divisum anatomy might require longer/multiple stenting because it is
associated with more frequent relapse of MPD stricture and of pain after stent removal
compared with MPD stenting in patients without pancreas divisum. Simultaneous placement
of multiple pancreatic stents was reported to be of additional benefit. Other authors reported
that after removal of a single stent, the stricture was dilated and multiple (mean of 3) plastic
stents 8.5–11.5 Fr diameter were placed [145]. The stents were removed 12 months later.
Stricture resolution was observed in 95% and pain relief in 84% on a 38-month follow-up.
Complications related to pancreatic stenting are reported between 6% and 39% [80, 105, 106,
143, 144]. They are usually mild and managed conservatively [83]. Mild pancreatitis is the most
frequent complication of MPD stenting. Occlusion of stents requires stent exchange. Usually
stent exchange was performed every 3 months or when symptoms developed [105-107]. The
aim of an “on-demand” stent exchange schedule is to reduce the number of ERCP sessions
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because occlusion usually occurs within 2–3 months, but symptoms of CP recur between 6 and
12 months [104]. Using of “on-demand” stent exchange schedule associate rare occurrence of
pancreatic abscesses and sepsis [80, 95], and failure to decrease the number of ERCP sessions
[95, 105]. MPD stent migration was present in 10% of patients [121]. Distal migration and
impaction on the duodenal wall can cause perforation while proximal migration into the
pancreas is a technical challenge for the endoscopist [83]. Proximal or distal stent migrations
as well as pancreatic abscesses requiring surgery have rarely been reported. Because of
elevated risk for pancreatic cancer, tissue samples are needed before endotherapy [146]. In
addition, MPD stents may produce ductal changes, including strictures or focal areas of chronic
pancreatitis [147, 148]. However, these changes may improve with time.
The ESGE recommended “treating dominant MPD stricture by inserting a single 10-Fr plastic
stent, with stent exchange planned within 1 year even in asymptomatic patients to prevent
complications related to long-standing pancreatic stent occlusion (Recommendation grade C)”
[86]. Simultaneous placement of multiple, side-by-side, pancreatic stents could be applied
more extensively, particularly in patients with MPD strictures persisting after 12 months of
single plastic stenting. From this point of vew, the ESGE Guideline recommended that
available options (e.g., endoscopic placement of multiple simultaneous MPD stents, surgery)
be discussed by a multidisciplinary team (Recommendation grade D) [86]. In Spanish Pancre‐
atic Club’s guideline is pointed that pancreatic stenting is effective for treating short-term pain
in patients with pancreatic duct stenosis, but it requires multiple ERCPs during follow-up, as
well as pancreatic stents must be maintained for at least 12 months [88].
The search for an ideal pancreatic stent continues and a new “wing stent” to prevent clogging
as well as an “S” shaped stent to prevent migration are undergoing evaluation [107, 149]. In
one study in 20 patients, inserted self-expandable, uncovered Wallstents and partially or
totally covered Wallstents in 18 patients with CP associated with dominant stricture of the
MPD [150]. The results using uncovered Wall stents were unsatisfactory because of frequent
stent dysfunction caused by tissue ingrowth (65%) through the wire mesh. In cases using
partially or totally covered stents, epithelial hyperplasia and stent migration were the major
late complications. The authors concluded that self-expandable stents provided disappointing
results. The use of covered self-expandable metal stents (CSEMS) for pancreatic strictures now
is also under evaluation. Preliminary data show that CSEMS is safe. They also allow pain relief
and resolution of MPD strictures in a majority of patients, but no follow-up longer than 1 year
is available [86]. The initially used CSEMS had the disadvantage of stent migration. A new
“bumpy stent” has antimigratory properties and its contours adapted to the MPD. The stents
were extracted at 3 months and were effective in resolving the MPD strictures [151, 152].
However, they were associated with the formation of de novo focal MPD strictures (16% of 32
patients). Further trials are needed to evaluate their long-term efficacy and safety. According
to the ESGE Guideline [86], uncovered SEMS should not be inserted in MPD strictures
(Recommendation grade D); temporary placement of fully CSEMS holds promise but it should
be performed only in the setting of trials with approval of the institutional review board
(Recommendation grade C).
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Endosonography-guided access and drainage (ESGAD) of the MPD in CP-related MPD
stricture includes puncturing the MPD through the gastric or duodenal wall, obtaining a
pancreatogram and advancing a guide wire into the MPD to proceed with transpapillary
(rendezvous technique) or transmural drainage [129]. The duodenal route is preferred [85].
ESGAD was effective in obtaining MPD drainage and pain relief (between 50% and100%) in
selected patients with painful obstructive CP with mild morbidity. Some data have shown
pain relief dropped with time from 69% to 20% after 450 days [153, 154]. In addition, some
patients had a diagnosis of cancer within a year of the procedure. Reported complications
related to ESGAD of the MPD are between 0% and 55% [91-94]. Most of them include relatively
mild postprocedure pain, but severe pancreatitis, perforation, bleeding, and hematoma have
been also observed [153-158]. No procedure-related mortality has been reported. Migration
and occlusion of stents occur in 20%–55% of patients, necessitating endoscopic reintervention.
No mortality was observed. On the basis of these data, ESGE [86] recommended: “ESGAD of
the MPD is indicated in carefully selected patients; patients considered for ESGAD should be
referred to tertiary centers with appropriate equipment and expertise (Evidence level 3,
Recommendation grade D).” Potential indications for ESGAD of the MPD include patients
with a symptomatic MPD obstruction and failed conventional transpapillary MPD drainage.
In a randomized trial comparing endoscopic transampullary drainage of the MPD and
operative pancreaticojejunostomy, complete or partial pain relief was achieved in 32% of the
patients receiving endoscopic drainage and in 75% of the patients receiving surgery [93]. The
rate of complications, length of hospital stay, and changes in pancreatic function were similar
between the two treatment groups, but patients receiving endoscopic treatment required more
procedures than those in the surgery group (median of 8 vs 3). These data show that surgical
drainage of the MPD was more effective than endoscopic treatment in patients with obstruc‐
tion of the MPD related to CP.
2.4. Endoscopic Ultrasound-guided Celiac Plexus Block (EUS-guided CPB)
Patients who have failed to respond to intensive medical or endoscopic therapy and are not
candidates suitable for surgery can be provided relief from pain by EUS-guided CPB. EUS-
guided CPB is one option for life-quality improvement for patients with CP, and it can be used
in patients with nondilated MPD [159]. A combination of corticosteroids (triamcinolone) and
local anesthetic agents (bupivacaine) is injected into celiac plexus nerves and around the celiac
plexus under EUS guidance [83, 86-88]. Celiac plexus neurolysis (CPN) involves injection of a
neurolytic agent (absolute alcohol) into the celiac plexus to ablate or destroy the ganglia,
thereby interrupting pain transmission [87]. There is no difference between central versus
bilateral injections in EUS-guided CPB [160]. No benefit of adding triamcinolone to bupiva‐
caine was observed [161]. Some investigators prefer to reserve alcohol to patients with cancer-
related pain [162]. In [48] it has been discussed that alcohol-based EUS-guided CPN provided
pain relief in 59%. Therefore, this procedure is effective in pain control due to CP, but with a
relatively lower efficacy compared to oncologic disease. The development of techniques or
new injected drugs seems to be needed.
Meta-analyses have reported that EUS-guided CPB provides pain relief in 51%–59% of patients
with painful CP for a period of 3–6 months [87, 163, 164]. In a prospective series of 90 patients,
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the proportion of patients with pain relief decreased from 55% immediately after EUS-guided
CPB to 10% at 24 weeks [165]. However, the efficacy of this therapy remains unclear. Patients
who are younger than 45 years or have previous pancreatic surgery are less likely to benefit.
In two randomized controlled trials, EUS-guided CPB appears to be associated with better
outcomes and low incidence of side effects, and patient preference, as well as is more cost-
effective than CT-guided route [166, 167]. In addition, EUS-guided route is not associated with
severe complications such as paraplegia and aortic pseudoaneurysms [168, 169]. EUS-guided
nerve block can produce diarrhea, hypertension due to sympathetic blockade because of the
relatively unopposed visceral parasympathetic activity [87, 164, 170].
The most common (30%–40% of patients) complications of EUS-guided CPB include transient
diarrhea, abdominal pain/pain exacerbation, and hypotension. However, they are usually mild
and self-limiting [48, 164, 171-172]. There are also infrequent reports of retroperitoneal
bleeding, peripancreatic abscess, abdominal ischemia, permanent paralysis, and also death
[48, 87]. It has been proposed that the risk of serious morbidity and mortality should be
weighed against expected benefits particularly in patients with a long life-expectancy (i.e.,
patients with CP).
ESGE experts [86] recommended considering CPB only as a second-line treatment for pain
in  CP.  EUS-guided CPB should  be  preferred  over  percutaneous  CPB (Recommendation
grade C).
2.5. Pancreatic Pseudocyst (PPC) in CP
Endoscopic  treatment  is  indicated  for  symptomatic  PPC (abdominal  pain,  gastric  outlet
obstruction, early satiety, weight loss, or jaundice) and infected or enlarging PPC [86, 88,
89,  173].  In most series,  spontaneous resolution of PPC in CP is rare (0%–9%) [174-176].
Only a single series reported a higher (26%–39%) resolution rate after a long follow-up [87,
177].The duration and size of the pseudocyst do not accurately predict the probability of
spontaneous  resolution  or  the  development  of  complications,  but  larger  (>4  cm)  and/or
longer-lasting (>6 weeks) pseudocysts are generally the ones that require active treatment
[178]. Therefore, prophylactic treatment can be performed in selected asymptomatic patients
with aim to prevent complications as pancreatic-pleural fistula, cysts >5 mm lasting for over
6 weeks, compression of major vessels, intracystic hemorrhage, cyst wall >5 mm, and PPC
with advanced MPD changes or pancreaticolithiasis (presence of large pancreatic stones in
MPD) [178, 179].
Many factors such as the size of the pseudocyst, bulging on the gut lumen, ductal communi‐
cation, coagulopathy/portal hypertension, tolerance to multiple procedures, and symptoms
can affect PPS management. Endoscopic therapy of PPC includes insertion of a drain from the
digestive lumen into the PPC, through the digestive wall (“transmural drainage”), through
the papilla (“transpapillary drainage”), or a combination of these routes. Transpapillary PPC
drainage is reserved for the case of direct communication between the PPC and the MPD, as
well as for small cysts (<6 cm size) [83, 180-183]. Transmural drainage is used for PPC which
bulge into the lumen of stomach or duodenum, and the distance between the gut wall and the
pseudocyst is less than 1 cm, with no intervening major vascular structures [83, 86, 89].
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Transduodenal drainage offers the best success when compared to transgastric drainage. This
is because cystoduodenal fistulas tend to remain patent
longer than cystogastric fistulas. A chronic cyst with clear liquid contents can be drained with
one or more stents. On the other hand, an infected cyst may be aided by irrigation with a
nasocystic catheter [87]. Placement of pigtailed stents is better when compared to straight
stents. Straight stents are associated with a higher rate of bleed (around 7%) as well as
migration [184]. Stents should be left in place for a longer duration as their removal within 2
months is associated with a higher incidence of PPC recurrence [86, 185]. Pseudoaneurysm
can complicate management of PPC because of the associated hemorrhage and consequent
high mortality [186]. Prophylactic embolization of pseudoaneurysms prior to drainage of an
adjacent PPC has been recommended [140]. EUS is ideal for drainage of nonbulging PPC and
cysts up to 4 cm from the stomach or duodenal wall [187], as well as in patients with portal
hypertension [87]. In the presence of collaterals, the site of drainage is better identified with
EUS, thus making the procedure safer. Technical success of endoscopic treatment is usually
defined as the ability to insert at least one stent from the PPC to the digestive lumen, or
resolution of the fluid collection but not necessarily of symptoms [184, 188-189]. Short-term
clinical success is usually defined as complete relief of the initial symptoms with a decrease in
PPC diameter of at least 30%–50% at 1 month [190]. In a summary of clinical trials, stent
placement was technically successful in 89% of the cases, with a success rate of 80%–95% at
most centers, a recurrence rate of 10%–20%. Complications as bleeding, infection, perforation
and leak were observed in 3%–34% and death in 0.3%-1% [86, 87, 184]. An infection is more
likely with transpapillary drainage and a leak is more likely with transmural drainage. Routine
antibiotic administration is needed for drainage of PPC [191]. These results are comparative
or better than surgery. In addition, compared with surgery, endoscopic drainage of uncom‐
plicated PPC provides similar long-term results at a lower cost, with shorter hospital stay, and
better quality of life during the first 3 months following treatment. Procedure-related mortality
is slightly lower with the endoscopic method [86]. Randomized controlled trials and large
reviews of noncomparative historical series of endoscopic and surgical treatments have also
showed that drainage via EUS is better or similar than surgery [189, 192-194]. In [189],
transmural and transpapillary drainage in 116 patients with PPC was compared. Successful
resolution of symptoms and collection occurred in 88% of the cases. No significant differences
were observed related to drainage technique or drainage site. In three nonrandomized studies,
transpapillary drainage was used for smaller PPCs than transmural drainage [182, 190, 195].
Transpapillary drainage was associated with lower morbidity (1.8% vs 15.4%) and similar
long-term success (94.6% vs 89.7%) than transmural drainage.
Technical success was higher with EUS-transmural PPC drainage compared to conventional
guidance in randomized controlled trials [188, 193]. All patients with failed conventional
drainage had a successful EUS-guided drainage. The complication rate was similar when PPCs
are drained with or without EUS guidance [188, 190]. Cystoduodenostomy is associated with
more long-term success than cystogastrostomy (83.1% vs 64.0%, respectively) but identical
morbidity (10%) [196]. PPC drainage with a single stent and a stenting duration ≤6 weeks were
independently associated with failure of endoscopic treatment [184].
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On the base of these data, the ESGE Guideline [86] recommended endoscopic therapy as the
first-line therapy for uncomplicated chronic PPC for which treatment is indicated and that are
within endoscopic reach (Recommendation grade A). “If transmural pseudocyst drainage is
indicated in the absence of luminal bulging, it should be performed under EUS guidance
(Recommendation grade A). For small collections communicating with the MPD in the head
or body of the pancreas, use transpapillary drainage first. Cystoduodenostomy should be
preferred over cystogastrostomy if both routes are deemed equally feasible. For transmural
PPC drainage, insert at least two double-pigtail plastic stents (Recommendation grade D);
these should not be retrieved before cyst resolution as determined by cross-sectional imaging
and not before at least 2 months of stenting (Recommendation grade B). In the case of portal
hypertension, transmural drainage should be performed under EUS guidance. If arterial
pseudoaneurysms are detected in the vicinity of the PPC, arterial embolization should be
considered prior to PPC drainage (Recommendation grade D), and antibiotic prophylaxis for
endoscopic PPC drainage (Recommendation grade D).” In addition, the ESGE also recom‐
mended “besides transmural PPC drainage, attempting transpapillary bridging of MPD
ruptures with a plastic stent. If the MPD rupture cannot be bridged, transmural stents should
be left in place for as long as the disconnected pancreatic tail secretes pancreatic juice (typically,
for years) (Recommendation grade D).”
2.6. CP-related biliary strictures
Generally accepted indications for treatment of CP-related biliary strictures are secondary
biliary cirrhosis, biliary stones, progression of biliary stricture, cases with symptoms or
asymptomatic elevation of serum alkaline phosphatase (>2 or 3 times the upper limit of normal
values), and/or raised serum bilirubin for longer than 1 month [83, 86, 87, 197]. Biliary brushing
as well as EUS-guided fine-needle aspiration is required to exclude the possibility of cancer
[86, 87]. Endoscopic treatment for biliary strictures includes stricture dilation using single or
multiple side-by-side plastic stents, as well as covered SEMS. Biliary strictures secondary to
CP respond less well to stenting than all other benign biliary strictures because of less frequent
resolve at the time of stent removal and are associated with more frequent relapses [198-200].
The presence of pancreatic head calcification is an important factor for failure of endoscopic
therapy with single plastic biliary stent, but this factor may be less relevant if simultaneous
multiple plastic stents are used [201, 202]. Some studies have shown that cholestasis can be
effectively resolved in the short-term setting by plastic biliary stenting [203, 204]. Patients
without restenosis showed improvement of hepatic fibrosis after long-term stenting [205].
Single plastic biliary stents are associated with poor resolution and higher relapse rate [83,
86]. Sustained benefit is seen in around 25% of patients on follow-up of 46 months [206].
Placement of simultaneous multiple plastic stents in CP-related biliary strictures is technically
successful in over 95% of patients and offers the best results [83, 86]. Complete therapy requires
approximately four ERCP procedures and stents exchanges performed every 3 months for
minimum 1 year [83, 207]. On the other hand, in the latter series, stents were exchanged at
ERCP only if they were clogged [86]. Single stents provided relief in 31% of 350 patients as
compared to 62% in 50 patients who received multiple stents [83]. One nonrandomized study
compared single and multiple biliary plastic stents in CP [202]. Clinically, success was reported
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in 92% with multiple stents as compared to 24% with single stents. Plastic biliary stents
placement in patients with alcoholic CP has been reported to be associated with high incidence
of cholangitis, because of poor patient compliance with scheduled stent exchanges [208].
Treatment with uncovered SEMS is associated with a high long-term morbidity and not
recommended. Placement of covered SEMS is an investigational option for CP-related biliary
stenosis [86, 200, 209, 210]. Other authors reported that the use of SEMS for long-term stenting
of benign biliary strictures due to CP was safe and that it provided successful and prolonged
biliary drainage in a selected group of patients in whom surgical intervention was not possible
or desirable [211]. A multicenter trial using fully covered SEMS in 127 patients of CP concluded
that these prostheses are useful for treatment of biliary strictures in patients with CP [212]. In
one systematic review of studies published from 2000 to 2012, the success rate and complica‐
tions of covered SEMS versus multiple plastic stents in CP-related benign biliary strictures
were compared [200]. A total of 12 SEMS (376 patients) and 13 plastic stent studies (570
patients) met the final inclusion criteria. A tendency to successful use of SEMS in strictures
related to CP was shown. In SEMS use, the incidence of late adverse events was lower in CP-
related strictures and the median number of ERCP was lower – 1.5 versus 3.9. Larger, pro‐
spective, randomized long-term studies are required to confirm these results [87].
There has been no head-to-head study comparing single or multiple plastic stents and metal
stents in biliary strictures due to CP and surgery [83]. According to [88], surgery is the
treatment of choice for symptomatic biliary stenosis. Stents should be reserved for patients
with high surgical risk to temporarily stabilize or improve them for surgery or for patients
who refuse surgical treatment. In such cases, the best results are obtained with the placement
of multiple stents or metal-covered stents [202, 213].
The ESGE Guideline [86] recommends: “The choice between endoscopic and surgical treat‐
ment should rely on local expertise, local or systemic patient co-morbidities (e.g., portal
cavernoma, cirrhosis) and expected patient compliance with repeat endoscopic procedures
(Recommendation grade D). If endoscopic therapy is elected, the ESGE recommends tempo‐
rary (1-year) placement of multiple, side-by-side, plastic biliary stents (Recommendation grade
A). Because of the risk of fatal septic complications, a recall system should be set up to care for
patients who do not present for scheduled stent exchanges. In cases of relapsing stricture after
stent removal at 1 year, the options available, including surgical biliary drainage, should be
evaluated by a multidisciplinary team (Recommendation grade D)”.
Today, there are many effective new and standard endoscopic techniques for the treatment of
CP, especially in patients with pain and dilated main pancreatic duct because of intraductal
calculi and/or strictures, as well as symptomatic or complicated pseudocysts, and CP-related
biliary strictures. Today, there is also better patient selection for specific techniques, leading
to more effective treatment. Earlier endoscopic therapy is more effective, less invasive than
surgery, and is associated with low morbidity and mortality. In addition, it can be repeated
and does not interfere with subsequent surgical procedure. Endotherapy became the first-line
treatment in selected patients with CP.
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3. Endoscopic therapy in Pancreatic Cancer (PC)
In the last years, the role of endoscopy as a part of multidisciplinary management of PC has
increased. Endoscopy (ERCP) and mainly endoscopic ultrasound (EUS) with EUS-FNA
and/or core biopsy are one of the most sensitive methods for the diagnosis and staging of PC.
Therapeutic endoscopy has an important role in the palliation of patients with inoperable PC,
including endoprosthesis stent placement in cases with biliary or duodenal obstruction, and
EUS-guided CPN to control the pain. Various EUS-guided procedures, as tumor ablation,
injection of antitumor agents, fiducial placement, and brachytherapy have been used for
therapy of selected cases with PC.
3.1. Endoscopic therapy in biliary/duodenal obstruction
PC is among the tumors with the worst prognosis, with very high mortality rate. Most cases
with PC are diagnosed at an advanced stage when surgical resection is not possible. Patients
with unresectable PC often develop biliary and/or duodenal obstruction during the course of
their disease, which are related with various complications and negative impact on quality of
life, and not rarely are a cause for discontinuation of chemotherapy [214, 215]. In the past,
surgical bypasses (biliary–digestive and gastro–jejunal anastomoses) were used for palliative
treatment of biliary or duodenal obstruction, but currently endoscopic stenting is the preferred
method. In the literature, several studies have compared the endoscopic and surgical palliative
treatment of jaundice or duodenal obstruction in patients with unresectable PC [216-223]. The
summary results show an advantage to endoscopic treatment in terms of quality of life,
duration of hospitalization, and cost. The results of meta-analysis by the Cochrane Collabo‐
ration showed that rate of technical success and short-term efficacy in comparison of palliative
endoscopic biliary drainage and surgical drainage for obstructing pancreatic carcinoma were
similar, but the morbidity and duration of hospitalization are higher for surgical bypass [217,
218]. It was reported by various authors that endoscopic treatment of duodenal stenosis
compared to bypass surgery was related with fewer complications, shorter hospitalization,
and lower cost [219-223].
Endoscopic treatment of biliary obstruction includes placement of biliary stent (plastic or
SEMS) during ERCP. The procedure is often associated with sphincterotomy, which facilitates
the insertion of the prosthesis or its eventual replacement [214]. The results of randomized
clinical studies showed that the success rate of endoscopic biliary stenting is over 90% of
unselected patients with PC, with a morbidity of 5% [217]. The type of prosthesis does not
influence the success rate of stent insertion and short-term efficacy, defined as regression of
jaundice, pruritus, and a decrease of serum bilirubin more than 20%. If cholangitis develops
or if bilirubin fails to fall by 20% within the first week after stent insertion, the patency and
position of the stent must be verified [214]. Placement of SEMS is the cost-saving strategy, as
plastic stents are associated with higher risk of recurrent biliary obstruction and consequently
with need of additional procedures and hospitalizations [217, 224-229]. On the basis of cost-
effectiveness analyses, the insertion of a metal prosthesis (more expensive but with a longer
duration of patency) has been recommended if the patient’s life expectancy is longer than 4
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months [230]. Insertion of SEMS was advised in cases with biliary SEMS occlusion, as it
provided longer patency and survival and decreased the number of subsequent procedures
by 50% (compared to plastic stents) [229]. Technical failure during ERCP is encountered in up
to 10% of cases due to various factors (duodenal obstruction, anatomical variations, periam‐
pullary diverticulum, tightness of the stricture) [214, 215]. In these cases, percutaneous
transhepatic biliary drainage (PTBD), EUS-guided biliary drainage (BD), and surgical drainage
are possible alternatives. The technical success rate for PTBD placement is 90% if the intrahe‐
patic system is dilated and 70% in a nondilated system. The morbidity is 7% and the mortality
is 5%, and it is contraindicated in the presence of ascites and coagulopathy. The results of recent
systematic review on studies of EUS-guided biliary drainage (1127 published cases) showed
that the mean technical and clinical success rates were of 91% and 88%, respectively, with the
mean overall complication rate of 26% and mortality 0.4% [48].The authors of one recent study
of 25 patients with unresectable malignant biliary obstruction and a previous failed ERCP
attempt reported 100% technical and clinical success after the use of one of both procedures –
percutaneous transhepatic biliary drainage or EUS-guided BD – with no difference in incidence
of adverse events [231]. It is summarized that EUS-guided BD appears to be a valid alternative
to percutaneous BD, showing similar efficacy and safety [48]. EUS-guided BD can be per‐
formed by one of the following approaches: direct transluminal stenting via transgastric or
transduodenal route, by rendezvous technique passing a guidewire through an intrahepatic
or extrahepatic access to the papilla, and by antegrade stent placement. EUS-guided transhe‐
patic access was associated with a higher incidence of complications compared to the extra‐
hepatic route (30.5% vs 9.3%), although the both access routes showed similar success rates
[232]. In comparison the outcomes of rendezvous technique and transluminal approach of
EUS-guided BD it was found that the effectiveness and safety of the both techniques were the
same [233].
Endoscopic treatment of duodenal stenosis, due to invasion of PC, includes placement of an
SEMS through the duodenoscope (Figure 4) [214, 215, 234]. The reported success rate is 92%–
100% and rapid alimentary recovery (usually within 24 h) occurs in 75%–93% of cases [217].
Early complications have been reported in 2%–12% of cases, including perforation, gastroin‐
testinal hemorrhage, aspiration pneumonia, jaundice or cholangitis, acute pancreatitis. The
main cause of failure is downstream obstruction by unrecognized carcinomatosis, insufficient
length to bridge the stenosis, prosthetic obstruction (food impaction or tumor ingrowth), or
migration of the prosthesis [214]. Duodenal stenting should be reserved for symptomatic
stricture since the introduction of prostheses into noncritical strictures is associated with a
greater risk of stent migration. In appearance of prosthetic obstruction, a repeat procedure may
be necessary (approximately 15% of cases) with insertion of a new prosthesis through the
original stent [223]. If endoscopic insertion of a duodenal stent is impossible, a percutaneous
transgastric approach is alternative. In cases with associated jaundice, endoscopic manage‐
ment begins with the placement of a metal biliary stent and followed by placement of the
duodenal stent. The biliary drainage must always precede the duodenal stent placement [235].
If a biliary stent has previously been placed, its patency should be confirmed before placing
the duodenal stent and replaced if necessary. If jaundice develops after duodenal stenting, the
alternatives approaches to the biliary tract as PTBD or EUS-guided BD could be used.
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Figure 4. Palliative endoscopic management of PC. a) A view of pyloric infiltration and duodenal obstruction in a case
with PC. b) Insertion of SEMS.
3.2. Endoscopic therapy for pain relief
Pain is reported in the majority of patients with advanced pancreatic cancer (90%) and its
palliation is often difficult [215]. About 15% of patients with inoperable PC, having dilated
main pancreatic beyond the stricture and an “obstructive” pain related to meals, may poten‐
tially benefit from endoscopic pancreatic stenting [236]. It was reported that pancreatic stenting
may be obtained in more than 80% of these selected patients, with low morbidity (less than
10%), and no procedure-related mortality; approximately 60% of patients treated because of
“obstructive” pain become symptom-free, and another 20%–25% significantly reduce the
amount of analgesic drugs. In the last years, a number of studies have shown that effective
pain control can be achieved in 70%–90% of advanced PC with EUS-guided celiac plexus
neurolysis (CPN) [48, 163, 163, 237-244]. Significant reduction of pain scores 12 weeks after
CPN was observed in 30 patients with advanced intraabdominal malignancy, while 91% of
these patients required same or less pain medication and 88% of patients had persistent
improvement in their pain score [237]. In one retrospective analysis of response to CPN in a
cohort 64 patients with PC, it was found that visualization of the celiac ganglia was the best
predictor of response: patients with visible ganglia were >15 times more likely to respond [242].
The results of two meta-analyses (including 8 studies/283 patients and 5 studies/119 patients)
showed that the pooled proportion of patients that experienced pain relief was 80.1% and
72.5% after alcohol-based EUS-CPN [163, 164]. In a recent randomized clinical trial of 96
patients with advanced pancreatic cancer who were randomly assigned to early EUS-guided
CPN or to conventional pain management, greater pain relief and a tendency toward lower
morphine consumption was observed in the EUS-guided CPN group at 3 months [240]. It was
also demonstrated that EUS-guided CPN significantly reduced pain, at 4 and 8 weeks, and
opioid consumption in comparison with opiods intake alone [241]. It was summarized that
EUS-guided CPN is superior to analgesic therapy in reducing pain in patients with PC. The
results of one study, including 50 patients with PC, showed that there were no differences
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regarding the onset or duration of pain relief in comparison between central and bilateral
alcohol injections in EUS-guided CPN [243]. Some authors found that EUS-direct celiac ganglia
neurolysis is superior to conventional EUS-guided CPN in inducing pain relief, with a higher
treatment response rate (73.5% vs 45.5%) and complete response rate (50.0% vs 18.2%) [244].
3.3. EUS-guided antitumor therapies
For a short time, the use of various EUS-guided antitumor treatments has been reported in
patients with locally advanced PC. The efficacy of EUS-guided ethanol injection alone or in
combination with paclitaxel in pancreatic cystic lesions was reported in several studies
[245-250]. A pilot study reported the efficacy of EUS-guided ethanol lavage in 25 patients with
different cystic pancreatic lesions, with no side effects or complications during follow-up [245].
It was found that EUS-guided ethanol lavage led to a greater reduction in cyst size compared
to simple saline injection (43% vs 11%) and resulted in complete cyst ablation in 33% of cases
(12 out of 36) [246]. Follow-up by CT scan at 2 years of patients who had obtained complete
cyst ablation after treatment showed persistent resolution of pancreatic cystic lesions in 75%
of cases [247]. Addition of paclitaxel to ethanol injection showed a greater treatment rate of
pancreatic cystic lesions compared to ethanol alone, with observed complete resolution in 62%
of patients after 1-year follow-up [248, 249]. In addition, the use of EUS-guided ethanol
injection was reported also in a small number of patients with pancreatic insulinoma [251-253].
In 3/5 patients with insulinoma, EUS-guided ethanol injection was related with symptoms
resolution and no complications [251]. The main potential problem of EUS-guided ethanol
ablation is the risk of acute pancreatitis due to diffusion of alcohol outside the lesion into the
main pancreatic duct and/or the pancreatic parenchyma [254].
EUS-fine needle injection (FNI) is a simple technique to deliver chemotherapeutic agents into
tumoral tissue for the treatment of locally advanced pancreatic cancer [48]. The technical
success rate of all the studies about EUS-FNI reached 100%, paralleling the ability of perform‐
ing EUS-FNA for cytological diagnosis. The clinical outcome varied greatly according to the
different chemical or biological agents being tested [255]. In the literature, there are few small-
size studies reporting the safety and feasibility of direct injection of different agents in patients
with PC. One study tested the safety and efficacy of FNI of allogeneic mixed lymphocyte
culture in 8 patients with locally advanced PC [256]. The authors reported that the procedure
was safe and two partial responses and one minor response were reported (median survival
13.2 months). In other study (n=21 patients with PC), assessing the effect of EUS-FNI of
adenovirus ONYX-015 in combination with systemic gemcitabine reported 2 patients with
partial regression and 2 with minor response, but 4 serious adverse events (2 sepsis and 2
duodenal perforations) [257]. In the pilot study (n=7) with EUS-FNI of immature dendritic cells
(inductors of primary T-cell response against tumor antigens), there were 1 complete and 3
partial responses reported and no adverse events [258]. In a multicenter study (n=50), the effect
of EUS-FNI of TNFerade (a replication-deficient adenovirus vector carrying the TNF-α gene)
in combination with systemic fluorouracil was tested [259]. The investigators observed 1
complete response, 3 partial responses, and 12 patients with stable disease after treatment as
additionally 7 patients became suitable for surgery. The safety, tolerability, and preliminary
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regarding the onset or duration of pain relief in comparison between central and bilateral
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treatment response rate (73.5% vs 45.5%) and complete response rate (50.0% vs 18.2%) [244].
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different cystic pancreatic lesions, with no side effects or complications during follow-up [245].
It was found that EUS-guided ethanol lavage led to a greater reduction in cyst size compared
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13.2 months). In other study (n=21 patients with PC), assessing the effect of EUS-FNI of
adenovirus ONYX-015 in combination with systemic gemcitabine reported 2 patients with
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of EUS-FNI of TNFerade (a replication-deficient adenovirus vector carrying the TNF-α gene)
in combination with systemic fluorouracil was tested [259]. The investigators observed 1
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additionally 7 patients became suitable for surgery. The safety, tolerability, and preliminary
Endoscopy - Innovative Uses and Emerging Technologies182
efficacy of EUS-FNI of BC-819 (a DNA plasmid developed to target the expression of diph‐
theria-toxin gene under the control of H19 regulatory sequences) in combination with
chemoradiotherapy was tested in 6 patients with PC – 3 of them showed partial response and
the other 2 patients who were downstaged were able to undergo surgical resection [260]. It is
summarized that direct intratumoral of various agents through FNI in patients with advanced
PC is technically easy, safe and can induce tumor downstaging in some cases. The role of this
method for cancer therapy will increase with the refinement of echoendoscopes, delivery
systems, and novel local antitumor agents [261-263].
EUS-guided radiofrequency ablation (RFA) could be also used as an alternative procedure of
treatment in unoperable patients with PC, but its translation into clinical practice has been
restricted because of limited data and procedure-related risks [264]. The performance and
effectiveness of EUS-guided RFA has been tested in several experimental studies, using
porcine models [264-266]. In one study, the safety and efficacy of EUS-guided cryothermal
ablation was assessed in 22 patients with locally advanced PC [267]. Using a newly developed
cryotherm probe, combining radiofrequency with cryogenic cooling, the authors reported that
the procedure was technically successful in 16 patients (72%) with a reduction in tumor size
in 6 of them and well-tolerability [56]. It is summarized that EUS-guided cryothermal ablation
is feasible in a subset of patients with locally advanced pancreatic cancer, but their safety and
clinical outcome need to be investigated in future studies.
Brachytherapy is a useful method for local control of various malignant tumors, including
pancreas [48, 215]. The placement of radioactive seeds allows steady radiation, leading to
localized ablation and avoiding the radiation of normal tissues surrounding the malignant
lesion. The feasibility, safety, and efficacy of EUS-guided implantation of iodine radioactive
seeds in patients with locally advanced PC were assessed in a few studies [48, 268-270]. It was
reported around 80% rate of positive response (decrease in tumor size) or stable disease, as
well as improvements of pain scores and performance status scores. Adverse event rate was
0%–20%. Hematologic toxicity (neutropenia, thrombocytopenia, and anemia) was usually
mild. Other complications reported less frequently were pancreatitis and pseudocyst forma‐
tion. [268]. The studies demonstrated the technical feasibility of EUS-guided implantation of
radioactive seeds in PC but larger studies evaluating the clinical outcome in a multimodality
approach, combining chemotherapy and/or radiotherapy are needed [215, 238].
EUS-guided fiducial placement to facilitate stereotactic radiotherapy was assessed in several
studies and was shown that it is a safe and precise, less invasive procedure [48, 215, 238, 271].
The placement of radiopaque fiducials inside or near the tumor allows performance of targeted
radiotherapy with higher doses while sparing adjacent healthy tissue. Two studies of EUS-
guided fiducial placement in a total of 101 patients with locally advanced PC reported high
technical and clinical success rates (88%–90%) [272, 273]. Overall complication rate was low
with only few minor adverse events (1 patient – a minor bleeding from the site of EUS needle
entrance and 2 – mild pancreatitis). Migration of the gold fiducials was reported in 7% of cases.
Another study observed no differences in visibility, migration, number of fiducial placement,
technical difficulty, as well as in complication rate comparing two different types of fiducials
(traditional vs coiled) [274].
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In conclusion, today endoscopic therapy with or without EUS is an approved management
option in selected patients with acute or chronc pancreatitis, or pancreatic cancer, showing the
advantages of minimally invasive method of treatment. It should be performed in specialized
centers with availaible multidisciplinary team.
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Abstract
The small bowel remains the “last frontier” in gastroenterology for a long period after
the start of endoscopy. Even with the advent of better endoscopes and colonoscopies
barium meal and follow through remained the preferred method of investigation of
the small bowel. Although push enteroscopy was present from the 1980’s it was not
until the advent of device assisted enteroscopy that the small bowel was finally
conquered. Device assisted enteroscopy includes, double balloon enteroscopy, single
balloon enteroscopy and spiral enteroscopy. The other method of visualizing the small
bowel was capsule enteroscopy. Capsule enteroscopy too revolutionized endoscopy
as it gave patients a degree for freedom never before enjoyed and would be the best
screening tool available. However, its main disadvantage remains the inability to
obtain biopsies.
Keywords: Enteroscopy, small bowel, double ballon, single balloon, spiral entero‐
scopy, capsule enteroscopy
1. Introduction
1.1. Imaging the small bowel – The last frontier
The small bowel has remained the “last frontier” in gastroenterology for a long period after
the start of endoscopy. Even with the advent of better endoscopes and colonoscopies. Barium
meal and follow through remained the preferred method of investigation of the small intestine
for many years [1]. This however, was inconvenient, exposed the patient to unwanted radiation
and provided poor quality pictures. In a way it was similar to the back and white television of
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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old. Other methods include computed tomography (CT) enteroclysis or enterography,mag‐
netic resonance enteroclysis or enterography and small bowel ultrasound.
One reason for this delay in finding a proper modality for imaging the small intestine maybe
the fact that small intestinal tumours are much less common than colonic polyps[2]. Thus the
need for the procedure may not have been as urgent as it was for say colonic investigation.
However, during the last ten years this “last frontier” has been well and truly conquered.
Balloon enteroscopy, and capsule endoscopy have revolutionized the investigation of small
bowel disorders. In this chapter we will discuss the various methods and their advantages and
disadvantages. Although push enteroscopy has been around since the 80’s the real break
through was after the onset of device assisted enteroscopy.
2. Enteroscopy
Enteroscopy is the act of passing an endoscope beyond the second part of the duodenum and
examining the small intestine. It can be divided into push enteroscopy(PE) and device assisted
enteroscopy (DAE). Although push enteroscopy has been around since the 1980’s this did not
allow the full visualization of the small bowel and was very difficult for the patient. This was
mainly due to excessive looping of the scope in the small intestine. The length of a PE ranges
from about 220 cm to 250 cm and is inserted per orally [3]. This was used occasionally, mainly
to try to visualize occult bleeding from the gastrointestinal tract. Enteroscopy was revolution‐
ized by the discovery of DAE the first of which was double balloon enteroscopy (DBE) which,
allowed full visualization of the entire small intestine [4]. Subsequently more methods of
enteroscopy have been introduced. These are single balloon enteroscopy (SBE) and spiral
enteroscopy(SE). With the use of DAE not only has complete visualization of the small intestine
been possible, various therapeutic procedures like polypectomy, dilatation or treatment of
bleeding hitherto possible only with surgery or laparoscopy could also be performed. This was
truly a revolution in gastroenterology.
3. DAE
3.1. Double Balloon (DUB)
Double balloon was first developed in 2001 by Professor Hironori Yammamoto [5]. The system
has an endoscope of with an outer diameter of 8.5 mm and a working length of 200cm. It has
a soft over tube of 145cm with a 12.2 mm outer diameter and a separate pump. Air insufflation
or carbon dioxide is used. Carbon dioxide is recommended as it results in less distension post
procedure.
Preparation for the procedure is the same as for a regular colonoscopy. Which will include
overnight fasting for solids and the consumption of 4 liters of polyethylene glycol preparation.
This is usually consumed in as a split preparation. That is two liters consumed the previous
night and the other two liters consumed the next morning.
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One balloon is attached to the tip of the scope and the other to the end of the scope [6]. The
procedure can be done in an anterograde (oral) or retrograde (anal) method. The endoscope
and the over tube is first advanced as far as possible, then the balloon on the over tube is inflated
to fix the over tube. Then the endoscope is further advanced as far as possible. Next the balloon
on the over tube is deflated and the over tube is advanced up to the inflated tip of the endo‐
scope. The balloon on the over tube is also inflated. Then both endoscope and over tube are
with drawn thus, pleating the small intestine. This maneuver is repeated till the scope cannot
be advanced any further. At this point the intestine is tattooed using India ink. Then the
procedure is repeated in a retrograde manor. The ileum is crossed as would be done during a
normal colonoscopy. Thus complete visualization of the small bowel is achieved.
This procedure could take from 70 minutes to 120 minutes. According to guidelines the patient
should receive proprofol anesthesia [7]. Fluoroscopy is useful during the learning phase but
is not essential. During the learning curve two operators are used. However, later a single
operator should suffice. Using the therapeutic channel of the enteroscope most therapeutic
procedures that can be performed with a normal upper gastro intestinal endoscope can be
done using the enteroscope. This makes it a very useful tool. Although this is relatively safe
procedure the complication do occur and will obviously depend on the experience of the
operator. The perforation rate is about 0.4 % which can increase to 3% if dilatation is attempted.
Other complications include pancreatitis (0.3%), this can be reduced if the balloon is inflated
after passing the papilla [8].
3.2. Single balloon enteroscopy(SBE)
Single balloon enteroscopy was introduced in 2007. It uses an enteroscope with a 200cm
working length and 2.8 mm channel diameter. The over tube has a diameter of 13.2 and a silicon
balloon with a separate pump(figure 1). The technique is the same as for DBE. However, the
tip of the balloon is used to anchor the enteroscope to the intestine. Thus there is only one
balloon. This makes SBE faster than DBE, Generally it can be used with one operator. As for
other types of enteroscopy anesthesia with propofol is the preferred type of anesthesia. Like
in DBE both the anterograde and retrograde approaches are used depending on the require‐
ment. Therapeutic procedure are similar with using the SBE. In addition to the speed and
simplicity of the procedure the other advantages of the SBE are the fact that is has variable
stiffness. Thus eliminating the need for a stiffing wire. It also can be used on patients who have
latex allergy. However, it has a lower rate of complete enteroscopy when compared to DBE in
most studies.
3.3. Spiral Enteroscopy (SE)
Spiral enteroscopy was introduced in 2008. It has a 118 cm Endo-EaseDiscovery TM SB overtube
with a internal diameter of 9.8mm with a softraised helix, a coupling device to fix to the
lubricated overtube to theenteroscope 25 cm from its tip. It has two handles for manual rotation
andan injection port for lubrication [9]. Clock wise rotation pleats the smallintestine into the
scope, once engaged and advances the same thustransforming the torching force into a linear
force. The push and rotatetechnique is used till it passes the ligament of Trietz. After that
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rotation isonly used. The mesentery of the small bowel prevents it from getting twisted. Like
in both DBE and SBE proprofol anesthesia is recommended.Two operators are used for the
procedure. One to operate the overtube andthe other to use the scope. Withdrawal is by anti
clockwise rotation. Themean time for the procedure is about 34 minutes[10].The major
advantages of SE is the speed of insertion and the fact that itdoesn’t need extra equipment like
a pump. Also the overtube can bedisengaged from the coupler enabling the enteroscope to be
withdrawn without loosing the position in the small intestine. This is particularly useful in
removing multiple polyps.The overall complication rate is about 0.3% with a perforation rate
of 0.4 %The rate of pancreatitis seems lower than in DBE and SBE. So SE seems a useful tool
to examine the small bowel as well.
4. Video Capsule Endoscopy (VCE)
The invention of the capsule endoscopy system about 15 years ago once again changed the
imaging of the small bowel for ever, giving clear imaging for the first time. Not only is less
invasive than endoscopy it gave pictures similar in quality as well. Capsule endoscopy system
consists of the wire less capsule which has video camera a sensing system (this includes sensing
belt, a data recorder unit, a battery pack and a real time viewer) and a personal computer work
station(figure 2). The work station is equipped with manufactures soft ware that offers various
functions (localization system, colour enhancement systems, blood detector, quick viewer,
scoring system, image atlas) this can help the examiner in reviewing and interpreting the
images(11). There are various VCE systems. The capsules themselves and the picture quality
has been advancing rapidly.
Figure 1. SBE with sheath
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Figure 2. Video capsule recording system
One of the main contraindications for VCE would be suspected intestinal obstruction,
strictures, fistulas and as this may result in capsule retention.
The incidence of capsule retention is about 1.4% [12]. VCE is also generally not performed with
patients with cardiac pacemakers due to the possibility of interference with these devices.
Pregnancy is another contraindication due to the lack of safety data.
Preparation before endoscopy, overnight fast for solids and the consumption of clear liquids
only coupled with two liters of poly ethylene glycol (PEG). Although the use of PEG is not
compulsory, the consensus is to use it. Generally about 80% of the patients have a complete
examination of their small bowel.
Common indications for VCE include, obscure gastrointestinal (GI) bleeding, Crohn’s disease,
coeliac disease and suspected small intestinal polyps. Of these indications the most commonly
used indication would be occult GI bleeding.
One of the biggest disadvantages of the capsule is that currently there is no possibility of
taking biopsies or applying any therapeutic procedure to the small intestine. Currently there
are some capsules have some degree of maneuverability. Also there is a capsule that does
not need the patient to wear any external devices at all. However, this capsule needs to be
retrieved to access the data. Future VCE should be able to overcome the disadvantage of
inability to take biopsies as currently research and development of a capsule with therapeu‐
tic capabilities are underway [13].
5. Conclusion
Due to the patient friendly nature of the examination ideally capsule endoscopy is used in
tandem with balloon enterosocopy. This is because currently one of the main disadvantage of
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VCE is the lack of the ability to take biopies and to deliver therapy. Also the VCE can give an
indication of whether to start the DAE in an anterograde or retrograde direction. When
comparing DBE, SBE and SE all are similar although SBE and SE are more simple DBE results
in more complete examination of the small intestine.
Device assisted enteroscopy and capsule endoscopy when used in tandem can provide the
gastroenterologist with a previously unimaginable access to the small bowel. To the patient it
provides hope and comfort that was never before available. Gastroenterolgist all over eagerly
await the development of maneuverable VCE with therapeutic options. Thus the “last frontier”
of gastroenterology the small intestine has been well and truly conquered.
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Abstract
Background In 2014, the new transnasal endoscopy with Blue laser Imaging (BLI) has
been developed. Aim We present the usefulness of the observation of from the
pharynx to the cervical esophagus using transnasal endoscopy with BLI. Patients and
Methods This study was conducted between June 2014 and October 2014. During this
period, 70 consecutive patients (60 men, 10 women; mean age 67.9 years old) with
esophageal or head and neck cancer underwent endoscopic screening at the orophar‐
ynx and hypopharynx by transnasal endoscopy with BLI system We performed this
endoscopic observation from oral cavity to pharynx before inserting into the cervical
esophagus.The visibility of subsites of the hypopharynx and the orifice of the
esophagus was evaluated. The extent of the view of hypopharyngeal opening was
classified into 3 categories (excellent, good, poor). Then, the diagnostic accuracy of
transnasal endoscopy with BLI system was estimated. Our screening is as follows.
First, the patient is asked to bow their head deeply in the left lateral position. We put
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oropharyngeal U-turn method). For examination of the hypopharynx and the orifice
of the esophagus, the patient is asked to blow hard and puff their cheeks while the
mouth remains closed (Trumpet maneuver). Results 8 elderly cases were excluded
because they could not perform the adequate ballooning. Finally, 62 cases were
investigated. The ballooning the pyriform sinus and posterior wall not only allows
accurate assessment of the stretched pharyngeal mucosa but also gives a view of
postcricoid subsite and the orifice of the esophagus. The wide endoscopic view of the
pharynx was obtained in a series of the procedures (excellent=53/62, 85.4%; good=7/52,
4.5%; and poor=2/62, 7.6%). Among 70 patients, 6 superficial lesions (8.6%) at the
oropharynx(n=1) and hypopharynx (n=5) were discovered with BLI system. Mucosal
redness, a pale thickened mucosa, white deposits or loss of a normal vascular pattern,
well demarcated areas covered with scattered dots are important characteristics to
diagnose superficial carcinoma. Conclusion The more progress achieved in transnasal
endoscopy rapidly in the last few years, it can improve for observing the blind area
using trans-oral endoscopy, therefore the trans-nasal endoscope will be a standard
tool for the screening of the upper gastrointestinal tract in the near future.
Keywords: Transnasal endoscopy, Blue laser imaging, Superficial pharyngeal cancer
1. Introduction
According to the “field cancerization” concept [1], head and neck cancer, especially pharyngeal
cancer, frequently coexist with esophageal cancer. Recently several reports [2, 3] have indicated
the possibility of applying narrow-band imaging (NBI) endoscopy with magnification to
improve the detection of superficial pharyngeal cancer. Compared with conventional endos‐
copy, NBI results in dramatic improvements in the rate detection of superficial lesions and
significant enhancement in visualizing the microvascular structure of the mucosal surface [4].
The superiority of NBI was also recently demonstrated in a multicenter randomized controlled
trial in Japan [5]. As more progress has been achieved in the field of endoscopy, the number
of superficial cancers in the head and neck region has increased.
However, some areas are difficult to observe with transoral endoscopy. In particular, achieving
circumferential observation of the hypopharyngeal mucosa is difficult during conventional
endoscopy due to the anatomically closed field, effects of the pharyngeal reflex and accumu‐
lation of saliva. On conventional endoscopic screening, the physician usually inserts the
endoscope from the left pyriform sinus of the hypopharynx to the cervical esophagus, with a
blind space in the posterior wall and postcricoid subsite of the hypopharynx as well as radix
linguae. Therefore, detecting early signs of cancer in the blind space is difficult for gastroin‐
testinal endoscopists. On the other hand, transnasal endoscopy may be performed comfortably
due to attenuation of the gag reflex. In Japan, the transnasal endoscopy is a very popular
procedure and can be performed without sedation. It has also been reported that transnasal
endoscopy may be performed less invasive with respect to the cardiopulmonary function [6,
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7], and the technique is considered to be more comfortable for the patient than conventional
endoscopy.
Since we developed the pharyngolaryngeal observation method using transnasal endoscopy
in 2009, we have constantly evolved the procedure in order to better detect carcinoma in the
head and neck at earlier stages in cases often coexistent with esophageal cancer. In 2014, a new
transnasal endoscopy device with Blue laser Imaging (BLI) was developed. The pharynx is the
orifice of the gastrointestinal tract. In this article, we present the usefulness of observing the
pharynx to the cervical esophagus using transnasal endoscopy with BLI.
2. Simple questionnaire
A complete medical history, including demographic and clinical data, was obtained prior to
the endoscopy procedure. Selected patients constituting a high-risk group for pharyngeal
carcinoma are beneficial targets of endoscopic surveillance. Epidemiological studies have
detected several strong predictors for identifying persons at high risk for pharyngeal and
esophageal squamous cell carcinomas. For example, alcohol drinking and tobacco smoking
synergistically increase the risk of both cancers [8, 9], as does a reduced intake of greenish-
yellow vegetables and fruits [10] and a low body mass index [11]. The presence of distinct
esophageal iodine-unstained lesions and melanosis is also associated with a risk of cancer [12,
13], and alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2)
and less active alcohol dehydrogenase (ADH1B) enhances cancer risks in a multiplicative
fashion [14, 15]. The detection of an enlarged mean corpuscular volume (MCV) [16], as induced
by heavy drinking or smoking, a high level of acetaldehyde exposure, and/or poor nutrition,
may be useful for identifying high-risk persons.
The results of a simple flushing questionnaire have been reported to predict the ALDH2
phenotype with a high accuracy [17].
3. Preparation
Transnasal endoscopy was performed without sedation. Prior to commencement of the
procedure, each nasal cavity was sprayed with 0.05% naphazoline nitrate to induce vasocon‐
striction, followed by premedication with 100 mg of dimethylpolysiloxane and 10 000 U of
pronase, with sodium bicarbonate to remove mucus and foam in the stomach. Nasal anesthesia
was started by spraying a solution of 4% lidocaine into the nostril for three minutes, after which
a swab covered with 8 % lidocaine spray was inserted into the deeper nasal cavity for two
minutes. The patient was then placed in the lateral decubitus position to receive endoscopy.
Antispasmodics such as scopolamine were not used for premedication.
3.1. Equipment
Recently, we applied a new transnasal esophagogastroduodenoscopy (EGD) device [EG-
L580NW, Fuji Film, Tokyo, Japan] with the LASEREO system (a video processor (VP‐4450:
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FUJIFILM Co. Tokyo) including a light source (LL‐4450; FUJIFILM Co. Tokyo)) under modi‐
fication of the endoscopic technique for observing head and neck cancers and obtained
excellent results. The endoscope is a transnasal endoscope that can provides high quality
endoscopic images to be viewed on a monitor and digitally recorded with a wide field view
of 140 degrees. The LASEREO system (FUJIFILM Co. Tokyo) is a novel endoscopic system
employing a semiconductor LASER as a light source. This system is equipped with two
LASERs with different in a wavelengths, one for white light sources (wavelength: 450 nm),
and one for BLI (wavelength: 410 nm). The white light observation mode consists of a 450 nm
LASER and fluorescence of white light phosphor, which is excited by a 450 nm LASER. The
phosphor exists in the endoscope. BLI observation mode, which consists of a 410 nm LASER
and feeble fluorescence light excited by a 450 nm LASER and is useful for acquiring mucosal
surface information, including patterns of the surface blood vessels and structures. The
endoscope allows for detailed observations in close view, as it has a focal length of 3 mm to
achieve good endoscopic images. The endoscope also has a forceps with channel measuring
2.4 mm in diameter, which improves the ability to aspirate saliva and gastric juices and remove
gastric mucus adhering to the tip of the endoscope. It has been reported that BLI is useful for
making the diagnosis of colorectal tumors [18], or upper gastrointestinal lesions [19]. An
abnormal microvascular pattern in brownish areas can be detected in most pharyngeal and
esophageal cancers in the near view with white light images and clearly observed on BLI
images. The color contrast of pharyngeal and esophageal cancers rises with BLI, resulting in
useful screening result.
3.2. Endoscopic examinations-from the oral cavity to the oropharynx
Our screening procedure is as follows. First, the patient is asked to bow their head deeply in
the lateral decubitus position. We then place a hand on the back of the patient’s head and push
it forward. The patient is then asked to lift the chin as far as possible (lateral sniffing position).
In order to avoid overlooking cancers in the floor of the mouth, soft plate and uvula, we first
observe the oral cavity (Figure 1). and then insert the endoscope without a mouthpiece and
subsequently observe the upper, lateral and posterior wall of the oropharynx while the patient
sticks their tongue forward (Figure 2).
After observing the buccal cavity, further oropharyngeal observation is carried out with a
retroflexed endoscope inserted via the nose. When the tip of the endoscope reachs the area
caudal to the uvula, the patient opens their mouth wide and sticks their tongue forward as
much as possible while making a vocal sound similar to ”ayyy”. The endoscopist causes the
endoscope to make a U-turn (intra-oropharyngeal U-turn method) and observes the orophar‐
ynx, in particular the radix linguae. A schematic drawing of the procedure is shown in (Figure
3). We previously reported the usefulness of the intra-oropharyngeal U turn method [20]. One
hundred and seventy-two patients underwent treatment with this method from April to
October 2012. It was possible to observe all areas of the tongue from the radix linguae to the
apex linguae, in 160 cases (93%) [21], and a frontal view of the papillae vallatae was obtained
in all patients (Figure 4). After completing the intra-oropharyngeal U-turn method, the tip of
the endoscope is inserted gently between the epiglottis and the tongue to observe the vallecula
and the tonsil side of the epiglottis.
Endoscopy - Innovative Uses and Emerging Technologies218
FUJIFILM Co. Tokyo) including a light source (LL‐4450; FUJIFILM Co. Tokyo)) under modi‐
fication of the endoscopic technique for observing head and neck cancers and obtained
excellent results. The endoscope is a transnasal endoscope that can provides high quality
endoscopic images to be viewed on a monitor and digitally recorded with a wide field view
of 140 degrees. The LASEREO system (FUJIFILM Co. Tokyo) is a novel endoscopic system
employing a semiconductor LASER as a light source. This system is equipped with two
LASERs with different in a wavelengths, one for white light sources (wavelength: 450 nm),
and one for BLI (wavelength: 410 nm). The white light observation mode consists of a 450 nm
LASER and fluorescence of white light phosphor, which is excited by a 450 nm LASER. The
phosphor exists in the endoscope. BLI observation mode, which consists of a 410 nm LASER
and feeble fluorescence light excited by a 450 nm LASER and is useful for acquiring mucosal
surface information, including patterns of the surface blood vessels and structures. The
endoscope allows for detailed observations in close view, as it has a focal length of 3 mm to
achieve good endoscopic images. The endoscope also has a forceps with channel measuring
2.4 mm in diameter, which improves the ability to aspirate saliva and gastric juices and remove
gastric mucus adhering to the tip of the endoscope. It has been reported that BLI is useful for
making the diagnosis of colorectal tumors [18], or upper gastrointestinal lesions [19]. An
abnormal microvascular pattern in brownish areas can be detected in most pharyngeal and
esophageal cancers in the near view with white light images and clearly observed on BLI
images. The color contrast of pharyngeal and esophageal cancers rises with BLI, resulting in
useful screening result.
3.2. Endoscopic examinations-from the oral cavity to the oropharynx
Our screening procedure is as follows. First, the patient is asked to bow their head deeply in
the lateral decubitus position. We then place a hand on the back of the patient’s head and push
it forward. The patient is then asked to lift the chin as far as possible (lateral sniffing position).
In order to avoid overlooking cancers in the floor of the mouth, soft plate and uvula, we first
observe the oral cavity (Figure 1). and then insert the endoscope without a mouthpiece and
subsequently observe the upper, lateral and posterior wall of the oropharynx while the patient
sticks their tongue forward (Figure 2).
After observing the buccal cavity, further oropharyngeal observation is carried out with a
retroflexed endoscope inserted via the nose. When the tip of the endoscope reachs the area
caudal to the uvula, the patient opens their mouth wide and sticks their tongue forward as
much as possible while making a vocal sound similar to ”ayyy”. The endoscopist causes the
endoscope to make a U-turn (intra-oropharyngeal U-turn method) and observes the orophar‐
ynx, in particular the radix linguae. A schematic drawing of the procedure is shown in (Figure
3). We previously reported the usefulness of the intra-oropharyngeal U turn method [20]. One
hundred and seventy-two patients underwent treatment with this method from April to
October 2012. It was possible to observe all areas of the tongue from the radix linguae to the
apex linguae, in 160 cases (93%) [21], and a frontal view of the papillae vallatae was obtained
in all patients (Figure 4). After completing the intra-oropharyngeal U-turn method, the tip of
the endoscope is inserted gently between the epiglottis and the tongue to observe the vallecula
and the tonsil side of the epiglottis.
Endoscopy - Innovative Uses and Emerging Technologies218
Figure 3. Schema of intra-oropharyngeal U-turn method.
Figure 1. A view of the floor of the mouth through a trans-oral approach.
Figure 2. A view of the oropharynx through a trans-oral approach.
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Figure 4. A view of the radix linguae through a trans-nasal approach.
3.3. Endoscopic examination from the hypopharynx to the cervical esophagus
The vocal cords and right and left pyriform sinus should be observed (Figure 5). When the
patient vocalizes, the vocal cords move to the anterior region, making observation of the
pyriform sinus easier. The technique of esophagogastroduodenoscopy (EGD) has also been
improved, although it is not possible to observe otorhinolaryngeal sites in some patients due
to the gag reflex. The postcricoid subsite and orifice of the esophagus are especially difficult
to visualize using flexible laryngopharyngoscopy. Several reports have suggested techniques
for improving the view of the hypopharynx with a flexible fiber optic laryngoscope. Spraggs
and Harris described a modified Valsalva technique involving the nose being squeezed shut
by the examiner’s hand while the patient attempts to blow through the obstructed nose [22,
23]. Other reports have described the trumpet maneuver [24], the anterior neck skin traction
maneuver [25] or a combination of the two [26]. However, these maneuvers have not been
attempted in conventional EGD due to the effects of the gag reflex.
Since we introduced the modified Valsalva maneuver using transnasal endoscopy in 2009
[27],  a  total  of  94  superficial  head  and  neck  cancers  were  found  in  70  patients  using
transnasal ESD over the last four years [28]. Furthermore, it has been reported the modified
Valsalva  maneuver  using  transnasal  endoscopy  is  prospectively  useful  for  detecting
superficial pharyngeal cancer [29].
For the examination of the hypopharynx and orifice of the esophagus, the patient is asked to
blow hard and puff their cheeks while keeping their mouth closed. The endoscopist pulls the
patient’s chin forward with the right hand, and the characteristics of the posterior wall of the
hypopharynx and postcricoid subsite pharyngeal wall enable the pharyngeal mucosa to be
stretched out and the postcricoid region (Figure 6) and orifice of the esophagus to be visualized
in an open space. The transnasal BLI system enables clear visualization of the palisade vessels
of the pharyngoesophageal junction (Figure 7). The total time required to perform the proce‐
dure is approximately two minutes. This technique is easy to perform and feasible in almost
all high-risk patients. The endoscope is then passed into the cervical esophagus.
Endoscopy - Innovative Uses and Emerging Technologies220
Figure 4. A view of the radix linguae through a trans-nasal approach.
3.3. Endoscopic examination from the hypopharynx to the cervical esophagus
The vocal cords and right and left pyriform sinus should be observed (Figure 5). When the
patient vocalizes, the vocal cords move to the anterior region, making observation of the
pyriform sinus easier. The technique of esophagogastroduodenoscopy (EGD) has also been
improved, although it is not possible to observe otorhinolaryngeal sites in some patients due
to the gag reflex. The postcricoid subsite and orifice of the esophagus are especially difficult
to visualize using flexible laryngopharyngoscopy. Several reports have suggested techniques
for improving the view of the hypopharynx with a flexible fiber optic laryngoscope. Spraggs
and Harris described a modified Valsalva technique involving the nose being squeezed shut
by the examiner’s hand while the patient attempts to blow through the obstructed nose [22,
23]. Other reports have described the trumpet maneuver [24], the anterior neck skin traction
maneuver [25] or a combination of the two [26]. However, these maneuvers have not been
attempted in conventional EGD due to the effects of the gag reflex.
Since we introduced the modified Valsalva maneuver using transnasal endoscopy in 2009
[27],  a  total  of  94  superficial  head  and  neck  cancers  were  found  in  70  patients  using
transnasal ESD over the last four years [28]. Furthermore, it has been reported the modified
Valsalva  maneuver  using  transnasal  endoscopy  is  prospectively  useful  for  detecting
superficial pharyngeal cancer [29].
For the examination of the hypopharynx and orifice of the esophagus, the patient is asked to
blow hard and puff their cheeks while keeping their mouth closed. The endoscopist pulls the
patient’s chin forward with the right hand, and the characteristics of the posterior wall of the
hypopharynx and postcricoid subsite pharyngeal wall enable the pharyngeal mucosa to be
stretched out and the postcricoid region (Figure 6) and orifice of the esophagus to be visualized
in an open space. The transnasal BLI system enables clear visualization of the palisade vessels
of the pharyngoesophageal junction (Figure 7). The total time required to perform the proce‐
dure is approximately two minutes. This technique is easy to perform and feasible in almost
all high-risk patients. The endoscope is then passed into the cervical esophagus.
Endoscopy - Innovative Uses and Emerging Technologies220
Figure 5. A view of the larynx and the hypopharynx.
Figure 6. Transnasal endoscopy using trumpet maneuver improves the visualization of the hypopharynx and the
pharyngoesophageal junction.
Figure 7. The endoscopic image of the pharyngoesophageal junction using Blue lasar imaging (BLI).
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4. Patients and Methods
This study was conducted between June 2014 and October 2014. During this period, 70
consecutive patients (60 males, 10 females; mean age: 67.9 years old) with esophageal or head
and neck cancer underwent endoscopic screening of the oropharynx and hypopharynx using
transnasal endoscopy with the BLI system at the Department of Esophageal and General
Surgery, Tokyo Medical and Dental University. We performed endoscopic observation from
the oral cavity to pharynx before inserting the endoscope into the cervical esophagus. BLI
images were obtained on a color video monitor by pushing a fingertip control switch. The
visibility of subsites of the hypopharynx and the orifice of the esophagus was evaluated, and
the extent of view of the hypopharyngeal opening was classified into three categories (excel‐
lent, good, poor). The diagnostic accuracy of transnasal endoscopy with the BLI system was
subsequently estimated. Two experienced endoscopists (K.K., N.F.) performed all of the
examinations, using the same endoscope.
The examinations were recorded onto video cassettes. Written informed consent was obtained
from all patients prior to the endoscopic examinations.
5. Results
Eight elderly patients were excluded due toinadequate ballooning. Finally, 62 patients were
investigated. Ballooning of the pyriform sinus and posterior wall allows for both an accurate
assessment of the stretched pharyngeal mucosa and provides a view of the postcricoid subsite
and orifice of the esophagus.
A wide endoscopic view of the pharynx was obtained in a series of the procedures (excel‐
lent=53/62, 85.4%; good=7/52, 4.5%; and poor=2/62, 7.6%). Among the 70 patients, six superfi‐
cial lesions (8.6%) at the oropharynx (n=1) and hypopharynx (n=5) were discovered with the
BLI system (Table 1). Three lesions were located at the piriform sinus and two lesions were
located on the posterior wall of the pharyngoesophageal junction, which in the blind area on
conventional screening. A representative lesion is shown in Figure 8. The hypopharynx was
stretched according to the trumpet maneuver, whicn allowed us to detect a slightly depressed
area. On BLI observation, a well demarcated brownish area was recognized, with scattered
brown dots within the areas on a close view (Figure 9). The lesion was resected via endoscopic
laryngopharyngeal surgery (ELPS). The area unstained with iodine was similar to the brown‐
ish area observed on BLI (Figure 10).
The histopathological examination revealed a diagnosis of squamous cell carcinoma with
microinvasion beneath the epithelium (Figure 11).
In one case, superficial oropharyngeal cancer was located at the radix linguae (Figure 12), and
the intra-oropharyngeal U-turn method was very effective for making the diagnosis.
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Table 1. The oropharyngeal and hypopharyngeal cancers detected by transnasal endoscopy with BLI.
Figure 8. A slightly depressed lesion was observed in the posterior wall of the hypopharynx using the trumpet maneu‐
ver.
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Figure 9. The endoscopic image using the BLI during the trumpet maneuver
Figure 10. A macroscopic image of the resected specimen.
Figure 11. Histopathological examination revealed a diagnosis of squamous cell carcinoma with microinvasion be‐
neath the epithelium.
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Figure 12. A case of superficial oropharyngeal cancer. The tumor observed using intra-oropharyngeal U-turn method.
5.1. Endoscopic features of superficial pharyngeal cancer
Recent advances in endoscopic procedures, such as magnifying endoscopy and the NBI
system, have enabled precise observation of the oropharynx and hypopharynx [2, 5]. Mucosal
redness, a pale and thickened mucosal apperance, white deposits and/or loss of the normal
vascular pattern are important characteristics for diagnosing superficial carcinoma upon
examination under white light (Figure 13). In addition, well demarcated areas covered with
scattered dots observed on a closer observation of superficial microvascular structures and
allows for the detection of a lesions at an earlier stages. The new transnasal endoscopy
procedure with the BLI system enables physicians to easily observe the presence of scattered
brown dots, contributing to the diagnosis of superficial cancers (Figure 14). Moreover, close
BLI examinations using transnasal endoscopy enable the physician to obtain a mucosal
diagnosis, even without magnification.
Figure 13. The white light image showed a 0-II b lesion of the right piriform sinus.
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Figure 14. The close BLI image showed brown dots in the 0-II b lesion.
The modified Valsalva maneuver is also useful for detecting proximal invasion of the cervical
esophageal cancer. This maneuver helps the physician to determine whether to preserve the
patient’s voice during surgery. On conventional screening, endoscopic images of hypophar‐
yngeal cancer are often observed, however the distal part of the tumor is not visualized (Figure
15). A BLI endoscopic image obtained during the modified Valsalva maneuver using trans‐
nasal ESD is shown in Figure 16. The whole image of the tumor was able to observe (Figure
17). The entire tumor was observed, as indicated in Figure 17: the advanced cervical esophageal
cancer had invaded the hypopharynx.
Figure 15. A reddish and irregular mucosa was shown in the hypopharynx. The distal part is not visualized.
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Figure 16. Advanced cancer was observed at the pharyngoesophageal junction using BLI during the trumpet maneu‐
ver.
Figure 17. The advanced cervical esophageal cancer had invaded the hypopharynx (arrows).
6. Further research
It has been reported that the application of magnifying endoscopy with the NBI system
drastically changes the diagnostic strategy for the early detection of early oropharyngeal and
hypopharyngeal cancers. The development of transnasal endoscopy with the BLI system now
enables the wider observation and can be used to obtain adequate information for diagnosing
early cancers without magnification. The modified Valsalva maneuver and intra-oropharyng‐
eal U-turn method using transnasal endoscopy are not popular in Japan as of yet, however
these techniques are very easy to perform, and we expect that this method will become a
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standard procedure for observing the pharynx and orifice of the esophagus in the near future.
Nevertheless, further studies, including randomized, prospective, multi-institutional joint
trials comparing conventional endoscopy with the NBI system or transnasal endoscopy with
the BLI system are required.
Transnasal endoscope technology is continually improving. From the viewpoint of early
detection of pharyngeal cancer, we hope that transnasal endoscopy will become more widely
adopted.
7. Conclusion
The significant progress achieved in the field of transnasal endoscopy rapidly within the last
few years has improved the ability to observe the blind area typically noted during conven‐
tional screening. Therefore, transnasal endoscopy is expected to become a standard tool for
screening of the upper gastrointestinal tract in the near future.
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Abstract
Endoscopes have rapidly become widely accepted in the performance of ear surgery.
Current chapter describes surgical technique and benefits and limitations for
endoscopic eradication of cholesteatoma, endoscopic tympanoplasty, endoscopic
stapedotomy and endoscopic cochlear implantation.
Minimally invasive endoscopic and endoscope-assisted surgical techniques are
increasingly being employed in the surgical management of cholesteatoma. Endo‐
scopic surgeries distinctly reduced residual cholesteatomas and the indications of
later tympanotomy thanks to the good visualization of residual cholesteatoma sites,
such as the anterior and posterior epitympanic spaces, sinus tympani, facial recess,
and hypotympanum. Minimally invasive transcanal endoscopic approach can be
applied as for primary cholesteatomas as well as for revision of CWU cases, when
residual/recurrent cholesteatoma is confined to the middle ear, and in CWD or radical
cavities, when residual/recurrent disease is hidden in the supratubal recess, sinus
tympani or under pseudo-membrane in the large mastoid cavities.
The use of endoscopes in myringoplasty is especially helpful in patients with narrow
external canals, anterior defects and bone overhang, when perforation's margins are
barely, if at all, visible under a microscope.
The transcanal endoscopic stapedotomy can be beneficial in improving the visibility
and accessibility of the stapes and the oval window niche, avoiding manipulation of
the chorda tympani nerve and blind fracture of the stapedial crurae.
An endoscopic cochlear implantation involves entering the middle ear by means of
endoscopic transcanal tympanotomy and insertion of the electrode array into the scala
tympani via the round window under direct endoscopic control. The main benefits of
the endoscopic transcanal approach to cochlear implant are improving the visibility
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
and accessibility of the round window membrane, obviating the need to divide the
chorda tympani nerve in order to obtain adequate exposure of the middle ear
structures, and eliminating the risk of the facial nerve injury since it is not in the
direction of drilling.
Keywords: endoscopic surgery, approach, tympanoplasty, stapedectomy, cochlear
implant
1. Introduction
The introduction of endoscopes completely changed the surgical approach to the middle ear
pathologies. Management of cholesteatoma continues to pose a surgical challenge, and the
choice of surgical technique depends on the extension of the disease, the surgeon's own
experience and skills, published data, and the patient's socioeconomic circumstances. Mini‐
mally invasive endoscopic and endoscope-assisted surgical techniques are increasingly being
employed in the surgical management of cholesteatoma.
2. Endoscopic surgery for cholesteatoma
Exclusive transcanal endoscopic approach (TEA) can be used for the resection of a primary
cholesteatoma or for endoscopic revision of an accessible residual/recurrent cholesteatoma in
the post-mastoidectomy cavity. In endoscope-assisted ear surgery (EAES), the endoscopes are
introduced intraoperatively for completion of surgery performed under a microscope.
Endoscopic ear surgery (EES) and EAES distinctly reduced residual cholesteatomas and the
indications of later tympanotomy thanks to the good visualization of residual cholesteatoma
sites, such as the anterior and posterior epitympanic spaces, sinus tympani, facial recess,
eustachian tube and hypotympanum [1-10]. Moreover, it was found that retraction pockets
extending into the facial recess may be more readily removed by using endoscopes than by
converting to an intact canal wall mastoidectomy with a facial recess approach [10,11].
The vast majority of cholesteatomas starts to develop in the middle ear and its extensions, and
only later involves the mastoid cavity. Thus, the most logical access to a cholesteatoma has not
yet advanced to the mastoid is the transcanal approach. However, the endoscopic approach
depends on the experience and skills of the surgeon. In addition, otosurgeons are accustomed
to using both hands at surgery while in the EES one hand is occupied with the endoscope and
the other performs the manipulations for the eradication of the pathology, suctioning,
hemostasis and subsequent reconstructions [10].
A cholesteatoma is defined as being accessible with TEA when it does not extend beyond the
level of the lateral semicircular canal [11]. In case of cholesteatoma inaccessible even with
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angled instruments under direct vision of angled endoscopes traditional mastoidectomy is
performed. The optimal surgical approach to residual/recurrent cholesteatoma is a controver‐
sial issue since residual lesions can be missed and cholesteatoma tends to recur despite the
variety of surgical options. The common sites of residual lesions and recurrences are sinus
tympani, attic, anterior epitympanic space, facial recess and the supratubal region, and they
can all be visualized and accessed using the TEA [3,5-7,12-26].
Preoperative assessment includes otoscopy and pure tone audiometry in all patients. Recent
studies have shown that non-echo planar (non-EPI) diffusion-weighted (DW) magnetic
resonance imaging (MRI) can accurately predict the presence and extent of cholesteatoma in
both primary and residual cases [27-31]. The size of lesion determined by the non-EPI DW
images correlated well with intra-operative findings, with error margins lying within 1 mm
[28-31]. Non-EPI DW MRI can distinguish cholesteatoma from other tissues and from mucosal
reactions in the middle ear (ME) and mastoid, and it can also demonstrate the extent of the
lesion [27-31]. Thus, we prefer performing the non-EPI DWI MRI prior to primary cholestea‐
toma surgery as well as before revision procedures [31]. Non-EPI DW images allow avoiding
the irradiation, and this point is extremely important for all patients, especially children [32].
The choice of approach as in primary as well as in revision surgery depends on the extent of
disease and on the preoperative otoscopic and radiological findings (Figures 1-8). We already
found that cholesteatoma < 8 mm in size and confined to the ME or its extensions can be
eradicated with a minimally invasive TEA, while endoscope-assisted retroauricular mastoi‐
dectomy is the preferable procedure for larger lesions [31].
Many primary and some residual/recurrent lesions can be accessed with endoscopes. How‐
ever, prior to undergoing the intervention, all the patients are informed of the possibility of
extending their surgery to a transmastoid approach in the event that the cholesteatoma could
not be satisfactorily eradicated by the transcanal endoscopic approach.
2.1. Surgical technique
The operating room setup, instrumentation and surgical technique were similar to those
proposed by Tarabichi [11-14]. Rigid 3-mm diameter, 0°, 30° and 45° endoscopes, angled picks
and forceps and routine otologic micro-instruments are used for all the TEA procedures (the
list of the instruments can be seen in the web site of the International Working Group on
Endoscopic Ear Surgery). A wide posterior tympanomeatal flap was elevated via the external
auditory canal and then transposed inferiorly in cases of cholesteatoma situated in the middle
ear (ME) under a closed or perforated tympanic membrane (TM). If needed, the scutum was
removed with a bone curette until the cholesteatoma extension and the mastoid antrum could
be visualized. The malleus and incus are removed when they are involved in the cholesteatoma
or when they limit access to cholesteatoma in the anterior or posterior epitympanic space.
When present, the stapes is left intact and meticulously and gently cleaned when it is involved
with the cholesteatoma. Scutumplasty is done with tragal cartilage, and TM defects are
reconstructed with the palisade technique and perichondrium in the relevant cases. In certain
cases, cholesteatoma can be assessed and removed using the endoscopes directly from the
radical cavity or from the mastoid cavity remaining after a canal-wall-down (CWD) procedure.
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An operating microscope is used when the surgeon needs both hands to complete the removal
of the cholesteatoma from the facial nerve or stapes footplate, and occasionally for ossicular
chain reconstruction (OCR). Operative time depends on the extension of the disease, ossicular
involvement in cholesteatoma and whether OCR is required.
Post-operative follow-up recommendations included repeated clinical examinations, and all
the patients are encouraged to perform non-EPI DWI MRI at approximately one year following
surgery. Second-look procedures or secondary OCRs usually are planned according to the
clinical and MRI findings and the postoperative audiometric results. Whatever the etiology of
cholesteatoma, scutumplasty with cartilage yielded good results in terms of prevention of
postoperative retraction pockets.
EES has several advantages as compared to traditional mastoidectomy. This is a minimally
invasive surgical approach in terms of incision, bleeding, drilling, postoperative pain and
healing, and it is curative in terms of the radical eradication of the pathology including hidden
areas poorly accessible and thus overlooked by a microscope. In the TEA, bony work can be
circumvented leading to a decrease of possible intraoperative complications. This is functional
surgery since scutumplasty and reconstruction of the tympanic membrane lead to conditions
favorable to the introduction of the water into the external auditory meatus, and primary
ossicular chain reconstruction can be done at the same setting. The patient can be discharged
on the same day or on the day after surgery, and the hospital stay can be shortened compared
to at least 2 days postoperative admission for uneventful retroauricular mastoidectomy. In
contrast to mastoidectomy, the EES can be performed under local anaesthesia, and there is no
need for postoperative wound care. Post-EES healing time is usually painless and is shorter
compared to mastoidectomy. The set-up time and costs of the endoscopic procedure are
comparable with mastoidectomy and even less since there is no need in drilling, cotton material
and cauterization for hemostasis, suturing of the wound, bandage and postoperative wound
care. The endoscopes and video-cameras are in routine use for endoscopic sinus surgery and
thus are already available in most departments. The routine otologic micro-sets should be
completed with some angled picks and forceps.
Although mastoidectomy is a procedure that is familiar to all otosurgeons, it can be compli‐
cated by accidental trauma to middle cranial fossa dura, dural exposure in the tegmen and
sinodural angle, and brain herniation into the mastoid cavity. Dural and tegmen defect due to
dural tears and cerebrospinal fluid leakage may result in pneumocephalus, brain herniation,
subdural empyema, epidural or brain abscess [33-39]. In addition to primary cholesteatoma
cases, minimally invasive TEA can be applied for revision of canal-wall-up (CWU) cases, when
residual/recurrent cholesteatoma is confined to the middle ear, and in CWD or radical cavities,
when residual/recurrent disease is hidden in the supratubal recess, sinus tympani or under
pseudo-membrane in the large mastoid cavities, when access to cholesteatoma via external ear
canal is difficult using the operating microscope due to the limited axis of work [24]. The TEA
can be one of the options for eradication of residual/recurrent lesions in addition to traditional
CWU and CWD techniques. The TEA avoids drilling in the mastoid region, thereby obviating
the risk of dural injury and postoperative intracranial complications. Pre-operative non-EPI
DWI MRI can predict cholesteatoma extension and is essential in planning revision surgery
Endoscopy - Innovative Uses and Emerging Technologies236
An operating microscope is used when the surgeon needs both hands to complete the removal
of the cholesteatoma from the facial nerve or stapes footplate, and occasionally for ossicular
chain reconstruction (OCR). Operative time depends on the extension of the disease, ossicular
involvement in cholesteatoma and whether OCR is required.
Post-operative follow-up recommendations included repeated clinical examinations, and all
the patients are encouraged to perform non-EPI DWI MRI at approximately one year following
surgery. Second-look procedures or secondary OCRs usually are planned according to the
clinical and MRI findings and the postoperative audiometric results. Whatever the etiology of
cholesteatoma, scutumplasty with cartilage yielded good results in terms of prevention of
postoperative retraction pockets.
EES has several advantages as compared to traditional mastoidectomy. This is a minimally
invasive surgical approach in terms of incision, bleeding, drilling, postoperative pain and
healing, and it is curative in terms of the radical eradication of the pathology including hidden
areas poorly accessible and thus overlooked by a microscope. In the TEA, bony work can be
circumvented leading to a decrease of possible intraoperative complications. This is functional
surgery since scutumplasty and reconstruction of the tympanic membrane lead to conditions
favorable to the introduction of the water into the external auditory meatus, and primary
ossicular chain reconstruction can be done at the same setting. The patient can be discharged
on the same day or on the day after surgery, and the hospital stay can be shortened compared
to at least 2 days postoperative admission for uneventful retroauricular mastoidectomy. In
contrast to mastoidectomy, the EES can be performed under local anaesthesia, and there is no
need for postoperative wound care. Post-EES healing time is usually painless and is shorter
compared to mastoidectomy. The set-up time and costs of the endoscopic procedure are
comparable with mastoidectomy and even less since there is no need in drilling, cotton material
and cauterization for hemostasis, suturing of the wound, bandage and postoperative wound
care. The endoscopes and video-cameras are in routine use for endoscopic sinus surgery and
thus are already available in most departments. The routine otologic micro-sets should be
completed with some angled picks and forceps.
Although mastoidectomy is a procedure that is familiar to all otosurgeons, it can be compli‐
cated by accidental trauma to middle cranial fossa dura, dural exposure in the tegmen and
sinodural angle, and brain herniation into the mastoid cavity. Dural and tegmen defect due to
dural tears and cerebrospinal fluid leakage may result in pneumocephalus, brain herniation,
subdural empyema, epidural or brain abscess [33-39]. In addition to primary cholesteatoma
cases, minimally invasive TEA can be applied for revision of canal-wall-up (CWU) cases, when
residual/recurrent cholesteatoma is confined to the middle ear, and in CWD or radical cavities,
when residual/recurrent disease is hidden in the supratubal recess, sinus tympani or under
pseudo-membrane in the large mastoid cavities, when access to cholesteatoma via external ear
canal is difficult using the operating microscope due to the limited axis of work [24]. The TEA
can be one of the options for eradication of residual/recurrent lesions in addition to traditional
CWU and CWD techniques. The TEA avoids drilling in the mastoid region, thereby obviating
the risk of dural injury and postoperative intracranial complications. Pre-operative non-EPI
DWI MRI can predict cholesteatoma extension and is essential in planning revision surgery
Endoscopy - Innovative Uses and Emerging Technologies236
for residual/recurrent lesions. Screening with non-EPI DWI MRI at one year postoperatively
is highly recommended to rule out residual disease, especially in patients who underwent
CWU mastoidectomies.
Figure 1. A view (with a 0° endoscope) of a left ear primary retraction pocket cholesteatoma.
Figure 2. Non-EPI DW coronal images of the same patient presented in Figure 2 shows a 7-mm hyperintense lesion in
the left attic (it was managed with TEA).
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Figure 3. Endoscopic view of right ear primary retraction pocket cholesteatoma extended to the mastoid cavity.
Figure 4. Non-EPI DW coronal images of the same patient presented in Figure 3 shows a hyperintense lesion occupied
whole mastoid cavity (it was managed with CWD mastoidectomy).
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Figure 5. Endoscopic view of right ear residual cholesteatoma presented 1 year after CWU mastoidectomy.
Figure 6. Non-EPI DW coronal images of the same patient presented in Figure 5 shows a 6-mm hyperintense lesion in
the right attic (it was managed with TEA).
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Figure 7. Endoscopic view of left ear recurrent cholesteatoma presented 2.5 years after CWD mastoidectomy.
Figure 8. Non-EPI DW coronal images of the same patient presented in Figure 7 shows a 9-mm hyperintense lesion in
the left middle ear with an extension to the mastoid (it was managed with TEA).
3. Endoscopic myringoplasty
Recently, different endoscopes have been used in the performance of ear surgery in general
and myringoplasty in particular, and the surgical success of endoscope-assisted myringoplasty
ranges between 80 and 100 % [40-46]. Myringoplasty can be technically difficult, especially in
pediatric patients, due to the narrowness of the external auditory canal and the generally small
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size of the ear [46]. Moreover, temporalis fascia grafts and myringoplasties for anterior
perforations are more likely to fail in children [40-43,47,48]. Surgical management of anterior
perforations requires total exposure of the anterior angle, but a microscope may fail to provide
a view of the anterior edge in 73 % of perforations that can, however, be entirely exposed with
an endoscope [44]. As a result, drilling of the anterior part of an external auditory canal is
usually unavoidable for the repair of anterior perforations when only a microscopic approach
is employed [47].
3.1. Surgical technique
Transcanal endoscopic myringoplasties are performed under local or general anesthesia with
a chondro-perichondrial graft that is harvested from the tragus and placed medial to the
tympanic membrane remnants, utilizing the underlay technique and 14-mm length, 3-mm
diameter, 0° and 30° endoscopes (Figures 9 and 10). Tympanomeatal flap is elevated using the
0° endoscope in all the cases, and the 30° endoscope can be utilized for better visualization of
anterior perforations. The margins of perforations are freshened using the 0° or 30°endoscopes.
A microscope is used for removal of the sclerotic plaques and releasing adhesions surrounding
the ossicles when bimanual manipulations are needed.
Figure 9. Endoscopic view of a large anterior perforation in the right tympanic membrane.
We found that an endoscope is very effective in ensuring satisfactory approximation of graft
material to the perforation margins in small, medium-sized, large and subtotal perforations as
well. The transcanal endoscopic myringoplasty had, in our hands, a 100% rate of surgical
success for closure of tympanic membrane defects. This technique is especially helpful in
patients with narrow external canals, anterior defects and bone overhang, when perforation's
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margins are barely, if at all, visible under a microscope. The choice of chondro-perichondrial
graft material and the meticulous removal of myringosclerotic plaques can enhance the
surgical outcome of endoscopic myringoplasty performed by an experienced otologist.
Figure 10. Endoscopic view of the same ear as in Figure 9 at the end of the myringoplasty.
4. Endoscopic stapedotomy
Stapedotomy can be technically difficult and challenging due to anatomic variations in size,
configuration, shape or irregularity of the external ear canal. The stapes and oval window niche
(OWN) can be obscured by the scutum. Excessive removal of the bone for better visualization
of the middle ear (ME) structures can rarely result in subluxation of the incus [49-51]. When
the posterior part of the bony annulus is removed to visualize the stapes, the chorda tympani
nerve (CTN) can be occasionally touched, stretched, manipulated or transected and result in
20-60% of postoperative taste disorders or tongue symptoms [52-57]. The existing data indicate
that the CTN should be preserved whenever possible, especially if surgery is bilateral
[53,54,57,58]. Bilateral CTN damage can result in transient or permanent bilateral ageusia of
the anterior two-thirds of the tongue, as well as a decreased resting salivary flow rate. In
addition, the patients may suffer from transient or persistent, distressing xerostomia or tactile
dysguesia [58-60]. However, damage to the CTN and subluxation of the ossicles or stapes
fracture significantly decreases in the hands of an experience surgeon.
Endoscopic stapedotomy was introduced in our department with the intent to avoid injury to
the CTN when attempting to achieve visibility of the ME structures. The CTN was preserved
in all cases, and our preliminary audiometric results were comparable with the others [61-63].
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4.1. Surgical technique
The position of the patients is the same as for routine otomicroscopic ear surgeries. The external
ear canal is injected with lidocaine 1% with 1:100.000 epinephrine. A fully endoscopic trans‐
canal procedure was undertaken using rigid endoscopes 3 mm diameter, 14-cm length, 0° and
30°. Angled picks and curved scissors and forceps are used in addition to the routine otologic
micro-instruments. A posterior tympanomeatal flap is elevated transmeatally with the 0°
endoscope and then transposed anteriorly. All the surgeries are performed with a 0° endo‐
scope, while a 30° endoscope can be required to better visualize the OWN, the anterior crus of
the stapes, the tympanic portion of the facial nerve and the pyramidal eminence in some cases
due to bony overhang in the posterior tympanum. Stapes fixation is confirmed by gentle testing
of ossicular chain mobility. The stapes tendon is cut with curved micro-scissors and the stapes
is separated from the incus in the incudo-stapedial joint. The anterior and posterior stapedial
crus are carefully fractured and the superstructure is removed. The distance between the
footplate and medial surface of the long process of the incus was measured to determine the
required prosthesis size. The hole in the footplate is created with a Skeeter microdrill using a
0.5-mm diameter diamond burr. A platinum/fluoroplastic piston prosthesis (0.4-mm diameter,
4.5/4.75-mm length) is placed into this hole and fitted along the long process of the incus
(Figures 11-14). The appropriate ossicular chain movement with the replaced stapes is ensured
by malleus palpation. The tympano-meatal flap is repositioned, and the external auditory canal
is filled with Gelfoam® soaked in ear drops containing antibiotics.
Figure 11. Endoscopic view of the right middle ear after an elevation of the tympano-meatal flap. Good access to the
stapes and oval window niche was achieved without removal of the scutum and without touching the chorda tympani
nerve.
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Figure 12. Endoscopic view of the right ear: cutting of the stapedius.
Figure 13. Endoscopic view of piston prosthesis placed in the hole that was created in the footplate and covered with a
small piece of fat.
The possible benefits of ES are excellent visibility and accessibility of the stapes and the OWN,
and avoiding manipulation of the CTN and blind fracture of the stapedial crurae. Assistance
Endoscopy - Innovative Uses and Emerging Technologies244
Figure 12. Endoscopic view of the right ear: cutting of the stapedius.
Figure 13. Endoscopic view of piston prosthesis placed in the hole that was created in the footplate and covered with a
small piece of fat.
The possible benefits of ES are excellent visibility and accessibility of the stapes and the OWN,
and avoiding manipulation of the CTN and blind fracture of the stapedial crurae. Assistance
Endoscopy - Innovative Uses and Emerging Technologies244
in using the operating microscope can be required when there is the need for two-hand
manipulations for proper placing and coupling of the prosthesis, especially during the
surgeon's initial endoscopic procedures. Finally, right-handed surgeon (L.M.) found that the
axis of work was initially more comfortable when performing surgery on right ears and that
the relative difficulty in creating a hole in the footplate and positioning the prosthesis in left
ears could be overcome with more training.
Transcanal fully endoscopic stapedotomy can be utilized in patients with unfavorable external
or middle ear anatomy, in candidates for revision or bilateral stapedotomy, in patients with
already impaired taste sensation, with food-, smell- or taste-related occupations, and in those
for whom the taste of food contributes appreciably to their quality of life.
5. Endoscopic cochlear implantation
Recent developments in cochlear implant electrode array design and modifications of surgical
techniques have resulted in improved post-implantation performance by minimizing intra‐
cochlear damage during implantation [64]. However, electrodes and the surgical procedures
used for their insertion still produce intracochlear trauma. An optimal site for cochleostomy
in terms of avoiding insertion trauma during cochlear implantation (CI) has not yet been
established. Some authors recommend the insertion of the electrode array through the
cochleostomy corresponding to the antero-inferior margin of the round window membrane
(RWM), while others contend that atraumatic insertion can be achieved directly through the
RWM by removing the antero-inferior overhang of the RW niche, drilling down the crista
fenestra, and incising the most lateral aspect of the RWM before insertion [64]. Regardless of
the site of electrode insertion, the first step is achieving adequate exposure of the RWM in order
to facilitate minimally invasive surgery. However, the topographical relationships among the
facial nerve (FN), CTN, and RW showed that the widest route of approach through the facial
recess (FR) frequently did not point directly towards the RW, but rather towards the basal turn
at the promontory [65]. RWM insertion using the FR approach can be more challenging in
pediatric patients, with the visibility of the RWM being limited in 11%-22 % of children even
after an "optimal" posterior tympanotomy. An extended membranous cochleostomy or
conventional bony cochleostomy may be required in some of these cases [66]. Moreover, the
access to the RWM may be compromised in an FR approach due to the bony overhangs,
abnormal course of the FN, jugular bulb location or abnormalities, anteriorly located sigmoid
sinus, narrow FR and an undeveloped mastoid [67-70].
An endoscopic CI involves entering the ME by means of endoscopic transcanal tympanotomy
and insertion of the electrode array into the scala tympani via the RW under direct endoscopic
control [71,72]. Limited access to the ME structures can result in electrode misplacement,
damage to the FN and injury to the CTN when a CI is carried out with an FR approach [73-78].
Indeed, bilateral sacrificing of the CTN due to a narrow FR in bilaterally implanted children
can lead to morbidity that has not yet been investigated in depth. One of the reasons for
incorrect electrode insertion using the microscopic approach through the FR can be the
Minimally Invasive Transcanal Endoscopic Ear Surgery
http://dx.doi.org/10.5772/60551
245
presence of a wide subcochlear canaliculus that could be mistaken with the RW niche [72]. Our
experience as well as findings of our colleagues showed that the direct visualization of the
RWM using a transcanal endoscopic approach permits electrode insertion through the RWM
into the scala tympani with less drilling of the niche comparing to the FR technique [72].
5.1. Surgical technique
The procedures are performed with the patients under general anesthesia. The position of the
patients, the skin incisions and the drilling of the implant wells are the same as for routine
otomicroscopic CI. The external ear canal is injected with lidocaine 1% with 1:100.000 epi‐
nephrine. Cortical mastoidectomy until visualization of the incus is performed. A 6 o’clock
vertical incision is made in the meatal skin, and a posterior tympano-meatal flap is elevated
transmeatally to expose the ME cavity using a rigid 0° endoscope 3 mm in diameter and 14 cm
in length held manually, and then transposed anteriorly. The CTN and body of the incus are
exposed. Visualization of the incus body serves as a target for drilling and preventing injury
to the FN which is located medial to it. The RWM is incised, and the electrodes are passed
through the tunnel from the mastoid to epitympanum, medial to the CTN and lateral to the
incus into the RW (Figure 15). The tympano-meatal flap is repositioned, and the external
auditory canal is filled with Gelfoam® soaked in ear drops containing antibiotics. The surgical
procedure can be modified in some procedures as follows: instead of inserting the electrodes
through a tunnel that could limit the angle of insertion, an open groove is drilled starting
superiorly and laterally to the CTN and ending in the mastoid region. The electrodes are passed
through the groove medially to the CTN and laterally to the incus into the scala tympani
through the RW, which is then covered with a small piece of temporalis fascia. The groove is
filled with bone dust that had been collected during the drilling of the implant well, and
covered with a large piece of fascia prior to repositioning of the tympano-meatal flap, aiming
to prevent extrusion of the electrode array into the external auditory canal or tracking of the
canal skin into the mastoid with cholesteatoma formation. All patients routinely receive
intravenous ceftriaxone intra-operatively, followed by a course of oral cephalexin during the
first postoperative week.
Fully endoscopic CI with complete electrode insertion via the RW was found more feasible for
insertion of Concerto (Medical Electronics, Innsbruck, Austria) electrode followed by
HiRes90K (Advanced Bionics Corporation, California, USA) and Nucleus 24 Contour Advance
(Cochlear Corporation, Australia) [71].
The main benefits of the TEA to CI are improving the visibility and accessibility of the RWM,
obviating the need to divide the CTN in order to obtain adequate exposure of the ME struc‐
tures, and eliminating the risk of FN injury since the FN is not in the direction of drilling. The
open groove technique was used several times in the past by the first author in cases of low-
set dura and anteriorly based sigmoid sinus. A follow up of these patients showed that there
is no protrusion of the electrode over a period of at least 5 years when the groove is filled with
bone dust and is covered with intact skin.
A good knowledge of the endoscopic anatomy of the middle ear and a good practical knowl‐
edge of the endoscopic technique are essential to ensure a safe endoscopic CI with good
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outcome. An assistance of another surgeon may be required for holding the endoscope during
the insertion of the electrode by a right-handed surgeon in the right cochlea and in removal of
stylet, when relevant. Moreover, modern electrodes designed for hearing preservation by all
companies are very thin and there is the need in bimanual manipulations for their safe and
slow insertion requiring the help of an assistant in holding the endoscope. An angle of electrode
insertion seems more comfortable in the transcanal approach compared to the epitympanic
root of insertion. Right-handed surgeons (e.g. the first author) found that the axis of work was
initially more comfortable when performing surgery on left ears and that the relative difficulty
in electrode insertion in right ears could be overcome with more training [71]. Complete
electrode insertion is achievable into the scala tympani via the round window both in children
and adults. This technique can be used as a first surgical option or complementarily to the
traditional posterior tympanotomy approach in patients with undeveloped or anomalous
mastoid, narrow facial recess, anteriorly based sigmoid sinus, abnormal course of the facial
nerve, high jugular bulb, malformed cochlea or distorted anatomy of the middle ear. The main
limitation of an endoscopic CI is that it is a difficult one-hand surgery, technically possible
only for highly skilled otosurgeons with extensive experience in performing classic aproaches
as well as various endoscopic ear procedures. In endoscopic CI, one hand is occupied by the
endoscope while the other performs manipulations during endoscopic CI including suction‐
ing, hemostasis and subsequent introduction of the electrode into the cochlea [71]. The lack of
stereoscopic vision was not considered to be a drawback by the first author in any surgery.
Figure 14. Wide exposure of the middle ear after elevation of the tympano-meatal flap in an endoscopic transcanal
cochlear implantation (left ear).
Minimally Invasive Transcanal Endoscopic Ear Surgery
http://dx.doi.org/10.5772/60551
247
Figure 15. An electrode array passing through the tunnel medial to the chorda tympani nerve and lateral to the incus in‐
to the cochlea via the round window in an endoscopic transcanal cochlear implantation (the same ear as in Figure 14).
6. Conclusion
The transcanal endoscopic approach is minimally invasive surgery that can be successfully
applied for various ear pathologies. Knowledge on middle ear anatomy, ear radiology and an
experience in classic techniques is essential before starting the endoscopic approach. The
assistance of an operating microscope may be required when there is the need for two-hand
manipulations in dissection of the cholesteatoma from the dehiscent facial nerve, ossicles,
stapes footplate, and in some cases of ossicular chain reconstruction, introduction of the
electrode array into the cochlea. In inexperienced hands, the endoscopic approach can be
associated with complications due to direct trauma from the tip of the endoscope to the facial
nerve, the ossicular chain and a low-lying tegmen.
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Abstract
The endonasal approaches for skull base surgery have evolved in the recent decade.
There are many publications of this technical safety and good outcomes, comparable
with conventional procedure and have less morbidities. In this chapter, the authors
describe the approach and surgical technique for each area of the skull base.
Keywords: Endoscopy, Skull base
1. Introduction
Lesions of paranasal sinuses, as well as those within skull base region, have long been
challenging to rhinologists and neurosurgeons for several decades. Historically, the only
available surgical approaches for these pathologies have traditionally been extensive and,
often, invasive open procedures. Despite ample corridor created by open surgery, its major
drawbacks during the surgery have been the poor visualization due to suboptimal illumination
and magnification of the surgical fields. This fact could become more significant in those with
pathologies in deep, narrow or complex anatomical areas. In some cases, en bloc tumor
resection can be more easily performed through an open technique while in deep and difficult
lesion may not possible to obtain the precise and free surgical margin due to poor visualization.
In addition to the limited visualization by open surgery, these massive maneuvers can result
in significant blood loss, morbidity or mortality.
Based on important principles, any evolution of surgical equipment and techniques has the
same crucial concepts. First, it needs to minimize the associated surgical morbidity/mortality.
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Second, it should maintain the patients’ functional outcomes, parallel to the high success rate
of surgery, i.e., for neoplasms, to achieve oncological control.
Later, development of surgical technique utilizing microscopy has been applied to the
operative management of intracranial pathologies. Microsurgery had proven better patients’
outcome compared to the historic open procedures, likely from the improved visualization
and magnification of the operative field. Consequently, smaller skin incision and less amount
of bone removal can achieve similar, if not better, overall result of the same lesions. Patients’
safety as well as satisfaction has been greater with microscopic surgery. Therefore, microsur‐
gery has been recognized as the standard of care for many neurosurgical and otolaryngological
procedures. However, despite the vast usefulness of the microscope in neurosurgery and
otolaryngology, it is not perfect. For the fact, shadow from an outside light source, an operating
microscope, can hinder clear visualization at corners of the lesions or critical structures. This
drawback is very obvious if one performs an operation through a small and narrow passage,
i.e., transsphenoidal route either by sublabial or transnasal technique. This may, indeed, result
in a subtotal resection.
For the past few decades, innovation of endoscopy has been developed and accepted as a
minimally invasive technique. Various endoscopic tools and techniques have been applied to
appropriate organs in different surgical fields. Unlike an outside light source from an operating
microscope as mentioned above, visualization under endoscope has the superiority, obtaining
a panoramic view with minimal or no shadow due to its light coming off the end of an
endoscope. This is very factual through the narrow corridor, i.e., transsphenoidal route. In
addition, endoscope provides excellent magnification that enhances the critical anatomical
view beyond the operating site. Furthermore, the variety of angled lens endoscope allows
surgeons to inspect “hidden” areas, especially “around the corners.” Hence, some surgeons
have been utilizing endoscopy as an assisting tool along with open or microsurgery so that it
enhances visualization around the corners to improve resection of the target pathology. It
reassures the complete removal of the tumors.
The treatment of the sinonasal tumors by endoscopy has been widely employed after the
evolution of the endoscopic application for the paranasal and sinus diseases in the 1980s, which
was introduced by Wigand and Messerklinger.[1, 2] Subsequently, the more properly designed
endonasal instruments were developed and adapted to the endoscopic methods. This was
popularized and spread over the otolaryngologists world by Stammberger and Kennedy.[3,
6] The endoscopic surgery for the intracranial pathology was first described in 1920s. Then, it
was mainly applied within the ventricular system for the treatment of hydrocephalus. In 1990s
it was, for the first time, reported for the treatment of pituitary lesions via transsphenoidal
route as a collaboration between the otolaringologists and the neurosurgeons.[7, 11]
Recently, endoscopy has been employed for surgical treatment of various sinonasal patholo‐
gies. With the success of endoscopic sinus surgery, this approach has progressed further to the
treatment of intracranial lesions namely in the vicinity of the skull base. In the aspect of skull
base area, by accessing the cranial base via the natural anatomical corridors such as the nostrils
or the oral cavity, endoscopic procedures can preserve critical and normal structures without
leaving patients with cutaneous/visible scar. Moreover, better visualization with little, or no,
brain retraction can be obtained. Hence, improvement of oncological control along with
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minimal functional morbidities has been reported by many authors. To date, there have been
several publications that reiterated excellent results of the surgical outcomes to prove the
efficacy of this innovative technique. Therefore, in some pathology, endoscopic procedures
are considered one of the available standard treatments.
The endoscopic surgery has been expanded for the treatment of the lesions along the skull
base, including both the median sagittal and paramedian coronal planes in the fashion of the
multidisciplinary team approach.[12, 14] True team work can enhance the most benefit of the
surgical techniques. The maintaining of clear visualization simultaneous with the two-hand
dissecting technique cannot be accomplished independently. Moreover, the team approach
has more efficient potential to manage the inevitable crisis during surgery.
Parallel to the surgical technique advancement, the safety from the new surgical method
should be assessed for clinical use. Although, the endoscopic surgery has been known as a
minimally invasive technique, it also carries a risk of complications. The incidence of compli‐
cation has the different degrees of possibility depending on the surgical pathologies and
procedures. The death and neurological deficits (transient or permanent) are the definite
sequelae of the major complications from the endoscopic skull base surgery that includes the
cerebrospinal fluid (CSF) leak, the intracranial infection and the neurovascular injury. The
following rhinological symptoms have been considered as the minor complications as they
don’t cause severe morbidities for the patients: the nasal obstruction, the change of smell and
sinusitis.
2. Patient selection
Not all the diseases could manage with endonasal technique. If the disease involves subcuta‐
neous of skin or skin itself, the external approach should be more proper. If the tumor extends
lateral to the center of the orbit, the orbit itself will be in the axis of the surgical corridor and
block the working space. However, the patient selection depends on surgeon’s experience.
3. Instrument
Author recommends using a high-definition camera, 4-mm telescopes in various angles (0, 30,
45, 70 degree), a powered instrument (microdebrider, ultrasonic aspirator, drill), hemostatic
materials and devices and material for skull base reconstruction. The image-guided surgery
system is highly recommended.
4. Surgical approaches
Surgical approaches for endonasal skull base can be classified into two groups based on
anatomical view: sagittal plane (Figure 1) and coronal plane (Table 1).
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Table 1. Surgical approaches
Figure 1. Endonasal approaches to the skull base in sagittal view. a) Transfrontal b) Transcribiform c) Transplanum d)
Transsellar e) Transclival f) Transodontoid
4.1. Sagittal view
4.1.1. Transfrontal approach
This approach can be used in chronic frontal sinusitis, frontal fibro-osseous lesion and frontal
sinus mucocele. This area can be reached by Draf III procedure or modified Lothrop which
has to remove posterior part of nasal septum, remove the bone anterior to frontal sinus and
connect both frontal sinus together by removing interfrontal sinus septum (Figures 3 and 4).
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4.1.1. Transfrontal approach
This approach can be used in chronic frontal sinusitis, frontal fibro-osseous lesion and frontal
sinus mucocele. This area can be reached by Draf III procedure or modified Lothrop which
has to remove posterior part of nasal septum, remove the bone anterior to frontal sinus and
connect both frontal sinus together by removing interfrontal sinus septum (Figures 3 and 4).
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Figure 2. Sagittal view of CT scan shows osteoma in frontal sinus.
Figure 3. Endonasal view of both frontal sinus after Draf III procedure; F, frontal sinus; MT, middle turbinate.
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Figure 4. Endonasal view of both frontal sinus after Draf III procedure; F, frontal sinus; MT, middle turbinate.
4.1.2. Transcribiform approach
This approach is commonly utilized for olfactory area tumor such as olfactory neuroblastoma
(esthesioneuroblastoma) and olfactory groove meningioma. This approach starts with
complete sphenoethmoidectomy and Draf IIa/b or Draf III. The nasal septum removal should
start from the crista galli to the sphenoid sinus.The anterior ethmoidal artery and posterior
ethmoidal artery should be cauterized and transected to prevent bleeding and decrease the
blood supply to the tumor. Cribiform plate should be thinned with diamond burr prior to its
removal by bone rongeur so that the dura is clearly seen. The required area of bone exposure
usually depends on oncological margin. The maximal bone removal at the cribiform plate can
be from posterior wall of frontal sinus to planum sphenoidale in sagittal view and from medial
wall of orbit to the other one in coronal view. The crista galli is thinned and removed from
from its dural attachment, the falx cerebri. After dural opening, similar microsurgical techni‐
que for tumor dissection is employed by two-hand method.
4.1.3. Transplanum approach
Neoplasms at suprasellar area, such as tuberculum meningioma (Figure 9) or craniopharyng‐
ioma, typically require this particular approach. Bone removal at the posterior nasal septum
and bilateral sphenoidotomy must be done as well as identification of optic nerves and optico-
carotid recesses on both sides. Using similar steps as previously mentioned, the bone of skull
base should be thinned and removed (Figures 10, 11). After dural opening, awareness of and
early identification of critical structures, i.e., optic nerves and chiasm, internal carotid and
anterior cerebral arteries and pituitary gland and its stalk (Figures 12, 13, 14), are critically
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early identification of critical structures, i.e., optic nerves and chiasm, internal carotid and
anterior cerebral arteries and pituitary gland and its stalk (Figures 12, 13, 14), are critically
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Figure 5. CT of an olfactory neuroblastoma. The tumor fully occupies the sino-nasal cavity and destroys the cribiform
plate with intracranial extension.
Figure 6. Left endonasal view, after endoscopic sinus surgery. The anterior ethmoidal artery was pulled with sinus
seeker. F: frontal sinus O: orbit AEA: anterior ethmoidal artery PEA posterior ethmoidal artery
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important. Bi-manual technique, using similar microsurgical dissection, should be delicately
performed. In some craniopharyngiomas, entry to the third ventricle is necessary for further
tumor resection (Figures 15, 16).
Figure 7. Endoscopic view of Draft III procedure and removal of nasal septum. The crista galli (C) in midline and first
branch of olfactory nerve lateral to crista galli both sides are shown. F: frontal sinus C: crista galli Ol: first branch of
olfactory nerve O: orbit
Figure 8. Endoscopic view after removing cribiform plate and dural opening demonstrates frontal lobe and orbit on
both sides. O: orbit Fr: frontal lobe
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Figure 9. Sagittal MRI shows planum meningioma with compression of optic apparatus. The anterior cerebral artery
complex is superior to the tumor.
Figure 10. Endonasal view of planum sphenoidale and sella. P: planum sphenoidale (bony area within dashed line
needs to be removed) O: optic nerve OCR: optico-carotid recess S: sellar C: clivus
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Figure 11. Endoscopic view demonstrates incision of the dura after removal of bony part of skull base. O: optic nerve
OCR: optico-carotid recess P: planum sphenoidale S: sellar
Figure 12. Endoscopic view after partial tumor removal illustrates the meningioma(Men), showing optic chiasm(OC)
and anterior cerebral artery(A). Men: meningioma OC: optic chiasm A: anterior cerebral artery (A1 segment)
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Figure 13. Endoscopic view after complete tumor removal depicts optic chiasm and pituitary stalk. OC: optic chiasm
PS: pituitary stalk
Figure 14. Endoscopic view of 30 degree angle lens, after complete tumor removal, shows more superiorly located
structure. OC: optic chiasm A1: left and right anterior cerebral artery (A1 segment) Aco: Anterior communicating ar‐
tery A2: left and right anterior cerebral artery (A2 segment)
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Figure 15. Endoscopic view using 30 degree lens looking upward after removal of craniopharyngioma depictsboth
foramen of Monroe. CP: choroid plexus running from both lateral ventricle into the third ventricle
Figure 16. Endoscopic view using 30 degree lens looking downward after removal of craniopharyngioma reveals pos‐
terior structures. PCA: posterior cerebral artery CNIII: oculomotor nerve MB: mammillary bod
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4.1.4. Transsellar approach
The most common disease for this approach is pituitary adenoma. This is the basic procedure
of skull base that a surgeon should start to practice. After posterior nasal septectomy and
bilateral sphenoidotomy, the sellar will come into the center of view. All the landmarks
structures, e.g., internal carotid artery (ICA), optic nerve, optico-carotid recess, sellar, clivus
and planum sphenoidale, should be identified. Sellar bone can be removed with diamond bur
and manual instrument to expose the dura. The dura needs to be opened by using bipolar
diathermy for hemostasis prior to incision with knife. The pituitary adenoma could be
removed in a variety of techniques depending on the consistency of the tumor. The pituitary
stalk, superior hypophyseal should be taken care for prevention of long-term endocrine
malfunction.
Figure 17. After removal of sellar bone, the sellar dura is exposed. O: optic nerve OCR: optico-carotid recess S: sellar
ICA: internal carotid artery
4.1.5. Transclival approach
The clivus extends from sphenoid floor to foramen magnum. The common disease in this area
includes meningioma and chordoma. This approach provides direct access to anterior surface
of brainstem. The bony part of the clivus has a rich blood supply which surgeon should be
cautious. After bony removal with diamond drill, the dura should carefully be incised because
the 6th cranial nerve could be injured as it runs more superficially laterally. The vertebrobasillar
artery should be carefully dissected and preserved.
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Figure 18. Sagittal MRI shows clivus chordoma pushing on brainstem, patient visit with diplopia from left lateral rec‐
tus muscle palsy.
Figure 19. Endonasal view while drilling clivus. S: sellar C: clivus ICA: internal carotid artery NP: nasopharynx
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Endoscopy - Innovative Uses and Emerging Technologies268
Figure 20. Endoscopic view after removal of bony clivus and incision of dura; meningioma was partially removed and
retracted laterally. CN VI: abducens nerve Men: meningioma BS: brainstem
Figure 21. Endoscopic view after complete removal of tumor depicts the basilar artery lies posterior to arachnoid mem‐
brane, running vertically in front of the brainstem. Ba: basilar artery
4.1.6. Transodontoid approach
This approach allows access to foramen magnum and upper cervical spine (C1 and C2).
Common diseases are pannus formation in rheumatoid arthritis and foramen magnum
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meningioma. This procedure is identical with transclival approach but necessitates further
inferior dissection of nasopharyngeal mucosa and muscular structures. Again, the bone of
anterior C1 and C2 should be thinned with high-speed drill before its removal.
4.2. Coronal view
4.2.1. Orbital approach
This approach use for tumor involve orbit, orbital roof. Start with complete endoscopic sinus
surgery (middle maxillary antrostomy, complete sphenoethmoidectomy, frontal sinusotomy)
and make a wide sinus cavity to ensure the orbital fat after decompression will not occlude to
sinonasal drainage pathway. The lamina papyracea is elevated from periorbita like peeling an
egg shell. The periorbita can be resected with sharp instrument. If the tumor is intraconal, the
surgical corridor should be done between medial and inferior rectus muscle while having
medial rectus retraction externally.
Figure 22. MRI shows tumor in left ethmoid sinus invading the left orbit.
Endoscopy - Innovative Uses and Emerging Technologies270
meningioma. This procedure is identical with transclival approach but necessitates further
inferior dissection of nasopharyngeal mucosa and muscular structures. Again, the bone of
anterior C1 and C2 should be thinned with high-speed drill before its removal.
4.2. Coronal view
4.2.1. Orbital approach
This approach use for tumor involve orbit, orbital roof. Start with complete endoscopic sinus
surgery (middle maxillary antrostomy, complete sphenoethmoidectomy, frontal sinusotomy)
and make a wide sinus cavity to ensure the orbital fat after decompression will not occlude to
sinonasal drainage pathway. The lamina papyracea is elevated from periorbita like peeling an
egg shell. The periorbita can be resected with sharp instrument. If the tumor is intraconal, the
surgical corridor should be done between medial and inferior rectus muscle while having
medial rectus retraction externally.
Figure 22. MRI shows tumor in left ethmoid sinus invading the left orbit.
Endoscopy - Innovative Uses and Emerging Technologies270
Figure 23. Endoscopic view after removal of the tumor, left cribiform plate, lamina papyracea and decompression of
left optic nerve. The medial wall of orbit still bulging from the residual intraconal tumor. O: orbit D: dura ON: optic
nerve S: sphenoid sinus (left)
Figure 24. After incision of the periorbita, eye ball was gently compressed by assistant surgeon; the tumor will show
up into the surgical field. The tumor could be removed by pushing externally and by intranasal dissection.
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Figure 25. After total removal of the tumor, the medial rectus muscle can be clearly seen. The medial rectus muscle is
retracted downward and upward for inspection with angle telescope to confirm that no tumor was left behind. MR:
medial rectus muscle
4.2.2. Transpterygoid approach
This approach is utilized for access to middle cranial fossa. By removing the pterygoid bone,
it can be used as a margin for tumor in sinus area, e.g., nasopharyngeal carcinoma. Other
pathologies require access to the lateral recess of sphenoid such as meningoencephalocele and
dural defect repair. This approach starts with maxillary antrostomy (medial maxillectomy is
necessary if dissection has to be done at the lower level of inferior turbinate) and complete
sphenoethmoidectomy. The sphenopalatine artery, which runs just behind ethmoidal process
of palatine bone, should be cauterized or ligated (Figure 26). High-speed drill is typically
necessary for removing medial and lateral pterygoid plate. The medial and lateral pterygoid
muscles lie beneath the bone plate where there is rich vascular supply; hence, careful hemo‐
stasis should be employed prior to performing deeper dissection (Figure 27).
4.2.3. Infratemporal fossa approach
The location of infratemporal space is lateral to the lateral pterygoid plate. This space contains
fat, internal maxillary artery, CN V2 (infraorbital nerve) and CN V3(mandibular nerve). The
internal maxillary artery should be controlled with vascular clip or electrocautery. Infraorbital
nerve is typically identified at the roof of posterior wall of maxillary sinus. For the mandibular
nerve, it usually runs laterally to the lateral pterygoid muscle.
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Figure 26. Endoscopic view of left nasal cavity after endoscopic sinus surgery and medial maxillectomy showing sphe‐
nopalatine artery running horizontally. MT: middle turbinate SPA: sphenopalatine artery MPT: medial pterygoid plate
P: posterior wall of maxillary sinus
Figure 27. Endoscopic view after sphenopalatine artery is cauterized along with removal of pterygoid plate; the medial
pterygoid and lateral pterygoid muscles can be identified. MPT: medial pterygoid muscle LPT: lateral pterygoid mus‐
cle
5. Reconstruction of skull base with endonasal technique
In the past, craniotomy for CSF leakage and reconstruction of skull base defect commonly
utilized vascularized pericranial or fascial flap harvested from skull. In this new era of
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endoscopy, with external scar and need for some brain retraction, craniotomy for CSF leak
repair has been preserved for those who failed endonasal endoscopic surgery. Upon access
from skull base, similar to approaches with violation of dura and arachnoid membranes, CSF
leak is one of the most common complications reported by many endoscopic series. However,
few studies found that the incidence of CSF leakage from conventional surgery was not less
frequent than endoscopic method. Among endoscopic procedures, the probability for CSF
leakage is usually higher for the extrasellar lesions than limited pituitary-sellar surgery. The
postresection communication between intracranial and nasal cavity must be thoroughly
repaired to prevent any possibility of intracranial infection. For small defects, repair is
accomplished independently of techniques for reconstruction.[15, 16] Conversely, larger
defects, particularly for the high flow CSF leak, need a vascularized mucosal flap reconstruc‐
tion in addition to a multilayer closure (Figure 28). It has been proven to yield better outcome
with the incidence of CSF leakage < 5%.[17, 21] The advent of new technique for the intranasally
harvested vascularized mucosal flap has been popularized. It has become well-known as the
Hadad-Bassagasteguy flap (HBF).[22] The flap was developed from the mucoperiosteum and
mucoperichondrium of the nasal septum that is supplied by the nasoseptal artery (Figures
29, 30, 31, 32, 33, 34). This reconstruction technique has improved the outcome of endonasal
endoscopy for the skull base. Although the endoscopic skull base surgery via the endonasal
corridor has the potential contamination from the sinonasal tract, the incidence of intracranial
infections is still relatively low. The common intracranial infections are meningitis and
intracranial abscess that have been reported in various incidences among the endoscopic series
from less than 1% up to 10%,[23, 27] while the traditional approaches had the higher incidences
from 15–30%.[28, 29] The intracranial infections were associated with the intradural resection,
and some studies stated that they were related to the refractory postoperative CSF leak.
Perioperative antibiotic prophylaxis is recommended to prevent the intracranial infections.
Figure 28. Endoscopic view of cribiform defect in pediatric patient after resection of fibro-osseous lesion.
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Figure 29. Endoscopic view of the same patient in Figure 28. The defect was reconstructed with multiple layers (fat
graft and two layers of fascia lata).
Figure 30. Endoscopic view, inferior incision for creation of nasoseptal flap is illustrated. This inferior incision typically
starts at the roof of nasopharynx then advances anteriorly to mucocutaneous junction of nasal septum. Superior inci‐
sion (not pictured) ideally starts at inferior level of sphenoid natural ostium and moves anteriorly to mucocutaneous
junction of nasal septum.
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Figure 31. Endoscopic view of same patient in Figure 30. The superior and inferior incision will be connected by a ver‐
tical incision at mucocutaneous junction. Submucoperichondrium dissection should proceed from anterior to posterior
toward its pedicle at the nasopharynx.
Figure 32. Endoscopic view of same patient in Figure 30. After elevation of nasoseptal flap, the pedicle is protected at
posterior to preserve arterial supply by septal branch of sphenopalatine artery. NSF: nasoseptal flap SC: septal carti‐
lage SO: sphenoid ostium
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Figure 33. Endoscopic view of same patient in Figure 30 demonstrates the large skull base defect at sellar and planum
after craniopharyngioma removal.
Figure 34. Endoscopic view of same patient in Figure 30. The nasoseptal flap was placed over the defect area after in‐
lay placement of fat.
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6. Surgical complications and morbidities
As mentioned earlier, although endoscopic skull base surgery creates direct communication
between intracranial and nasal compartment, the incidence of intracranial infections is
relatively low. Reports of the postoperative incidence of intracranial infection varied from less
than 1% up to 10%.[23, 27]
Vascular injury during endoscopic procedures can be catastrophic, in particular when it
involves the ICA. The ventral perspective of ICA that is perceived via endoscopic view is less
familiar to surgeons than transcranial procedures. Higher rate of the ICA injury was more
commonly associated with paramedian coronal plane dissection. Complete understanding of
the ICA pathway and its surgical landmarks together with advanced intraoperative image-
guided technology can minimize this feared intraoperative vascular complication. Fortunate‐
ly, major ICA injury is uncommon with overall incidence of 0.9%. Experienced surgeons with
multidisciplinary team approach as well as efficient instruments must be prepared to promptly
deal with this critical event.[27] Though the ideal concept for management of an injured artery
is to maintain lumen patency of the vessel, it is, unfortunately, extremely difficult to achieve
in real situation. Direct repair with suture is close to impossible given the narrow corridor in
light of profuse hemorrhage. Although several hemostatic agents or patches have varying
success in damage control, at least temporarily, from our experience, crushed muscle has been
the best. When all attempts fail, nasal packing is performed. Subsequently, angiographic study
of the ICA is necessary. In some, balloon occlusion test is advocated in the preoperative plan
in selected patients who carry high risk of vascular complications. Previous surgery or
irradiation as well as tumor encasing ICA have been found to be factors predicting arterial
injury.
Intraoperative neural injury from endoscopic series has been reported, with lower incidence
than the traditional techniques. In addition, its majority was transient. The most commonly
injured nerve was the CN VI. This could be related to its poor tolerance for manipulation.[27]
Electromyographic cranial nerve monitoring during the surgery can signal surgeons of
proximity to cranial nerves while dissecting a lesion. Dissection beyond the lateral limit of
given cranial nerves is principally contraindicated for the endoscopic approach. Therefore,
combined approaches from traditional craniotomy may occasionally be required for an
extensive pathology.
The lower rate of overall complications from endonasal endoscopic approach seems more
encouraging than the traditional techniques. Nevertheless, specialized training to gain
experiences in this complex anatomical area along with advanced technological equipment is
essential to surgeons to overcome obstacles in the course of his/her learning curve. With
increased experience after several cases, the incidences of complication should typically
approach acceptable reported incidence.
Over the past few decades, many authors have reported the feasibility and safety in the clinical
uses of pure endoscopy in treatment of skull base pathologies. Understandably, with shorter
follow-up time, endoscopic endonasal surgery cannot perfectly prove its efficacy, namely the
long-term oncological control and functional outcome that has been its common target for
criticism.
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The general principle to achieve the oncological control is the complete resection of the tumor.
The malignant pathologies, the surgical margins need to be extended. Via endoscopic ap‐
proach, the en bloc tumor removal at the invasion site has been considered more fundamental
than the en bloc resection of the entire tumor. The intraoperative frozen section is a tool to
confirm the surgical margin after the en bloc resection at the tumor invasion site. The tumors
arising in the sinonasal cavities usually have some parts situated in the air-filled space. The
floating tumors in the cavities can be debulked in order to allow the surgeons comfortably
insert the surgical instruments through the limited space and gain access to manage the tumors.
At present, there is limited data to evaluate the oncological recurrence and disease-free
survival rate. Many authors reported a small number of patients in the series of endonasal
endoscopic surgery for skull base lesions for whom the oncological outcomes were favorable
and comparable to the open techniques with lesser morbidities.[30, 33]
Although most of the surgeons have been experienced with the excellent functional outcomes
and quality of life of the patients who underwent the endonasal endoscopic surgery, the
published data has been limited. The obviously favorable outcomes include faster recovery
without external scar and that the patients can regain normal or near-normal functions. The
endonasal endoscopic skull base surgery has many steps of operation that can affect the
patient’s life in different ways. The further subanalysis of quality of life in each aspect of the
procedure can lead to development of the completed data in the endoscopic surgical field.
7. Conclusion
Endoscopic endonasal surgery is challenging and dynamic. Coupling between the adjustments
of the endoscopic lens position to acquire optimal view and the movement of instruments to
provide the surgical freedom in the limited space requires tremendous experience and
teamwork. It delivers enormous advantages for the various skull base pathologies which
surgical corridor provides the most direct access to the ventral cranial base area. Proper
selection of patients for endoscopic approach is crucial to achieve good outcome while
avoiding untoward events. Comprehensive knowledge in complex skull base anatomy,
training in advanced and high-volume institutes, advanced surgical technologies and strong
teamwork are the keystones to gain the most benefit from this surgical method.
Author details
Boonsam Roongpuvapaht1*, Kangsadarn Tanjararak1 and Ake Hansasuta2
*Address all correspondence to: boonsamr@yahoo.com
1 Department of Otolaryngology Head and Neck Surgery, Ramathibodi Hospital, Faculty of
Medicine, Mahidol University, Thailand
Endoscopy for Skull Base Surgery
http://dx.doi.org/10.5772/60556
279
2 Division of Neurosurgery, Department of Surgery, Ramathibodi Hospital, Faculty of Med‐
icine, Mahidol University, Thailand
References
[1] Messerklinger W: Diagnosis and endoscopic surgery of the nose and its adjoining
structures. Acta Otorhinolaryngol Belg 1980;34:170–176.
[2] Wigand ME: Transnasal ethmoidectomy under endoscopical control. Rhinology
1981;19:7–15.
[3] Kennedy DW: Functional endoscopic sinus surgery: technique. Arch Otolaryngol
1985;111:643–649.
[4] Stammberger H: Endoscopic endonasal surgery – concepts in treatment of recurring
rhinosinusitis. I. Anatomic and pathophysiologic considerations. Otolaryngol Head
Neck Surg 1986;94:143–147.
[5] Stammberger H: Endoscopic endonasal surgery – concepts in treatment of recurring
rhinosinusitis. II. Surgical technique. Otolaryngol Head Neck Surg 1986;94:147– 156.
[6] Stammberger H, Posawetz W: Functional endo- scopic sinus surgery: concept, indica‐
tions and results of the Messerklinger technique. Eur Arch Otorhinolaryngol
1990;247:63–76.
[7] Duffner F, Freudenstein D, Wacker A, Straub Duffner S, Grote EH: 75 years after
Dandy, Fay and Mixter – looking back on the history of neuroendoscopy. Zentralbl
Neurochir 1998;59:121–128.
[8] Harris LW: Endoscopic techniques in neurosurgery. Microsurgery 1994;15:541–546.
[9] Carrau RL, Jho HD, Ko Y: Transnasal-transsphenoidal endoscopic surgery of the pi‐
tuitary gland. Laryngoscope 1996;106:914–918.
[10] Jho HD, Carrau RL: Endoscopy assisted transsphenoidal surgery for pituitary adeno‐
ma: technical note. Acta Neurochir (Wien) 1996;138:1416–1425.
[11] Jho HD, Carrau RL, Ko Y, Daly MA: Endoscopic pituitary surgery: an early experi‐
ence. Surg Neurol 1997;47:213–222; discussion 222–223.
[12] Kassam AB, Snyderman CH, Mintz A, Gardner P, Carrau RL: Expanded endonasal
approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica. Neurosurg Fo‐
cus 2005;19:E3.
[13] Kassam AB, Snyderman CH, Mintz A, Gardner P, Carrau RL: Expanded endonasal
approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum.
Neurosurg Focus 2005;19(1):E4.
Endoscopy - Innovative Uses and Emerging Technologies280
2 Division of Neurosurgery, Department of Surgery, Ramathibodi Hospital, Faculty of Med‐
icine, Mahidol University, Thailand
References
[1] Messerklinger W: Diagnosis and endoscopic surgery of the nose and its adjoining
structures. Acta Otorhinolaryngol Belg 1980;34:170–176.
[2] Wigand ME: Transnasal ethmoidectomy under endoscopical control. Rhinology
1981;19:7–15.
[3] Kennedy DW: Functional endoscopic sinus surgery: technique. Arch Otolaryngol
1985;111:643–649.
[4] Stammberger H: Endoscopic endonasal surgery – concepts in treatment of recurring
rhinosinusitis. I. Anatomic and pathophysiologic considerations. Otolaryngol Head
Neck Surg 1986;94:143–147.
[5] Stammberger H: Endoscopic endonasal surgery – concepts in treatment of recurring
rhinosinusitis. II. Surgical technique. Otolaryngol Head Neck Surg 1986;94:147– 156.
[6] Stammberger H, Posawetz W: Functional endo- scopic sinus surgery: concept, indica‐
tions and results of the Messerklinger technique. Eur Arch Otorhinolaryngol
1990;247:63–76.
[7] Duffner F, Freudenstein D, Wacker A, Straub Duffner S, Grote EH: 75 years after
Dandy, Fay and Mixter – looking back on the history of neuroendoscopy. Zentralbl
Neurochir 1998;59:121–128.
[8] Harris LW: Endoscopic techniques in neurosurgery. Microsurgery 1994;15:541–546.
[9] Carrau RL, Jho HD, Ko Y: Transnasal-transsphenoidal endoscopic surgery of the pi‐
tuitary gland. Laryngoscope 1996;106:914–918.
[10] Jho HD, Carrau RL: Endoscopy assisted transsphenoidal surgery for pituitary adeno‐
ma: technical note. Acta Neurochir (Wien) 1996;138:1416–1425.
[11] Jho HD, Carrau RL, Ko Y, Daly MA: Endoscopic pituitary surgery: an early experi‐
ence. Surg Neurol 1997;47:213–222; discussion 222–223.
[12] Kassam AB, Snyderman CH, Mintz A, Gardner P, Carrau RL: Expanded endonasal
approach: the rostrocaudal axis. Part I. Crista galli to the sella turcica. Neurosurg Fo‐
cus 2005;19:E3.
[13] Kassam AB, Snyderman CH, Mintz A, Gardner P, Carrau RL: Expanded endonasal
approach: the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum.
Neurosurg Focus 2005;19(1):E4.
Endoscopy - Innovative Uses and Emerging Technologies280
[14] Kassam AB, Gardner P, Snyderman CH, Mintz A, Carrau RL: Expanded endonasal
[15] approach: fully endoscopic, completely transnasal approach to the middle third of
[16] the clivus, petrous bone, middle cranial fossa, and infratenporal fossa. Neurosurg Fo‐
cus 2005;19(1):E6.
[17] Hegazy HM, Carrau RL, Snyderman CH, Kassam AB, Zweig J: Transnasal endoscop‐
ic repair of
[18] cerebrospinal fluid rhinorrhea: a meta-analysis. Laryngoscope 2000;110(7): 1166–
1172.
[19] Senior BA, Jafri K, Benninger M: Safety and efficacy of endoscopic repair of CSF
leaks and encephaloceles: a survey of the members of the American Rhinologic Soci‐
ety. Am J Rhinol 2001;15(1):21–25.
[20] Kassam AB, Thomas A, Carrau RL, Snyderman CH, Vescan A, Prevedello D, et al.:
Endoscopic reconstruction of the cranial base using a pedicled nasoseptal flap. Neu‐
rosurgery 2008; 63(1 suppl 1):ONS44–ONS53.
[21] Zanation AM, Carrau RL, Snyderman CH, Germanwala AV, Gardner PA, Prevedello
DM, et al.: Nasoseptal flap reconstruction of high flow intraoperative cerebral spinal
fluid leaks during endoscopic skull base surgery. American Journal of Rhinology &
Allergy 2009;23(5):518–521.
[22] Shah RN, Surowitz JB, Patel MR, Huang BY, Snyderman CH, Carrau RL, et al.: Endo‐
scopic pedicled nasoseptal flap reconstruction for paediatric skull base defects. Lar‐
yngoscope 2009;119(6):1067–1075.
[23] El Sayed IH, Roediger FC, Goldberg AN, Parsa AT, McDermott MW: Endoscopic re‐
construction of skull base defects with the nasal septal flap. Skull Base: An Interdisci‐
plinary Approach 2008;18(6):385–394.
[24] Harvey RJ, Nogueira JF, Schlosser RJ, Patel SJ, Vellutini E, Stamm AC: Closure of
large skull base defects after endoscopic transnasal craniotomy. Clinical article. Jour‐
nal of Neurosurgery 2009;111(2):371–379.
[25] Hadad G, Bassagasteguy L, Carrau RL, Mataza JC, Kassam A, Snyderman CH, et al.:
A novel reconstructive technique after endoscopic expanded endonasal approaches:
vascular pedicle nasoseptal flap. Laryngoscope 2006;116:1882–1886.
[26] Cappabianca P, Cavallo LM, Colao A, De Divitiis E: Surgical complications associat‐
ed with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.
J Neuro- surg 2002; 97:293–298.
[27] Dehdashti AR, Ganna A, Karabatsou K, Gentili F: Pure endoscopic endonasal ap‐
proach for pituitary adenomas: early surgical results in 200 patients and comparison
with previous microsurgical series. Neurosurgery 2008; 62:1006–1017.
Endoscopy for Skull Base Surgery
http://dx.doi.org/10.5772/60556
281
[28] Frank G, Pasquini E, Doglietto F, Mazzatenta D, Sciarretta V, Farneti G, et al.: The
endoscopic extended transsphenoidal approach for craniopharyngiomas. Neurosur‐
gery 2006; 59 (1 Suppl 1):ONS75–ONS83.
[29] Frank G, Sciarretta V, Calbucci F, Farneti G, Mazzatenta D, Pasquini E: The endo‐
scopic transnasal transsphenoidal approach for the treatment of cranial base chordo‐
mas and chondrosarcomas. Neurosurgery 2006; 59 (1 Suppl 1): ONS50–ONS57.
[30] Kassam AB, Preveldello DM, Carrau RL, et al.: Endoscopic endonasal skull base sur‐
gery: analysis of complications in the authors’ initial 800 patients. J Neurosurg
[31] 2011;114:1544–1568.
[32] Sen C, Triana A: Cranial chordomas: results of radical excision. Neurosurg Focus
2001;10(3):E3.
[33] Feiz-ErfanI, Han PP, Spetzler RF, Horn EM, Klopfenstein JD, Porter RW, et al.: The
radical transbasal approach for resection of anterior and midline skull base lesions. J
Neurosurg 2005;103:485–490.
[34] Stammberger H, Anderhuber W, Walch C, et al.: Possibilities and limitations of endo‐
scopic management of nasal and paranasal sinus malignancies. Acta Otorhinolaryng‐
ol Belg 1999;53:199– 205.
[35] Casiano RR, Numa WA, Falquez AM: Endoscopic resection of esthesioneuroblasto‐
ma. Am J Rhinol 2001;15:271.
[36] Castelnuovo PG, Delu G, Sberze F, et al.: Esthesioneuroblastoma: Endonasal endo‐
scopic treatment. Skull Base 2006;16:25–230.
[37] Snyderman CH, Carrau RL, Kassam AB, et al.: Endoscopic skull base surgery: princi‐
ples of endonasal oncological surgery. Journal of Surgical Oncology 2008;97:658–664.
Endoscopy - Innovative Uses and Emerging Technologies282
[28] Frank G, Pasquini E, Doglietto F, Mazzatenta D, Sciarretta V, Farneti G, et al.: The
endoscopic extended transsphenoidal approach for craniopharyngiomas. Neurosur‐
gery 2006; 59 (1 Suppl 1):ONS75–ONS83.
[29] Frank G, Sciarretta V, Calbucci F, Farneti G, Mazzatenta D, Pasquini E: The endo‐
scopic transnasal transsphenoidal approach for the treatment of cranial base chordo‐
mas and chondrosarcomas. Neurosurgery 2006; 59 (1 Suppl 1): ONS50–ONS57.
[30] Kassam AB, Preveldello DM, Carrau RL, et al.: Endoscopic endonasal skull base sur‐
gery: analysis of complications in the authors’ initial 800 patients. J Neurosurg
[31] 2011;114:1544–1568.
[32] Sen C, Triana A: Cranial chordomas: results of radical excision. Neurosurg Focus
2001;10(3):E3.
[33] Feiz-ErfanI, Han PP, Spetzler RF, Horn EM, Klopfenstein JD, Porter RW, et al.: The
radical transbasal approach for resection of anterior and midline skull base lesions. J
Neurosurg 2005;103:485–490.
[34] Stammberger H, Anderhuber W, Walch C, et al.: Possibilities and limitations of endo‐
scopic management of nasal and paranasal sinus malignancies. Acta Otorhinolaryng‐
ol Belg 1999;53:199– 205.
[35] Casiano RR, Numa WA, Falquez AM: Endoscopic resection of esthesioneuroblasto‐
ma. Am J Rhinol 2001;15:271.
[36] Castelnuovo PG, Delu G, Sberze F, et al.: Esthesioneuroblastoma: Endonasal endo‐
scopic treatment. Skull Base 2006;16:25–230.
[37] Snyderman CH, Carrau RL, Kassam AB, et al.: Endoscopic skull base surgery: princi‐
ples of endonasal oncological surgery. Journal of Surgical Oncology 2008;97:658–664.
Endoscopy - Innovative Uses and Emerging Technologies282
Chapter 13
Endoscopic Skull Base Surgery in the Pediatric Patient
Patrick C. Walz, Charles A. Elmaraghy and
Kris R. Jatana
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/60555
Abstract
Pathology along the anterior and posterior skull base has long posed challenges to
surgeons due to the difficulty accessing these locations and complexity of the
surrounding neurovascular anatomy. Initial surgical management of these disorders
included open craniofacial approaches and/or craniotomy and these approaches are
still utilized today for selected cases. However, advances in the later half of the 20th
century in optics, endoscope design, and high definition digital images allowed the
development of microscopic and, more recently, endoscopic approaches to the skull
base. This technology was initially developed and used in adults, but has been
adapted over time for use in the pediatric patient. In this chapter, the salient points
regarding pediatric endoscopic skull base surgery will be reviewed to provide the
reader a framework for understanding the indications, pertinent anatomy, preoper‐
ative evaluation, and intraoperative management of skull base pathology, highlight‐
ing challenges and circumstances unique to the pediatric population.
Keywords: skull base, pediatric surgery
1. Introduction
Pathology along the anterior and posterior skull base has long posed challenges to surgeons
due to the difficulty of accessing these locations and the complexity of the surrounding
neurovascular anatomy. Initial surgical management of these disorders included open
craniofacial approaches and/or craniotomy, and these approaches are still utilized today for
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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select cases. However, advances in the later half of the 20th century in optics, endoscope design,
and high-definition digital images allowed the development of microscopic and, more
recently, endoscopic approaches to the skull base. This technology was initially developed and
used in adults, but has been adapted over time for use in the pediatric patient. In this chapter,
the salient points regarding pediatric endoscopic skull base surgery will be reviewed to
provide the reader a framework for understanding the indications, pertinent anatomy,
preoperative evaluation, and intraoperative management of skull base pathology, highlighting
the challenges and circumstances unique to the pediatric population.
2. History of endoscopic skull base surgery
Transnasal access to the skull base was introduced over a century ago by Schloffer, and Hirsch
and Cushing respectively popularized the sublabial and transnasal approaches [1–3]. After
Cushing’s initial experience with transsphenoidal pituitary surgery, he turned to the subfron‐
tal intracranial approaches [2]. The intracranial approaches remained popular until the
introduction of the operating microscope in the 1960s allowed for the refinement of the
transseptal transsphenoidal approach [4]. While modest efforts were made in addressing the
anterior skull base and clival pathology endonasally with the microscope, it was not until the
advent of the endoscope that the field expanded its scope to address pathology outside the
sella, extending from the crista galli to the foramen magnum [4, 5]. In the 1990s endoscopic
endonasal approaches to address pituitary lesions and cerebrospinal fluid leaks were pro‐
posed, which led to the gradual expansion of the field [6–11]. In 2005, the Center for Cranial
Base Surgery at the University of Pittsburgh published several landmark papers highlighting
the expanded endonasal endoscopic approaches to the skull base [4, 5, 12] and the use of these
techniques has expanded steadily since the early 2000s. One key point emphasized by the
Pittsburgh collaborative was the idea of “team surgery” in which the neurosurgeon and
otolaryngologist—head and neck surgeon work simultaneously throughout all phases of the
procedure [4]. With this binostril, four-handed approach, the surgeons can both visualize and
manipulate the full extent of the midline skull base. In the last decade, the extent of the
expanded endonasal approaches have continued to grow, pushing the limits of endonasal
access anteriorly, laterally, superiorly, and posteriorly.
3. Applications to pediatric patients
The use of expanded endonasal endoscopic approaches in pediatric populations also devel‐
oped as the field expanded. The application of open skull base approaches in the pediatric
patient was described following its use in adults [13, 14]. The earliest case reports focusing on
the use of endoscopic skull base surgery in children were published in the late 1990s [10, 11,
15] and steadily increased in the following decades. Though the techniques of endoscopic skull
base surgery were carried on to the pediatric population, there has been limited publication
on the topic compared to adult literature. There are several case reports outlining the use of
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endoscopic techniques in the management of congenital meningoencephaloceles [16-19],
benign tumors [20, 21], and bony lesions [22]. As juvenile nasopharyngeal angiofibroma (JNA)
is exclusive to the adolescent age group, endoscopic management of this lesion is more widely
described [15, 23-28]. There have also been several case series highlighting the application of
endoscopic skull base surgery in the pediatric patient [29-31]. In Kassam et al.’s 2007 review,
access to the entire skull base via a fully endoscopic approach demonstrated multiple advan‐
tages of over the previously utilized open approaches for these lesions. Key advantages
discussed included minimal disruption of growth centers, lack of brain retraction with
associated morbidity, and improved pituitary stalk visualization and potential preservation
of the pituitary function [30].
4. Key differences between pediatric and adult skull base surgery
Though the general principles of endoscopic skull base surgery remain the same for both adults
and pediatric patients, some critically important differences must be carefully considered in
the pediatric patient preoperatively. These differences center around the development and
aeration of the paranasal sinuses, size constraints encountered in the pediatric nose, and
concern regarding skull base growth centers. A more complete review of developmental
anatomy as it relates to endoscopic skull base surgery is described later in this chapter.
Regarding size constraints, it is generally accepted that the nasal aperture is of sufficient size
at the age of 6–7 years to accommodate a binostril endoscopic skull base approach [32]. Prior
to this age, the interpyriform distance can preclude the introduction of endoscopes and
instruments together and must be addressed on a case-by-case basis. Even with adequate nasal
access, the intercavernous carotid distance may preclude adequate access in pediatric patients
[32, 33] and must be evaluated preoperatively, especially if sellar or suprasellar access is the
goal of the procedure. Lastly, the pediatric skull base is a dynamic structure and continues to
expand and remodel until it reaches adult configuration following puberty. Careful attention
must be paid to minimize disruptions to skull base growth centers in the prepubertal patient
to abate growth disruptions [33, 34].
5. Developmental anatomy review
5.1. Sinonasal
First noted in the fourth week of development, the nasal capsule’s lateral walls enlarge and
fold by the ninth week, forming six ethmoturbinals, all derived from ectoderm from the
frontonasal process. The first ethmoturbinal becomes the uncinate process while the second
develops into the ethmoid bulla. The developmental end point of the third ethmoturbinal is
the ground lamella of the middle turbinate and the fourth ethmoturbinal becomes the superior
turbinate. The fifth and sixth ethmoturbinals may regress or fuse to become a supreme
turbinate.
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The four paired paranasal sinuses each have a distinct developmental trajectory. The maxillary
sinuses project from the ethmoid infundibulum between the first and second ethmoturbinals
and are first noted at week 9 of development. Present at birth, the maxillary sinus expands
most significantly between ages 0–3 and 6–12, reaching adult size at approximately age 18. The
ethmoid sinuses are also present at birth and continue to mature in an anterior to posterior
fashion in the first 12 years of life. The frontal sinus is last to begin development in the fourth
month of gestation as a superior evagination of the frontal recess. However, the frontal sinus
is not distinguishable radiographically until approximately the third year of life and does not
reach the frontal bone until age 5. The frontal sinus reaches adult size toward the end of puberty
and can continue to aerate the frontal bone throughout adult life [35–37]. The sphenoid sinus
is of primary importance in the endoscopic skull base surgery. It is first noted in the fourth
week of gestation as an evagination from the sphenoethmoid recess and slowly aerates over
the first 10–15 years of life. Aeration begins in the inferior and anterior aspect of the sinus and
extends posteriorly and superiorly such that the dorsum sellae is last to aerate. At age 6–7, the
sphenoid face is typically fully pneumatized and the planum is aerated in the majority of the
patients. By age 10, the clival recess is typically pneumatized but dorsum sellae is infrequently
pneumatized, 16% of the time [32, 33].
5.2. Sella and Skull Base
The  sella  itself  divides  the  anterior  and  posterior  skull  base.  The  skull  base  develops
primarily from cartilaginous precursors, which ossify over the first two decades of life. The
anterior skull base derives from a neural crest cell origin while the clivus and other posterior
skull base structures have paraxial mesodermal origins [32, 35]. The remaining details of
skull  base  development  and  ossification  are  beyond  the  scope  of  this  chapter  and  are
described elsewhere [35].
6. Surgical indications
The indications for surgical intervention at the skull base are fairly limited in terms of broad
categories and include cerebrospinal fluid (CSF) leak, neoplasms, and congenital abnormali‐
ties. While the surgical goal with CSF leak is clear, when addressing neoplasms, the role of
surgery can range from biopsy for diagnosis to surgical debulking to complete resection (clear
margins) and is largely dependent upon the pathology being addressed and the location. In
the setting of malignancies such as rhabdomyosarcoma or other sarcomas, the role of surgery
may vary, and it becomes important to pre-operatively define the goals of the surgical
treatment in these cases.
6.1. Cerebrospinal fluid leak
Whether spontaneous, posttraumatic, or iatrogenic, the presumptive diagnosis of CSF leak is
made when persistent clear rhinorrhea is identified (Figure 1). The confirmation of CSF is made
with a laboratory analysis for β-2 transferrin. Imaging with CT can identify areas of bony
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discontinuity. In cases where the location is difficult to assess, MR or CT myelography can be
performed to help localize the area of CSF egress. The initial approach to CSF leaks often entails
conservative management with lumbar drain placement and medical management to decrease
intracranial pressures with surgery reserved for refractory leaks or high-flow CSF leaks not
likely to resolve with conservative management alone.
Figure 1. CSF leak from multiple skull base fracture: (A) cribriform plate and (B) left sphenoid. This was successfully
repaired using transnasal endoscopic techniques.
6.2. Neoplasms
Neoplasms can vary in both pathology and presentation. A thorough discussion of each tumor
is beyond the scope of this chapter, and tumors have been widely described in the literature.
A brief overview of the various pathologies and their most common locations are shown in
Table 1. Figure 2 demonstrates a rhabdomyosarcoma.
Lesion Category Location
Fibrous dysplasia Benign neoplasm Anterior skull base, perisellar, clivus
Fibro-osseous tumors Benign neoplasm Anterior skull base
Pituitary adenoma Benign neoplasm Sella
Craniopharyngioma Benign neoplasm Sella
Chordoma Benign neoplasm Clivus
Schwannoma Benign neoplasm Clivus, infratemporal fossa









Glomus jugulare Benign neoplasm Clivus
Chondrosarcoma Malignant neoplasm Clivus
Esthesioneuroblastoma Malignant neoplasm Anterior skull base
Meningoencephalocele Congenital abnormality Anterior skull base, perisellar, clivus
Glioma Congenital abnormality Anterior skull base, perisellar, clivus
Nasal dermoid Congenital abnormality Anterior skull base
Cerebrospinal fluid leak Iatrogenic, traumatic, idiopathic Anterior skull base, perisellar, clivus
Table 1. Differential Diagnosis of Pediatric Skull Base Abnormalities
Figure 2. A 3-year-old male with right pterygopalatine fossa rhabdomyosarcoma. (A) Pretreatment and (B)Post-che‐
moradiation therapy. Given some residual enhancing tissue, multiple endoscopic biopsies were performed after treat‐
ment to ensure no residual disease and were consistent with radiation changes.
7. Developmental abnormalities
Disruptions in the normal development of skull base structures may result in meningoence‐
phaloceles (Figure 3), gliomas, and nasal dermoids. These lesions can be characterized by their
location of origin and contents [18, 38–40], but all share a common origin in aberrant ectodermal
differentiation and/or closure of the neural folds [18].
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Figure 3. Newborn child with a large sphenoethmoidal meningoencephalocele. With a skull base defect this large in a
newborn, open repair is the only option. The left image is a sagittal noncontrasted CT scan performed for initial diag‐
nosis. On the right is a T2-weighted sagittal MRI to further characterize this lesion, identifying no neural components
within the sac.
8. Clinical presentation
Clinical presentation varies for each lesion and is dependent upon the lesion’s origin and
compression of the surrounding structures. Pituitary lesions that are hormonally active may
also present with endocrine disturbances [30]. Compression of the optic nerve or tracts may
present with unilateral or bilateral ocular symptoms depending upon the location of the
compression [30]. Sellar lesions extending into the cavernous sinus may compress cranial
nerves 3 or 4 and the ophthalmic branch of 5 or 6. The sixth nerve is the most sensitive to
compression and lateral rectus palsy is often the first presenting symptom of cavernous sinus
involvement. Clival lesions may also compress cranial nerves 9, 10, 11, and rarely 12. Menin‐
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ranial portion of the sac [18]. Osseous lesions such as fibrous dysplasia may present with
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9.1. History and physical examination
A thorough history and physical examination is essential for any patient. Careful attention to
progression and timing of symptoms in the history and to the cranial nerve examination on
physical examination can help to direct the differential diagnosis. Nasal endoscopy can be
helpful in the presence of nasal obstructive symptoms or olfactory disturbances to assess
intranasal involvement and characterize the extent and potential origin of any lesion in
question. A biopsy of any pediatric nasal mass should not be performed prior to imaging, and
if tissue diagnosis is needed, the procedure should be done in the operating room. Figures 4
and 5 demonstrate examination findings as to why imaging is necessary prior to interventions.
In the setting of CSF leak, a thorough history of any traumatic injuries or previous sinonasal
or intracranial procedures is valuable in helping to identify the etiology and potential location
of the CSF leak.
Figure 4. Right nasal endoscopy in an infant with nasal obstruction symptoms, which was found to have a nasophar‐
yngeal/skull base mass, consistent with a meningocele on MRI imaging.
9.2. Labs
Laboratory assessment is pathology-driven. In the presence of a suspected hormonally active
pituitary lesion, a “pituitary panel” may be ordered to assess cortisol response, TSH, prolactin,
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FSH, and LH levels. In the presence of a vascular tumor, preoperative hematologic labs
including blood typing and cross-matching are indicated, as surgical resection can entail
significant blood loss requiring transfusion.
9.3. Imaging
Preoperative imaging is integral to surgical planning in any endoscopic skull base procedure.
Imaging allows the characterization of the extent of the lesion and enables identification of
carotid artery involvement or encasement, intracranial extension, orbital invasion, and
infratemporal fossa extension.
9.3.1. Computed Tomography (CT)
CT provides excellent bony detail and can help to identify stable surgical landmarks for
intraoperative use. While soft tissue resolution is not as clear as with magnetic resonance
imaging (MRI), the overall extent of the lesion can be characterized. While a non-contrast
CT scan is often the first performed test with which a skull base lesion is diagnosed, a scan
for intraoperative surgical  navigation use should be a fine-cut,  axially oriented contrast-
enhanced scan that includes the maxillary alveolus, nasal tip, and extends superiorly far
enough to capture the optic tracts or cranial aspect of the lesion in question, whichever is
more cranial. With these images, coronal and sagittal reconstructions can be created and
the images can be loaded onto a surgical navigation system for intraoperative use. The use
of contrast clearly outlines the carotid arteries in their tortuous course through the clivus
and cavernous sinus.
Figure 5. Right nasal endoscopy demonstrating a sinonasal mass in a 15-year-old male, consistent with JNA.
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Figure 6. (A) Axial CT scan showing JNA, arising from right sphenopalatine foramen. (B) Coronal MRI showing prox‐
imity to sphenoid sinus and extension into nasopharynx and oropharynx.
9.3.2. Magnetic Resonance Imaging (MRI)
MRI utilizes the differential response of hydrogen atoms to magnetic fields to generate images
with higher resolution of the soft tissue characteristics than can be obtained with CT. Whereas
inspissated secretions within a sinus would be indistinguishable from the tumor invasion of
that sinus on a CT scan, these two scenarios are clearly differentiated with a MRI scan. With
the use of multiple image sequences including T1-weighted, T2-weighted, and contrast
enhancement, soft tissue interfaces can be delineated and signal characteristics can narrow the
differential diagnosis of the lesion. MRI images can also be utilized for intraoperative surgical
navigation and should be formatted in a similar fashion to that described for CT. Of note, MRI
requires the patient to remain still for up to 2 hours to obtain multiple sequences without image
distortion from movement. For this reason, pediatric patients often require sedation or general
anesthesia to obtain adequate images. Figure 6 shows a JNA and Figure 7 a meningocele on
MRI.
9.3.3. Angiography and possible embolization
Several circumstances benefit from preoperative angiography and possible endovascular
embolization (Figure 8). First, in the case of juvenile nasopharyngeal angiofibroma, preoper‐
ative embolization 24–48 hours prior to the planned resection enables significant devascula‐
rization of the contribution of the external carotid artery to the lesion, which leads to a
decreased intraoperative blood loss [41, 42], though this finding is seen primarily when the
Endoscopy - Innovative Uses and Emerging Technologies292
Figure 6. (A) Axial CT scan showing JNA, arising from right sphenopalatine foramen. (B) Coronal MRI showing prox‐
imity to sphenoid sinus and extension into nasopharynx and oropharynx.
9.3.2. Magnetic Resonance Imaging (MRI)
MRI utilizes the differential response of hydrogen atoms to magnetic fields to generate images
with higher resolution of the soft tissue characteristics than can be obtained with CT. Whereas
inspissated secretions within a sinus would be indistinguishable from the tumor invasion of
that sinus on a CT scan, these two scenarios are clearly differentiated with a MRI scan. With
the use of multiple image sequences including T1-weighted, T2-weighted, and contrast
enhancement, soft tissue interfaces can be delineated and signal characteristics can narrow the
differential diagnosis of the lesion. MRI images can also be utilized for intraoperative surgical
navigation and should be formatted in a similar fashion to that described for CT. Of note, MRI
requires the patient to remain still for up to 2 hours to obtain multiple sequences without image
distortion from movement. For this reason, pediatric patients often require sedation or general
anesthesia to obtain adequate images. Figure 6 shows a JNA and Figure 7 a meningocele on
MRI.
9.3.3. Angiography and possible embolization
Several circumstances benefit from preoperative angiography and possible endovascular
embolization (Figure 8). First, in the case of juvenile nasopharyngeal angiofibroma, preoper‐
ative embolization 24–48 hours prior to the planned resection enables significant devascula‐
rization of the contribution of the external carotid artery to the lesion, which leads to a
decreased intraoperative blood loss [41, 42], though this finding is seen primarily when the
Endoscopy - Innovative Uses and Emerging Technologies292
JNA is supplied exclusively by the external carotid system. Nevertheless, preoperative
angiography identifying the location of internal carotid feeding vessels can guide dissection
for vascular control [24].
The second situation in which preoperative angiography and possible embolization are
beneficial is in the case of suspected carotid artery encasement. In this situation or similar
situations in which the integrity of the carotid wall is in question, angiography allows for
preoperative characterization of the intracranial blood flow and affords the opportunity to
perform balloon occlusion testing to determine the impact of unilateral carotid sacrifice [43].
As this intervention still carries a 6% risk of cerebrovascular accident [44, 45], the decision for
preoperative occlusion is reserved for situations in which intraoperative carotid injury is
highly likely.
10. Surgical planning
Pediatric skull base surgery is a rapidly developing field involving multiple specialties. The
collaboration between otolaryngology, neurosurgery, neuroradiology (including interven‐
Figure 7. A nasopharyngeal/skull base mass, consistent with a meningocele in an infant who presented with nasal ob‐
struction and feeding difficulties as seen with T2-weighted sagittal MRI scan.
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tional radiology), critical care, pediatrics, nursing, and surgical staff has evolved to allow for
the optimal management of pediatric patients. Technology has driven the advancement of the
management of neoplasms of the nasal cavity and skull base. Endoscopy has become critical
in surgical approaches and its applications to neoplasms of the nasal cavity have been a major
advance in otolaryngology and neurosurgery. Endoscopic approaches are the standard of care
for most sinonasal problems and the instrumentation has been well developed.
10.1. Endoscopes and camera
Currently, rigid endoscopes are the standard for use during a surgical intervention. Although
flexible scopes are used and available, they are typically used for diagnostic purposes. Rigid
endoscopes allow visualization with a wide field of view, as opposed to a microscope. The
Figure 8. Angiography of external carotid artery, showing tumor blush. Blood supply from sphenopalatine artery, a
branch of the internal maxillary artery. This vessel was embolized preoperatively by the interventional radiology team.
Sometimes there can be feeding vessels off branches of the ipsilateral internal carotid artery or contralateral carotid
system so complete assessment is necessary.
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rod-lens rigid scopes are the most commonly used as they provide a high-quality image. They
consist of three parts: shaft, glass fiber bundle, and optics. The endoscopes are available in
various diameters but the goal is to use the largest diameter that can be accommodated. The
most common rigid scopes are 2.7 and 4 mm in diameter. Endoscopes larger than 4 mm become
difficult to use transnasally with other instruments. Although the use of a smaller diameter
endoscope allows for greater degrees of freedom, the amount of light transmitted is decreased,
which can make surgery at the skull base difficult. Several different angles are available with
rigid endoscopes. Standard endoscopes part of a surgical set should include 0°, 30°, 45°, and
70°. The more angled the scope, the more disorienting the image may be. The standard
approach is with the 0° to maintain the image projected as anatomic and changing to angled
endoscopes as necessary. The endoscopes are attached to a light source that should be xenon.
The cable is made of glass fibers, which poorly transmit heat, preventing the endoscope from
causing thermal damage. The endoscopes are also attached to a HD camera that transmits the
images to be projected onto monitors strategically placed in the operating room. The advance‐
ment in image technology has allowed for high resolution necessary to operate around
neurovascular structures.
10.2. Surgical instrumentation
Instruments designed for endoscopic sinus surgery are standard for use in skull base proce‐
dures. The design of the instruments allows for intranasal use with a concurrent endoscope.
The instruments are inserted transnasally and the nostril is used as a fulcrum about which the
endoscope is pivoted. Angled instruments are part of a standard set for anterior skull base and
frontal sinus and are used often with the angled endoscopes. Straight instruments are designed
to be low profile and allow for easy visualization of the tip of the instrument and the endonasal
structures. Instruments including curettes, elevators, scissors, forceps with and without
cutting capability, and drills are each designed specifically for working intranasally. Powered
drills and microdebriders are used often to remove tissue for access and for the resection of
certain lesions. Bipolar forceps are designed with appropriate size and length to work
intranasally in order to achieve hemostasis. Monopolar cautery is to be avoided close to
neurovascular structures but is integral to harvesting of pedicled vascular flaps.
10.3. Use of surgical navigation systems
The use of intraoperative surgical navigation systems has become commonplace in the field
of endoscopic skull base surgery. Often neoplasms obscure normal landmarks, and navigation
systems allow for greater spatial awareness during these dissections. Image-guidance systems
use both optical and magnetic field technology and both have advantages and disadvantages.
Image guidance for skull base is typically based on preoperative high-resolution CT scans but
can be fused with MRI images as well. The information provided by this technology has been
referred to as “image guidance,” but this is a misnomer when utilized appropriately. The use
of surgical tools connected to the navigation system allows additional confirmation of visually
identified landmarks and assists in determining the extent of resection in complex skull base
lesions or anatomy in a field distorted by the disease process or previous surgery [46]. In the
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management of CSF leaks, intraoperative surgical navigation can confirm visually suspected
areas of bony dehiscence. While not a sine qua non in endoscopic skull base surgery, intrao‐
perative surgical navigation is a valuable tool that should be utilized when available. Of utmost
importance in the use of these systems is ensuring accurate registration of the patient and to
periodically confirm accuracy with navigation to known landmarks [46, 47].
11. Operating suite
Endoscopic skull base surgery is often a two-surgeon procedure and the setup of the operating
room must accommodate this arrangement. With two surgeons on either side of the patient
with a surgical technician, a nurse, or an assistant, it is necessary to have the patient in the 180°
position from anesthesia. Communication with the anesthetist for the control of the airway is
necessary as these procedures can take several hours. Establishing and securing the airway,
intravenous vascular access, arterial lines, and monitors are necessary to prevent adjustments
or interruptions of the procedure. The head of the patient can be elevated slightly as well to
facilitate venous drainage. The HD monitors and image guidance system can be integrated in
the operating room and each surgeon and assistant must have a monitor in a direct line of site.
This necessitates a suite designed with multiple monitors linked to a central control center.
The instrument table and assistant should be positioned equidistant from the two surgeons
without physical obstruction to passing of instruments.
12. Surgical approaches
Total endoscopic approach is appropriate for many sinonasal tumors. The neoplasms can be
removed through one or both nostrils depending on the extent. The use of both nostrils requires
a trans-septal approach either by creating a perforation or by resection of the posterior septum.
The choice is dependent on the location of the tumor. The uninostril (through one nostril)
procedure is less destructive to normal structures but can limit the degrees of freedom and the
number of instruments placed in the nose. Binostril approach allows for one surgeon to work
bimanually and another surgeon to control the suction and the endoscope. For extensive
lesions, this is the preferred technique.
The approaches have variations in the trajectory to the skull base and four different endonasal
approaches have been described: transnasal, transethmoid, transsphenoidal, and transptery‐
goidal.
The transnasal approach does not traverse the sinuses but essentially keeps the septum and
the middle turbinate as the boundaries. Lesions of the cribiform plate such as encephaloceles
can be managed in this manner. In addition, clival and odontoid pathology can be addressed
through the choana.
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The transethmoid approach requires a total ethmoidectomy and can expose the skull base from
the frontal to sphenoid sinus. The lamina papyracea is exposed as well. This approach is useful
for encephaloceles or orbital apex lesions.
The transsphenoidal approach requires removal of the anterior face of the sphenoid and often
the sphenoid rostrum and posterior septum. Removal of the middle turbinate can increase the
degrees of freedom and optimize visualization. The transsphenoid approach is used for sellar,
pituitary, upper clival, and cavernous sinus lesions. Figure 9 shows a craniopharyngioma
which was managed in this manner.
The transpterygoidal approach requires a corridor through the maxillary sinus and the
removal of the posterior wall of the sinus. A medial maxillectomy and ligation of the spheno‐
palatine artery are necessary which is often done with JNA resection (Figure 10). This approach
is useful for the infratemporal fossa. Figure 11 required the pterygoid bone to be removed for
access to a rhabdomyosarcoma.
Figure 9. A 13-year-old male who presented with new onset vision loss was found to have a craniopharyngioma on
this sagittal T1-weighted MRI with contrast. An endoscopic, transsphenoid approach was performed for removal.
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Figure 10. A JNA s/p endoscopic resection from pterygopalatine fossa, nasal cavity, sphenoid sinus, and nasopharynx.
Figure 11. Right endoscopic view for approach and biopsy of pterygopalatine fossa mass that was a rhabdomyosarco‐
ma. The pterygoid bone had to be drilled down medially in order to get access. S=septum, NP=nasopharynx, MT=mid‐
dle turbinate, E=ethmoid, Max=maxillary sinus, PPF=pterygopalatine fossa.
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13. Hybrid approaches
Although many lesions can be approached by endoscopic-only approach, certain lesions
necessitate a hybrid approach with the use of open techniques. Lateral lesions of the infra‐
temporal fossa may require a Caldwell-Luc combined with transpterygoid. Lesions that are
far anterior, such as neoplasms at the anterior pyriform aperture or of the frontal sinus, often
require a hybrid approach. Other open approaches such as bicoronal, lateral rhinotomy, or
palatal split (Figure 12) can be used depending on the extent of surgery, and endoscopy can
be a useful adjunct to ensure complete resection. Transcervical endoscopic-assisted surgery of
the skull base can be a useful adjunct to access difficult-to-reach areas as shown in Figure 13.
Endoscopic-assisted trephination of the frontal sinus with a repair of an isolated posterior table
fracture with CSF leak has been described in a pediatric patient. This avoided the need for
bicoronal flap and craniotomy for open repair [48].
Figure 12. (A) Endoscopic-assisted, transpalatal/palatal split approach to skull base in nasopharynx for excision of me‐
ningocele in an infant. The palatal flaps are retracted and a vascularized pharyngeal flap was placed over a cartilage
graft on right side of superior nasopharynx to repair the bony defect in skull base. (B) Multilayer repair of the palate.
14. Staging surgery
The goal of any approach to a neoplasm is ideally total removal of the tumor with minimal
damage to normal structures. The strategy for sinonasal tumors must be defined and the
pathology often dictates the approach. Some tumors such as juvenile nasopharyngeal angio‐
fibroma can be diagnosed by imaging. Other lesions need initial biopsy. Biopsy of the sinonasal
tumors requires adequate imaging to ensure safety of any disruption of the tumor as intra‐
cranial extent or prominent vascularity can make limited biopsies potentially dangerous.
Consultation with the radiologist can be helpful for planning.
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Due to the proximity of neurovascular structures such as the optic nerve and carotid artery,
incomplete resection may be necessary to preserve function or prevent injury. Certain benign
pathologies such as fibrous dysplasia can make this a feasible strategy. In addition, lymphomas
and certain subtypes of rhabomyosarcoma are chemotherapy- and radiation-sensitive, and the
morbidity of complete resection makes this approach prohibitive.
15. Reconstructive options
The endoscopic approach to resection of sinonasal tumors is only feasible because reconstruc‐
tive techniques exist to maintain the separation between the nonsterile nasal cavity and the
sterile intracranial contents. As the extent of tumors and surgical approach varies, so do the
reconstructive techniques. The goal is to create a water- and air-tight closure to prevent CSF
leak and meningitis. Preoperative planning includes reconstruction for the anticipated defect.
Reconstruction may span from no reconstruction with healing by secondary intention to the
use of vascularized grafts. Ideally, the reconstruction should match the tissue resected. If a
large bony defect is encountered, rigid support may be necessary to prevent herniation of
intracranial contents. Bone, cartilage, fascia, mucosa, and fat can be used as autologous free
grafts.
Free tissue grafts can be harvested intranasally. If middle turbinate is resected, the bone and
mucosa can be used for small defects of the skull base. The middle turbinate free graft can be
Figure 13. Endoscopic-assisted, transcervical approach to the left parapharyngeal space and skull base for excision of
recurrent pleomorphic adenoma after initial excision at age 15. The mass was dissected from the skull base with endo‐
scopic visualization and avoidance of mandibulotomy and plating for surgical access.
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filleted open and used as an onlay graft. If a more rigid tissue is necessary, cartilage can be
harvested from the nasal septum and used as an inlay graft to repair skull base defects.
Multilayered grafts that combine various types of tissues are often used. Once the grafts are
placed, fibrin-sealing agents can be placed over the surface of the reconstruction to provide a
watertight closure.
One of the recent advances in skull base reconstruction is the use of the pedicled nasal septal
flap, which is based on the posterior septal artery [49]. This flap is useful for defects with a
concomitant CSF leak. Planning of this flap is important specifically with transsphenoidal
approaches in order not to damage the blood supply to this flap. Other intranasal flaps include
the inferior turbinate flap or middle turbinate flap, both based on branches of sphenopalatine
artery. Scalp flaps include the pericranial flap (supraorbital and supratrochlear arteries),
temporoparietal fascia flap (superficial temporal artery), or temporalis muscle flap (deep
temporal arteries).
All of the skull base reconstructions require some packing to keep contact and ensure adequate
healing. A combination of absorbable and non-absorbable packing can be used. Typically, gel
foam is placed over the reconstruction, and non-absorbable splint or packing is used for
additional reinforcement.
15.1. Use of lumbar drain
In the past, lumbar drains were routinely used for decompression during an endoscopic repair
of a CSF leak. With the advent of reliable vascularized flaps, the need for lumbar drainage has
decreased. It is now thought that low-flow CSF leaks can generally be managed surgically
without the use of the lumbar drain, while in some high-flow leaks it should be considered [50].
16. Postoperative management
After surgical intervention, close monitoring in the hospital setting is recommended for
pediatric patients. Depending on the extent of surgery and need for hemodynamic monitoring,
and frequent neurologic checks, the patient may go to the pediatric ICU setting as opposed to
a traditional floor. When there is any violation of the dura or CSF leak repair is preformed
intraoperatively, there should be close observation for any CSF rhinorrhea. Activity levels
should be determined based on the extent of surgery. Stool softeners can help reduce straining,
as constipation may increase intracranial pressure and a risk of CSF leak. Antibiotic prophy‐
laxis postoperatively is considered in a setting of CSF leak repair [51] or when absorbable
packing is used to reduce the risk of infection.
17. Surgical complications
There are several potential complications from endoscopic skull base surgery. Given the high
vascularity of these operative sites, and even despite “near complete” embolization of a JNA,
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there can be significant blood loss intraoperatively, which requires blood transfusion. In a
pediatric patient, the decision to stage resection is sometimes made to avoid blood transfusion.
A major vascular injury to the cavernous sinus, carotid artery at skull base, or intracranial
hemorrhage can occur. Cerebral vascular accident or strokes can also occur. When the muscles
of mastication are within the surgical field, trismus postoperatively can occur and patients
should begin jaw-stretching exercises at the earliest stages. CSF leak can occur when the dura
is violated, but the key is recognizing it and performing an endoscopic repair. The risk of
meningitis is significantly reduced with prompt and proper repair of a CSF leak. Infections
including sinusitis and meningitis are possible. Endocrinopathy can occur when the pituitary
gland is involved. Altered olfaction can result from either a change in nasal airflow dynamics
or injury to the olfactory bulb or other special sensory fibers within the nasal cavity. Other
cranial nerve injuries, including vision loss or blindness, diplopia, dry eye symptoms, and
facial numbness can also occur.
18. Conclusions
The use of pediatric endoscopic skull base surgery has continued to grow as techniques and
technology pioneered in the adult population have been applied to children. The need for open
surgical approaches has decreased with the advancement of endoscopic techniques that are
now available to address pathologic conditions of the skull base in the pediatric population.
Experienced surgical teams with multidisciplinary support at tertiary care pediatric facilities
can best manage these young patients.
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18. Conclusions
The use of pediatric endoscopic skull base surgery has continued to grow as techniques and
technology pioneered in the adult population have been applied to children. The need for open
surgical approaches has decreased with the advancement of endoscopic techniques that are
now available to address pathologic conditions of the skull base in the pediatric population.
Experienced surgical teams with multidisciplinary support at tertiary care pediatric facilities
can best manage these young patients.
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Abstract
Endoscopic-assisted surgery is becoming a more and more important tool in the
neurosurgical armamentarium. This chapter provides a broad overview of the role
of this technique in various skull base procedures. It starts with a historical perspec‐
tive followed by a thorough exploration of the various principles and techniques for
different indications. Additionally, the topics of “minimally invasive” techniques
using “key hole” approaches are explained. At the end of this chapter, advantages
and pitfalls with endoscopic assisted techniques are discussed.
Keywords: Endoscopic assisted skull base surgery, aneurysm clipping, vestibular
schwannoma, key hole surgery
1. Introduction
The neuroendoscopic technique has its roots in the early 20th century, applied at the beginning
to treat hydrocephalus with cauterization or removal of the choroid plexus [1, 2]. Pure
endonasal endoscopic resection of pituitary tumors became more popular in the 1990s, and
skull base endoscopy has made timid advances since then. Increased development in skull
base endoscopy occurred just before 2005 [3]. The new generation of neuroendoscopes allowed
neurosurgeons to use them in the subarachnoid space and to use their excellent light quality
and optical resolution in the depth during microsurgical procedures [1, 4].
Nowadays the neuroendoscope is used in different intracranial procedures as the main
visualization tool or as an additional device. In modern skull base surgery, it has a significant
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
supplementary value and has been used more and more frequently for different pathologies
and in diverse occasions. Some advantages of the neuroendoscope for the skull base surgery
are as follows:
a. Very good illumination
b. The possibility to demonstrate structures from a different angle (“look around the corner”)
c. Less invasiveness by reduction of approach size and retraction of structures
Different from intraventricular endoscopy, there are no preformed cavities in skull base
surgery, and the need of retraction of structures is not infrequent. Vestibular schwannomas,
cerebellopontine angle meningiomas, trigeminal neuralgia, epidermoid tumors, hemifacial
spasms, and aneurysms are some of the skull base pathologies in which the endoscope can be
helpful giving additional information on the target. The possibility of introduction of the tip
of the endoscope into deep areas and the use of different angle scopes widening the field of
view permit the reduction of surgical trauma during the approach, by reduced retraction of
structures.
The endoscopic-assisted technique is becoming a very powerful method to be added to the
armamentarium of neurosurgical technologies in skull base surgeries. This chapter provides
a broad overview of the role of this technique in a wide spectrum of skull base diseases, starting
with a historical perspective of the evolution of the use of the endoscope in skull base surgery
and followed by the exploration in depth of the principles and techniques of the different
surgical methods. In addition, the topic of “minimally invasive” skull base surgery using
“keyhole” approaches and finally the learning curve and complications associated with the
application of these new techniques is discussed.
2. Evolution of neuroendoscopy
The name endoscope comes from two Greek words — endon that means within and skopein
that means to view [5]. Along the years, this visualization instrument has been used to look
inside every natural opening and cavity in the human body.
At the beginning, the direct visualization inside of the bladder, female genital organs, or the
digestive tract using a speculum was restricted to a few centimeters. The view into deeper
cavities was restricted by the difficulty of illumination and poor visual quality. The son of
Italian immigrants and born in Mainz, Germany, in 1773, physician Philipp Bozzini construct‐
ed at the beginning of the 19th century what may be considered as a rudimental endoscope.
This equipment consisted of a speculum with two chambers — one for the transmission of
light and the other one for the visualization. Bozzini called this instrument “Lichtleiter” what
in German means “light conductor” [2].
After several improvements and developments of this equipment in Germany and Austria,
the serial production of cystoscopes began in the United States at the beginning of the 20th
century. The initial use of this technique in neurosurgery has its roots in the early 20th century.
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The urologist Victor Darwin L’Esspinasse and the neurosurgeon Allen Buckner Kanavel used
for the first time an endoscope to perform the cauterization of the choroid plexus in two
children with hydrocephalus in 1910 [1, 2].
Guiot et al. in Paris documented the first case of a pure transsphenoidal endoscopic resection
of a pituitary tumor in 1962. This surgical technique became more popular, however, in the
mid-1990s. After a short break, increased development of the endoscopy of the skull base could
be observed again at the beginning of the 21st century. These advances were fruit of two
important elements present at this time: technology and creativity [3]. Endoscopes with better
light quality and capable of exceptional image reproduction allowed an excellent exposition
of the deep surgical field in the skull base. New ideas and attempts to solve old problems as
the restricted straight-line view of the microscope were responsible for additional discoveries
in this field [1, 4].
Endoscopic skull base surgery techniques as the minimally invasive approaches, endoscopic-
assisted surgery and full-endoscopic surgery are today in continuous development.
Advances of the neuroendoscopic equipment like the endoscope-integrated near-infrared
indocyanine green video angiography for aneurysm surgery and the continuously variable-
view rigid endoscope with possibility to alternate the view angle without the necessity of
changing the scope just as well contribute to the rapid progress of skull base endoscopy [6-8].
In the same way, the combination with other known methods as robot-assisted neuroendo‐
scopy and neuro-navigated endoscopy propel the progress of this technique.
3. Skull base surgery
Skull base surgery comprises the treatment of several pathologies that are located or have their
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Tumors, aneurysms, and neurovascular conflicts are the most frequent pathologies treated in
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3.1. Goals of skull base surgery
Skull base pathologies may be very complex and the decision of the right treatment is not
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However, in many of these patients, different therapy options or no therapy at all (“wait and
see”) should be considered. So that the best advice may be given to a patient, the physician
must have the knowledge concerning the natural history of the disease and also be up-to-date
about the current and new treatment alternatives [10].
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The goal of every medical treatment is of course the well-being of the patient. To achieve that,
some objectives as tumor complete resection, partial resection, or simply biopsy for eventually
further radio- or chemotherapy should be considered in different situations [11]. The skull base
surgery aim should be very well analyzed in every case and the expectations of the patient
need to be considered for the final decision of the therapy strategy.
The main objective during the surgery of tumors in this region is the complete removal with
preservation of function provoking as little physical and mental pressure as possible to the
person being treated. If total resection is not possible or represents a great risk of impairment
of important functions as in some cases of sphenoid wing meningiomas, large vestibular
schwannomas, or petroclival meningiomas, cytoreductive surgery as preparation for radio‐
therapy should be considered [12, 13]. In certain cases of elderly or, for example, patients with
neurofibromatosis type 2, purely decompression may be the main goal of the operation [12, 14].
In most cases, however, the final goal is to achieve a complete tumor resection, aneurysm
clipping, or neurovascular decompression with total neurovascular function preservation and
minimal patient stress.
4. Clinical features
The clinical presentation of skull base pathologies is very variable, depending on the nature
and location of the underlying cause. Cranial nerve dysfunction, cerebellar symptoms,
hydrocephalus (e.g., in tumors of the posterior cranial fossa obstructing the 4th ventricle), and
thunderclap headache (in patients with subarachnoid hemorrhage after aneurysm rupture)
are some of the possible presentations. Furthermore, a considerable number of patients with
a skull base disease are referred to a neurosurgical department with no complains and an
incidental finding. The actual patient’s complains and results expectations should be consid‐
ered during decision and planning of the most appropriate treatment modality.
5. Diagnosis and neuroimaging
As said before, skull base pathologies are much diversified. The ideal image method should
be elected depending on the current questions for each case.
Magnetic resonance imaging (MRI) is useful in almost every case due to its magnificent ability
to demonstrate soft tissues. The routine T1-, T2-, and T1 with endovenous contrast injection-
weighted images should be obtained in all three planes — axial, coronal, and sagittal — so that
an accurate study of each case can be carried out. The fluid-attenuated inversion recovery
(FLAIR) is a pulse sequence using an inversion recovery technique that nulls fluids. It is very
sensitive to edema and some parenchymal abnormalities and can be used to indirectly
demonstrate lesions that are not evident in other sequences. Diffusion weighted imaging
(DWI) sequences are useful in differentiating epidermoid tumors, that are hyperintense due
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its solid composition), from arachnoid cysts shown hypointense, demonstrating high diffu‐
sivity. Some authors still report about the importance of this sequence during the assessment
of clival tumors, particularly in differentiating chordoma from chondrosarcoma [15]. The
gradient echo sequence provides information about hemoglobin breakdown products and
calcifications [16].
Computed tomography (CT) scan is the image of choice for demonstrating bony structures.
Before surgeries involving the internal auditory canal (IAC) or sella, for example, a thin-layer
CT scan is mandatory. Also during surgery of sphenoid wing meningioma with bone involve‐
ment or when using the supraorbital approach, a CT scan may be valuable. Preoperatively,
the evaluation of several aspects is important:
a. Disposition of the bony labyrinth (vestibule, semicircular canals, and cochlea) before
drilling of the IAC and avoiding injury of these structures
b. Disposition and height of the jugular bulb in relation to the posterior wall of the IAC
c. Extension of the pneumatization of the mastoid cells during suboccipital craniotomy and
opening of the IAC’s posterior wall
d. Location of the emissary vein during suboccipital craniotomy
e. Location of the frontal sinus when using the supraorbital approach
f. Configuration of the sella and sphenoid sinus during surgery of intra-, para-, and
suprasellar lesions
g. Extension of bone infiltration by tumors such as sphenoid wing meningioma and others
Preoperative computed tomography angiography (CT-angiography) is useful in some cases,
demonstrating tumor blood supply and patency of sinuses, veins, and arteries. Tridimensional
representation of aneurysm configuration and its relationship with parent, branching, and
perforating arteries is likewise helpful in selected circumstances when conceiving the surgical
strategy.
Angiography is losing ground to CT-angiography and magnetic resonance angiography but
is still the gold standard image method for aneurysm, arteriovenous malformation, and dural
arteriovenous fistula evaluation before surgery.
Cervical spine x-ray should be performed preoperatively to rule out gross deformities
depending on the patient positioning chosen. If there is necessity of extreme rotation, flexion,
or extension of the head as in the semi-sitting position, for example, a cervical study prior to
surgery may avoid major injuries.
Preoperative planning is a very important “part of the surgery.” Previous and meticulous
study of images to understand the individual anatomy of each patient should be performed.
Planning of surgery should start with choosing the best craniotomy site and the optimal
trajectory to the desired spot. Reachability and view angle using microscope and different
angled endoscopes should be taken into consideration. Recognition of anatomical variations
and the neurovascular relationship is important to achieve the surgical goal with minimal
Skull Base Endoscopic-Assisted Surgery
http://dx.doi.org/10.5772/60588
313
effort and without undesirable surprises. The comprehension of aneurysm configuration or
exact tumor extension when analyzing images before surgery reduces intraoperative time and
fulfills surgeon and staff.
6. Underlying pathologies and current indications for endoscopic-assisted
surgery
There are several situations in skull base surgery in which the use of the endoscope may
supplement the traditional microscopic visualization technique. Endoscopy may, in these
surgeries, commonly enhance the exposure of the operative field and frequently provide new
information for the surgeon [17-22]. In the authors’ experience, benefits of this visualization
technique are noted especially in cases in which important neurovascular structures constitute
a hindrance for the straight-line view of the microscope or in cases with a narrow surgical
corridor and “keyhole” approaches (e.g., supraorbital approach, retrosigmoidal approach,
etc.). Situations in which it is important to have a lateral view as in lesions invading the IAC,
for example, are another interesting indication for this technique. Because of the high definition
images delivered and the proximity of the endoscope tip to the region observed, superior
exposition of surface texture may help in differentiating some lesions from normal tissue.
6.1. Aneurysm surgery
Surgical clipping is still the most complete treatment alternative for intracranial aneurysms
[19, 23, 24]. Aneurysm complete exclusion of the circulation after clipping without occlusion
of parent, branching, and perforation vessels is the main goal of the surgical therapy. Large
series reported incidences of unexpected residual filling and parent artery occlusion after
clipping 4–19% and 0.3–12%, respectively [19, 23]. With the continuous advances in endovas‐
cular technologies for the treatment of aneurysms, patients undergoing coiling have increased
considerably [25]. Reduction of undesirable and preventable events is essential to support that
the surgical technique remains as a reliable treatment alternative [19].
The gold standard examination for evaluation after aneurysm clipping is still the intraopera‐
tive digital subtraction angiography (DSA). Routine intraoperative DSA is however not
available in most centers [19]. New techniques to better expose and understand the aneurysm
anatomy and parent and branching vessels’ configuration intraoperatively as the near-infrared
indocyanine green video angiography (ICG-VA) and microvascular Doppler sonography
(mDs) have been developed. A study in 2010 analyzing both techniques concluded that the
methods are complementary and the drawbacks could be compensated by each other. In this
report, when both techniques were simultaneously used, 90% of all aneurysms could be
correctly evaluated. If only one of these techniques was used, evaluations were correct in about
80% of the cases [23]. These intraoperative techniques have also some weak points. Blood flow
assessment in small perforators is not possible using the mDs and illumination deep in the
surgical field may be deficient during ICG-VA when small craniotomies are performed [23].
Particularly, because of the straight-line view of the microscope, these techniques have the
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limited capacity to expose areas behind vessels or the aneurysm sac. To overcome this
situation, a mirror or a high-definition image endoscope may be used.
Endoscopy has several advantages (definition, magnification, etc.) in comparison with a
simple micromirror during aneurysm surgery. It has been used in different stages of surgery
and presented to be safe and effective diminishing unexpected findings as incomplete
aneurysm occlusion or parent vessels’ compromise in large series reports [19, 26, 27]. About a
lower retraction of the nervous structures and reduced morbidity has also been reported [26].
The decision of whether or not to use the endoscope should be based on the preoperative
imaging. If this reveals an intricate anatomy, endoscope set and tower should be prepared for
possible application. Intraoperative, insufficient exposure of perforators and/or aneurysm
anatomy is an indication for the endoscopic-assisted surgery.
6.2. Cerebellopontine angle
The cerebellopontine angle (CPA) is a complex region of the skull base, with elaborated
neurovascular structures and little space. Tumors growing in the CPA tend to disturb cranial
nerve functions, brainstem, cerebellum, and eventually cerebrospinal fluid circulation.
Different tumors incurring in this location present different behaviors, infiltrating, pushing,
or adhering to important structures. Some lesions “create space,” pushing structures and
sometimes facilitating the approach. Epidermoid tumors, for example, frequently spread
around cranial nerves, arteries, and veins invading recesses and corners making complete
tumor resection under the straight line view of the microscope difficult, sometimes impossible.
Use of endoscopy additionally to the microscope enables a safe removal of such tumors,
reduces the extra retraction of nerves and vessels, and eliminates the necessity of enlarging
the craniotomy in some cases [22].
The use of the endoscopic-assisted technique during the removal of epidermoid tumors of the
posterior fossa is recommended in almost all cases because of the growing behavior of these
lesions.
6.2.1. Vestibular Schwannoma
Vestibular schwannomas are benign tumors that generally arise from the vestibular portion
of the vestibulocochlear nerve. The region where this tumor grows (Obersteiner–Redlich zone),
where the nerve covering myelin changes from central to peripheral type, is close to the
opening of the internal auditory canal (IAC) [28]. Dandy considered, in 1941, that surgery of
these tumors was the most difficult of all neurosurgical procedures [29]. Resection of these
kinds of lesions is still nowadays frequently not easy. One reason for that is the invasion of
tumor in the IAC. Visualization of the whole resection area of intrameatal tumors using the
microscope is usually just possible after opening the posterior meatus wall. In several cases,
the opening of the IAC is not sufficient by risk of damage to the vestibular system and cochlea.
By some patients, with high jugular bulb, the complete opening of the IAC is difficult or,
sometimes, nearly impossible. Because of the histological benign behavior of this tumor,
complete tumor resection with preservation of neurovascular structures and their function is
in most cases the aim of surgery.
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The capability of the wide view angle of the endoscope associated to the superb illumination
of the field enables a deeper exposure of the IAC and eventually residual tumor after resection
under microscope view [18, 30-34].
Endoscopy is indicated in cases with deep intrameatal seated vestibular schwannomas, far
medial placed labyrinth structures, and high jugular bulb.
6.2.2. Neurovascular compression syndromes
Microvascular decompression (MVD) is an important alternative in the treatment of trigeminal
neuralgia and hemifacial spasm. Other neurovascular compression syndromes, such as
disabling positional vertigo, tinnitus, and glossopharyngeal neuralgia may also, sometimes,
be treated through this surgical option [35]. Several vessels may be responsible for the
neurovascular conflict. Arteries and also veins can be compressing the nerve. The neurovas‐
cular conflict usually occurs at the root exit or entry zone, but compression of the trigeminal
nerve distally in Meckel’s cave has been described as well [35].
The incidence of identification of a neurovascular conflict during MVD using the microscope
oscillates between 25% and 98% in large series [35-37]. The reason of the inability to recognize
a neurovascular conflict could be a negative exploration, as the probability to find the site of
nerve compression increases with the surgeon’s experience [35, 36]. Insufficient visualization
of the root exit zone in Meckel’s cave or an incomplete view of the inferior and anterior aspect
of the trigeminal nerve were also described as a possible reason for a negative exploration
during decompression [35].
The use of endoscopy in MVD surgeries has already been described by some authors in the
literature [35, 36, 38, 39]. In these cases, a recognition of 100% of the site of compression was
reported [35, 36, 38, 39].
During surgeries of neurovascular compression syndromes, the use of endoscopy is specially
indicated in cases with unclear or poor exposure of the neurovascular conflict.
6.3. Intraparenchymal lesions of the brainstem and cerebellum
The neurosurgical approach to deep seated intraparenchymal lesions of the cerebellum and
particularly of the brainstem should be kept as small as possible to avoid unnecessary injuries.
Because of the balloon-like shape frequently assumed by the resection cavity, the whole
operative field view is not always possible using the straight-line view of the microscope. In
these cases, an incomplete resection of the lesion with the microscopic vision may occur.
Bertalanffy et al. described in 1991 about the increased risk of a secondary hemorrhage after
incomplete resection of deep-seated brainstem cavernomas. In this series, residual cavernous
hemangioma induced bleeding in two cases [40]. The use of an endoscope may be useful
decreasing the deficit of the microscope during the exposure of a cavity though a small
opening. This technique can help the surgeon, peculiarly in cases of cavernous hemangiomas
and hemangioblastomas. The use of endoscopy should be indicated in cases of deep seated
brainstem and cerebellum lesions and by the existence of a small resected cavity.
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6.4. Meningioma
Surgery of skull base meningiomas is challenging. The frequently demanding approach, the
close relation with important neurovascular structures, and the possible involvement of bone
are some of the adversities found during the surgical treatment of this disease. Not rarely,
bone, dura mater, vessels, and cranial nerves are superposed to tumor parts and restrict the
straight-line view of the microscope [41]. The endoscopic-assisted microsurgery technique is
an advantage for skull base meningioma surgery in the hand of experienced surgeons. Use of
different angled endoscopes may reduce craniotomy size, skull base drilling, and brain
retraction in selected cases [41].
Reasons for employing the endoscope during surgery of skull base meningiomas are the
intricate relationship of tumor with neurovascular structures, deep seated lesions, and
inadequate exposure of the anatomy because of an insufficient angle of view, small craniotomy,
and preoperative images revealing possible blind corners.
7. Treatment
The first step before treatment of a skull base pathology is the individual understanding of the
disease, patient’s anatomy, and patient’s expectations. By means of a careful imaging exami‐
nation and recognition of the relationship of important anatomical structures, possible
pathways and eventual pitfalls as well as the understanding of the clinical presentation and
patient’s expectation, the decision for the best treatment choices can be made.
Whether or not to use the endoscope initially, during or at the end of surgery for inspection
may be determined by the pathology or preoperative image findings. There are different
endoscopic-assisted techniques available, and the most appropriate should be chosen de‐
pending on the needs of each case. Some of these endoscopic-assisted surgical alternatives for
the treatment of skull base pathologies are discussed in the following text.
7.1. Surgical clipping
The endoscopic technique during aneurysm clipping should always be used in combination
with the standard microscopic visualization so that benefits of both methods may represent
an advantage (Fig. 1). The endoscopic-assisted surgical technique may be used in different
situations during aneurysm clipping:
a. Inspection of the aneurysm anatomic and topographical configuration as well as of its
surroundings
b. Clipping under endoscopic view, when the approach is limited (e.g., supraorbital keyhole
approach)
c. Post-clipping evaluation, checking for complete occlusion, parent vessel, or perforating
artery occlusion or restriction [19]
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Use of this technique showed to enhance the completeness of aneurysm occlusion and diminish
compromise of involved vessels in a large study series [19].
A novel technique with the endoscopic near-infrared indocyanine green video angiography
(ICG-VA) was developed. The aim of this new method is to compensate the weakness of the
traditional microscope ICG-VA in the evaluation of vessels located in the depth of the surgical
field particularly through small craniotomies. The first results of the comparison of both
methods in 40 cases revealed that in 27.5% of cases the endoscopic ICG-VA provided better
results for the evaluation of the post-clipping situation. Prevention of neck remnant or branch
occlusion could be prevented in four cases, changing the surgical procedure [6].
7.2. Cerebellopontine angle tumor resection
Endoscopy may help in different situations maximizing the exposure of the surgical field
during operations in the CPA. The deepness of this region and the complexity of its neuro‐
vascular anatomy represent an obstacle to the straight-line view of the microscope. Use of the
endoscope in the CPA should, also because of that, be performed by experienced hands. We
advocate that insertion of the endoscope in the posterior fossa should always be performed
under microscopic view. After initial orientation, the surgeon’s sight may switch to the
endoscopic monitor.
Changes between angled endoscopes should be performed to offer the optimal exposition for
different situations. It is very important to pay attention to the direction of the insertion of the
endoscope, especially when using angled optics. With the angled view, the direction of
Figure 1. Endoscopic view during inspection of a basilar artery aneurysm before clipping and exposure of the surgical
field through the left opto-carotid window and a pterional approach. III, oculomotor nerve; PCA, posterior cerebral
artery; SCA, superior cerebellar artery; BA, basilar artery; A, aneurysm sac. (Klinik fuer Neurochirurgie—Universitaet
des Saarlandes—Prof. Oertel/Dr. Montibeller)
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movement is not the same of sight. Depending on the angle of the optic used and the angle of
view, the trajectory of positioning may eventually not be seen with the endoscope.
Because of the narrowness of this region, lens blurring is a frequent problem encountered
during inspection. To prevent this issue, the suction tip can be held close to the endoscope tip.
This reduces the moisture and keeps the lenses dry. Cleaning of lenses with warmed-up water
also helps to minimize this undesirable situation.
7.2.1. Intrameatal tumor resection
Endoscopy may be useful during surgery of tumors invading the IAC (Fig. 2). Especially those
with a deep extension inside the canal. The endoscope revealed to be helpful finding residual
tumor in 11.1–48.1% of selected cases after microscopic resection during vestibular schwan‐
noma surgery [18, 21, 31-34, 42]. An advantage could also be seen during surgery of other
tumors invading the IAC [17]. The capability to look further inside the IAC even before opening
it in comparison with the microscope has been proven in cadaveric studies [30].
Figure 2. Endoscopic view of the opened internal auditory canal after microscopic resection of a small intrameatal ves‐
tibular schwannoma at the right side in semi-sitting position. Detection of intrameatal residual tumor (arrow) due the
angled view of the 30° endoscope. VIII, vestibulocochlear nerve. (Klinik fuer Neurochirurgie—Universitaet des Saar‐
landes—Prof. Oertel/Dr. Montibeller)
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The recognition of the facial nerve was facilitated and it could be identified in the early stages
of the dissection of vestibular schwannomas using the “look around the corner” technique [32].
Identification of opened air cells minimizing the chance for postoperative cerebrospinal fluid
fistula may be another advantage of the endoscopic-assisted technique [31, 43].
Because of the extended view delivered through endoscopy, drilling of the posterior wall of
the IAC in cases of a medially placed labyrinth or high jugular bulb may be reduced [30, 44].
7.3. Microvascular decompression
The advantages of the endoscopic-assisted technique during MVD have been described by
many authors [17, 35, 36, 38, 39]. The endoscope may be used to inspect the trigeminal and
facial nerve root as well as Meckel’s cave. This technique may help to identify the compression
site, find multiple spots of neurovascular contact, and confirm decompression at the end of
surgery [17].
Fully endoscopic MVD has also been described with good results [45].
7.4. Anterior fossa tumor resection
By surgery of tumors of the anterior cranial fossa, the endoscope may also be useful during
inspection before and after microscopic resection. Especially in cases of olfactory groove
meningiomas, endoscopy may play a role accessing the integrity of the olfactory nerve.
7.5. Intraparenchymal lesions of the brainstem and cerebellum
Introduction of the endoscope inside small resection cavities of brainstem or cerebellum may
provide an advantage for the inspection of the whole wall of the cavity and rule out bleeding
spots or residual tumor after microscopic resection.
8. Endoscopic setting
Special microsurgical instruments and technique are necessary as well as microsurgical
experience. Changing the views between microscope and endoscope requires attention of the
surgeon and his assistant. Several modalities of observing the endoscopic and microscopic
images at the same time have been described [4]. Alternating between oculars of microscope
and the video screen of the endoscopy, numerous variations may be possible. We use the
oculars of the microscope for the microscopic image and a video screen placed in front of the
surgeon to display the endoscopic image (Fig. 3). The position of equipment and staff in the
operating room is very important so that the surgeon is able to move in an ergonomic or user-
friendly way maximizing his coordination. An example with a possible distribution is seen in
Fig. 4.
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9. Advantages of endoscopic-assisted surgery
Neuroendoscopy may offer several advantages in selected cases of skull base surgery in
comparison with the microscope. The better illumination of the field due to the proximity of
Figure 3. Endoscopic-assisted technique showing the introduction of the endoscope in the surgical field by the surgeon
under microscopic view (a) and the position of the endoscope screen (b). (Klinik fuer Neurochirurgie—Universitaet
des Saarlandes—photograph of the department: Ruediger Koop)
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the endoscope tip to the tissue and the high definition images delivered by the new generation
equipment offer an excellent visualization of the surgical field. Also, the different perception
of tissue texture is observed when both techniques are compared. The expanded view angle
and different possible “looks” using a movable instrument is of course also a benefit in some
skull base surgeries with a complex anatomy. Reduced tissue mobilization and the necessity
of retraction of important structures as well as reduced trauma are a consequence of the
different view angle capability of the neuroendoscope when compared with the microscope.
Finding additional information at target in some skull base surgeries is obviously a great
benefit of the endoscopy. In the authors’ experience, most of this technique during skull base
surgery in the actual days may be achieved when using both techniques, microscope and
neuroendoscope, together as supplementary and additive devices.
10. Disadvantages of endoscopic-assisted surgery
Some disadvantages of the endoscope when compared with the image delivered by the
microscope are as follows:
a. Inferior 3D-perception of the images. Compensated with surgeon’s experience time but
cannot be set side by side with the microscope, at least not with the current technology.
New 3D-endoscopes are in development and trying to improve this issue.
Figure 4. Possible distribution of equipment in the operation theatre providing a user-friendly movement of the sur‐
geon. M: microscope, E: endoscope screen, N: neuronavigation screen. (Dr. Erasmo Barros da Silva Junior)
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b. Distortion of images is another issue that should be considered a disadvantage of the
endoscopic images. Especially in deep areas, images get deformed in size. Angled
endoscopes also distort the images that are distant from the tip [30].
c. Time consuming — Gerganov et al. analyzed the additional time for the use of this
technique during the removal of vestibular schwannomas and concluded that 15–20
minutes extra time was needed in the operating theater applying the endoscope [13]. We
believe it is very difficult to exactly calculate the additional time needed for the use of this
technique. Some information given through endoscopy may even shorten the operative
time. Particularly, only one case with complete tumor removal instead of leaving remnant
tumor behind will justify any additional surgical time. If the endoscopic equipment is
prepared and set in standby in every skull base surgery, undesirable waste of time may
be avoided.
11. Complications and risks
Some authors also reported about the complications and limitations of this technique [22, 34,
41, 46, 47]. The use of endoscopy during skull surgery may correlate with iatrogenic damage
of nerves and vessels [46]. Hori et al. reported about the injury of the facial nerve during
inspection with the endoscope in one case of a series [34].
The risk of using this instrument, especially with the 30°, 45°, and 70° angulated optics should
be kept in mind. With angulated scopes, it is not always easy to know where the tip of the
instrument is and the introduction of this tool in the operative field should be performed under
microscopic view.
12. Conclusions
Vestibular schwannomas, trigeminal schwannomas, epidermoid tumors, hemifacial spasms,
cerebellopontine angle meningiomas, anterior fossa meningiomas, and aneurysms between
others are some of the skull base pathologies with which the endoscope can be helpful giving
some additional information on the target. The neuroendoscope is usually used for inspection
of the situs and not as the main source for imaging. In a few selected circumstances, endoscopic-
assisted surgery present a benefit in comparison with the microscope and can be used during
the preparation of structures, resection of tumors (e.g., intrameatal vestibular schwannoma or
epidermoid tumor), or clipping intricate aneurysms.
Endoscopy in microsurgical removal of vestibular schwannomas may be useful, especially in
cases with small deep intrameatal tumors and of high-positioned jugular bulb. Inspection of
the fundus of the internal auditory canal may permit the identification of eventual remnant
tumor.
In epidermoid tumors, endoscopic inspection, and endoscopic-assisted tumor resection are of
great value, particularly in the posterior fossa, finding remnant tumor and reaching difficult
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and delicate areas. In epidermoid tumor surgery of the cerebellopontine angle, when remnants
are not visible in a straight line, the endoscope-assisted technique can contribute to safe tumor
removal. It also allows the resection of tumor extensions without retracting neurovascular
structures or enlarging the craniotomy.
In trigeminal neuralgia, the endoscope may help when the neurovascular conflict cannot be
identified using the straight-line view of the microscope.
In aneurysm surgery, endoscopy is especially useful in deep-seated lesions and in aneurysms
with suspicion of perforators on their backside. In some cases, additional information on
aneurysm occlusion and on the patency of parent, branching, and perforating arteries can be
gained.
The possibility of introduction of the tip of the endoscope into deep areas and the use of
different angle scopes widening the field of view permit the reduction of surgical trauma
during the approach, by reduced retraction of structures. Discovery of additional information
at target, however, is certainly the principal advantage of this tool. Novel indications for
endoscopy in the skull base surgery are growing fast and different uses of this device are being
tested.
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Abstract
Clival lesions still represent a challenge for neurosurgeons. A variety of expansive
process, either benign or malignant, may be identified in the clival and paraclival
region.
Surgery of this region with classical open approaches is associated with a significant
rate of complication, and the treatment is risky despite technological progress. The
acceptance and utilization of endoscopic techniques on a regular basis in transsphe‐
noidal surgery have allowed its application to regions far beyond the sella turcica, such
as to reach the clival and paraclival region.
Long-term follow-up studies show how the extent of oncological resection is related
to long-term prognosis for the most common clival malignancies. Gross total removal
is therefore mandatory, and the selection of the best surgical approach is essential for
the achievement of this goal.
The choice of the surgical approach depends on the location and the extent of the
lesion. Through a complete overview of surgical anatomy, we propose a surgical
classification with three corridors in the sagittal plane and three zones in the coronal
plane. We finally summarize the indications and the limits for the endoscopic
technique. In selected cases, endoscopic approaches allow similar oncological
outcomes as classical open approaches with a lower rate of complications.
Keywords: Clival tumors, Clival chordoma, Clival chondrosarcoma, Meningioma,
Extended endoscopic endonasal approach, Skull base surgery
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
1. Introduction
The clival region may be involved in a copious number of disorders. The most common clival
lesions are chordomas, but meningiomas, chondroma and chondrosarcoma may also occur.
Furthermore, the clivus may be secondarily invaded by a variety of metastatic malignancies.
A radical excision is related to long-term prognosis and survival and a gross total resection is
the primum movens of every surgical procedure when judged possible. The deep location and
the presence of important neurovascular structures make of the clivus a challenging working
area. Surgery of this region through classical open approaches implies neurovascular and
cerebral retraction with a significant rate of neurological morbidities. Neurosurgeons have
thus progressively searched for innovative ways to reach the clival region and to limit the
complication rate.
Endoscopy started to be used as a diagnostic tool [1, 2] and then developed as a therapeutic
option for sellar lesions [3, 4]. During the last decades, endoscopic techniques were applied to
the skull base with encouraging results in terms of surgical resection and rate of complications
[5]. Clear advantages of endoscopic surgery are principally a limited retraction on neurovas‐
cular structures with a concomitant wide vision and large exposure. Furthermore, patients
have no external marks, and the length of hospitalization is normally shorter than with open
procedures.
According to their location and extension, clival tumors may be reached through an anterior
approach, as extended subfrontal, Le Fort I, transoral approach or maxillotomy, or through a
lateral approach as the transpterygoid or infratemporal craniotomy or as the transpetrosal or
far lateral approach. The endoscopic technique may represent a valid alternative to these open
approaches, and the aim of this chapter is to expose the expanded endoscopic approach as
first-line treatment in well-selected patients.
2. Preoperative evaluation
A satisfying preoperative evaluation implies T1 and T2-weighted MRI sequences, with and
without gadolinium administration, to evaluate the extent and the precise localization of the
lesion in the axial, coronal and sagittal plane. A high-resolution skull base CT scan with bone
windows will help to plane the surgical approach and to evaluate bone invasion and osseous
pneumatization. A CT angiography will then help to characterize vessels’ characteristics, in
particular of the ICA, and their reciprocal relationship with the lesion, thus defining the extent
of resection. A 3D-scannographic reconstruction may better help understanding the real
surgical anatomy of the ventral skull base, with a particular concern for the location of foramen
lacerum and vidian canal. Patients should also have an ENT evaluation with a specialized
neuro-otological examination and undergo a preoperative endonasal endoscopy to plan the
access for the surgery.
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3. Surgical procedure
3.1. Surgical anatomy and classification of the surgical approach
The clivus separates the nasopharynx from the posterior cranial fossa and a natural access is
possible through the nasal cavities.
From a purely anatomical point of view, the clivus is traditionally divided into basisphe‐
noid (sphenoid body) and basiocciput (basilar part of the occipital bone) (Figure 1).
Figure 1. Anatomical classification of the clivus, which is divided into basisphenoid and basiocciput. Classically the
sphenoid body forms the basisphenoid while the basiocciput belongs to the occipital bone.
From a surgical point of view, the clivus has classically been divided into [6] (Figure 2):
• an upper clivus extending from the dorsum sellae to the plane of Dorello canal;
• a middle clivus extending from the Dorello canal to the pars nervosa of the jugular foramen;
• a lower clivus extending from the pars nervosa of the jugular foramen to the foramen
magnum.
The choice of the surgical approach depends on the location and extension of the lesion, which
are the principal determinants for the extent of bone removal. The relationship between the
lesion and the pneumatization of the sphenoidal sinus represents the basis of our surgical
classification proposed here.
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Three corridors may be identified in the sagittal plane, separated by two lines (Figure 3). The
superior line joins the nostril with the sellar floor, while the inferior line joins the nostril with
the inferior wall of the sphenoidal sinus. The superior line separates the trans-sellar corridor,
used for lesions of the anterior cranial base and extending till the posterior clinoid process,
and the sphenoidal corridor, where the natural pneumatization allows a direct access to the
sellar and retrosellar region without the necessity to transpose the pituitary gland as in the
trans-sellar corridor [7] (Figure 4). In front of a well-pneumatized sphenoid sinus, the sphe‐
noidal corridor gives an excellent access to mid-clival lesions. The inferior line separates the
sphenoidal corridor from the infra-sphenoidal corridor, used to access to the lower part of the
clivus after the lateralization of the longus capitis and longus colli muscles. The identification of
the foramen magnum and hypoglossal canals is fundamental to safely use this corridor. A
different inclination of the endoscope in the sagittal plane combined with a more or less
pronounced flexion or extension of the head of the patient allows direct access to one of the
three corridors.
According to our endoscopic conception, three zones are also identified in the coronal plane:
the median, paramedian and lateral zone (Figure 5). The medial line, extending from the
medial wall of the cavernous sinus to the medial border of the foramen lacerum, separates the
median from the paramedian zone. The lateral line, extending from the lateral wall of the
Figure 2. Surgical classification of the clivus. The upper third extends from the dorsum sellae to the Dorello canal. The
middle third extends inferiorly till the jugular foramen, while the inferior third extends to the foramen magnum.
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cavernous sinus to the lateral edge of the foramen lacerum, separates the paramedian zone
from the lateral zone.
To work safely in the paramedian zone, the identification of the vidian nerve and of the ICA
is fundamental [8]. Lesions limited to the median and paramedian zones may be completely
Figure 3. Sagittal view showing the three surgical corridors: the trans-sellar, the sphenoidal and the infra-sphenoidal
corridors. The corridor must be chosen on the basis of the location of the lesion. Head flexion and the use of angulated
endoscope may help in performing the procedure.
Figure 4. Cadaveric view of a trans-sellar corridor. The pituitary is transposed to drill out the posterior clinoids and the
dorsum sellae. The posterior ethmoidal cells are also opened and the left optic nerve is here exposed.
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excised through an endoscopic approach, while for lesions extending to the lateral zone a
pterygoid or infratemporal craniotomy may be preferred or combined with endoscopy.
Figure 5. Coronal representation of the three coronal zones. The cavernous sinus and the foramen lacerum represent
two important landmarks. A lesion situated solely in the median or paramedian zone may be completely resected
through an endoscopic approach. For lesions extending to the lateral zone a combined approach must be considered.
3.2. Operative technique
In most centers, an interdisciplinary team consisting of a neurosurgeon and an otolaryngolo‐
gist performs the surgery. The patient is positioned supine with the head elevated of 30° and
slightly hyperextended. A general anesthesia is performed with an orotracheal intubation. As
nerves retraction represent one of the main risk, intraoperative neuromonitoring is performed,
allowing direct monitoring of cranial nerve function. Direct stimulation through a monopolar
device is commonly used, with a frequency of 1Hz, a monophasic negative 200 µs duration
and a 1 to 5 mA intensity stimulation. Eyeball movements are thus monitored through
electrodes capturing the displacement of the retina dipole to evaluate the integrity of oculo‐
motor, trochlear and abducens nerves. The frontalis, orbicularis oculi, orbicularis ori and
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mentalis muscles are evaluated to monitor the functionality of the facial nerve. Electrodes
incorporated in the endotracheal tube (Xomed®) are used for glossopharyngeal and vagus
nerves while electrodes in trapezius and hypoglossal muscles are used to monitor accessory-
spinal and hypoglossal nerves respectively. Somatosensory evoked potentials and brain stem
auditory potentials are also used as complement for brainstem function assessment.
Some centers guide their extent of resection with a neuronavigation system and a Doppler
ultrasonography to better visualize adjacent vascular structures as the sphenopalatine artery,
the ICA and the basilar artery.
A binostral approach is used according to the four-hand technique (Figure 6). The procedure
is performed with a hand-held short 0°, 30° or 45° endoscope till the sellar floor opening. The
endoscope is classically first introduced from the right nostril unless the preoperative endo‐
nasal evaluation showed a preferential way in the left nostril. The endoscope is oriented
slightly rostrally to better visualize the clivus and normally handled in the nostril contralateral
to the lesion during the operative procedure.
Figure 6. Representation of the four-hand technique. The endoscopic is kept by the operative aid in the nostril contrala‐
teral to the lesion, while the surgeon freely operates with both hands in the other nostril. This technique implies the
presence of two well-trained operators and a strong collaboration between the two surgeons.
Through the endonasal approach, the inferior turbinate is encountered first, then the medial
and the superior one, which may be resected or just retracted (Figure 7). To obtain a wider
surgical corridor, a resection of the middle and superior turbinates is preferred for extended
endoscopic approaches [9, 10, 11, 12, 13] (Figure 8 and 9). Turbinectomies allows also a better
visualization of branches of the sphenopalatine arteries, important to preserve for the closure
stage.
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Figure 7. In vivo visualisation of the right nasal cavity through a 0° endoscope. At the beginning of the endonasal ap‐
proach the inferior turbinate is first visualized (left). More deeply the middle turbinate is identified and laterally dis‐
placed or resected to gain a wider access to the clival region.
Figure 8. Cadaveric view of the right nasal fossa. The middle turbinate is visualized as well as the bulla ethmoidalis in
the lateral wall of the nasal cavity.
The coanes and the inferior wall of the sphenoid sinus are identified.
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The mucosa is incised with an endoscopic knife over the vomer (Figure 10) and retracted
laterally until the vidian nerve, which represents the lateral limit for exposure and resection.
The vidian nerve conducts in fact to the junction between the horizontal portion of the petrous
ICA and the vertical paraclival segment of the ICA at the foramen lacerum.
After vomer subluxation and bilateral wide sphenoidotomies (Figure 11), the following steps
of the surgery depend on the location and the extent of surgery (Figure 12). The osseous
Figure 9. A middle turbinectomy is performed in a cadaveric specimen. A wider endonasal access is thus obtained for
more extended approaches. The middle turbinate may then be used during the closure stage.
Figure 10. Cadaveric view showing sphenoid rostrum exposition after the septal mucosa is incised and the vomer is
dislocated laterally. The two sphenoid ostia are here visualized, giving access to the sphenoid sinus.
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structure of the clivus is exposed and resected through a diamond burr drill (Figure 13) and
secondarily a 1 and 2 mm Kerrison bone punch, according to a cranio-caudal direction from
the inferior wall of the sphenoid ostium down to the foramen magnum (Figure 14). The
paraclival ICA represents the lateral limit for exposure at this level. If necessary the ICA can
be carefully dissected and mobilized in the medio-lateral plane to provide adequate access to
the tumor in the paramedian zone.
Figure 11. Bilateral exposition of the sphenoid ostia. A bilateral sphenoidotomy is then performed trhough a diamond
drill and a small Kerrison bone punch to gain access to the sphenoid sinus.
The lateral extension of bone removal is defined by the pterygoid canal, which is found about
5mm lateral to the vomer-sphenoid junction. The vidian nerve may be followed proximally
till the pterygoidcanal. The lateral boundaries limiting bone resection are thus represented in
a craniocaudal fashion by the cavernous sinus, paraclival carotid arteries and the foramen
lacerum.
The dura is thus exposed and the integrity of the basilar plexus, situated between the two layers
of the dura of the upper clivus, should be respected to avoid copious bleeding. Bleeding from
the basilar venous plexus is in fact often difficult to cauterize, but it may be managed with the
use of hemostatic materials (Floseal Hemostatic Matrix®, Bayter Healthcare SA) and packing.
The abducens nerve may be identified as traversing laterally the basilar plexus, and the
paraclival ICA is also found.
For intradural lesions, a median longitudinal incision can be made initially on the outer layer
of the dura. Then the internal layer is opened, with the visualization of the prepontine cistern
and basilar artery (Figure 14).
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The lesion is removed under endoscopic guidance in a piecemeal fashion with ultrasound
dissectors. Intraoperative pathologic examination of tumor tissue is generally performed to
decide on the extent of tumor resection on the basis of diagnosis.
Figure 12. After a wide opening, the surgeon can choose the best sagittal corridor to reach the clival region of interest.
The pituitary max be transposed to follow the supra-sellar corridor and gain access to the dorsum sellae or to the pos‐
terior clinoids or the clivus may be further drilled inferiorly. The lateral limits for the exposition are represented by the
paraclival ICA. The vidian nerve should be identified and followed as it conducts directy to the foramen lacerum and
may guide in defining the lateral limits of dissection.
Figure 13. Drilling of the clival bone. The drilling is performed in a cranio-caudal fashion. It is important to respect
dural integrity during this process.
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The closure step is as important as the dissection and excision steps. A nasoseptal flap
vascularized by the septal branches of the sphenopalatine artery may be prepared at the
beginning of the procedure and displaced in the oropharynx, under the soft palate, to be
protected during the surgery. It is important that the size of the pedicle of the flap stays
sufficiently large to avoid necrosis of its borders. The use of the Hadad flap is now widespread,
and it has allowed a significant reduction in the rate of postoperative CSF leaks after endo‐
scopic techniques.
The reconstruction surface should be widened: flaps tend easily to shrink and we proposed
the superposition of two nasoseptal flaps vascularized by branches of the posterior septal
arteries in a lambdoid shape to ensure a correct closure. The middle turbinate resected at the
beginning of the procedure may also be superimposed to increase the sealing in combination
with biologic glue (Tisseel, Fibrin Sealant ®, Baxter AG).
3.3. Indications/management
Chordomas are slow-growing extra-axial tumors deriving from vestigial remnants of the
notochord and the most common site at the sacrum and the clivus. A male predominance was
described (3:1). They are considered low-grade malignancies but locally aggressive with a high
recurrence rate. For this reason, gross total resection is fundamental but often difficult to
achieve because of tumor extension and invasiveness and the proximity of important neuro‐
vascular structures. At clinical presentation, intracranial extension has normally occurred and
complete resection is difficult in most cases (Figure 15).
When invading the basion, the most common presentation is represented by the XIIth cranial
nerve palsy, while when the middle part of the clivus is interested (most common), chordomas
may manifest as nasopharyngeal obstructive masses in cases of ventral extension or with VIth
cranial nerve palsy in cases of dorsal extension. Chordomas arising at the upper third of the
Figure 14. Exposition of the prepontine cistern in a cadaveric specimen. The two layers of the dura are opened and the
posterior circulation is visualized.
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clivus may present with hypopituitarism signs or bitemporal hemianopia due to chiasmal
compression.
A lateral extension may also occur with consequent invasion of cavernous sinus in the upper
part of the clivus or it may manifest with otologic symptoms like deafness, tinnitus and vertigo
or facial paralysis because of involvement of the petrous bone.
Chondrosarcomas are malignant tumors derived from cartilaginous tissue arising from bone
or soft tissues. They are less aggressive than other sarcomas but the natural history is charac‐
terized by multiple local recurrences after surgical excision. Distant metastases are rare. Both
sexes are equally affected. About 75% of all cranial chondrosarcoma arise at the skull base, in
particular in the middle cranial fossa. Imaging shows mottled calcifications within a soft tissue
mass. Clinical manifestations are similar to those described for chordomas. Expansive lesions
involving primarily the petrous apex may expand anteriorly and involve the clivus.
Meningiomas in particular may arise in close proximity to the porus acusticus or from a
separate origin on the face of the petrous bone, and they may slowly extend to the clival region.
They are five times more frequent in women, and the main clinical presentation is with
vestibulocochlear symptoms. Secondarily, peripheral facial weakness or facial numbness are
found accompanied by indirect signs of clival involvement in more advanced cases.
A complete local resection should be attempted along with resection or cauterization of dural
attachment to minimize the risk of local recurrence.
The goal of every oncologic surgery should be gross total resection. However, to avoid
complications and preserve neurovascular structures is the first compromise to accept when
working in the clival region, and this is the first principle to guide the extent of resection.
Lesions showing wide intracavernous sinus extension, vascular encasement (ICA or vertebral
artery) or brainstem involvement should be preoperatively planned as subtotal resection.
Figure 15. This young patient presented with neck pain. Preoperative sagittal T2-weighted cerebral MRI (left), showing
a lesion involving the whole clivus. The sphenoidal and infrasphenoidal corridors were used to resect the lesion
through EEEA. The postoperative MRI (right) shows a gross total resection of the lesion. The lesion was completely
extradural. The patient was free of disease at 5-years follow-up.
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Furthermore, the extended endoscopic approach may be used as a valid alternative for
debulking surgery or in palliative cases to limit the symptomatology of the patient or to allow
a following complementary treatment, as radiotherapy or proton beam radiotherapy.
Traditionally clival lesions were treated through different trans-cranial approaches with a
consequent important brain retraction, and a high risk of injury for the vessels and nerves
crossed during the procedure [14-22].
The increased confidence in endoscopic techniques allowed a widespread application of the
extended endoscopic approach to treat clival lesions. The first cadaveric study conducted in
2002 showed the feasibility of the procedure [23] and since then endoscopy has not ceased to
find other applications. The main advantage is related to the avoidance of brain retraction and
nerves crossing. Technological advancements allowed the development of a specialized
instrumentation to work properly in the endonasal route, and many centers are pushing the
application of endoscopic techniques far beyond the midline. Thanks to angled instruments,
a dynamic 360° view may be obtained [24].
The results of the extended endoscopic approach for clival chordomas have been widely
reported [7, 25-29]. In terms of gross total removal, it was equivalent or superior to classical
open approaches [30, 31]. The extent of resection is the most important prognostic factors for
survival in these cases, with a survival at 5 years of follow up dropping from 90% for GTR to
52% for partial resection [22]. The principal determinants for the surgical resection are the
tumor volume and the lateral extension. The literature analysis shows how endoscopy
represents an excellent approach for median lesions, with good results, especially for extra‐
dural lesions.
Following the increased experience with endoscopic techniques for extradural clival tumors,
some centers started to use the trans-clival approach for the management of intradural tumors
with good operative results [11, 13, 25, 31-33].
For lateral lesions or intradural lesions, however, the endoscopic approach is more complex,
and it should be combined with traditional open approaches. After an excision as radical as
possible, a complementary treatment through fractionated radiotherapy, stereotactic radio‐
surgery or proton beam radiotherapy represents the best management policy [34].
The tumor may thus be divided ideally into different compartments, which may be approached
through a different surgical technique, endoscopic or transcranial, or treated with external
irradiation. This conception allows minimizing the neurological morbidity and the complica‐
tion rate because each technique is used safely. Furthermore, it is possible to realize a maximal
resection with minimal access.
3.4. Complications
Both the extent of resection and the rate of complications are related to the experience of the
first operator. The reconstructive step is as crucial as the excisional step, and it may be even
more complicated in cases of large skull base defects. The first descriptive studies about the
endoscopic skull base surgery reported an incidence of cerebrospinal fluid (CSF) leaks as high
as 33.3% [27]. This complication may represent a medical emergency when not perceived in
time because of the risk of infectious meningitis. CSF leak may be treated either with a surgical
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The increased confidence in endoscopic techniques allowed a widespread application of the
extended endoscopic approach to treat clival lesions. The first cadaveric study conducted in
2002 showed the feasibility of the procedure [23] and since then endoscopy has not ceased to
find other applications. The main advantage is related to the avoidance of brain retraction and
nerves crossing. Technological advancements allowed the development of a specialized
instrumentation to work properly in the endonasal route, and many centers are pushing the
application of endoscopic techniques far beyond the midline. Thanks to angled instruments,
a dynamic 360° view may be obtained [24].
The results of the extended endoscopic approach for clival chordomas have been widely
reported [7, 25-29]. In terms of gross total removal, it was equivalent or superior to classical
open approaches [30, 31]. The extent of resection is the most important prognostic factors for
survival in these cases, with a survival at 5 years of follow up dropping from 90% for GTR to
52% for partial resection [22]. The principal determinants for the surgical resection are the
tumor volume and the lateral extension. The literature analysis shows how endoscopy
represents an excellent approach for median lesions, with good results, especially for extra‐
dural lesions.
Following the increased experience with endoscopic techniques for extradural clival tumors,
some centers started to use the trans-clival approach for the management of intradural tumors
with good operative results [11, 13, 25, 31-33].
For lateral lesions or intradural lesions, however, the endoscopic approach is more complex,
and it should be combined with traditional open approaches. After an excision as radical as
possible, a complementary treatment through fractionated radiotherapy, stereotactic radio‐
surgery or proton beam radiotherapy represents the best management policy [34].
The tumor may thus be divided ideally into different compartments, which may be approached
through a different surgical technique, endoscopic or transcranial, or treated with external
irradiation. This conception allows minimizing the neurological morbidity and the complica‐
tion rate because each technique is used safely. Furthermore, it is possible to realize a maximal
resection with minimal access.
3.4. Complications
Both the extent of resection and the rate of complications are related to the experience of the
first operator. The reconstructive step is as crucial as the excisional step, and it may be even
more complicated in cases of large skull base defects. The first descriptive studies about the
endoscopic skull base surgery reported an incidence of cerebrospinal fluid (CSF) leaks as high
as 33.3% [27]. This complication may represent a medical emergency when not perceived in
time because of the risk of infectious meningitis. CSF leak may be treated either with a surgical
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revision or conservatively with a lumbar drain. The main determinant factor is the surgeon’s
judgment about any intraoperative source of leakage. The CSF leak rate was severely reduced
during the last years after the introduction of the vascularized nasospetal flap as described by
Hadad [35], the gasket type seal and the multi-layered closure technique. The lumbar drain,
which once was systematically used in the early postoperative period, may thus be avoided
in most cases with a precocious mobilization of patients.
Infectious complications may be treated either with medical therapy or with surgical revision.
Vascular lesions may also occur, with early or delayed hemorrhagic complications (intracranial
hematoma occurred in about 6% of cases according to Carrabba et al [36]). Though a careful
dissection is realized, damage to the ICA may occur, often with catastrophic results. A
preoperative occlusion test may help evaluate the consequences of an eventual ICA sacrifice.
The consequences of an intraoperative ICA sacrifice may vary from the death of the patients
to permanent neurological deficit to a simple Horner syndrome.
Cranial nerve palsies are significantly less frequent with the endoscopic approach when
compared to the open approaches and transient in the majority of cases [36]. The majority of
patients report an improvement in preoperative cranial nerve palsy due to surgical decom‐
pression. After surgery, patients mostly complain about transient minor symptoms as
headache, blurred vision and nasal obstruction.
Patients having a postoperative syndrome of inappropriate antidiuretic hormone hypersecre‐
tion are also reported, as well as manifestations of hypopituitarism as a consequence of
pituitary manipulation.
3.5. Limitations
Classical open approaches continue to be the gold standard for lesions extending lateral to the
internal carotid artery, the vertebral arteries or lateral to the optic nerve, into the mastoid or
inferior to the dens.
The excision of tumors extending into the cavernous sinus is actually possible with the
endoscopic technique, but the postoperative cranial nerve palsy remains significant. A subtotal
resection is performed in the majority of cases and the residual tumor may be treated with
adjuvant stereotactic radiosurgery.
Furthermore, for intradural tumors a combined approach (extended endoscopic endonasal
approach with transcranial microsurgery) is preferred.
4. Conclusion
The expanded endoscopic approach provides a good exposure to efficiently treat lesions of the
clival region. This minimally invasive technique allows obtaining satisfying results in terms
of oncological resection without skin incision and neurovascular retraction in a cohort of well-
selected patients.
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Abstract
Hysteroscopy is the most accurate technique in order to visualise the endometrial
cavity and diagnose relevant pathologies. Despite the further evolvement of ultraso‐
nography, hysteroscopy provides not only diagnosis but also treatment, when
needed. Based on fine hysteroscopes produced recently, hysteroscopy can be easily
performed in an office-based environment, not only for diagnostic but also for
treatment of minor pathologies. The more attractive office environment compared
with the conventional operating theater, the no-need for general anaesthesia and the
reduced cost compared to the classic hysteroscopy are the main advantages that
characterize office hysteroscopy and that made it more popular during the last years.
Keywords: Office, hysteroscopy, diagnostic, operative, minimal invasive surgery
1. Introduction
The evolution of the medical technology during the last decades has introduced hysteroscopy
in the everyday clinical practice, for the visualization of the endometrial cavity for diagnostic
and also operative purposes. This has led to the precise management of gynecological
problems in the field of infertility, recurrent miscarriages, postmenopausal bleeding, uterine
cancer, and menstrual disorders. Although transvaginal ultrasound scanning in 2D and 3D
mode are considered useful tools for first line screening, the gap between precise diagnosis
before treatment was covered by the introduction of a fine hysteroscope, which provides more
accurate information. Nevertheless in most cases operative hysteroscopy substituted the blind
technique of dilation and curettage, solely used over the past years.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Office hysteroscopy is a very useful technique for diagnosis and treatment of uterine pathology
in an office-based environment (Figure 1). It is directly related to the technological explosion,
which during the last years has further evolved and given us the opportunity to perform
hysteroscopy without providing general anesthesia or sedation to the patients, due to the
narrow width of the latest generation hysteroscopes. This means that after adequate and
thorough experience and toward the reduction of the cost and satisfaction of the patients,
hysteroscopy in an outpatient environment, called office hysteroscopy, has started to attract
the majority of gynecologists.
The aim of this chapter is to familiarize the clinicians in the field of gynecology with the
instrumentation and setup, the technique itself, indications, and contraindications for per‐
forming office hysteroscopy and finally the advantages for the patient and the clinician who
perform this endoscopic approach.
Figure 1. Typical setup for office hysteroscopy in a private office-based practice
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2. Instruments
2.1. Hysteroscopes
There are two different types of hysteroscopes available. The rigid hysteroscopes are composed
of two parts, the scope and the outer sheath with a total diameter of 2.9–4 mm (Figure 2, Figure
3). The outer sheath comes with suction and irrigation valves, which allows the inflow and
outflow of the distension medium of the uterine cavity and can be mounted on an irrigation-
suction device. Further, there is an operating channel from which specifically designed
instruments can go through for operative purposes or retrieval of endometrial tissue for
biopsy. The advantages are that they are exactly the same as the non-office hysteroscopes, so
for a clinician who is experienced in hysteroscopy there is no learning curve, and they can be
used without inserting a vaginal speculum (no-touch technique or vaginoscopic approach).
Furthermore, they can be used with suction device, while a great variety of instruments are
specifically designed for these and the scopes are available in 12, 25, or 30 degrees angular
vision. In the disadvantages we need to mention that they come in many parts and also the
optics are very thin, from 2 mm in diameter, which makes them very fragile during cleaning
and disinfection, while there is an existing risk of uterine perforation due to the rigidity. Finally,
they have greater width compared with the flexible hysteroscopes.
Figure 2. Operative hysteroscope for office hysteroscopy
The flexible hysteroscopes (Figure 4) are compact without any additional part, even the light
source cable is permanently fixed on these. They do not come with an outer sheath, which
means that they lack suction mechanism but there is a working channel, through which flexible
instruments can be inserted and used for biopsy and minor surgical procedures. The visual
angle is up to 120 degrees due to the flexibility, so there is no external manipulation of the
hysteroscope, which can minimize the discomfort of the patient. Cleaning, disinfection, and
storage are simpler than the rigid ones. The possible perforation of the uterus is quite non-
existing, but on the contrary during insertion the scope might be obstructed by even loose
adhesions or endometrial structures such as large polyps or fibroids. In practice, and from our
experience, it means that it is preferable to dilate the cervical canal before insertion with a thin
dilator. The vaginoscopic approach is more difficult to be performed with a flexible hystero‐
scope compared to the rigid ones and therefore in all cases the use of a vaginal speculum is




almost never needed, as long as due to the flexibility the scope can easily go through all types
of uterus (anteverted, retroverted, etc.). Finally, there is clear evidence that in procedures
where flexible hysteroscopes are used patients experience less pain and discomfort [1].
Figure 3. Distal part of an office operative hysteroscope
Figure 4. Flexible hysteroscope of 3.1 mm total diameter
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3. The setup
The basic setup in order to perform an office hysteroscopy consists of a camera, a camera
control unit connected to a -DVD recording device, a light source, and a monitor, connected
exactly the same way as in the operating theater, all of them placed on an equipment cart, or
there are also compact devices where all the above mentioned come as a single appliance. An
irrigation-suction unit for the distension medium can be used, but for diagnostic purposes a
handcuff with a manual air pump can be used for irrigation, around the bottle of the distension
medium, as long as for experienced clinicians the whole procedure will last less than 5 minutes
and the amount of the distension medium to be used will be less than 200 ml. Additional
equipment ready for use can be a dental syringe fitted with a sealed cartridge containing
anesthetic solution for cervical local anesthesia and a plastic cervical dilator, a vaginal
speculum, sterile gauges, and a forceps in order to control spotting bleeding from the cervix,
after injection of local anesthetic, all placed on a secondary equipment cart. The patient is
placed on a gynecological chair, in lithotomy position that will allow the clinician to perform
manipulations with the hysteroscope without restrictions. It is advised that a flat examination
bed is also present in the same room, in case of vasovagal reaction after the end of the proce‐
dure. A typical setup is shown in Figure 1. Finally it is advised that a chaperon is present during
the procedure, but in terms of assistance the setup described is ideal for a single person to
perform.
4. Analgesia/anesthesia
There is no clear evidence that local anesthesia should be used prior to office hysteroscopy,
while results from several studies cannot reach a definite conclusion. Nevertheless in cases of
non-vaginoscopic procedures from our experience, we strongly recommend the proposal of
cervical local anesthetic, which can possibly lead to less pain experienced by the patients,
especially if cervical dilatation is needed, but also gives a feeling of confidence to the patients
before getting through the procedure. Moreover, in cases where the use of tenaculum is
needed, local cervical anesthesia should be applied [2]. It should be mentioned that use of
intracervical or paracervical local anesthesia for preventing vasovagal reactions is not an
indication.
Conscious sedation should not be used as it does not contribute to pain control more than local
anesthesia and also dangerous complications that may occur cannot be controlled in an office-
cased environment [3].
As far as analgesia is concerned, it is recommended that NSAIDS (non-steroidal anti-inflam‐
matory drugs) should be used an hour prior to the procedure for pain relief but the use of
opioids should be avoided as they may have adverse effects like nausea, vomiting, and
drowsiness [2].
In general the choice for analgesia prior or during the procedure should be decided by the




condition of the uterine cervix (nulliparous or multiparous), and the reluctancy of the patient
regarding the possible pain that she may experience during the procedure. All the choices
should be offered to the patients during the consent procedure.
5. Distention medium
Office hysteroscopy can be performed with the use of normal saline solution or CO2. It is
advisable that the choice of the medium is at the discretion of the clinician. Nevertheless, there
seem to be advantages from the use of normal saline as long as it can provide better visibility
and clearing out of blood clots and debris, less possible vasovagal reactions (sickness, brady‐
cardia, and hypotension) from the patients, and also the setup is more simple and more
practical compared to CO2. Furthermore, the use of normal saline does not offer reduction of
pain but can lead to quicker procedures [4,5], but the latter is clearly affected also by the
clinician’s experience with the medium and the procedure itself.
6. Types of office hysteroscopy
6.1. Diagnostic office hysteroscopy
Office hysteroscopy is the most accurate diagnostic tool for endometrial pathologies and a
second line tool after primary diagnosis deriving from 2D or 3D transvaginal ultrasound scan.
Compared to the hysteroscopy performed in the operating theater under general anesthesia
or sedation, there are clear benefits for the patients, such as the avoidance of taking general
anesthesia, especially for patients who are at high-risk for anesthetic complications. The
reduced time of the whole procedure and also the location, especially when performed in an
out-of hospital environment, are crucial for the patients in order to decide. Also, the reduced
cost of around 40–60%, as long as hospital and anesthetic costs are excluded, attracts more
patients and also more clinicians to propose, especially in current years of financial recession.
Finally the provision of this diagnostic tool in an office-based environment gives an added
value to the private practice and its services, but also assists the clinicians to provide more than
one choice to their patients.
Indications for diagnostic office hysteroscopy can be categorized for premenopausal and
postmenopausal women.
6.1.1. Premenopausal women
Abnormal uterine bleeding is an indication for office hysteroscopy, if there is clear evidence
of pathology at the ultrasound scan. The authors recommend that before proposing the
technique, if there are no obvious ultrasonographic findings, it is wise to exclude any other
endocrine, ovarian, or cervical pathology.
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In terms of infertility investigation, office hysteroscopy is very useful in the investigation of
the endometrial cavity in women who underwent two complete cycles of in vitro fertilization
(IVF) – two failed implantations, even if there is no ultrasonographic evidence. The same
indication stands for women with recurrent miscarriages – more than three consecutive
miscarriages. Small endometrial polyps, uterine septae, endometrial adhesions, and cervical
adhesions are common findings, which can be revealed with hysteroscopy. This approach is,
also, very useful for the evaluation of the quality of the endometrium during the luteal phase.
Women who take tamoxifen as a regime for breast cancer are in need of endometrial assessment
by biopsy and thus hysteroscopy is not an absolute indication, but in cases where endometrial
thickness is ≥ 8 mm it is highly recommended in order to exclude an endometrial polyp or
ongoing endometrial cancer [6].
6.1.2. Postmenopausal women
Postmenopausal women with uterine bleeding should be investigated with office hysterosco‐
py regardless of the ultrasonographic findings, which apart from benign pathologies can lead
to the diagnosis of uterine or cervical cancer. In cases of cancer the benefit of accurate diagnosis
outweighs the risk of spreading neoplastic cells into the abdominal cavity and thus dilatation
and curettage is advised not to be preferred over hysteroscopy [7]. A finding of an endometrial
polyp in postmenopausal women is not a rare finding.
6.2. Operative office hysteroscopy
Operative procedures performed in an office-based environment are quite limited. There is no
specific guideline regarding operative procedures but usually minor procedures such as
endometrial biopsies, removal of endometrial polyps, dissection of loose intrauterine adhe‐
sions, removal of intrauterine devices with a missing thread or foreign objects and also for
permanent tubal sterilization with the insertion of tubal coils (Essure®) are performed in the
everyday clinical practice and are well tolerated by the patients. Operative office hysteroscopy
can be an extension of diagnostic office hysteroscopy, as long as there are no special setup
requirements and cervical preparation is not needed.
Contraindications for both diagnostic and operative hysteroscopy are heavy uterine bleeding
or menstruation, vaginal infection, active pelvic inflammatory disease, and history of adverse
reactions during a previous office hysteroscopy. As mentioned earlier, suspicion of cancer is
not a contraindication for performing diagnostic hysteroscopy and biopsy.
7. Advantages and disadvantages of office hysteroscopy
7.1. For the patient
Office hysteroscopy is mainly designed for the patient’s advantage. The use of hysteroscopy




practice, can give fast and accurate diagnosis and treatment without waiting lists and at a
substantially lower cost, as hospital and anesthetic costs are excluded. Without the use of
sedation or anesthesia, patients can go back to their everyday activities just after the end of the
procedure. The disadvantage of the possible discomfort during the procedure or the cramp-
like lower abdominal pain after are outweighed by the benefits that the patients can have.
7.2. For the clinician
For the clinicians in the fields of gynecology, infertility, and gynecological oncology, office
hysteroscopy is the ultimate tool for accurate diagnosis of endometrial pathologies. A future
management plan can be easily scheduled after the end of the procedure, unless a further
pathology report from biopsies is expected.
Regarding the diagnosis, from our experience, miniature hysteroscopes with a low width
inflow channel for the distention medium provide low pressure distention of the uterine cavity
and so in cases of soft tissue structures like polyps, adenomyomas, and fundal adhesions we
get a first more realistic depiction of the uterine cavity.
Of course the setup in a private practice is not time-consuming, as long as the time needed for
the setup arrangements before and after the procedure is many times more than the procedure
itself and so it is suggested that a special separate room or appointment on a specific day should
be used, if the same room is to be used after for other examination purposes. In general though,
in a private gynecological practice, application of office hysteroscopy extends the list of the
provisional services and gives the clinician an added value, though even in our days the
technique is not very widespread.
8. Discussion
Office hysteroscopy is the undoubtful gold-standard tool for the investigation of the uterine
cavity. It is a technology-based technique that has greatly evolved during the last decade, and
there is still place for further improvements. Ideas for change come from the gynecologists,
through the everyday practice, and should be addressed to the manufacturing companies in
the field.
For the clinicians who want to apply hysteroscopy in an office-based environment, the training
is much shorter and easier if they had previous training and experience in hysteroscopy under
general anesthesia. This, on the other hand may restrict many clinicians from getting involved
for the first time with diagnostic office hysteroscopy, which is a simple and low-risk technique.
This reluctance may also derive from up-to-date guidelines, which are unclear in specific
details as the type of hysteroscope to choose, provision of local anesthesia or not.
Practically, from the patient’s point of view and against all the benefits that office hysteroscopy
provides, the only fear is the experience of pain and discomfort during the procedure. On the
contrary pain intensity is a subjective evidence described in relative research, thus local
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anesthetic should always be discussed with the patients when consenting and provided
according to the possible length of the procedure.
The use of flexible hysteroscopes result in less painful diagnostic procedures compared to the
rigid one, so for a clinician who will only perform diagnostic hysteroscopy in the office seems
like a better choice, though taking into consideration that the learning curve is longer,
compared to the rigid hysteroscope.
Clinicians in the field of gynecology who are reluctant against the technique should get more
familiar with office hysteroscopy where training is available, courses or any type of medical
literature. Further research will probably clarify some details and assist the clinicians to take
the right decisions for providing the best possible care according to the patients’ needs. We
assume that in the near future almost all diagnostic and minor operative hysteroscopic
procedures will be solely performed in an office-based environment either inside a hospital or
in a private practice.
9. Conclusions
It is evident that office hysteroscopy enables the clinician to perform not only diagnostic but
also minor operative procedures in an office setting with less risk, low cost, and better results.
The near future comprises improvements in the hysteroscopic instrumentation, new energy
supplies, and new systems for controlling intrauterine pressure, which will yield further
benefits for the patients and the clinicians.
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Chapter 17
Endoscopy in Renal Cancer Organ Preservation
Treatments
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Abstract
This chapter traces the shift in treatment of localised renal cancer from major open
surgery to endoscopic (ie laparoscopy) techniques. It also details the shift in treat‐
ment intent for localised Renal cancer toward Organ preservation. With advance‐
ment in technology and experience, the principles of endoscopic surgery have been
adapted to treat renal malignancy with minimum complications and with maximal
preservation of Renal function so much so that endoscopic techniques are seen as
the “gold standard” by many. The chapter details these minimally invasive techni‐
ques of laparoscopic and Robotic partial nephrectomy and compares and contrasts
both Oncological and Functional outcomes from both.
Keywords: Renal Cancer, Prostate cancer, Minimally invasive Surgery, Focal thera‐
py, Partial Nephrectomy
1. Introduction
Urology is rapidly becoming a speciality where operative treatment of disease is primarily
endoscopically administered The two last bastions of open surgical procedures in urology
were reconstruction and radical surgical treatment of malignancy. In uro-oncology and in
intra-abdominal reconstructive procedures such as Pelvi-Ureteric Junction (PUJ) obstruction,
minimally invasive techniques are rapidly becoming the norm and indeed the debate is about
which endoscopic technique results in the best outcomes [1]. From being the standard, open
techniques are now limited to the worst locally advanced malignancies or revision recon‐
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
structive procedures. This review will chart the course of endoscopy in the treatment of
localised RCC and especially in the era where organ preservation techniques have become
paramount.
2. From open to Laparoscopic Radical Nephrectomy (LRN)
Perhaps the area which best illustrates this shift in emphasis in uro-oncology from open
procedures to endoscopy is the treatment of localised Renal Cell Cancer. Robson et al.
demonstrated improved survival established using open Radical Nephrectomy (all tissue
within Gerotas fascia and ipsilateral adrenal and nodal tissue), and the technique became the
gold standard treatment for localised renal cell cancer (T1–T2, see table 1 [2]. For about two
decades, this remained the case, but there were concerns regarding complication rates and
increased patient dissatisfaction, especially with flank incisions. An illustrative example of the
latter is Chatterjee's work from 2004, which showed a 50% dissatisfaction rating vis-à-vis flank
bulging and approximately 25% with ongoing wound pain [3].
In the early 1990's, the first laparoscopic procedures on the kidney were performed [4]. As
experience with the technique grew and with favourable reports, it became the preferred
choice. By mid to late 2000s, laparoscopic nephrectomy was the new gold standard after
numerous studies demonstrated equivalent oncological outcomes in addition to enhanced
patient experience. An example is the case-controlled study of Dunn et al. wherein equivalent
short-term oncological outcomes were demonstrated in a comparative study of open and
laparoscopic nephrectomy.
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However,  laparoscopic nephrectomy was associated with more than a 50% reduction in
blood loss, analgesic requirement, hospital stay and time to return to normal activities [5].
This  low complication rate  (eg  bleeding rate  of  2.8% and transfusion rate  of  0.7%)  was
confirmed by a 2006 meta-analysis. The conversion rate was 2.5% and colonic injury was
1.5% [6].  This difference persists to the present day with Xu et al.  showing a significant
reduction in Claivan grade 2 complications, a 36% reduction in all complications and a 17%
reduction in length of hospital stay [7]. Luo`s study published in 2010 confirmed the long-
term oncological equivalence [8].
Primary lesion
TX Not assessable
T1a 0–4 cm diameter, limited to kidney
T1b 4–7 cm, limited to kidney
T2a 7–10 cm, limited to kidney
T2b > 10 cm, limited to kidney.
T3a Renal vein or segmental branch invasion
Peri-renal / Renal sinus invasion confined to gerotas fascia
T3b Invasion of IVC below diaphragm
T3c Invasion of IVC above diaphragm
Direct IVC wall invasion
T4 Invasion beyond Gerotas fascia




N1 Single node involved




Table 1. TNM staging of Renal Cell Cancer (2009) – EAU Guidelines [9]
3. Organ preservation
As laparoscopic nephrectomy was becoming more widely practiced, two separate trends
conspired against this endoscopic technique. The first was a stage migration of renal masses
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(i.e. presumed cancers) downward, which coincided with an increased incidence secondary
to incidentally imaging (US and CT) detected lesions [10-11]. Allied to this was the increased
identification of benign pathology in nephrectomy specimens performed for these small
masses, which approached 20% in some series.
The second was an increasing realisation that the adverse effect of radical nephrectomy on
renal function may result in reduced survival because of an association with cardiac mortality.
Go et al. published a sentinel paper in the NEJM, which followed 120,295 adults over five years.
Increased mortality, increased risk of vascular and cardiac disease and hospitalisations were
significantly more common in those with chronic renal impairment (e GFR < 60 ml/min/ 1.73
m2) [12]. It was well documented that radical nephrectomy was associated with the develop‐
ment of renal failure. In 2006, Huang et al. demonstrated a reduction in the probability of
developing new renal failure from 65% to 20% by the use of Nephron sparing Surgery (NSS)
[13].
Studies like the above lead to an increasing search for alternatives to RN for T1a (< 4 cm) and
T1b RCC (< 7 cm). NSS was the most extensively researched and in time has become a gold
standard, especially for T1a lesions. It also led to the introduction of ablative technologies such
as cryotherapy, HIFU (High-Intensity Focused Ultrasound) and RFA (Radio Frequency
Ablation).
Partial Nephrectomy (table 2-3)
The aim of partial nephrectomy is the complete removal of the detected lesion with a margin
of normal tissue of as little as 1 mm and as little damage to the remaining renal tissue as
possible. Confirmation of a negative margin often requires frozen section analysis of the
specimen. The initial indications for partial nephrectomy were tumours in a solitary kidney,
multiple/ bilateral tumors or patients with poor renal function (table 3).
T stage Recommendation
T 1a Partial Nephrectomy (PN) is the preferred option
T 1b Radical Nephrectomy (RN) or PN
T2 Radical Nephrectomy
Partial Nephrectomy is associated with greater chance of local failure
Table 2. Accepted indications for PN
Absolute Lesions in a single Kidney
Bilateral synchronous lesions
T1a lesions with low PADUA scores (see page 6)
Relative T1b /T2 lesions with a normal contra-lateral Kidney but significant potential of future renal
failure due to comorbidities
Hereditary RCC
Elective T1/ T2 lesion; other kidney normal, no “reno-toxic” comorbidity
Table 3. EAU guidelines for surgical treatment of localised Renal Cell Cancer (RCC) [9]
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Traditionally, this involved dissection of the renal pedicle and subsequent clamping of the
renal artery (± renal vein). This results in reduced blood loss and a reduced tissue tension,
which makes dissection easier and improves visualisation. The perirenal fat is removed from
the relevant area apart from directly over the lesion. The lesion is excised and the collecting
system repaired. The kidney is then repaired and when done so satisfactorily, the clamp is
removed.
Unfortunately, clamping is associated with ischaemia, which led to techniques to reduce the
effects of ischaemia, and the concept of hypothermia following preconditioning prior to
clamping with mannitol was introduced. The purported effect of mannitol is as promoter of
renal vasodilation, thus promoting blood flow. It also prevents cast formation and decreases
post-ischaemic swelling [14]. Hypothermia aims to get the renal core temperature to 15–200C
and is achieved by cooling with ice slush for 10–15 minutes post clamping. This slows
metabolism down to minimise the effects of ischaemia.
Initially this was thought to be possible only using open techniques, which meant a reduction
in laparoscopic renal cancer procedures, although this tended to be mainly driven by academic
centres. With time, the use of PN spread and Kim et al. using a US nationwide dataset showed
the percentage of small renal masses treated by RN fell from 85% to 75% in the period from
2002 until 2008 [15].
The initial studies confirmed that OPN produces equivalent oncological outcomes compared
to RN. Lau et al. showed equal cancer-specific survivals for both groups and metastatic disease
in less than 5% of both RN and OPN groups in the case-controlled study of 164 patients in each
group [16]. Similarly, Tan et al. showed excellent long-term cancer-specific survival again
comparable to RN. Using the SEER database, they compared outcomes for 1925 PN against
5213 RN and showed similar RCC mortality from both PN (1.9%) and RN (4.3%) [17].
A significant proportion of the early debate in OPN focused on the question of the determinants
of local recurrence and the potential effect on survival. One such risk is a positive surgical
margin and Yossepowitch estimated that to happen in 2–8% of OPN [18]. Thankfully, this does
not appear to have a survival impact, judging by the review of Van Popell and Joniou [19].
They have suggested that a 1 mm clear margin is enough to prevent local recurrence. An
alternative technique practiced by some is lesional enucleation. This would be expected to be
associated with greater local failure, but from the study of Minnervi et al., this would appear
not to be the case [20]. Similarly, good oncological outcomes are achieved where PN is
performed for lesions up to 7 cm [21].
Much of the early work on partial nephrectomy was done by the Cleveland Clinic group,
especially by Novick and Gill. Some of their initial work confirmed the hypothesis that LRN
was associated with significantly worse renal function (as measured by serum creatinine) at
follow up albeit with reduced peri-operative complications in terms of bleeding, analgesia
requirement and hospital stay. However, the two groups were not well matched as the LN
group were significantly older, of greater comorbidity (as judged by ASA score) and had larger
masses [22]. By the time Lesage`s review paper came out in 2007, the gap had narrowed and
the complication rates were not significantly different, although there was a trend towards
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greater complications in the OPN groups. Importantly, the significantly increased risk of renal
failure with RN compared to PN was confirmed [23]. Up to 22% of LRN patients had insuffi‐
ciency at 10 years compared to at most 11.6% of the OPN group [16].
There are three factors, which contribute to renal function loss post any renal surgical inter‐
vention. These are pre-operative renal function (including comorbidity affecting renal
function), the volume of excised/ damaged renal tissue and any intraoperative surgical
ischaemia (be this warm or cold ischaemia). Of these, it is the ischaemia time which is the only
variable open to surgical control. Warm ischaemia time (WIT) is defined as the length of time
the blood supply is cut off or reduced at body temperature. Essentially, this equates to
clamping time. Cold ischaemia time (CIT) is the time between when a tissue is cooled, has its
blood supply reduced or cut off and is then re-warmed to body temperature [24].
It was because of the absolute centrality of clamping (and therefore a resultant ischaemic insult)
to PN that the pendulum swung back to open surgery. This was the case even in centres that
were pioneers in the field of PN and laparoscopic urology. IS Gill in an editorial in December
2012 stated of his time working with Dr. Novick at the Cleveland Clinic that “never did we even
discuss the possibility of doing major PN surgery without clamping the main renal artery” [25].
As experience with PN grew and it became clear that PN was associated with superior
functional and equivalent oncological outcomes, research shifted to focus on what if any was
the limit of WIT and on methods to reduce ischaemic time. It is worth noting the primary tasks,
which have to be completed during this time. These are removal of the lesion with a negative
margin. The second is the repair of any collecting system injury, which may be checked by
intravenous administration of indigo carmine and thirdly, the closure of the kidney using
continuous sutures and adjunct measures. As can be imagined, the more complicated the lesion
(larger, centrally placed or single kidney), the longer each step took, and hence, a greater
potential for ischaemic injury.
The early animal and clinical studies suggested that 20 minutes of WIT and 120 min of CIT
was the safe threshold above which irreversible renal damage was done [26]. This was not
universally accepted and others argued that a WIT of up to 30 minutes was acceptable [27].
An elegant combined functional (MAG 3nuclear scan) and anatomical study (CT) from Japan
would appear to suggest that the ideal time is around 25 minutes. In this study, Funahashi et
al. used functional data from a MAG 3 study to show a net 25% drop in uptake at one week
and more crucially that this drop had not recovered by six months. Importantly, the decreased
uptake was globally seen and not limited to or concentrated on the operated site [28]. Becker
et al. detail an excellent review on the topic of renal ischaemia in partial nephrectomy, which
is worth reading as it details the pathophysiology, etc. Basically, the insult comes from a
reperfusion injury brought on by free radical release, which, in turn, were formed by adenosine
triphosphate breakdown due to vascular endothelial damage. It would also appear that, given
that modern OPN is associated with WIT usually below 30 minutes, that there may be no
benefit from cold ischaemia or indeed from mannitol. Where used, cold ischaemia is delivered
using surface ice slush usually but can also be delivered using a retrogradely placed ureteric
catheter or rarely by direct canulation of the renal artery [27].
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Given  this  benchmark  WIT  of  20–25  minutes,  it  became  crucial  that  techniques  were
developed to minimise WIT. The techniques considered were early unclamping, selective
clamping or in select cases,  control of the artery and vein with manual clamping of the
hilum if necessary. This led to an upsurge in laparoscopic partial nephrectomy as the biggest
fear amongst those offering LPN was to what extent the prolonged WIT of the early LPN
experience had on renal outcomes. In a laparoscopic partial nephrectomy, there are three
key steps. The first is lesion excision followed by accurate closure of the tumour bed and
collecting system using two layers of interrupted sutures and thirdly, closure of the renal
parenchyma. It is the latter that takes most time. Early unclamping is removal of the clamp
once the lesion is excised and any repair required to the collecting system is finished. Any
bleeding from the tumour bed can be controlled with separate sutures at that time. Nguyen
and Gill dropped their WIT from a mean of 31.9 minutes to 13.9 minutes by this simple
measure in a series of 100 consecutive LPN. There were more complications in the early
unclamping group but this did not reach significance [29]. Similarly, a group from Europe
in a cohort of 40 LPN demonstrated an equally impressive reduction in WIT from a mean
of 27.2 minutes (± 5) to 13.7 (± 4), where two continuous sutures were used to close the
tumour bed before unclamping and 10.3 (± 1.2), where one suture was used. In this study,
there  were  no  differences  in  blood loss,  operative  time  or  the  need  for  transfusion  be‐
tween the control and early unclamping groups. Interestingly, the one major urinary leak
happened in the control group and unfortunately required nephrectomy for management.
The two vascular complications were also in the control group [30].
Selective arterial clamping (with laparoscopic bulldogs) appears to be more commonly studied
in the minimally invasive PN series, especially in the robotic partial nephrectomy literature
(RPN). The aim is to clamp the second-, third- or fourth-level branches within the renal sinus
so that the area of ischaemia is limited to the renal mass only if possible or failing this that the
area rendered ischaemic is a small as possible. It requires quite a sophisticated approach, which
starts with 3D rendering of the kidney, its tumour and especially, its blood supply. The cross-
sectional imaging used for this mapping is most commonly CT but can also be MRI. One- to
three-mm slices are taken and processed using software, which provides the 3D reconstruction.
The arterial and venous trees can then be mapped from the main artery and vein right up to
the lesion. The level of the planned clamping is decided at this time and does not change unless
due to unavoidable intraoperative reasons such as unexpected vessels. These images are thus
available for review in theatre or in the case of robotic PN can be displayed on the operator's
viewscreen.
Suitability for RPN/LPN and the extent of possible complications can be predicted using a
variety of nephromotory scoring systems. One of the more commonly used is the Pre-operative
Aspects And Dimensions Used for Anatomical (PADUA) system (table 4). It uses six charac‐
teristics to classify each lesion. These are relationship to the sinus line, location relative to renal
border, relationship to renal sinus, collecting system involvement, the depth of penetration
and the lesion size. The minimal score is 6 and the maximal score is 14. Not only can it be used
to predict complexity (and thus suitability for PN) but it also correlates with complications.
On this basis, lesions can be assigned to one of three groups, Low (6–7), intermediate (8–9) and
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high (>10) risk. Complications are significantly more likely to occur if the score is above 8.
Using a baseline score of 6–7 as a comparator, those with a score of 8–9 had a 14-fold increased
risk of complications and this increased to a 30-fold increased risk for score > 10 [31].
Shao et al. reported their experience of laparoscopic selective clamping in 125 patients over a
two-year period and with 18 months of follow up. Visual clamping of the tumour vessel(s)
was achieved in over 90% of cases, with the remainder requiring main artery clamping. The
number of vessels clamped was totally dependent on tumour characteristics and this in turn
predicted loss of renal function. Clamping of two or more vessels significantly increased the
risk of bleeding and reduction in eGFR. Interestingly, they showed that posterior tumours
were more likely to require 2 or more vessels clamped. This is slightly surprising given their
approach to the kidney is retroperitoneal. Other factors predictive of multiple vessel clamping
were size > 3 cm, endophytic lesions or lesions which were < 50% exophytic and lesions which
involved both surfaces. Multiple vessel clamping in turn increases renal parenchymal tissue
loss and thus renal function [32].
IS Gill is one of the “founding fathers” of PN and has been heavily involved in laparoscopic
and robotic renal surgery. He has detailed his experience of LPN and his progression from full
clamping through early unclamping, through selective clamping and finally to what he calls
“zero ischaemia” [33-34]. This is the ultimate in selective clamping and entails clamping only
the lesional vessel. As mentioned above, the preoperative lesional mapping is extremely
important and this group uses 2–3 mm slices through the kidney and its vasculature. For their
robotic work, the reconstructed images are displayed on the operating surgeons console.
Putting this simply, the operating surgeon has a roadmap in front of them as they operate. Not
only do they isolate the renal artery and its segmental branches but depending on tumour
position, they can dissect third- and fourth-order branches. In addition to the highly detailed
roadmap, the visual magnification from the use of MIS and the extra dexterity in tissue
Anatomical feature Scores 1 Scores 2 Scores 3
Sinus line Entirely polar
Crosses line < 50%
Crosses > 50%
Between sinus lines












Depth of penetration into
kidney
> 50% Exophytic < 50% Exophytic Endophytic
Size of lesion < 4 cm 4–7 cm > 7 cm
Table 4. PADUA score
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manipulation from using robotic instruments, this group uses two other adjunct techniques to
minimise bleeding and clamping. The first was hypotensive anaesthesia. The second is to
quantify the ischaemic area using either laparoscopic colour flow doppler ultrasound or more
recently, intravenous indocyanine green [34-35].
Hypotensive anaesthesia involved controlled pharmacological lowering of systemic blood
pressure. The aim is to avoid vasoconstriction of the arterial tree, thus maintaining perfusion
in the setting of low pressure. Initially, the patient is given a mannitol solution followed by
preloading with crystalloid. The required MAP of 60 mmHg is reached at the time at which
the operator is dissecting the deep part of the lesion. It is achieved using a nitroglycerine
infusion and isoflurane inhalation with heart rate support from a short-acting beta blocker. On
removal of the lesion, the pressure is reversed. The advantage is that blood loss is minimised
by reduced pressure while maintaining tissue oxygenation and thus preventing an ischaemic
cascade. The disadvantage is that hypotension may trigger other end-organ failure and result
in significant comorbidity. In their later experience, this group no longer used this technique.
This is due to a combination of concern regarding the possibility of ischaemic complications
such as myocardial infarction or cerebrovascular accidents and improved lesional vascular
dissection helped in part by the adjunct technique described below [34-35].
Gill's group now uses indocyanine green as an adjunct to confirm devascularisation. This is
used in conjunction with near-infrared fluorescence, which shows a black and white image
with perfused areas being bright green. This group place the lesional vascular bulldog clamp.
They then intravenously inject 7.5 mg of indocyanine green, switch to near infrared and
confirm uptake by visualisation of the renal artery by its being outlined in green following
which they visualise the lesion. If it is dark, then super-selective dissection has been successful;
if not, they either search for an accessory vessel or convert the procedure to a standard clamped
PN [35].
In their pilot study of 34 patients, some 80% underwent zero-ischaemia RPN. Most of the
failures were due to persistent fluorescence, indicating accessory vessels. When paired with a
cohort of “standard” clamped RPNs, the only differences were a longer operating time and
better renal function in the zero-ischaemia group. None of the patients studied had a positive
margin [35].
A very interesting by-product of the use of indocyanine green as a marker of devascularisation
is that it appears to be poorly absorbed by RCC. Of 10 tumours, seven RCC appears were hypo-
perfused, suggesting that this marker may have a further part to play in PN.
The previous ten paragraphs have described some of the techniques and strategies used by
those at the cutting edge of partial nephrectomy to marry the enhanced patient experience of
MIS with the improved functional outcomes from partial nephrectomy. These trail blazers
describe a trifecta for minimally invasive PN of negative surgical margins, minimal loss of
renal function and no urological complications. The question to be asked is can similar results
be delivered by others.
The more widespread uptake of LPN started when the trail blazing units started to publish
their experience. Initially, the lesions treated were the Anterior, polar and exophytic lesions,
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which scored a 6–7 using a PADUA system [31]. As experience was gained, units started doing
more complicated lesions, while at the same time, experienced open surgeons with some
laparoscopy skills began using robotic techniques. To this end, it can be difficult to compare
OPN to LPN/ RPN as the number of centres publishing outcome data from LPN/RPN is very
small. Amongst others to do such a comparative review was Van Poppel in a publication in
2010 [36]. This review looked at the published data at that time and as such was mainly, but
not exclusively, from trail blazing units. The review has multiple tables which, for illustrative
purposes, we have, somewhat crudely, condensed into two. The first (Table 5) attempts to
summarise the oncological comparison. As would be expected, the mean follow-up is shorter
and the mean lesion size is smaller for the LPN group. That said, the immediate (positive
margins, local recurrence) oncological measure would appear to be equivalent. The inter‐
mediate performance comparator (% 5 year CSS – Cancer Specific Survival) would also suggest
LPN provides an equivalent outcome.
OPN LPN
# Patients per quoted study 51–75 34–430
Mean size lesion (cm) 2.5–5.5 2.9–3.6
% Positive surgical margin 0– 5 0–2.9
% local recurrence 0–5.9 0–2.4
% 5 year CSS 89–98 91–100
% 10 year CSS 76–97
Mean FU (months) 35–120 15–68
Table 5. Comparison of oncological outcomes of OPN (open partial nephrectomy) and LPN (laparoscopic partial
nephrectomy) – modified from Van Poppel [36]
In partial nephrectomy, preservation of renal function and lack of urological complications are
equally as important as excellent oncological outcomes. The second of the two tables (Table
6) summarises these outcomes from that Van Poppel publication. Some explanation of the table
layout is required. The quoted studies had varying number of patients and hence the wide
bands of reported complications. In an attempt to put each complication into context, the
cumulative columns were constructed. Thus it can be seen that the operative and functional
complications of LPN are equivalent to OPN [36].
One of the concerns expressed about the widespread expansion of LPN/RPN was that WIT
times would increase as less experienced surgeons would prioritise tumour excision and renal
repair. The accepted optimal WIT has been established at 20-30 minutes [26-28]. However it
would appear from the “zero-ischaemia” work quoted above that each minute of WIT
increases tissue loss [34-35]. One of the criticisms of MIS is the length of time it takes to become
proficiently skilled in the procedure, the so-called learning curve. This is a controversial topic.
One definition quoted is the number of cases to achieve a WIT of < 20 minutes. For robotic PN,
Mottrie et al. put this at as little as 30–40 cases and based it on a single surgeon experience
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where the mean time for WIT in a group of 10 patients was less than 20 minutes. The caveat
to this is that this group had significant robotic experience. However, the editorial comment
accompanying their paper appeared incredulous that such a number could be quoted. The
author of this editorial had > 400 LPNs under his belt. In LPN, the same debate seems to be
taking place [37].
IS Gill suggests that it took him about 550 cases to become what he deemed to be proficient [33].
This is from one of the leading laparoscopic and robotic protagonists of PN. On the other hand,
Springer et al. in their paper comparing OPN and LPN state that the fact that the two main
surgeons had performed over 90 OPN and LPN each helped overcome the learning curve [38].
Their paper is worth summarising, representing as it does the experience of an early adapter
of LPN where previously OPN was the procedure of choice. This group compared 140
consecutive LPNs (May 2005–November 2010) to a historic control group of 140 OPN (May
1999–April 2005). Overall, the oncological results, both in terms of positive margins (1.2 %
LPN, 1.7 % OPN) and five-year CSS (91% LPN, 88% OPN), were identical and identical to the
review by Van Poppel, which is tabulated above [36]. In addition, the functional outcomes
were identical with approximately 5% of each group having post-operative complications.
Hence, it would appear that the excellent results from LPN performed at centres of excellence
are transferrable to the wider urological community.
This may be a moot point because of the rapid expansion in centres offering RAPN. Primarily,
this is because robotics offers several significant advantages over “traditional” LPN. These are
improved magnification, greater surgeon ergonomic comfort, instruments such as the
endoWrist, which give greater degrees of movement facilitating easier dissection and suturing
[35-37]. One of the latest meta-analyses on series comparing LPN and RPN is from Zhang et
al. They identified seven valuable studies from an initial find of 569 studies on the topic.
Unsurprisingly, there was no difference in tumour characteristics nor indeed in any discussed
parameter apart from WIT. This was significantly shorter in the RAPN groups. While this is
not a new finding, it is not universally found. It does appear to reaffirm the fears about LPN
being associated with prolonged WIT. Looking at the tables in a little more detail, it becomes
apparent that the series with larger numbers tended to have identical and more acceptable
OPN LPN
Range Cumulative Range Cumulative
# Patients per quoted
study
59–1029 2756 49–507 1679
% Overall
complications
4.1–38.6 587 (21%) 9–33 337 (20%)
% Haemorrhage 0–7.5 88 (3%) 1.5 - 9.5 82 (5%)
% Urine leak 0.7–17.4 109 (4%) 1.4–10.6 57 (3%)
% sepsis 0 - 2.7 13 (0.4%) 0–2.5 11 (0.7%)
% Renal Failure 0–12.7 38 (1.4%) 0–2 12 (0.7%)
Table 6. Comparison of complications of OPN and LPN again modified from Van Poppel [36]
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WIT for both RAPN and LPN. If 21 minutes is used as a marker for an acceptable WIT limit,
four of the LPN and two of the RAPN trials are well above that limit. This is not discussed in
the review but it may represent a learning curve effect or may reflect surgeons switching to
the technically less demanding robotic approach [39]. Some evidence, albeit circumstantial, for
the latter point is that having access to robotic technology increases the uptake of PN [40].
As can be seen from the preceding tables, it can be difficult to compare the MIS techniques for
PN. In an effect to standardise reporting of outcomes, the MIC system was proposed and some
groups have reanalysed their data accordingly. The MIC system is based on the trifecta
discussed earlier. That is, negative surgical margins, WIT < 20 minutes and no significant
complications. MIC is present when all three factors are present. Acceptability in terms of a
study is where the global MIC score is > 80%. In their study, Porpiglia et al. showed increasing
MIC with increasing experience and that acceptability was achieved after approximately 150
cases of LPN, i.e. the learning curve is 150 cases. The other factor negatively affecting MIC was
increasing complexity of cases [41].
The future of endoscopically delivered NSS is secure and judging by recent publications
describing MIS PN for increasingly more complex lesions, the focus will shift to which
technique will become most practised. The debate is no longer about whether OPN is superior,
it is now how about which of the endoscopic techniques will best achieve MIC.
4. Renal ablative therapies
Whilst most groups focused on organ preservation through PN other looked at the role of
ablative technologies. The European Association of Urology guidelines suggest ablative
RPN LPN
Ranges Cumulative Ranges Cumulative
Numbers in quoted
studies
11–220 425 14–102 341
Mean operating time in
mins
152.17–233 176.2 117.5–226.5 194.35
Mean WIT mins 14.1–35.3 19.83 17.2–36.4 41.9
Mean blood loss mls 122.4–286.4 239.51 146.3–387.5 232.31








Positive margins N = 0–18 N= 22
5.58%










LOS days 2.51–6.1 4.98 2.7–6.8 4.48
Table 7. Comparison of complications and immediate oncological outcomes of RAPN (Robotic assisted) and LPN
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WIT for both RAPN and LPN. If 21 minutes is used as a marker for an acceptable WIT limit,
four of the LPN and two of the RAPN trials are well above that limit. This is not discussed in
the review but it may represent a learning curve effect or may reflect surgeons switching to
the technically less demanding robotic approach [39]. Some evidence, albeit circumstantial, for
the latter point is that having access to robotic technology increases the uptake of PN [40].
As can be seen from the preceding tables, it can be difficult to compare the MIS techniques for
PN. In an effect to standardise reporting of outcomes, the MIC system was proposed and some
groups have reanalysed their data accordingly. The MIC system is based on the trifecta
discussed earlier. That is, negative surgical margins, WIT < 20 minutes and no significant
complications. MIC is present when all three factors are present. Acceptability in terms of a
study is where the global MIC score is > 80%. In their study, Porpiglia et al. showed increasing
MIC with increasing experience and that acceptability was achieved after approximately 150
cases of LPN, i.e. the learning curve is 150 cases. The other factor negatively affecting MIC was
increasing complexity of cases [41].
The future of endoscopically delivered NSS is secure and judging by recent publications
describing MIS PN for increasingly more complex lesions, the focus will shift to which
technique will become most practised. The debate is no longer about whether OPN is superior,
it is now how about which of the endoscopic techniques will best achieve MIC.
4. Renal ablative therapies
Whilst most groups focused on organ preservation through PN other looked at the role of
ablative technologies. The European Association of Urology guidelines suggest ablative
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therapies can be used for High risk patients who are keen to have definitive treatment. Two
ablative techniques have entered main stream clinical practice and these are radiofrequency
ablation (RFA) which uses heat energy and Cryotherapy (CA) which uses cold energy applied
in a heat–thaw cycle to produce cell death. Tissue destruction happens when sufficient energy
is applied at a rate equal to the rate thermal energy is removed (i.e. Heat sink). These techniques
can be performed under general anaesthesia or sedation and in either an operating theatre
(using ultrasound as the image guidance technique) or interventional radiology suite (using
CT or MRI). Both require intensive imaging-based follow-up schedules as post-ablative biopsy
histology is not very accurate. Failure (persistent contrast enhancement or growth on serial
scans) or success (no contrast enhancement, lesion shrinkage) is based on cross-sectional
imaging findings [42].
4.1. Cryotherapy Ablation (CA)
Cryotherapy has primarily been delivered laparoscopically. The principle is to deliver
sufficient energy using freeze–thaw cycles to cause apoptosis and cell damage by mechanical
and vascular means. The initial freeze cycle (using Argon gas) causes ice formation within the
extracellular spaces. This acts as an osmotic agent and attracts fluid from the intracellular space.
Freezing also causes mechanical cell damage. Thawing (using Helium gas) restores blood flow
but damaged cells are released into the vasculature and result in thrombosis. The ideal freeze
time appears to be 10 minutes for RCC based on basic science and clinical studies. The ideal
tissue temperature is approximately -400C. The margin of the iceball should be approx. 0.5 cm
beyond the rim of the lesion [42].
Most of the studies on CA for localised RCC have involved a large proportion of small lesions
< 3 cm and have at best short- to medium-term follow-up. The majority have performed
laparoscopically. The initial oncological results seem encouraging with reported 3- and 5-year
CSS equivalent to that of PN AT 98–100% and 92%, respectively. The downside is that there is
a significant local failure rate of 10–20%. Aron et al. have 5-year follow-up on a group of 80
patients. Their 5-year CSS is 92% but the local recurrence rate is 14%. The definition of
recurrence post CA is radiological because of the difficulty interpreting post CFA biopsy
specimens. Exophytic, small (<3 cm) lesions along the lateral rim of the kidney are those with
the best outcomes [43].
While CA appears to be an effective therapy, there are very few head-to-head trials comparing
it to PN. One such trial was conducted by Tanagho et al., who compared CA to RAPN. This
trial used the Clavien classification of complications, which standardises definitions and
allows for more accurate reporting. Many criticisms of LCA trials had discussed complication
reporting in addition to a more favourable lesional profile. They compared 267 patients treated
by CA to 233 RAPN and the groups were matched for all matched characteristics. The
immediate complication rate was equal (CA 8.6% vs. RAPN 9.4%). The renal preservation was
significantly better for CA, but this was at the cost of a 12.7% local recurrence rate at approx.
40 months versus 0% for RAPN at a mean fu of approximately 22 months. That said, they
conclude that CA is an excellent therapy [44].
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4.2. Radio Frequency Ablation (RFA)
This is predominantly delivered percutaneously. A probe is advanced under screening into
the lesion and heating begun using a high-frequency alternating current. This induces
molecular oscillation, which leads to friction and cell death by coagulative necrosis. The
temperature at the centre of the lesion lies between 50 and 120 °C depending on the interplay
between device and patient factors. Device factors include the probe composition, its surface
area, length and duration of use. Patient factors include the position of the lesion vis-à-vis the
hilum (i.e. collecting system and major vessels), which can affect the heat sink principle as
proximity to a major vessel results in greater heat dissipation, which in turn leads to less
thermal injury to the lesion unless more energy is delivered. Depending on the tissue temper‐
ature, the destruction can be instantaneous or result in the triggering of an inflammatory
cascade [42].
A recent report on 200 RFA in 165 patients is one of the largest to date and is unusual in that
most of the treatments were performed under general anaesthesia. This may explain the
technical success rate of 98.5% in a group of lesions of mean size 2.9 cm (range 1–5.6). For
central lesions, they used cold pyeloperfusion to cool the upper ureter and collecting system
via a retrogradely placed ureteric catheter. They also describe hydrodissection to move bowel
within 1 cm of an exophytic lesion. This is achieved by the instillation of dextrose solution (i.e.
nonconductive).
In terms of oncological outcomes, this group achieved a 97.9% CSS with exophytic and tumours
< 3 cm doing best. Nine required retreatment and of those, six were tumour free after a further
1–2 treatments. From a functional outcome, Only 2% of their cohort had long-term renal
function loss [45].
5. Conclusion
Open Radical Nephrectomy has gone from being the only therapy available to treat localised
RCC to a therapy which is now rarely practised. Indeed, partial nephrectomy seems to be
competing with ablative therapies for localised disease. This chapter has attempted to trace
that change albeit trying to simplify the often crossing timelines between the various inter‐
ventions. The place of endoscopy in organ preservation in localised RCC is however secure.
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Abstract
The use of endoscopy is critical to the management of pediatric tracheobronchial and
esophageal foreign bodies. Children may present with nonspecific symptoms, and the
diagnosis can be difficult when the ingestion or aspiration events go unwitnessed.
Advances in endoscopic techniques and the use of optical graspers in the removal of
foreign bodies in children have helped decrease morbidity and mortality. In this
chapter, the history, clinical presentations, workup, and management for pediatric
aerodigestive foreign bodies are discussed.
Keywords: foreign body, pediatric airway, esophagus, endoscopic, aspiration, in‐
gestion
1. Introduction
The history of endoscopic management of pediatric foreign bodies was predated by significant
innovations allowing for the evolution of adult and pediatric bronchoesophagology. Prior to
these advances, tracheotomy was the accepted method for successful removal of airway
foreign bodies [1]. In 1806, Philipp Bozzini, reported using the "lichtleiter" or "light conductor"
to visualize the upper esophagus using candle illumination [2]. While his instruments and
methods did not gain wide acceptance during his lifetime, they set the stage for further
innovations that occurred over the ensuing decades. Desormeaux, a urologist, is credited with
coining the term "endoscopy" in 1867 [3] and is considered by most to be the "Father of
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Endoscopy" [4]. Kussmaul is credited with performing the first direct esophagoscopy, and his
student Killian further explored these techniques and instrumentation. Mikulicz further
refined the techniques and instrumentation of esophagoscopy, bringing it into more common
use [5].
In 1895, Alfred Kirstein, a laryngologist in Berlin who was familiar with the work of Kussmaul
and Mikulicz, was the first to directly visualize the larynx and trachea [6]. Killian became
interested in Kirstein's achievements and began to practice laryngoscopy on cadavers and
tracheotomized patients. In 1897, he was the first to remove a foreign body from the right
mainstem bronchus of an adult via the translaryngeal route. His contributions and achieve‐
ments have prompted many to consider him the "Father of Bronchoscopy" [7]. Following these
innovations, tracheoscopy and bronchoscopy became accepted surgical techniques.
Chevalier Jackson became interested in laryngology while studying medicine in Pennsylvania
and eventually furthered his studies in London. After learning the techniques of his mentors
and as an instrument maker, he created an esophagoscope allowing for direct visualization of
the esophagus. With this design, he was successful in removing esophageal foreign bodies
from both adults and children. Jackson further refined his technique and the instruments he
used, eventually developing the largest endoscopy clinic in the world [5]. Through the
innovations of Jackson and his predecessors, the techniques for removal of esophageal and
airway foreign bodies was perfected, reducing the mortality from foreign body ingestion or
aspiration from more than 50% to less than 2% [5].
2. Endoscopic equipment
Modern endoscopic equipment is available in various sizes and configurations to accommo‐
date patient age and size, and the use of flexible vs. rigid endoscopic equipment are both
available (Figure 1). There are some clear advantages to the use of rigid bronchoscopy for
removal of a tracheobronchial foreign body. The scope is designed to have ventilating ports
so the anesthesia circuit can be directly attached for active ventilation and control of the airway
during the procedure.
Flexible bronchoscopy can be done with insufflation techniques in the oropharynx or through
the scope, but the channel on the scope is small, thus limiting flow of gas. Alternatively, the
flexible scope can be passed through a secured endotracheal tube (Figure 2). If the foreign body
cannot fit through the endotracheal tube, then this creates a problem for removal with the tube
in place. The foreign body forceps have more limited sizes with flexible bronchoscopy, and
there is also less control of the scope itself since it can bend to various configurations. Certainly
in our experience, flexible bronchoscopy can be a useful adjunct to removal of foreign bodies,
as it can give more distal visualization of the lower airways for small food particles, like nuts,
that may fall further than the rigid scopes can reach. Such smaller, distal airways can be
irrigated with saline and additional attempts using flexible or rigid bronchoscopy can then be
utilized to remove these small fragments using endoscopic optical graspers or suction.
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Figure 2. Flexible bronchoscopy cart setup.
Figure 1. A) Various non-optical and optical graspers used for removal of foreign bodies from the aerodigestive tract.
B) Rigid, ventilating bronchoscopes of various sizes. Selection depends on the age of the patient and size of the airway.
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For esophagoscopy, the use of the rigid scope allows for use of the same endoscopic optical
graspers used in airway cases. While many esophageal foreign bodies are safely removed with
flexible endoscopy, the rigid scope does not require insufflation of the esophagus with air and
using rigid equipment, more direct visualization of the insertion through the upper esophageal
sphincter can be made. There are fewer options for types of graspers available for the flexible
esophagoscope. In our opinion, the endoscopic optical graspers themselves used through the
rigid scope allow for enhanced visualization and easier foreign body removal (Figure 3).
Figure 3. An example of an endoscopic, optical coin grasper, with a fine tooth at the tip, which allows the coin to pivot
or swivel through the path of least resistance through the esophagus during removal.
3. Relevant airway anatomy
The upper aerodigestive tract extends from the lips and nasal vestibule to the upper esophagus
and trachea and mainstem bronchi. It can be divided into anatomic subsites, including the
nasal cavity, nasopharynx, oropharynx, hypopharynx, larynx, trachea, bronchi, and esopha‐
gus.
With regard to the nasal cavity, foreign bodies typically get lodged between the inferior
turbinate and the septum. As the nasal cavity is part of the airway, care must be taken during
removal attempts in the office setting to avoid converting this upper airway foreign body into
a lower airway foreign body.
Several differences between the adult and pediatric airway exist that the endoscopist should
consider when evaluating and treating patients with aerodigestive foreign bodies. First, the
infantile larynx is positioned much higher in the neck. Additionally, the neonatal larynx is
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approximately one-third the size of the adult larynx, with the narrowest portion being at the
level of the cricoid cartilage and not at the level of the glottis, as in adults [8]. A small reduction
in the size of the pediatric airway can have significant and devastating consequences. The size
of the airway must be kept in mind when choosing the appropriate size of the bronchoscope.
As a general rule, the largest size ventilating scope that can be placed based on age of the child
and size of subglottis, allows for optimal ventilation, visualization, and endoscopic removal.
Figure 4. A 13-month old presented to the emergency room with wheezing and coughing. The child had reportedly
put something into its mouth earlier that day. An A-P plain film showed hyperinflation of the left lung with right-
sided mediastinal shift. There was no radiopaque foreign body noted on the plain film. Direct laryngoscopy with rigid
bronchoscopy revealed a left mainstem foreign body, consistent with half of a wooden bead that was removed with an
endoscopic optical forceps.
The presence of a foreign body within the tracheobronchial tree can lead to a ball-valve effect,
resulting in early hyperinflation of the lung ipsilateral to the foreign body (Figure 4). Over
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time, the obstructed lung segment becomes atelectatic. In addition to its physical obstruction,
the presence of a foreign body disrupts the normal mucociliary clearance of the tracheobron‐
chial tree. These factors can contribute to the rapid accumulation of secretions and subsequent
superimposed pneumonia [9].
The right  mainstem bronchus creates  a  more  obtuse  angle  with  the  trachea when com‐
pared to the left mainstem bronchus, leading to a higher incidence of right-sided airway
foreign bodies [10].
4. Relevant esophageal anatomy
There are several anatomic considerations that can lead to arrested passage of an esophageal
foreign body through the digestive tract and into the stomach. These sites include the upper
esophageal sphincter or cricopharyngeus, the mid-esophagus where the aortic arch crosses,
and the lower esophageal sphincter. Additionally, there are a few pathologic conditions that
can predispose pediatric patients to dysphasia and esophageal foreign bodies, including
vascular rings and slings.
5. Pediatric airway foreign bodies
5.1. Epidemiology
Airway foreign bodies represent an important cause of pediatric morbidity and mortality both
in developed and developing countries. According to the US CDC's Morbidity and Mortality
Weekly Report, nonfatal choking-related episodes among children less than 14 years old were
responsible for approximately 17, 000 emergency room visits in the year 2001 alone, with an
estimated rate of 29.9 episodes per 100, 000 children. The incidence was greatest in patients
less than 1 year old (140.4 per 100, 000) and steadily declined with increasing age. Seventy-
seven percent of patients presenting with chocking-related symptoms were three years old or
younger. In their data, there was a higher incidence in males (55.1%) and a higher incidence
of food-related substances when compared to nonfoods (59.5% vs. 31.4%, 9% unknown) [11].
The most commonly aspirated foreign bodies include round, hard foods such as nuts, seeds,
beans, corn, and berries [12].
In Tan et al.'s 10-year retrospective review of children treated for airway foreign bodies via
bronchoscopy, they reported a male preponderance (63.7%) in a series of 135 cases. Three
quarters of their patients were under 3 years of age [13]. Both of these trends mirror that of
other published series [14–16]. Tan proposed that the higher incidence of foreign body
aspiration in younger children was due to their poor oro-motor control and their lack of
dentition, in addition to their propensity to explore the world with their mouths.
Prior to the advent of modern endoscopic techniques, the reported mortality from aspirated
foreign bodies was as high as 50% or greater [5]. Following the advent of endoscopic techniques
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and increased public awareness, the mortality rate of patients with foreign bodies is approxi‐
mately 1% [17]. The total number of foreign body--related deaths in the United States is
estimated to be between 500 and 2000 [13].
The nasal cavity is the most common sub-site for foreign bodies when considering the entire
upper aerodigestive tract, accounting for approximately two-thirds of all foreign bodies. In
Chinski’s study of aerodigestive tract foreign bodies in Argentina, 1559 nasal foreign bodies
were reported. The most common objects found in the nose in decreasing order were pearls,
stationery, food, seeds/nuts/beans, pins/nails/metal, other inorganic materials and stones,
followed by other less common items, including 1 button battery and 11 magnets [18]. The
majority of nasal foreign bodies occur on the patient's right side, with this trend increasing
with the patient’s age [19]. Interestingly, some studies have demonstrated a decreased
incidence of nasal foreign bodies during the summer months [20]. Others have commented on
the increased incidence of nasal foreign bodies during the months of January, March, April,
and October, coinciding with the months near Christmas, Easter, and Halloween when
children are exposed to more toys and treats [19].
5.2. Clinical evaluation
5.2.1. Nasal foreign bodies
Many nasal foreign bodies are asymptomatic, presenting only because their placement was
witnessed or admitted (Figure 5). Unwitnessed or untreated nasal foreign bodies may present
with a variety of symptoms, including unilateral purulent rhinorrhea or nasal obstruction,
halitosis, epistaxis, sinusitis, or a combination of these symptoms [19, 21]. A nasal septal
hematoma should be differentiated from a nasal foreign body (Figure 6). In a European study
assessing complications and hospitalizations due to nasal foreign bodies, Gregori et al.
demonstrated that battery nasal foreign bodies were more likely to experience complications
and require hospitalizations when compared to many other types of nasal foreign bodies [21].
As with other studies regarding aerodigestive foreign bodies, they reported a fairly high
incidence of children placing nasal foreign bodies while under adult supervision (38%).
5.2.2. Laryngeal and tracheobronchial foreign bodies
Foreign bodies of the laryngotracheobronchial tree can present with varying degrees of airway
symptoms depending on their location, shape, size relative to airway, and chronicity.
Larnygeal Foreign Bodies
Foreign bodies of the larynx, while infrequent,  are associated with the most devastating
outcomes. In addition to more common symptoms associated with foreign bodies of the
trachea and bronchi,  these patients are more likely to present with hoarseness,  aphonia,
drooling,  stridor,  and  drooling.  Complete  obstruction  can  cause  cyanosis,  respiratory
distress, and respiratory arrest followed by death. Persistent irritation can lead to signifi‐
cant laryngeal edema that can persist and cause significant symptoms even after foreign
body removal [10, 22].




Patients with tracheal foreign bodies may present with biphasic stridor, a dry cough with an
associated "sharp crack" or "slap" when a moving foreign body impacts the subglottis. Patients
Figure 5. Right nasal foreign body, a piece of broken glass, placed by a 5-year old boy. This was removed in the operat‐
ing room, instead of clinic setting, due to sharp edges and risk of bleeding following removal.
Figure 6. Right nasal septal hematoma after nasal trauma could be mistaken for a foreign object; the mucoperichondral
flap is fluctuant to palpation with a cotton tip applicator. Surgical drainage is the required treatment to prevent abscess
formation and cartilage necrosis.
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may place themselves in the "tripod" position, leaning forward with elbows or hands on their
knees. There may also be a dramatic shift in symptoms when the patient changes positions,
owing to the mobility of the foreign body [22].
Bronchial Foreign Bodies
In Tan et al.'s series, the most common presenting symptoms of tracheobronchial foreign
bodies were "choking, coughing, gagging" with 91.8% of patients presenting in this manner.
This  was  followed  by  "wheezing"  in  84.4%  of  patients  and  finally  the  classic  triad  of
"coughing, wheezing, and reduced breath sounds" in only 57% of patients. Less common
symptoms reported in their  series  included fever,  pneumonia,  stridor,  chest  pain,  blood
stained  mucous,  restlessness,  throat  discomfort,  sternal  discomfort,  increased  seizure
episodes, and nose bleed [13].
5.3. Radiographic evaluation
A thorough history and physical  exam are paramount in the evaluation of  a child with
suspected foreign body and can frequently lead to a diagnosis without the need for further
diagnostic workup or imaging. Traditionally, plain film radiography has been advocated
for patients with suspected foreign body aspiration. A-P and lateral plain films may reveal
a radiopaque foreign body within the tracheobronchial tree.  Additionally,  sequelae from
the presence of the foreign body may be recognized, including air-trapping with associat‐
ed mediastinal shift,  atelectasis,  or pneumonia from long-standing foreign body. Decubi‐
tus films may demonstrate lack of dependent mediastinal shift on the side ipsilateral to the
foreign body [23].
The use of plain film radiography does not need to be routinely employed in patients where
there is a high index of suspicion for foreign body based on history and physical examination.
In a 6-year retrospective review of 93 cases of possible airway foreign body cases, Silva et al.
reported a imaging study sensitivity and specificity of 74% and 45%, respectively [24]. In a
series of 232 patients with pre-operative radiography in whom foreign bodies confirmed via
bronchoscopy, 110 had plain film imaging that was considered normal by the surgeon (47%).
For patients with radiology reports, 42% of patients with bronchial foreign bodies and 81% of
patients with tracheal foreign bodies had negative imaging reports. The same study did note
that patients with long-standing foreign bodies are more likely to have positive findings on
plain film radiography when compared to patients with foreign bodies that have been present
for less than 24 h [25]. In their retrospective reviews, neither Assefa nor Brown found sufficient
evidence to support the routine use of decubitus films in the identification of airway foreign
bodies, citing the lack of sensitivity [23, 26].
Some studies have reported on the diagnostic utility of CT imaging and CT virtual broncho‐
scopy, with reported sensitivities and specificities ranging from 90% to100% [27, 28]. Foreign
bodies that are radiolucent on plain films may be identified on CT. The risks of ionizing
radiation and the inability to concurrently diagnose and treat foreign body aspiration should
be recognized when considering these modalities.
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Despite negative imaging studies, if the history is concerning for possible aspiration, then
endoscopic evaluation should still be considered given the potential morbidity and mortality
of airway foreign bodies.
5.4. Airway foreign body removal
Nasal foreign bodies can frequently be managed in the clinic if the object is in the anterior nasal
cavity. After removal, confirmation using nasal endoscopy can ensure that no additional
retained foreign body is present. Objects that are difficult to grasp or that are posterior within
the nasal cavity may require sedation or a general anesthetic removal. If the object is round,
using a right angle probe behind it and pulling anterior is safest, to avoid propelling the object
into the pharynx or causing it to be aspirated into the lower tracheobronchial tree. Other upper
airway foreign bodies require direct laryngoscopy and removal with endoscopic visualization
of the pharynx and larynx (Figure 7). These are considered an emergency as they can poten‐
tially lead to lower airway obstruction if the object is aspirated. When done in the operating
room, the endoscopist must be prepared for emergent bronchoscopy, should the object fall
distally during induction of anesthesia. Thorough discussion with the anesthesia team on the
plan prior to induction must take place. All potential non-optical and optical graspers should
be available to quickly use as needed. In addition, instrumentation for emergent tracheostomy
placement should be immediately available should the need arise. Figures 8-14 demonstrate
a variety of cases where endoscopic management was performed.
5.4.1. Anesthetic considerations
The choice of anesthetic technique should be based on a discussion between the surgeon and
anesthesiologist. Pediatric airway and esophageal foreign body removal is performed under
general anesthesia. Anesthetic induction can be achieved either by inhalation of volatile
anesthetic gas or intravenous medications. Anesthesia can then be maintained with sponta‐
neous ventilation or paralysis with control of the airway. This choice is surgeon and anes‐
thesiologist dependent, but should be agreed upon prior to the start of the procedure.
Especially in the case of tracheobronchial foreign bodies, constant and deliberate communi‐
cation regarding the airway should be maintained between the surgical and anesthesia teams.
This situation represents a true “shared airway”[29, 30].
An age-appropriate size bronchoscope and one size smaller should always be set up for
tracheobronchial foreign bodies. A back-up fiberoptic light source is helpful in case one fails
during the procedure. Given that the rigid bronchoscope itself is a means of ventilation,
strategic use of the instrument during the procedure is important. For example, if the oxygen
saturations drop, the telescope can be removed and this increases the ventilating diameter,
and therefore the volume of airflow through the bronchoscope tube with occlusion of the
proximal end with a cap. The mouth and nose can be manually sealed around the scope to
create some “positive pressure” as needed. Optical graspers of various shapes can be easily
passed through the bronchoscope while maintaining ventilation, and foreign bodies can be
removed under direct endoscopic visualization. The surgeon must ensure all equipment is
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functional, available, and all desired instruments fit through the bronchoscope size selected
prior to the patient’s anesthetic induction.
Tracheostomy is rarely required; however, equipment should be immediately available for
obtaining an emergent surgical airway in the management of airway foreign bodies. This is
always discussed with the parents during the informed consent process.
5.4.2. Adjunctive procedures
In the rare case where the foreign body cannot be removed endoscopically, additional
interventions may be required. As a temporizing measure, the use of extracorporeal membrane
oxygenation (ECMO) may allow oxygenation in a case of inability to ventilate [31]. This is a
highly specialized technique that is not available in all centers. It allows oxygenation of the
blood and maintenance of circulation until a definitive plan for removal can be facilitated.
Figure 7. An 11-month old with an open safety pin in the upper airway. The patient presented with irritability and
drooling of several hours duration, and the mother felt the child might have put something into its mouth. A-P and
lateral plain films confirmed the diagnosis.
In cases where the foreign body cannot be removed endoscopically, open approaches may be
required [32]. Cervical esophagostomy for proximal esophageal foreign bodies, or thoracoto‐
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my with bronchotomy, may be required for tracheobronchial foreign bodies. In these rare
cases, close collaboration with pediatric thoracic surgeons or pediatric surgeons is required.
Figure 8. A 9-year-old patient presenting with cough and stridor with concurrent fever. Direct laryngoscopy with rigid
bronchoscopy revealed bacterial tracheitis. Tracheal casts can cause airway symptoms similar to aspirated foreign bod‐
ies.
Figure 9. A 12-month old presented to the Emergency Department with increased work of breathing and stridor after
reportedly having swallowed a piece of a pen. Plain film imaging was unrevealing. Given the clinical presentation, the
patient underwent direct laryngoscopy with rigid bronchoscopy, revealing a plastic foreign body in the right main‐
stem bronchus.
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Figure 10. A 12-month old presenting with respiratory symptoms and concern for foreign body aspiration. Direct lar‐
yngoscopy with rigid bronchoscopy confirms a high-powered magnet sphere within the right mainstem bronchus. An‐
other was trapped in the esophagus directly behind this. This has the potential to cause a tracheoesophageal fistula
given magnetic strength and tissue necrosis between the two magnets. Severe injuries are more common in the lower
gastrointestinal tract causing perforation when more than one of these is swallowed (this child had additional magnet‐
ic spheres in the small bowel which caused transmural necrosis and perforation requiring repair).
Figure 11. While having a tooth extracted at a dentist office, this child accidently aspirated the tooth, found in the right
mainstem bronchus.
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Figure 12. Plastic bronchitis in a patient with congenital heart disease, showing a cast in the left bronchial tree.
Figure 13. A 2-year-old boy was given peanuts by an older sibling, choked, was in severe respiratory distress, found to
have several fragments in the lower airways. These were removed with optical graspers through the rigid broncho‐
scope.
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Figure 14. A 2-year-old patient presented to the Emergency Department with multiple facial lacerations following a
motor vehicle accident during which she was ejected through the passenger side window. She had no respiratory
symptoms as presentation. As part of her trauma workup, she underwent both plain film and CT imaging of the chest,
both showed a possible left-sided airway foreign body. Direct laryngoscopy with bronchoscopy confirmed the diagno‐
sis, and the object was endoscopically removed without difficulty.
6. Pediatric Esophageal Foreign Bodies
6.1. Epidemiology
Foreign body ingestion is a relatively common occurrence, with an estimated 100, 000 cases
per year in the United States alone. Like airway foreign bodies, the majority of cases occur in
children aged between 6 months and 3 years [33]. For the majority of esophageal foreign bodies,
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a child’s caregiver either witnesses or suspects that their child has ingested a foreign body [34].
While the majority of ingested foreign bodies will pass on their own, there is still a real risk of
significant morbidity and mortality. Of all patients with esophageal foreign bodies seeking
medical attention, 80%–90% pass the foreign body without any intervention, 10%--20% require
endoscopic removal, and only 1% require surgical removal [33]. It has been estimated that 1,
500 deaths occur annually in the United States alone due to foreign body ingestion [35].
Recently, there has been a sharp rise in the use of button-battery powered hand-held electronic
equipment. This has coincided with a rise in the incidence of button battery--related emergency
department visits [36].
6.2. Clinical presentation
As with airway foreign bodies, a thorough history and physical exam are critical in the workup
of the pediatric patient with a suspected esophageal foreign body. As previously stated,
frequently, a caregiver has witnessed the ingestion and can positively identify the object, which
may have implications regarding urgent intervention, such as in the case of an ingested button
battery or magnet.
Many esophageal foreign body ingestions go unwitnessed and a large proportion of these pass
without incident or development of symptoms [37]. When children do have symptoms, they
tend to be nonspecific and can lead to a missed or delayed diagnosis. In a retrospective review
by Arana et al. of 325 pediatric patients presenting with esophageal foreign bodies, only 54%
of patients had transient symptoms at the time of ingestion [38]. When patients are sympto‐
matic, they primarily present with nonspecific gastrointestinal or pulmonary complaints,
including coughing, choking, gagging, drooling, odynophagia, and/or dysphagia. Patients
may also present with stridor or wheezing due to inflammation of adjacent tracheobronchial
mucosa.
In their retrospective study of 248 cases of patients undergoing esophagogastroduodenoscopy
(EGD) for foreign body removal, Denney et al. assessed the incidence of esophageal injury as
it related to presenting symptoms. In their series, 59 children (30%) were found to have mucosal
ulceration. They found that a presenting complaint of substernal pain correlated with mucosal
ulceration, whereas symptoms of vomiting, respiratory distress, and drooling did not. The vast
majority of foreign bodies in their series were coins (81%) and 8 cases of batteries were reported.
They did not comment on any injuries from batteries [34].
6.3. Radiographic evaluation
The patient’s clinical presentation should be corroborated with imaging to ensure that a foreign
body requiring urgent removal is not misdiagnosed [35]. Imaging for esophageal foreign body
workup should typically include the chest and abdomen in both AP and lateral planes (Figure
15). It should be noted, however, that about 1/3 of foreign bodies are radiolucent [38].
Jatana et al. reported on the utility of plain film radiography in distinguishing esophageal coins
from button batteries [39]. They described the "double ring" or "halo" sign created by a button
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battery or magnet.
Many esophageal foreign body ingestions go unwitnessed and a large proportion of these pass
without incident or development of symptoms [37]. When children do have symptoms, they
tend to be nonspecific and can lead to a missed or delayed diagnosis. In a retrospective review
by Arana et al. of 325 pediatric patients presenting with esophageal foreign bodies, only 54%
of patients had transient symptoms at the time of ingestion [38]. When patients are sympto‐
matic, they primarily present with nonspecific gastrointestinal or pulmonary complaints,
including coughing, choking, gagging, drooling, odynophagia, and/or dysphagia. Patients
may also present with stridor or wheezing due to inflammation of adjacent tracheobronchial
mucosa.
In their retrospective study of 248 cases of patients undergoing esophagogastroduodenoscopy
(EGD) for foreign body removal, Denney et al. assessed the incidence of esophageal injury as
it related to presenting symptoms. In their series, 59 children (30%) were found to have mucosal
ulceration. They found that a presenting complaint of substernal pain correlated with mucosal
ulceration, whereas symptoms of vomiting, respiratory distress, and drooling did not. The vast
majority of foreign bodies in their series were coins (81%) and 8 cases of batteries were reported.
They did not comment on any injuries from batteries [34].
6.3. Radiographic evaluation
The patient’s clinical presentation should be corroborated with imaging to ensure that a foreign
body requiring urgent removal is not misdiagnosed [35]. Imaging for esophageal foreign body
workup should typically include the chest and abdomen in both AP and lateral planes (Figure
15). It should be noted, however, that about 1/3 of foreign bodies are radiolucent [38].
Jatana et al. reported on the utility of plain film radiography in distinguishing esophageal coins
from button batteries [39]. They described the "double ring" or "halo" sign created by a button
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battery on an A-P plain film (Figure 16). The 20mm 3 volt lithium batteries consistently
demonstrate this finding. They also demonstrated the "step-off" that can be seen on lateral
plain films of button batteries, though they caution that some new thinner button batteries will
not demonstrate this finding. Clinicians must not rely on lateral x-rays alone.
Many experts argue against the use of contrast studies for diagnosing esophageal foreign
bodies given the increased risk of aspiration with a foreign body obstructing the esophagus.
The presence of contrast could compromise the ability of the endoscopist to find the foreign
body during retrieval and may also limit mucosal assessment [41]. In addition, the contrast
Figure 15. A 5-year old presented to the Emergency Department with several episodes of emesis. She admitted to swal‐
lowing a penny while at day care earlier that day. A-P and lateral plain films confirmed the diagnosis of an esophageal
foreign body. A penny was identified and removed via rigid esophagoscopy. Minimal esophageal mucosal irritation
was noted.
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typically pushes back general anesthesia 8 h, and delays operative intervention. Esophagram
does have a role in assessing for esophageal perforation or stricture due to foreign bodies, but
generally only after operative removal of the foreign body.
Figure 16. A) Button battery in upper esophagus. B) Coin in upper esophagus. By zooming into the foreign body, the
“double ring or halo sign” can be clearly seen for the battery. Zooming into the image is most helpful for differentia‐
tion. Reproduced with permission, Jatana [40].
Figure 17. Esophageal injury secondary to a button battery in a 4-year old. The injury involves the muscular layer of
the esophagus. Reproduced with permission, Jatana [40].
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Several authors have described the utility of hand-held metal detectors in the management of
patients with suspected coin ingestion. Younger et al. performed a 2-year prospective study
of patients presenting for evaluation of esophageal foreign bodies. With a hand-held metal
detector, they were able to positively identify the presence and location of esophageal coins in
all 26 patients who had positive plain films [42]. Lee et al. performed a systematic review of
11 studies and found that the sensitivity and specificity of identifying the presence of coins
was 99.4% and 100%, respectively, when compared to plain films. They do note however, that
non-coin metal objects were not detected as frequently as coins in one study reviewed. The
authors point out the benefit of avoiding ionizing radiation when using a hand-held metal
detector [43].
Repeat imaging has a role in the management of esophageal foreign bodies that are managed
expectantly. An x-ray can ensure that an esophageal foreign body has passed into the stomach.
In addition, should the object not be found in the stools over time, repeat abdominal x-ray can
confirm that there is no retained opaque foreign body in the lower gastrointestinal tract.
6.4. Esophageal foreign body removal
Management of esophageal foreign bodies varies considerably based on several factors,
including anatomic location, type of foreign body, patient presenting symptoms, and existing
complications. A button battery lodged in the esophagus is an emergency. The current
generated around the battery causes hydroxide ion to form at the negative pole, causing rapid
injury. Serious injury can occur in only 2 h. The 20 mm diameter, 3 volt lithium batteries cause
the most severe injury as they combine high power, with large enough size to get stuck; these
are frequently used in many household electronics [39]. A common misconception is that the
leaking battery acid is the major source of mucosal injury, rather than the generated electrical
current. In addition, “dead” batteries, meaning those that no longer have enough charge to
power their intended electronics, can still have enough residual electrical current to cause
mucosal injury (Figure 17).
Coins lodged in the esophagus can be managed with an initial period of observation, and if
they fail to pass into the stomach, can be removed endoscopically.
Rigid esophagoscopy allows for the scope to be placed under constant direct visualization for
removal of the foreign body using endoscopic optical graspers that are most suited for the
object. In general, a second-look esophagoscopy can not only confirm the absence of any
additional non-opaque foreign bodies, but also assess any injury to the esophageal wall. If a
perforation is suspected, keeping the patient with nothing by mouth and obtaining an
esophagram is best. When probable perforation or known severe circumferential injury exists,
consideration of placing a nasogastric tube under direct visualization through the rigid scope
can serve as temporary means of nutrition and keep the region stented open to avoid complete
stricture. It should also be kept in mind that when severe injury exists, advancing the esoph‐
agoscope past the site of injury can potentially lead to greater injury.
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7. Complications of pediatric airway foreign bodies
The most feared acute complication of airway foreign bodies is complete airway obstruction
with cardiopulmonary arrest and death. Wheezing is very common after the procedure and
close monitoring in the hospital setting is required until symptoms have stabilized. Pneumonia
is common due to lower airway obstruction and should be appropriately treated with
antibiotics. Intraoperative cultures can be taken to help guide treatment. Given that injury can
occur to the tracheobronchial tree, pneumomediastinum and pneumothorax can occur. When
the airway is severely inflamed, bleeding and granulation tissue can limit visualization, and
the decision to do a planned second-look bronchoscopy must be made to ensure no retained
foreign body is present. Laryngeal injury when removing an airway foreign body can occur.
8. Complications of pediatric esophageal foreign bodies
Children who develop a fever after removal of any esophageal foreign body should be assessed
for an esophageal perforation by esophagram. Other potential complications include: bleeding
or major arterial fistula, mediastinitis, mediastinal abscess, respiratory distress (secondary
tracheomalacia/compression), tracheoesophageal fistula, vocal cord paresis/paralysis, esoph‐
ageal stricture, and death. Repeat endoscopy to follow healing of significant esophageal injury
is an alternative to follow-up esophagram, and has the advantage of allowing for debridement
or dilation of early stricture formation.
9. Conclusions
The management of pediatric airway and esophageal foreign bodies carries the potential for
morbidity and mortality, and can be challenging to diagnose if an unwitnessed aspiration or
ingestion occurs in a young child. The symptoms can be somewhat nonspecific, not easily
differentiated from common viral illnesses in children. Clinical decision making based on
thorough history and physical examination is critical. Centers with airway surgeons and
endoscopists trained in foreign body management, and with pediatric ICU care are best
equipped to manage the most complex cases in the children.
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